Fidelity National Financial (FNF) 10-K 28 Feb 25 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2024	Jan. 31, 2025	Jun. 28, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2024
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	1-32630
Entity Registrant Name	FIDELITY NATIONAL FINANCIAL, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-1725106
Entity Address, Address Line One	601 Riverside Avenue
Entity Address, City or Town	Jacksonville
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32204
City Area Code	904
Local Phone Number	854-8100
Title of 12(b) Security	FNF Common Stock, $0.0001 par value
Trading Symbol	FNF
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 12,817,158,134
Entity Common Stock, Shares Outstanding		274,989,699
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Entity Central Index Key	0001331875

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	Jacksonville, Florida

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Investments:
Fixed maturity securities available for sale, at fair value, as of December 31, 2024 and 2023, at an amortized cost of $51,681 and $45,606, respectively, net of allowance for credit losses of $67 and $42, respectively, and includes pledged fixed maturity securities of $495 and $489, respectively, related to secured trust deposits	$ 48,218	$ 42,373
Derivative investments	794	797
Mortgage loans, net of allowance for credit losses of $70 and $66 as of December 31, 2024 and 2023, respectively	5,926	5,336
Investments in unconsolidated affiliates	3,731	3,334
Other long-term investments	811	703
Short-term investments	3,050	2,119
Total investments	63,615	56,049
Cash and cash equivalents, as of December 31, 2024 and 2023 includes $69 and $262, respectively, of pledged cash related to secured trust deposits	3,479	2,767
Trade and notes receivables, net of allowance of $32 as of December 31, 2024 and 2023, respectively	471	442
Reinsurance recoverable, net of allowance for credit losses of $20 and $21 at December 31, 2024 and 2023, respectively	13,380	8,977
Goodwill	5,271	4,830
Prepaid expenses and other assets	2,047	1,900
Market risk benefits assets	189	88
Lease assets	351	348
Other intangible assets, net	5,976	4,627
Title plants	420	418
Property and equipment, net	173	168
Total assets	95,372	80,614
Liabilities:
Contractholder funds	56,404	48,798
Future policy benefits	8,749	7,050
Accounts payable and accrued liabilities	3,249	3,009
Market risk benefits liability	549	403
Notes payable	4,321	3,887
Reserve for title claim losses	1,713	1,770
Funds withheld for reinsurance liabilities	10,867	7,083
Secured trust deposits	551	731
Lease liabilities	385	394
Income taxes payable	52	0
Deferred tax liability	0	29
Total liabilities	86,840	73,154
Equity:
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2024 and 2023, respectively; outstanding of 275 and 273 as of December 31, 2024 and 2023, respectively, and issued of 331 and 329 as of December 31, 2024 and 2023, respectively	0	0
Preferred stock, $0.0001 par value; authorized 50 shares; issued and outstanding, none	0	0
Additional paid-in capital	5,976	5,913
Retained earnings	5,982	5,244
Accumulated other comprehensive earnings	(2,052)	(2,119)
Less: Treasury stock, 56 shares as of December 31, 2024 and 2023, at cost	(2,152)	(2,130)
Total Fidelity National Financial, Inc. shareholders’ equity	7,754	6,908
Non-controlling interests	778	552
Total equity	8,532	7,460
Total liabilities and equity	95,372	80,614
Preferred securities
Investments:
Securities, at fair value	443	621
Equity securities
Investments:
Securities, at fair value	$ 642	$ 766

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Available-for-sale securities, amortized cost, net	$ 51,681	$ 45,606
Available for sale securities, allowance for credit losses	67	42
Available-for-sale securities, pledged securities, secured trust deposits	495	489
Mortgage loans, allowance for credit loss	70	66
Cash, pledged, secured trust deposits	69	262
Allowance for doubtful accounts, premiums and other receivables	32	32
Expected credit losses on reinsurance recoverable	$ 20	$ 21
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	275,000,000	273,000,000
Common stock, shares issued (in shares)	331,000,000	329,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	56,000,000	56,000,000

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Direct title insurance premiums	$ 2,200	$ 1,982	$ 2,858
Agency title insurance premiums	2,953	2,610	3,976
Escrow, title-related and other fees	5,321	4,717	4,333
Interest and investment income	3,124	2,607	1,891
Recognized gains and losses, net	83	(164)	(1,493)
Total revenues	13,681	11,752	11,565
Expenses:
Personnel costs	3,148	2,908	3,192
Agent commissions	2,287	2,008	3,064
Other operating expenses	1,558	1,521	1,721
Benefits and other changes in policy reserves	3,791	3,553	1,126
Market risk benefit (gains) losses	(25)	95	(182)
Depreciation and amortization	739	593	491
Provision for title claim losses	232	207	308
Interest expense	209	174	115
Total expenses	11,939	11,059	9,835
Earnings before income taxes and equity in earnings of unconsolidated affiliates	1,742	693	1,730
Income tax expense	367	192	439
Earnings before equity in earnings of unconsolidated affiliates	1,375	501	1,291
Equity in earnings of unconsolidated affiliates	16	17	15
Net earnings	1,391	518	1,306
Less: Net earnings attributable to non-controlling interests	121	1	12
Net earnings attributable to Fidelity National Financial, Inc. common shareholders	$ 1,270	$ 517	$ 1,294
Earnings per share
Net earnings per share attributable to FNF common shareholders, basic (in usd per share)	$ 4.69	$ 1.91	$ 4.71
Net earnings per share attributable to FNF common shareholders, diluted (in usd per share)	$ 4.65	$ 1.91	$ 4.67
Weighted average shares outstanding FNF common stock, basic basis (in shares)	271	270	275
Weighted average shares outstanding FNF common stock, diluted basis (in shares)	273	271	277

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net earnings		$ 1,391	$ 518	$ 1,306
Other comprehensive earnings:
Unrealized (loss) gain on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)	[1]	(157)	961	(4,783)
Unrealized gain on investments in unconsolidated affiliates	[2]	32	12	9
Unrealized (loss) gain on foreign currency translation	[3]	(22)	6	(18)
Reclassification adjustments for unrealized gains and losses included in net earnings	[4]	(8)	126	173
Changes in current discount rate - future policy benefits	[5]	224	(189)	764
Changes in instrument-specific credit risk - market risk benefits	[6]	5	(34)	67
Other comprehensive (loss) earnings attributable to non-controlling interest	[7]	(7)	(134)	35
Minimum pension liability adjustment	[8]	0	3	5
Other comprehensive earnings (loss)		67	751	(3,748)
Comprehensive earnings (loss)		1,458	1,269	(2,442)
Less: Comprehensive earnings attributable to non-controlling interests		121	1	12
Comprehensive earnings (loss) attributable to Fidelity National Financial, Inc. common shareholders		$ 1,337	$ 1,268	$ (2,454)
[1] Net of income tax (benefit) expense of $(43) million, $238 million, and $(1,246) million for the years ended December 31, 2024, 2023, and 2022, respectively. Net of income tax expense of $9 million, $3 million, and $3 million for the years ended December 31, 2024, 2023, and 2022, respectively. Net of income tax (benefit) expense of $(6) million and $2 million, and $(4) million for the years ended December 31, 2024 and 2023, and 2022, respectively. Net of income tax (benefit) expense of $(1) million, $34 million and $45 million for the years ended December 31, 2024, 2023 and 2022, respectively. Net of income tax expense (benefit) of $1 million, $(9) million and $18 million for the years ended December 31, 2024, 2023 and 2022, respectively. Net of income tax (benefit) expense of $(3) million, $(35) million and $9 million for the years ended December 31, 2024, and 2023, and 2022, respectively. Net of income tax expense of $2 million for the year ended December 31, 2022.

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023		Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Unrealized (loss) gain on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates), tax expense (benefit)	[1]	$ (43)	$ 238		$ (1,246)
Unrealized gain on investments in unconsolidated affiliates, tax expense	[2]	9	3		3
Unrealized (loss) gain (benefit) expense		(6)	2	[3]	(4)
Reclassification adjustments for change in unrealized gains and losses included in net earnings, tax (benefit) expense		(1)	34		45
Changes in current discount rate - future policy benefits , tax expense (benefit)	[4]	59	(50)		203
Changes in instrument-specific credit risk - market risk benefits, tax expense (benefit)	[5]	1	(9)		18
Other comprehensive (loss) earnings attributable to non-controlling interest, tax (benefit) expense		$ (3)	$ (35)		9
Minimum pension liability adjustment, tax expense					$ 2
[1] Net of income tax (benefit) expense of $(43) million, $238 million, and $(1,246) million for the years ended December 31, 2024, 2023, and 2022, respectively. Net of income tax expense of $9 million, $3 million, and $3 million for the years ended December 31, 2024, 2023, and 2022, respectively. Net of income tax (benefit) expense of $(6) million and $2 million, and $(4) million for the years ended December 31, 2024 and 2023, and 2022, respectively. Net of income tax expense (benefit) of $1 million, $(9) million and $18 million for the years ended December 31, 2024, 2023 and 2022, respectively.

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total		F&G	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital F&G	Retained Earnings	Accumulated Other Comprehensive Earnings (Loss)	Treasury Stock	Non-controlling Interests	Non-controlling Interests F&G
Beginning balance (in shares) at Dec. 31, 2021				325,000,000
Beginning balance at Dec. 31, 2021	$ 10,004			$ 0	$ 5,810		$ 4,818	$ 878	$ (1,545)	$ 43
Beginning balance, Treasury stock (in shares) at Dec. 31, 2021									42,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				2,000,000
Exercise of stock options	39				39
Non-controlling interest associated with current period acquisition	46									46
Treasury stock repurchased (in shares)									13,000,000
Treasury stock repurchased	(549)								$ (549)
Issuance of restricted stock (in shares)				1,000,000
Purchase of incremental share in consolidated subsidiaries / F&G purchases of treasury stock	(14)				(3)					(11)
Other comprehensive earnings - unrealized (loss) gain on investments and other financial instruments	(4,783)							(4,783)
Other comprehensive earnings — unrealized gain on investments in unconsolidated affiliates	9	[1]						9
Other comprehensive earnings - unrealized (loss) gain on foreign currency translation	(18)	[2]						(18)
Other comprehensive earnings - minimum pension liability adjustment	5							5
Reclassification adjustments for unrealized gains and losses included in net earnings	173	[3]						173
Other comprehensive earnings attributable to non-controlling interest	(9)							35		(35)
Stock-based compensation	49				48					1
Dividends declared	(490)						(490)
Shares withheld for taxes and in treasury	(15)								(15)
Change in current discount rate — liability for future policy benefits	764	[4]						764
Changes in instrument-specific credit risk - market risk benefits	67	[5]						67
Distribution of 15% of the common stock of F&G					(24)		(397)			421
Subsidiary dividends declared to non-controlling interests	(24)									(24)
Net earnings	1,306						1,294			12
Ending balance (in shares) at Dec. 31, 2022				328,000,000
Ending balance at Dec. 31, 2022	6,569			$ 0	5,870		5,225	(2,870)	$ (2,109)	453
Ending balance, Treasury stock (in shares) at Dec. 31, 2022									55,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				0
Exercise of stock options	15				15
Treasury stock repurchased	(4)								$ (4)
Issuance of restricted stock (in shares)				1,000,000
Purchase of incremental share in consolidated subsidiaries / F&G purchases of treasury stock	(19)		$ (19)		(11)	$ (1)				(8)	$ (18)
Other comprehensive earnings - unrealized (loss) gain on investments and other financial instruments	961							961
Other comprehensive earnings — unrealized gain on investments in unconsolidated affiliates	12	[1]						12
Other comprehensive earnings - unrealized (loss) gain on foreign currency translation	6	[2]						6
Other comprehensive earnings - minimum pension liability adjustment	3							3
Reclassification adjustments for unrealized gains and losses included in net earnings	126	[3]						126
Other comprehensive earnings attributable to non-controlling interest	35				(2)			(134)		136
Stock-based compensation	59				55					4
Dilution from share issuance by consolidated subsidiary					(13)					13
Dividends declared	(498)						(498)
Shares withheld for taxes and in treasury (in shares)									(1,000,000)
Shares withheld for taxes and in treasury	(17)								$ (17)
Change in current discount rate — liability for future policy benefits	(189)	[4]						(189)
Changes in instrument-specific credit risk - market risk benefits	(34)	[5]						(34)
Subsidiary dividends declared to non-controlling interests	(29)									(29)
Net earnings	518						517			1
Ending balance (in shares) at Dec. 31, 2023				329,000,000
Ending balance at Dec. 31, 2023	$ 7,460			$ 0	5,913		5,244	(2,119)	$ (2,130)	552
Ending balance, Treasury stock (in shares) at Dec. 31, 2023	56,000,000								56,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				1,000,000
Exercise of stock options	$ 21				21
Non-controlling interest associated with current period acquisition	139									139
Issuance of restricted stock (in shares)				1,000,000
Purchase of incremental share in consolidated subsidiaries / F&G purchases of treasury stock	(21)				(13)					(8)
Other comprehensive earnings - unrealized (loss) gain on investments and other financial instruments	(157)							(157)
Other comprehensive earnings — unrealized gain on investments in unconsolidated affiliates	32	[1]						32
Other comprehensive earnings - unrealized (loss) gain on foreign currency translation	(22)	[2]						(22)
Reclassification adjustments for unrealized gains and losses included in net earnings	(8)	[3]						(8)
Other comprehensive earnings attributable to non-controlling interest	3				(1)			(7)		8
Stock-based compensation	82				80					2
Dilution from share issuance by consolidated subsidiary					(24)					$ 24
Dividends declared	(532)						(532)
Shares withheld for taxes and in treasury (in shares)										(12,000,000)
Shares withheld for taxes and in treasury	(34)								$ (22)
Change in current discount rate — liability for future policy benefits	224	[4]						224
Changes in instrument-specific credit risk - market risk benefits	5	[5]						5
Subsidiary dividends declared to non-controlling interests	(48)									$ (48)
Net earnings	1,391						1,270			121
Ending balance (in shares) at Dec. 31, 2024				331,000,000
Ending balance at Dec. 31, 2024	$ 8,532			$ 0	$ 5,976		$ 5,982	$ (2,052)	$ (2,152)	$ 778
Ending balance, Treasury stock (in shares) at Dec. 31, 2024	56,000,000								56,000,000
[1] Net of income tax expense of $9 million, $3 million, and $3 million for the years ended December 31, 2024, 2023, and 2022, respectively. Net of income tax (benefit) expense of $(6) million and $2 million, and $(4) million for the years ended December 31, 2024 and 2023, and 2022, respectively. Net of income tax (benefit) expense of $(1) million, $34 million and $45 million for the years ended December 31, 2024, 2023 and 2022, respectively. Net of income tax expense (benefit) of $1 million, $(9) million and $18 million for the years ended December 31, 2024, 2023 and 2022, respectively.

CONSOLIDATED STATEMENTS OF EQ_2

CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividend to shareholders, pro rata percentage of common stock	15%	15%

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash Flows From Operating Activities:
Net earnings	$ 1,391	$ 518	$ 1,306
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	739	593	491
Equity in earnings of unconsolidated affiliates	(16)	(17)	(15)
(Gain) loss on sales of investments and other assets and asset impairments, net	(339)	542	533
Interest credited/index credits to contractholder account balances	1,327	1,409	(560)
Change in market risk benefits, net	(25)	95	(182)
Deferred policy acquisition costs and deferred sales inducements	(1,419)	(1,084)	(814)
Charges assessed to contractholders for mortality and administration	(291)	(255)	(221)
Non-cash lease costs	132	136	142
Operating lease payments	(147)	(153)	(154)
Distributions from unconsolidated affiliates, return on investment	127	122	151
Stock-based compensation cost	82	60	49
Change in NAV of limited partnerships, net	(350)	(220)	(109)
Change in valuation of derivatives, equity and preferred securities, net	189	(388)	947
Change in derivative collateral liability, net	91	410	(398)
Changes in assets and liabilities, net of effects from acquisitions:
Change in reinsurance recoverable	(13)	78	276
Change in future policy benefits	1,853	1,325	1,071
Change in funds withheld from reinsurers	3,795	3,386	2,056
Net (increase) decrease in trade receivables	(43)	37	178
Net decrease in reserve for title claim losses	(57)	(40)	(73)
Net change in income taxes	83	(50)	66
Net change in other assets and other liabilities	(294)	(26)	(385)
Net cash provided by (used in) operating activities	6,815	6,478	4,355
Cash Flows From Investing Activities:
Proceeds from calls and maturities of investment securities	12,274	5,875	6,340
Fundings of notes receivable	(21)	(19)	(99)
Additions to property and equipment and capitalized software	(146)	(132)	(138)
Purchases of investment securities	(17,825)	(13,985)	(13,148)
Net (purchases of) proceeds from sales and maturities of short-term investment securities	(1,076)	340	(2,571)
Other acquisitions/disposals of businesses, net of cash acquired/disposed	(586)	(299)	(180)
Additional investments in unconsolidated affiliates	(1,131)	(1,296)	(1,077)
Distributions from unconsolidated affiliates, return of investment	621	423	335
Net other investing activities	28	3	14
Net cash used in investing activities	(7,862)	(9,090)	(10,524)
Cash Flows From Financing Activities:
Borrowings	18	6	550
Debt offering	1,050	845	0
F&G Credit Agreement repayments, net	(365)	(185)	0
Debt costs/equity issuance additions	(20)	(16)	(4)
Debt service payments	(250)	0	(400)
Dividends paid	(532)	(500)	(489)
Subsidiary dividends paid to non-controlling interest shareholders	(49)	(32)	(20)
Exercise of stock options	21	15	39
Net change in secured trust deposits	(179)	(132)	(72)
Purchase of additional share in consolidated subsidiaries	(21)	(19)	(15)
Payment of contingent consideration for prior period acquisitions	(17)	(10)	(6)
Payment for shares withheld for taxes and in treasury	(34)	(17)	(15)
Contractholder account deposits	10,147	7,787	8,530
Contractholder account withdrawals	(8,010)	(4,625)	(3,450)
F&G repurchases of F&G stock	0	(18)	0
Purchases of treasury stock	0	(6)	(553)
Net cash provided by financing activities	1,759	3,093	4,095
Net increase (decrease) in cash and cash equivalents	712	481	(2,074)
Cash and cash equivalents at beginning of period	2,767	2,286	4,360
Cash and cash equivalents at end of period	$ 3,479	$ 2,767	$ 2,286

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies The following describes the business and significant accounting policies of Fidelity National Financial, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "FNF"), which have been followed in preparing the accompanying Consolidated Financial Statement s. Description of the Business We are a leading provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty products, (ii) technology and transaction services to the real estate and mortgage industries and (iii) annuity and life insurance products. FNF is one of the nation’s largest title insurance companies operating through its title insurance underwriters - Fidelity National Title Insurance Company ("FNTIC"), Chicago Title Insurance Company ("Chicago Title"), Commonwealth Land Title Insurance Company ("Commonwealth Title"), Alamo Title Insurance and National Title Insurance of New York Inc. - which collectively issue more title insurance policies than any other title company in the United States. Through our subsidiary, ServiceLink Holdings, LLC ("ServiceLink"), we provide mortgage transaction services, including title-related services and facilitation of production and management of mortgage loans. We are also a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through our majority owned subsidiary, F&G Annuities & Life ("F&G"). For information about our reporting segment refe r to Note J Seg ment Information . Recent Developments Redemption of 5.50% F&G Senior Notes On February 1, 2025, F&G redeemed the outstanding $300 million aggregate principal amount of its 5.50% Senior Notes due May 1, 2025 (the "5.50% F&G Senior Notes"). The notes were redeemed for a redemption price equal to 100% of the principal amount of the notes plus accrued and unpaid interest to, but excluding, the redemption date. On and after the redemption date, interest will cease to accrue on the notes. 7.30% F&G Junior Notes On January 13, 2025, F&G completed its public offering of its 7.30% Junior Subordinated Notes due 2065 with an aggregate principal amount of $375 million (the "7.30% F&G Notes"). F&G used a portion of the net proceeds of this offering to redeem the outstanding $300 million aggregate principal amount of its 5.50% F&G Senior Notes. F&G intends to use the remaining net proceeds of this offering for general corporate purposes. The 7.30% F&G Notes were registered under the Securities Act of 1933 (as amended) (the “Securities Act”). 6.25% F&G Senior Notes On October 4, 2024, F&G completed its public offering of its 6.25% Senior Notes due 2034 with an aggregate principal amount of $500 million (the "6.25% F&G Notes"). The 6.25% F&G Notes are guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreements. A portion of the net proceeds were used to pay off the outstanding balance of $365 million on the Company’s revolving credit facility. The 6.25% F&G Notes were registered under the Securities Act. Acquisition of PALH On July 18, 2024, F&G acquired a 100% ownership stake in the equity of PALH, LLC ("PALH"). PALH markets and sells life insurance and annuity products of various insurance carriers to individuals through a network of agents. Prior to the acquisition date, PALH owned a 70% ownership stake in an operating company of which F&G owned 30% equity. Total consideration of approximately $314 million is comprised of cash of $215 million, settlement of a prepaid asset of $8 million, acquisition date fair value of the previously held interests of $92 million, net of $1 million cash acquired. 6.50% F&G Senior Notes On June 4, 2024, F&G completed its public offering of $550 million aggregate principal amount of its 6.50% Senior Notes due 2029 (the "6.50% F&G Notes"). The 6.50% F&G Notes are guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. A portion of the net proceeds were used to finance a cash tender offer by its wholly owned subsidiary Fidelity & Guaranty Life Holdings, Inc. ("FGLH") for an aggregate principal amount of $250 million of FGLH’s 5.50% Senior Notes due 2025 (the "5.50%" F&G Notes). The 6.50% F&G Notes were registered under the Securities Act. For more information related to the F&G Notes refer to Note G Notes Payable . Amendment to our Revolving Credit Facility On February 16, 2024, we entered into a Sixth Amended and Restated Credit Agreement for our $800 million revolving credit facility (the "Amended Revolving Credit Facility") with Bank of America, N.A., as administrative agent and other agents party thereto (the "Sixth Restated Credit Agreement"). For further information related to the Amended Revolving Credit Facility and the Sixth Restated Credit Agreement refer to Note G Notes Payable . Amendment to the F&G Credit Agreement On February 16, 2024, we entered into a Second Amended and Restated F&G Credit Agreement of our $665 million credit agreement, with the guarantors party thereto, the financial institutions party thereto as lenders, and Bank of America, N.A., as administrative agent, swing line lender and an issuing bank (the "Second Amended and Restated F&G Credit Agreement"). For more information related to the Second Amended and Restated F&G Credit Agreement refer to Note G Notes Payable . Investment of $250 million in F&G On January 12, 2024, we completed a $250 million preferred stock investment in F&G. F&G will use the net proceeds from the investment to support growth of its assets under management. Under the terms of the agreement, we invested $250 million in exchange for 5 million shares of F&G's 6.875% Series A Mandatory Convertible Preferred Stock, par value $0.001 per share (the "Mandatory Convertible Preferred Stock"). Each share of Mandatory Convertible Preferred Stock has a liquidation preference of $50.00 per share. Unless earlier converted at the option of the holder, each outstanding share of the Mandatory Convertible Preferred Stock will automatically convert into shares of common stock of F&G on January 15, 2027 (the "Mandatory Conversion Date"). Upon conversion on the Mandatory Conversion Date, the conversion rate for each share of the Mandatory Convertible Preferred Stock will be no more than 1.1111 shares of common stock and no less than 0.9456 shares of common stock per share of Mandatory Convertible Preferred Stock, depending on the value of F&G's common stock. Acquisition of ROAR On January 2, 2024, F&G acquired a 70% majority ownership stake in the equity of Roar Joint Venture, LLC ("Roar") resulting in the consolidation of Roar in F&G's financial statements. Roar wholesales life insurance and annuity products to banks and broker dealers through a network of agents. Total initial consideration is comprised of cash of approximately $269 million and $48 million of contingent consideration. Under the terms of the purchase agreement, the Company has agreed to make cash payments of up to approximately $90 million over a three year period upon the achievement by Roar of certain earnings before interest, taxes, depreciation and amortization ("EBITDA") milestones. For more information regarding the Roar and PALH acquisitions, refer to Note B Acquisitions . Principles of Consolidation and Basis of Presentation The Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and include our accounts as well as our wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany profits, transactions and balances have been eliminated. Non-controlling interests recorded on the Consolidated Statements of Earnings represent the portion of a majority-owned subsidiary's net earnings or loss that is owned by non-controlling shareholders of the subsidiary. Non-controlling interests recorded on the Consolidated Balance Sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling shareholders. We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. We assess our relationships with VIEs to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our Consolidated Financial Statements. See Note E Investments for additional information on our investments in VIEs. I nvestments Fixed Maturity Securities Available-for-Sale Fixed maturity securities are purchased to support our investment strategies, which are developed based on factors including rate of return, maturity, credit risk, duration, tax considerations and regulatory requirements. Our investments in fixed maturity securities have been designated as available-for-sale ("AFS") and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Fair values for fixed maturity securities are principally a function of current market conditions and are primarily valued based on quoted prices in markets that are not active or model inputs that are observable or unobservable. We recognize investment income on fixed maturities based on the effective interest method, which results in the recognition of a constant rate of return on the investment equal to the prevailing rate at the time of purchase or at the time of subsequent adjustments of book value. In our title segment, realized gains and losses on sales of our fixed maturity securities are determined on the basis of the cost of the specific investments sold and are credited or charged to income on a trade date basis. Our F&G segment uses first-in first-out cost basis and generally records security transactions on a trade date basis except for private placements, which are recorded on a settlement date basis. Realized gains and losses on sales of fixed maturity securities are reported within Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. Fixed maturity securities AFS are subject to an allowance for credit loss and changes in the allowance are reported in net earnings as a component of Recognized gains and losses, net. For details on our policy around allowance for expected credit losses on AFS securities, refer to Note E Investments. Preferred and Equity Securities Preferred and equity securities held are carried at fair value as of the balance sheet dates. Changes in fair value and realized gains and losses on sales of our preferred and equity securities are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Realized gains and losses on sales of our preferred and equity securities are determined on the first in first out cost basis and are credited or charged to earnings on a trade date basis unless the security is a private placement in which case settlement date basis is used. Interest and dividend income from these investments is reported in Interest and investment income in the Consolidated Statements of Earnings. Derivative Financial Instruments In our F&G segment, we hedge certain portions of our exposure to product related equity market risk by entering into derivative transactions (primarily equity options). We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. All such derivative instruments are recognized as either assets or liabilities in the Consolidated Balance Sheets at fair value. The changes in fair value are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. The change in the fair value of derivative instruments is included in (Gain) loss on sales of investments and other assets and asset impairments, net, in the Consolidated Statements of Cash Flow. We purchase financial instruments that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. Mortgage Loans Our investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less allowance for expected credit losses. For details on our policy around allowance for expected credit losses on mortgage loans, refer to Note E Investments . Commercial mortgage loans ("CMLs") are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors. CMLs are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below certain thresholds and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. We define delinquent mortgage loans as 30 days past due, consistent with industry practice. Residential mortgage loans ("RMLs") have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming RMLs as those that are 90 or more days past due and/or in nonaccrual status, which is assessed monthly. Generally, nonperforming RMLs have a higher risk of experiencing a credit loss. We consider residential mortgage loans that are 90 or more days past due and have an LTV greater than 90% to be foreclosure probable. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Interest income, amortization of premiums and discounts, prepayment fees, and loan commitment fees are reported in Interest and investment income in the accompanying Consolidated Statements of Earnings. Short-term investments Short-term investments consist of financial instruments with an original maturity of one year or less when purchased and include short-term fixed maturity securities and money market instruments, which are carried at fair value, and short-term loans, which are carried at amortized cost, which approximates fair value. Investments in Unconsolidated Affiliates In our F&G segment, we account for our investments in unconsolidated affiliates using the equity method or by electing the fair value option. Initial investments are recorded at cost. For investments subsequently measured using the equity method (primarily limited partnerships), adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by net asset value ("NAV") in the unconsolidated affiliates’ financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. Our pro rata share of NAV adjustments are reported in Interest and investment income and realized gains and losses on sales are reported in Recognized gains and (losses), net in the Consolidated Statements of Earnings. Distributions received from investments measured using the equity method are recorded as a decrease in the investment balance. Recognition of income and adjustments to the carrying amount can be delayed due to the availability of the related financial statements, which are obtained from the general partner or managing member generally on a one to three-month delay. Management inquires quarterly with the general partner or managing member to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter NAV adjustments and investment income. For investments subsequently measured using the fair value option, adjustments to the carrying amount reflecting the change in fair value of the investment and realized gains and losses on sales are reported in Recognized gains and (losses), net in the Consolidated Statements of Earnings. Distributions received from investments measured using the fair value option are reported within Interest and investment income in the Consolidated Statements of Earnings. For descriptions of the fair value methodologies used for our investments, refer to Note D Fair Value of Financial Instruments . In our title segment, we account for our investments in unconsolidated affiliates using the equity method of accounting and earnings on our investments in unconsolidated affiliates are recorded within Equity in earnings of unconsolidated affiliates within the Consolidated Statements of Earnings. We classify distributions received from unconsolidated affiliates in our Consolidated Statements of Cash Flows using the cumulative earnings approach. Under the cumulative earnings approach, distributions are considered returns on investment and classified as cash inflows from operating activities unless the Company’s cumulative distributions from an investee received exceed the cumulative equity in earnings of such investee. When cumulative distributions from an investee exceed cumulative equity in earnings of the investee, such excess is considered a return of investment and is classified as a cash inflow from investing activities. Interest and investment income Dividends and interest income are recorded in Interest and investment income and recognized when earned. Income or losses upon call or prepayment of fixed maturity securities are recognized in Interest and investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in Interest and investment income over the contractual terms of the investments, and for callable investments at a premium, based on the earliest call date of the investments, in a manner that produces a constant effective yield. For mortgage-backed and asset-backed securities, included in the fixed maturity securities portfolios, one of two models may be used to recognize interest income. For higher rated securities, interest income will be estimated based on an effective yield that considers cash flows received to date plus current expectations of future cash flows. For all other securities, interest income will be estimated based upon an effective yield that considers current expectations of future cash flows. For both interest income models, the estimated future cash flows include assumptions regarding the performance of the underlying collateral pool. Interest and investment income is presented net of investment expenses and the effects of certain reinsurance contracts. Cash and Cash Equivalents Highly liquid instruments purchased as part of cash management with original maturities of three months or less are considered cash equivalents. The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value. Trade and Notes Receivables The carrying values reported in the Consolidated Balance Sheets for trade and notes receivables approximate their fair value. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete and reported to us. Premium revenues from agency operations and related commissions include an accrual based on estimated historical transaction volume data for policies that have closed in a particular period in which premiums have not yet been reported to us. Historically, the time lag between the closing of these transactions by our agents and the reporting of these policies, or premiums, to us has been up to 15 months, with 61% - 92% reported within three months following closing, an additional 7% - 29% reported within the next three months and the remainder within seven fifteen Fair Value of Financial Instruments The fair values of financial instruments presented in the Consolidated Financial Statements are estimates of the fair values at the balance sheet date using available market information and appropriate valuation methodologies. These estimates are subjective in nature and involve uncertainties and significant judgment in the interpretation of current market data. See a description of the fair value methodology used in Note D Fair Value of Financial Instruments . Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations The Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 805, Business Combinations, requires an acquirer to recognize, separately from goodwill, the identifiable assets acquired, liabilities assumed, and any non-controlling interest in the acquiree, and to measure these items generally at their acquisition date fair values. If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, we are required to report provisional amounts in the financial statements for the items for which the accounting is incomplete. Adjustments to provisional amounts initially recorded that are identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. During the measurement period, we are also required to recognize additional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period ends the sooner of one year from the acquisition date, or when we receive the information we were seeking about facts and circumstances that existed as of the acquisition date or learn that more information is not obtainable. Goodwill Goodwill represents the excess of cost over fair value of identifiable net assets acquired and assumed in a business combination. Goodwill and other intangible assets with indefinite useful lives are reviewed for impairment at the reporting unit level on an annual basis or more frequently if circumstances indicate potential impairment, through a comparison of fair value to the carrying amount. In evaluating the recoverability of goodwill, we perform a qualitative analysis at the reporting unit level to determine whether there are any events or circumstances that would indicate it is more likely than not that the fair value of our recorded goodwill exceeds its carrying value, prior to performing a full fair-value assessment. We complete annual goodwill impairment analyses in the fourth quarter of each period presented using a September 30 measurement date. For the years ended December 31, 2024, 2023 and 2022, we determined there were no events or circumstances which indicated that the carrying value of a reporting unit exceeded the fair value. Insurance and Reinsurance Related Intangible Assets We have insurance and reinsurance related intangible assets, which include the value of insurance and reinsurance contracts acquired (hereafter referred to as “VOBA”), DAC, DSI, and cost of reinsurance (“COR”). VOBA, DAC, and DSI are reported in Other intangible assets, net, on the Consolidated Balance Sheets. COR may be reported in Prepaid expenses and other assets or in Accounts payable and accrued liabilities on the Consolidated Balance Sheets as described below under “Reinsurance - Cost of Reinsurance.” VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts (“VIF”) in a life insurance company acquisition. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. VOBA is a function of the VIF, current GAAP reserves, GAAP assets, and deferred tax liability. The VIF is determined by the present value of statutory distributable earnings less opening required capital. DAC consists principally of commissions and other acquisition costs that are related directly to the successful sale of new or renewal insurance contracts that are deferred as they are incurred. When insurance contracts are reinsured and reinsurance accounting is applied, acquisition cost reimbursements from reinsurers are recorded as a reduction to DAC. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred and are offset by maintenance expense reimbursements within a reinsurance arrangement, when reinsurance accounting is applied to the respective arrangement DSI represents up front bonus credits and persistency or vesting bonuses credited to contractholder fund balances. COR represents net cash flows on reinsurance coverage to ensure no gain or loss is recognized at inception. VOBA, DAC, DSI, and COR are amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Contracts are grouped by product type, feature and issue year into cohorts consistent with the grouping used in estimating the associated liability, where applicable. The constant level amortization bases of VOBA, DAC, DSI, and COR varies by product type. For universal life and IUL insurance products, the constant level basis used is face amount in force. For deferred annuities (indexed annuities and fixed rate annuities), the constant level basis used is initial premium deposit for DAC and DSI and vested account value as of the acquisition date for VOBA and ceded initial premium for COR. For immediate annuity contracts, the VOBA balance is amortized in alignment with the Company’s accounting policy of amortizing the deferred profit liability (“DPL”). All amortization bases are adjusted by full lapses, which includes deaths, full surrenders, annuitizations and maturities, where applicable. The constant level basis used for amortization are projected using mortality and lapse assumptions that are based on Company’s experience, industry data, and other factors and are consistent with those used for the FPB, where applicable. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at that time. Unexpected contract terminations, due to higher mortality and/or lapse experience than expected, are recognized in the current period as a reduction of the capitalized balances. All balances are reduced for actual experience in excess of expected experience with changes in future estimates recognized prospectively over the remaining expected grouped contract term. The impact of changes in projected assumptions and the impact of actual experience that is different from expectations impact the amortization of these intangible assets, which is reported within Depreciation and amortization for VOBA, DAC DSI and for COR, if the net COR balance is in a deferred gain position is reported within Life insurance premiums and other fees, and if the net COR balance is in a deferred loss position is reported within Other operating expenses in the Consolidated Statements of Earnings. Some of our IUL policies require payment of fees or other policyholder assessments in advance for services that will be rendered over the estimated lives of the policies or contracts. These payments are established as URL upon receipt and included in Accounts payable and other accrued liabilities in the Consolidated Balance Sheets. URL is amortized like DAC over the estimated lives of these policies. Other Intangible Assets We have other intangible assets, not including goodwill, VOBA, DAC or DSI, which consist primarily of customer relationships and contracts, the value of distribution network acquired ("VODA"), trademarks and tradenames, state licenses, and computer software, which are generally recorded in connection with business combinations at their fair value . Intangible assets with estimable lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In general, customer relationships are amortized over their estimated useful lives using an accelerated method, which takes into consideration expected customer attrition rates. VODA is an intangible asset that represents the value of an acquired distribution network and is amortized using the sum of years digits method. Contractual relationships are generally amortized over their contractual life. Trademarks and tradenames are generally amortized over ten years. Capitalized computer software includes the fair value of software acquired in business combinations, purchased software and capitalized software development costs. Purchased software is recorded at cost and amortized using the straight-line method over its estimated useful life. Software acquired in business combinations is recorded at its fair value and amortized using straight-line or accelerated methods over its estimated useful life. For internal-use computer software products, internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred during the application development stage are capitalized and amortized on a product-by-product basis commencing on the date the software is ready for its intended use. We do not capitalize any costs once the software is ready for its intended use. We review VOBA, DSI and other intangible assets for impairment annually or when events or circumstances occur that indicate a potential change in the underlying basis. F or further information, refer to Note M Intangibles for details of impairment expense. Title Plants Title plants are recorded at the cost incurred to construct or obtain and organize historical title information to the point it can be used to perform title searches. Costs incurred to maintain, update and operate title plants are expensed as incurred. Title plants are not amortized as they are considered to have an indefinite life, if maintained. Sales of title plants are reported at the amount received net of the adjusted costs of the title plant sold. Sales of title plant copies are reported at the amount received. No cost is allocated to the sale of copies of title plants unless the carrying value of the title plant is diminished or impaired. Title plants are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable. We reviewed title plants for impairment for the years ended December 31, 2024, 2023 and 2022 and did not record any impairment expense in the year ended December 31, 2023. We reco rded $2 million and $1 million of impair ment expense related to title plants in the year ended December 31, 2024 and 2022, respectively . Property and Equipment Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is computed primarily using the straight-line method based on the estimated useful lives of the related assets: twenty three recorded $2 million of impairment expense related to property and equipment in our title segment in the year ended December 31

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions Owned Distribution - Acquisition of Roar Joint Venture, LLC On January 2, 2024, F&G acquired a 70% majority ownership stake in the equity of Roar Joint Venture, LLC (“Roar”). Roar wholesales life insurance and annuity products to banks and broker-dealers through a network of agents. Under the terms of the purchase agreement, the Company has agreed to make cash payments of up to approximately $90 million over a three-year period upon the achievement of certain EBITDA milestones of Roar. The initial purchase price is as follows (in millions): Cash paid for 70% majority interest of Roar shares $ 269 Less: Cash acquired net of non-controlling interests 1 Net cash paid for 70% majority interest of Roar 268 Initial fair value of contingent consideration 48 Total initial consideration $ 316 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 268 Prepaid expenses and other assets 3 Other intangible assets 183 Total assets acquired 454 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Non-controlling interests (fair value determined using income approach) 136 Total liabilities assumed and non-controlling interests 138 Net assets acquired $ 316 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the Roar acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 179 12 Definite lived trademarks, tradenames, and other 4 10 Total Other intangible assets $ 183 Goodwill consists primarily of intangible assets that do not qualify for separate recognition, such as the assembled workforce and synergies between the entities. The total amount of goodwill recorded is expected to be deductible for tax purposes. Roar’s revenues of $78 million and net earnings attributable to F&G common shareholders of $6 million are included in the Consolidated Statements of Earnings for the year ended December 31, 2024. Contingent Consideration Under the terms of the purchase agreement for Roar, we have agreed to make cash payments of up to $90 million over a three-year period upon the achievement by Roar of certain EBITDA milestones. The contingent consideration is recorded at fair value in Accounts payable and accrued liabilities. Refer to Note A Basis of Financial Statements for more information on the Roar purchase and refer to Note D Fair Value of Financial Instruments for more information regarding the fair value of the contingent consideration. Owned Distribution - Acquisition of PALH, LLC On July 18, 2024, F&G acquired a 100% ownership stake in the equity of PALH, LLC (“PALH”). PALH markets and sells life insurance and annuity products of various insurance carriers to individuals through a network of agents. Prior to the acquisition date, PALH owned a 70% ownership stake in an operating company of which F&G owned 30% equity. Immediately before the acquisition date, the fair value of F&G’s minority stake in the operating company was approximately $92 million, derived from the transaction value. The transaction value contemplates measures such as EBITDA margin, revenue growth over time periods and growth opportunities. This remeasurement resulted in a realized gain of $2 million recorded in Recognized gains and losses, net in the Consolidated Statements of Earnings during the year ended December 31, 2024 . The initial purchase price is as follows: (In millions) Cash paid $ 215 Less: Cash acquired 1 Net cash paid 214 Settlement of prepaid asset 8 Acquisition date fair value of previously held interests 92 Total consideration $ 314 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 162 Prepaid expenses and other assets 5 Other intangible assets 149 Total assets acquired 316 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Net assets acquired $ 314 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the PALH acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 131 20 Definite lived trademarks, tradenames, and other 18 5 to 10 Total Other intangible assets $ 149 Goodwill consists primarily of intangible assets that do not qualify for separate recognition, such as the assembled workforce and synergies between the entities. A portion of the total amount of goodwill recorded is expected to be deductible for tax purposes. PALH’s revenues and net loss attributable to F&G common shareholders of $3 million and $6 million, respectively, are included in the Consolidated Statements of Earnings for the year ended December 31, 2024.

Summary of Reserve for Title Cl

Summary of Reserve for Title Claim Losses	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Summary of Reserve for Title Claim Losses	Summary of Reserve for Title Claim Losses A summary of the reserve for title claim losses follows: Year Ended December 31, 2024 2023 2022 (Dollars in millions) Beginning balance $ 1,770 $ 1,810 $ 1,883 Change in insurance recoverable (10) 15 (128) Claim loss provision related to: Current year 232 207 308 Prior years — — — Total title claim loss provision 232 207 308 Claims paid, net of recoupments related to: Current year (25) (22) (21) Prior years (254) (240) (232) Total title claims paid, net of recoupments (279) (262) (253) Ending balance of claim loss reserve for title insurance $ 1,713 $ 1,770 $ 1,810 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 % 4.5 % Several lawsuits were filed by various parties against Chicago Title Company and Chicago Title Insurance Company as its principal (collectively, the “Named Companies”) by plaintiffs claiming they were investors who were solicited by Gina Champion-Cain through her former company, ANI Development LLC (“ANI”), or other affiliates to provide funds placed in an escrow account that purportedly were to be used for high-interest, short-term loans to parties seeking to acquire California alcoholic beverage licenses. Plaintiffs further alleged that employees of Chicago Title Company assisted Ms. Champion-Cain and her entities in diverting the funds placed into an escrow account maintained by Chicago Title Company into which some of the plaintiffs’ funds were deposited. In connection with the alcoholic beverage license scheme, the SEC filed a civil enforcement proceeding asserting claims for securities fraud against Champion-Cain and ANI in a lawsuit styled, Securities and Exchange Commission v. Gina Champion-Cain and ANI Development, LLC , pending in the United States District Court for the Southern District of California. The receiver, who was appointed by the court to preserve the assets of the defendant affiliated entities, then filed a lawsuit in San Diego County Superior Court against the Named Companies seeking damages in a lawsuit styled, Krista Freitag v. Chicago Title Co. and Chicago Title Ins. Co. The Named Companies reached a global settlement with the receiver and several other investor claimants and jointly sought court approval of the global settlement and entry of an order barring any claims against the Named Companies related to the alcoholic beverage license scheme. On November 23, 2022, the federal court overruled any objections by non-joining investors and entered an order approving the global settlement barring further claims against the Named Companies (“Settlement and Bar Order”). After her receipt of the settlement funds, the receiver dismissed the lawsuit against the Named Companies. Some of the non-joining investor claimants who objected to entry of the Settlement and Bar Order appealed the decision to the United States Court of Appeals for the Ninth Circuit by (Cases 22-56206, 22-56208, and 23-55083). On February 20, 2025, the Ninth Circuit affirmed the district court's Settlement and Bar Order, barring all ongoing and future litigation against CTC stemming from the scheme operated by Ms. Champion-Cain. If appellants wish to seek further review of the Ninth Circuit's decision, they have a limited time to file a petition for rehearing or rehearing en banc , and/or a petition for review with the U.S. Supreme Court. Once the appellate decision is final, the remaining lawsuits pending in the Superior Court of San Diego County for the State of California involving claimants/investors who objected to CTC's settlement with the receiver are expected to be dismissed as to CTC. Chicago Title Company has also resolved a number of other pre-suit claims and previously-disclosed lawsuits from both individual and groups of alleged investors under confidential terms. Based on the facts and circumstances of the remaining claims, including the settlements already reached, we have recorded reserves included in our reserve for title claim losses, which we believe are adequate to cover losses related to this matter, and believe that our reserves for title claim losses are adequate. We continually update loss reserve estimates as new information becomes known, new loss patterns emerge or as other contributing factors are considered and incorporated into the analysis of reserve for claim losses. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims and other factors. Due to the uncertainty inherent in the process and to the judgment used by management, the ultimate liability may be greater or less than our current reserves. If actual claims loss development varies from what is currently expected and is not offset by other factors, it is possible that additional reserve adjustments may be required in future periods in order to maintain our recorded reserve within a reasonable range of our actuary's central estimate. Regulation Title Our insurance subsidiaries, including title insurers, underwritten title companies and insurance agencies, are subject to extensive regulation under applicable state laws. Each of the insurance underwriters is subject to a holding company act in its state of domicile that regulates, among other matters, the ability to pay dividends and enter into transactions with affiliates. The laws of most states in which we transact business establish supervisory agencies with broad administrative powers relating to issuing and revoking licenses to transact business, regulating trade practices, licensing agents, approving policy forms, accounting practices, financial practices, establishing reserve and capital and surplus as regards policyholders (“capital and surplus”) requirements, defining suitable investments for reserves and capital and surplus and approving rate schedules. The process of state regulation of changes in rates ranges from states that set rates, to states where individual companies or associations of companies prepare rate filings that are submitted for approval, to a few states in which rate changes do not need to be filed for approval. Since we are regulated by both state and federal governments and the applicable insurance laws and regulations are constantly subject to change, it is not possible to predict the potential effects on our insurance operations, particularly the Title segment, of any laws or regulations that may become more restrictive in the future or if new restrictive laws will be enacted. Statutory-basis financial statements are prepared in accordance with accounting practices prescribed or permitted by the various state insurance regulatory authorities. The National Association of Insurance Commissioners' Accounting Practices and Procedures manual (“NAIC SAP”) has been adopted as a component of prescribed or permitted practices by each of the states that regulate us. Each of our states of domicile for our title insurance underwriter subsidiaries have adopted a material prescribed accounting practice that differs from that found in NAIC SAP. Specifically, in both years, the timing of amounts released from the statutory unearned premium reserve under NAIC SAP differs from the states' required practice. Statutory surplus at December 31, 2024 and 2023 was lower by approximately $33 million and $34 million than if we had reported such amounts in accordance with NAIC SAP. Pursuant to statutory accounting requirements of the various states in which our insurers are domiciled, these insurers must defer a portion of premiums earned as an unearned premium reserve for the protection of policyholders and must maintain qualified assets in an amount equal to the statutory requirements. The level of unearned premium reserve required to be maintained at any time is determined by statutory formula based upon either the age, number of policies and dollar amount of policy liabilities underwritten, or the age and dollar amount of statutory premiums written. As of December 31, 2024, the combined statutory unearned premium reserve required and reported for our title insurers was $1,608 million. In addition to statutory unearned premium reserves, each of our insurers maintains reserves for known claims and surplus funds for policyholder protection and business operations. Each of our insurance subsidiaries is regulated by the insurance regulatory authority in its respective state of domicile, as well as that of each state in which it is licensed. The insurance commissioners of their respective states of domicile are the primary regulators of our title insurance subsidiaries. Each of the insurers is subject to periodic regulatory financial examination by regulatory authorities. Our insurance subsidiaries are subject to regulations that restrict their ability to pay dividends or make other distributions of cash or property to their immediate par ent company without prior approval from the Department of Insurance of their respective states of domicile. As of December 31, 2024, $1,141 million of our net assets are restricted from dividend payments without prior approval from the Departments of Insurance. During 2025, our title insurers can pay or make distributions to us of approximately $498 million, without prior approval. The combined statutory capital and surplus of our title insurers was approximately $1,223 million and $1,225 million as of December 31, 2024 and 2023, respectively. The combined statutory net earnings of our title insurance subsidiaries were $587 million, $503 million, and $778 million for the years ended December 31, 2024, 2023 and 2022, respectively. As a condition to continued authority to underwrite policies in the states in which our insurers conduct their business, the insurers are required to pay certain fees and file information regarding their officers, directors and financial condition. In addition, our escrow and trust business is subject to regulation by various state banking authorities. Pursuant to statutory requirements of the various states in which our insurers are domiciled, such insurers must maintain certain levels of minimum capital and surplus. Required levels of minimum capital and surplus are not significant to the insurers individually or in the aggregate. Each of our insurers has complied with the minimum statutory requirements as of December 31, 2024. Our underwritten title companies, primarily those domiciled in California, are also subject to certain regulation by insurance regulatory or banking authorities relating to their net worth and working capital. Minimum net worth and working capital requirements for each underwritten title company is less than $1 million. These companies were in compliance with their respective minimum net worth and working capital requirements at December 31, 2024. There are no restrictions on our retained earnings regarding our ability to pay dividends to shareholders although there are limits on the ability of certain subsidiaries to pay dividends to us, as described above. F&G Through our majority owned F&G subsidiary, our insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, except for Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed but approved by state regulators. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G's non-U.S. insurance subsidiaries, F&G Life Re (Bermuda) and F&G Cayman Re (Cayman Islands) file financial statements with their respective regulators. In our F&G segment, our principal insurance subsidiaries' statutory financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows: Subsidiary (state of domicile) (a) FGL Insurance (IA) FGL NY Insurance (NY) Raven Re (VT) Corbeau Re (VT) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ 150 $ 8 $ 54 $ (458) Year ended December 31, 2023 (462) 5 60 (644) Year ended December 31, 2022 (243) (15) (111) — Statutory Capital and Surplus: December 31, 2024 $ 1,654 $ 97 $ 168 $ 178 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Regulation - U.S. Companies FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re’s respective statutory capital and surplus satisfy the applicable minimum regulatory requirements. To enhance the regulation of insurers’ solvency, the NAIC adopted a model law to implement risk-based capital ("RBC") requirements for life, health and property and casualty insurance companies. All states have adopted the NAIC’s model law or a substantially similar law. RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk, and (iv) business risk. As of the most recent annual statutory financial statements filed with insurance regulators, the RBC ratios for each of our U.S Insurance Companies exceeded the minimum RBC requirements. Dividends The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively. FGL Insurance dividends are paid as declared by its Board of Directors. Pursuant to Iowa insurance law, any proposed payment of a dividend is classified as an "extraordinary dividend" if it, together with the aggregate fair market value of other dividends or distributions made during the preceding twelve months, exceeds the greater of (i) 10% of capital and surplus as of the preceding December 31 or (ii) net gain from operations before realized capital gains or losses for twelve month period ending December 31 of the preceding year. No extraordinary dividends may be paid without prior approval of the IID. In addition, no ordinary dividends may be paid except from the earned profits arising from FGL Insurance's business, which does not include contributed capital or contributed surplus. FGL Insurance did not pay dividends to its parent, Fidelity & Guaranty Life Holdings, Inc. ("FGLH"), for the years ended December 31, 2024, 2023, and 2022. Pursuant to the limitations described above, it is estimated that FGL Insurance's maximum ordinary dividend capacity for 2025 is $0. Each year, FGL NY Insurance may pay a certain limited amount of ordinary dividends or other distributions without being required to obtain the prior consent of the New York State Department of Financial Services (“NYDFS”). However, to pay any dividends or distributions in a calendar year immediately following a calendar year in which the FGL NY's net gain from operations, not including realized capital gains, was negative, approval from the NY Superintendent is required. FGL NY Insurance has historically not paid dividends. Based on the limitations described above, it's estimated that the maximum amount of ordinary dividends FGL NY Insurance will be permitted to distribute during 2025 is approximately $10 million. Raven Re and Corbeau Re dividends are paid as declared by their Board of Directors. Under the laws of the State of Vermont, no captive insurance company may pay a dividend out of, or other distribution with respect to, capital or surplus, without prior approval. Based on the limitations described above, no dividends may be paid in 2025 by either Raven Re or Corbeau Re without prior regulatory approval. Prescribed and permitted practices FGL Insurance - FGL Insurance applies Iowa-prescribed accounting practices prescribed by Iowa Administrative Code (" IAC ") Chapter 97, “Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve”, for its indexed annuities and IUL products. Under these alternative accounting practices, the equity option derivative instruments that hedge the growth in interest credited on index products are accounted for at amortized cost with the corresponding amortization recorded as a decrease to net investment income and indexed annuity reserves are calculated based on Standard Valuation Law and Actuarial Guideline XXXV assuming the market value of the equity options associated with the current index term is zero regardless of the observable market value for such options. In addition, based on a permitted practice received from the IID, FGL Insurance carries one of its limited partnership interests which qualifies for accounting under SSAP No. 48, “Investments in Joint Ventures, Partnerships and Limited Liability Companies”, on a net asset value per share basis. This is a departure from SSAP No. 48 which requires such investments to be carried based on the investees underlying GAAP equity (prior to any impairment considerations). This limited partnership investment was redeemed as of December 31, 2024. In addition, the financial statements of Raven Re and Corbeau Re include certain permitted practices approved by the Vermont Department of Financial Regulations. Without these permitted practices, the carry value of these two entities would be zero. The prescribed and permitted practices resulted in increases to statutory capital and surplus of $454 million and $194 million at December 31, 2024 and 2023, respectively. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset, which increased Raven Re’s statutory capital and surplus by $175 million and $200 million at December 31, 2024 and 2023, respectively. In addition, FGL Insurance’s statutory carrying value of Corbeau Re reflects the effect of permitted practices Corbeau Re received to treat the excess of loss as an admitted asset, which increased Corbeau Re’s statutory capital and surplus by $1,230 million and $765 million at December 31, 2024 and 2023, respectively. Refer to Note O - F&G Reinsurance for a discussion of the XOL and letter of credit. Raven Re - Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance and also has approval to include as an admitted asset the value of a letter of credit serving as collateral for reinsurance credit taken by FGL Insurance. Without such permitted statutory accounting practices, Raven Re’s statutory capital and surplus (deficit) would be $(13) million and $(89) million as of December 31, 2024 and 2023, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent (refer to discussion of letter of credit in Note O F&G Reinsurance ). FGL Insurance’s statutory carrying value of Raven Re was $168 million and $140 million at December 31, 2024 and 2023, respectively. Corbeau Re - Corbeau Re has four permitted practices pursuant to Vermont Statute, Title 8, Chapter 141 – (8 V.S.A. § 6048k(a)(2), whereby the Vermont Department authorizes the Company to (i) account for the amount equal to the excess of loss amount (“XOL Asset”) as an asset on its statutory financial statements; (ii) calculate the reserves with respect to the Retirement Pro Contracts in accordance with the following reserving methodology: the reserves are calculated as the present value of reinsured benefits when account value equals zero less the present value of reinsurance premiums from the winning integrated stream, floored at zero and capped as necessary to keep the net statutory reserve at the net cash surrender value. For benefits associated with all other contracts (“the GMWB Riders”), the reserves are calculated as the statutory reserves for the entire contract (i.e., the base contracts plus the GMWB Riders) minus the statutory reserves for the base contracts only (“Reserve Calculation Permitted Practice”); (iii) calculate its company action level risk-based capital as defined in Section 8301(13)(A) and, calculated using the risk-based capital factors and formulas prescribed by the NAIC, applying a factor of 0.62% to the XOL Asset Value; and (iv) annually perform a total company solvency analysis in lieu of cash flow testing and actuarial opinion and memorandum under Section 2010-2 of the Vermont Administrative Code. In addition, Corbeau Re assumes reserves that are equal to the reserves ceded by FGL Insurance which includes application of IAC Insurance 191, Chapter 97, "Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve". Without such permitted statutory accounting practices, the Company’s statutory capital and surplus (deficit) would be $(1,052) million and $(594) million as of December 31, 2024 and 2023, respectively, and its risk-based capital would fall below the minimum regulatory requirements. FGL Insurance’s statutory carrying value of Corbeau Re was $178 million and $171 million at December 31, 2024 and 2023, respectively. FGL NY Insurance - As of December 31, 2024 and 2023, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices. Non-U.S. Companies F&G's non-U.S. insurance subsidiaries, F&G Cayman Re and F&G Life Re, file financial statements with their respective regulators. For the annual period ended December 31, 2023, F&G Cayman Re began to file financial statements that are prepared in accordance with SAP prescribed or permitted by such authorities, which may vary materially from GAAP. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G Cayman Re has two permitted practices which have been approved by the Cayman Islands Monetary Authority (“CIMA”). F&G Cayman Re has a permitted practice approved by CIMA to include, as an admitted asset, the value of the letters of credit (“LOCs”) acquired to support reinsurance transactions. Also, F&G Cayman Re has a permitted practice, approved by CIMA, for PRT reinsurance transactions to use U.S. statutory book value adjusted for best estimate reserve calculations (consistent with GAAP prior to ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts). These reserve calculations will be subject to annual assumption reviews consistent with other GAAP liability balances. If F&G Cayman Re had not been permitted to calculate PRT assumed reserves using best estimate reserve calculations or include the value of the LOCs as an admitted asset, statutory surplus would be $(64) million and $102 million as of December 31, 2024 and December 31, 2023, respectively. Without such permitted statutory accounting practices, F&G Cayman Re’s risk-based capital would fall below the minimum regulatory requirements as of December 31, 2024 and December 31, 2023. F&G Life Re files financial statements based on GAAP. Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows: Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ (11) $ 139 Year ended December 31, 2023 133 151 Year ended December 31, 2022 71 (339) Statutory Capital and Surplus (Deficit): December 31, 2024 $ 734 $ 123 December 31, 2023 543 11 Regulation - Bermuda F&G Life Re is a Bermuda exempted company incorporated under the Companies Act 1981, as amended (the “Bermuda Companies Act”) and registered as a Class E insurer under the Insurance Act 1978, as amended, and its related regulations (the “Bermuda Insurance Act”). F&G Life Re is regulated by the Bermuda Monetary Authority (“BMA”). In addition to the requirements under the Bermuda Companies Act (as discussed below), the Bermuda Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re without prior regulatory approval. F&G Life Re is prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. If F&G Life Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA. In addition, as a Class E insurer, F&G Life Re must not declare or pay a dividend to any person other than a policyholder unless the value of the assets of such insurer, as certified by the insurer’s approved actuary, exceeds its liabilities (as so certified) by the greater of its margin of solvency or ECR. In the event a dividend complies with the above, F&G Life Re must ensure the amount of any such dividend does not exceed that excess. Furthermore, as a Class E insurer, F&G Life Re must not declare or pay a dividend in any financial year which would exceed 25% of its total statutory capital and surplus, as set out in its previous year’s Bermuda statutory financial statements, unless at least seven days before payment of such dividend F&G Life Re files with the BMA an affidavit signed by at least two directors of F&G Life Re and its principal representative under the Bermuda Insurance Act stating that, in the opinion of those signing, declaration of such dividend has not caused the insurer to fail to meet its relevant margins. The Bermuda Companies Act also limits F&G Life Re’s ability to pay dividends and make distributions to its shareholders. F&G Life Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities. F&G Life Re’s ability to pay dividends in 2025 is subject to the limitations described above. Regulation - Cayman Islands F&G Cayman Re is a Cayman Islands exempted company incorporated under the Companies Act, as amended (2023 Revision) and licensed as a Class D insurer in the Cayman Islands under the Insurance Act, 2010 as amended and its related regulation (the “Cayman Islands Insurance Act”). F&G Cayman Re is regulated by CIMA. F&G Cayman Re dividends are paid as declared by its Board of Directors. The dividends will be in accordance with CIMA regulatory requirements and contractual obligations and any dividends require approval by CIMA. F&G Cayman Re can only request approval for dividends if (i) the ending capital, including considerations for future business plans, will maintain a surplus over the CIMA approved and permitted target modified RBC, and (ii) contractual language pursuant to the PRT reinsurance agreement requiring a US RBC above specified target is met. As of the most recent annual financial statement filed with CIMA, the RBC ratios for F&G Cayman Re exceeded these minimum requirements. Pursuant to the limitations described above, no dividends may be paid in 2025 by F&G Cayman Re without prior regulatory approval. The prescribed and permitted statutory accounting practices have no impact on our audited Consolidated Financial Statements, which are prepared in accordance with GAAP. Equity On August 3, 2021, our Board of Directors approved the 2021 Repurchase Program under which we may purchase up to 25 million shares of our FNF common stock through July 31, 2024 (the "2021 Repurchase Program"). On July 31, 2024, our Board of Directors approved a new three-year stock repurchase program effective July 31, 2024 (the "2024 Repurchase Program") under which we are authorized to purchase up to 25 million shares of our FNF common stock through July 31, 2027. We may make repurchases from time to time in the open market, in block purchases or in privately negotiated transactions, depending on market conditions and other factors. During the year ended December 31, 2023, we repurchased a total of 100,000 FNF common shares for an aggregate of $4 million or an average of $38.45 per share under the 2021 Repurchase Program. During the year ended December 31, 2024, we did not repurchase any FNF common stock under the 2021 Repurchase Program or the 2024 Repurchase Program. Subsequent to December 31, 2024 and through market close on February 21, 2025, we did not repurchase any FNF common stock under the 2024 Repurchase Program.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Our measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include our own credit risk. We estimate an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). We categorize financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique, along with net asset value. The three-level hierarchy for fair value measurement is defined as follows: Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. NAV - Certain equity investments are measured using NAV as a practical expedient in determining fair value. In addition, our unconsolidated affiliates (primarily limited partnerships) are primarily accounted for using the equity method of accounting with fair value determined using NAV as a practical expedient. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the unconsolidated affiliate’s financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the unconsolidated affiliates may have significant unobservable inputs, which may include, but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. Additionally, management inquires quarterly with the general partner to determine whether any credit or other market events have occurred since prior period financial statements to ensure any material events are properly included in current period valuation and investment income. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources. Our assets and liabilities measured and carried at fair value on a recurring basis, summarized according to the hierarchy previously described, are as follows: December 31, 2024 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 3,479 $ — $ — $ — $ 3,479 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,513 8,143 — 15,656 Commercial mortgage-backed securities — 5,182 — — 5,182 Corporates 41 18,698 2,957 — 21,696 Hybrids 35 546 — — 581 Municipals — 1,386 — — 1,386 Residential mortgage-backed securities — 2,793 3 — 2,796 U.S. Government 631 6 — — 637 Foreign Governments — 280 4 — 284 Short term investments 2,995 18 37 — 3,050 Preferred securities 189 246 8 — 443 Equity securities 575 — 10 57 642 Derivative investments — 791 3 — 794 Investment in unconsolidated affiliates — — 272 — 272 Loan receivable, included in Prepaid expenses and other assets — — 11 — 11 Reinsurance related embedded derivative, included in other assets — 109 — — 109 Market risk benefits asset — — 189 — 189 Other assets — — 65 — 65 Other long-term investments — — 32 — 32 Total financial assets at fair value $ 7,945 $ 37,568 $ 11,734 $ 57 $ 57,304 Liabilities Derivatives: Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in Contractholder funds $ — $ — $ 5,220 $ — $ 5,220 Interest rate swaps — 10 — — 10 Equity options 1 — — — 1 Contingent consideration obligation — — 74 — 74 Market risk benefits liability — — 549 — 549 Total financial liabilities at fair value $ 1 $ 10 $ 5,843 $ — $ 5,854 December 31, 2023 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 2,767 $ — $ — $ — $ 2,767 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,220 7,122 — 14,342 Commercial mortgage-backed securities — 4,457 18 — 4,475 Corporates 25 15,892 1,979 — 17,896 Hybrids 95 523 — — 618 Municipals — 1,562 49 — 1,611 Residential mortgage-backed securities — 2,426 3 — 2,429 U.S. Government 662 16 — — 678 Foreign Governments — 308 16 — 324 Preferred securities 214 399 8 — 621 Equity securities 692 — 15 59 766 Derivative investments — 740 57 — 797 Investment in unconsolidated affiliates — — 285 — 285 Short-term investments 2,111 8 — — 2,119 Reinsurance related embedded derivative, included in other assets — 152 — — 152 Other long-term investments — — 37 — 37 Market risk benefits asset — — 88 — 88 Total financial assets at fair value $ 6,566 $ 33,703 $ 9,677 $ 59 $ 50,005 Liabilities Derivatives: Indexed annuities/IUL embedded derivatives, included in Contractholder funds $ — $ — $ 4,258 $ — $ 4,258 Market risk benefits liability — — 403 — 403 Equity options 1 — — — 1 Total financial liabilities at fair value $ 1 $ — $ 4,661 $ — $ 4,662 Valuation Methodologies Cash and Cash Equivalents The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value. Fixed Maturity, Preferred and Equity Securities We measure the fair value of our securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity, preferred or equity security, and we will then consistently apply the valuation methodology to measure the security’s fair value. Our fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. We use observable and unobservable inputs in our valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. We believe the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. We analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. However, we did not adjust prices received from third parties as of December 31, 2024 or 2023. Certain equity investments are measured using NAV as a practical expedient in determining fair value. Derivative Financial Instruments Our call options and put options (together referred to as “equity options”), futures contracts, and interest rate swaps can either be exchange traded or over the counter. Exchange traded derivatives typically fall within Level 1 of the fair value hierarchy if there is active trading activity. Two methods are used to value over-the-counter derivatives. When required inputs are available, certain derivatives are valued using valuation pricing models, which represent what we would expect to receive or pay at the balance sheet date if we cancelled or exercised the derivative or entered into offsetting positions. Valuation models require a variety of inputs, which include the use of market-observable inputs, including interest rate, yield curve volatilities, and other factors. These over-the-counter derivatives are typically classified within Level 2 of the fair value hierarchy as the majority trade in liquid markets, we can verify model inputs and model selection does not involve significant management judgment. When inputs aren’t available for valuation models, certain over-the-counter derivatives are valued using independent broker quotes, which are based on unobservable market data and classified within Level 3. Effective September 30, 2024, pricing for certain derivatives was obtained from internal models using substantially all market observable inputs, and those derivatives were transferred out of Level 3 to Level 2. The fair value of the reinsurance-related embedded derivatives in the funds withheld reinsurance agreements are estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therefore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2. See Note O F&G Reinsurance for further discussion on F&G reinsurance agreements. The fair value measurement of the indexed annuities/IUL embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and treasury rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase equity options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier and non-performance spread. The mortality multiplier at December 31, 2024 and 2023 was applied to the 2012 Individual Annuity mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in treasury rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. Investments in Unconsolidated affiliates We have elected the fair value option for certain investments in unconsolidated affiliates as we believe this better aligns them with other investments in unconsolidated affiliates that are measured using NAV as a practical expedient in determining fair value. Investments measured using the fair value option are included in Level 3 and the fair values of these investments are determined using a multiple of the affiliates’ EBITDA. The EBITDA is based on the affiliates’ financial information. The multiple is derived from market analysis of transactions involving comparable companies. The inputs are considered unobservable, as not all market participants have access to this data. Short-term Investments The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value. Certain short-term investments are valued based on third-party pricing services or broker quotes and are classified as Level 2 or 3. Loan receivable Concurrent with the Roar purchase agreement, F&G executed a separate loan agreement with the sellers of Roar. The loan is collateralized by the sellers’ minority equity stake in Roar. The loan receivable is measured at fair value using a discounted cash flow model applied using a Monte Carlo simulation of estimated cash flows at each measurement period and for each simulated path relative to the estimated collateral value. The Monte Carlo simulation utilizes the outstanding principal balance, a risk-adjusted discount rate, and risk-free rates to discount the expected cash flows and compare to the estimated collateral value for each payment period and simulated path. The discounted cash flow approach applies a company-specific discount rate to future expected interest and payoff payments to calculate the estimated fair value based on the average outcome from the simulation. This loan receivable is included in Level 3 and the inputs are considered unobservable, as not all market participants have access to this data. Other long-term investments We hold a fund-linked note, which provides for an additional payment at maturity based on the value of an embedded derivative based on the actual return of a dedicated return fund. Fair value of the embedded derivative is based on an unobservable input, the NAV of the fund at the balance sheet date. The embedded derivative is similar to an equity option on the NAV of the fund with a strike price of zero since F&G will not be required to make any additional payments at maturity of the fund-linked note in order to receive the NAV of the fund on the maturity date. A Black-Scholes model determines the NAV of the fund as the fair value of the equity option regardless of the values used for the other inputs to the option pricing model. The NAV of the fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the fund. As the value of the fund increases or decreases, the fair value of the embedded derivative will increase or decrease. See further discussion on the available-for-sale embedded derivative in Note F Derivative Financial Instruments . The fair value of the credit-linked note is based on a weighted average of a broker quote and a discounted cash flow analysis. The discounted cash flow approach is based on the expected portfolio cash flows and amortization schedule reflecting investment expectations, adjusted for assumptions on the portfolio's default and recovery rates, and the note's discount rate. The fair value of the note is provided by the fund manager at the end of each quarter. Other Assets Mortgage servicing rights are measured at fair value using a discounted cash flow model, which incorporates assumptions that market participants use in estimating future net servicing income cash flows. These assumptions include estimates of prepayment rates, discount rates, cost to service (including delinquency and foreclosure costs), escrow account earnings, contractual servicing fee income, and ancillary income. Contingent Consideration The contingent consideration is measured at fair value using a discounted cash flow model applied using a Monte Carlo simulation of estimated EBITDA at each measurement period and for each simulated path relative to contractual EBITDA milestones. The Monte Carlo simulation utilizes a risk-adjusted discount rate, volatility assumption, and risk-free rates to assess the probability Roar's EBITDA trajectory reaches required milestones for the earn out payments to be made. The discounted cash flow approach applies a company-specific discount rate based on F&G credit profile to future expected earn out payments to calculate the estimated fair value based on the average outcome from the simulation. See further discussion on the contingent consideration in Note H Commitments and Contingencies. MRBs MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits. The fair value is calculated using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, rider benefit utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread which reflects the credit of the reinsurer. See further discussion on MRBs in Note X Market Risk Benefits . Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2024 and 2023, excluding assets and liabilities for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2024 (in millions) December 31, 2024 Assets Asset-backed securities $ 95 Third-Party Valuation Discount Rate 4.83% - 7.15% (6.33%) Corporates 7 Discounted Cash Flow Discount Rate 13.33% - 100.00% (96.45%) Corporates 750 Third-Party Valuation Discount Rate 2.00% - 22.53% (6.76%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.89%-5.89% (5.89%) Foreign Governments 4 Third-Party Valuation Discount Rate 12.14% - 12.14% (12.14%) Investment in unconsolidated affiliates 272 Market Comparable Company Analysis EBITDA Multiple 8.7x - 23.6x (14.6x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% - 100.00% (100.00%) Equity securities 4 Discounted Cash Flow Discount rate 4.80% - 14.10% (9.40%) Market Comparable Company Analysis EBITDA multiple 5.8x - 7.5x (7.0x) Other assets 65 Discounted Cash Flow Discount Rate 10.60% - 12.00% (11.30%) Conditional Prepayment Rate 6.24% -11.99% (9.12%) Other long-term investments: Available-for-sale embedded derivative 32 Black Scholes Model Market Value of AnchorPath Fund 100.00% Prepaid expenses and other assets: Loan receivable 11 Discounted Cash Flow Risk-Adjusted Discount Rate 7.22% - 7.22% (7.22%) Collateral Volatility 35.00% - 35.00% (35.00%) Market risk benefits asset 189 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.05%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.48% - 0.95% (0.75%) GMWB Utilization 50.00% - 75.00% (61.77%) Total financial assets at fair value (a) $ 1,433 Liabilities Derivatives: Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 5,220 Discounted Cash Flow Market Value of Option 0.00% - 20.81% (2.92%) Mortality Multiplier 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 50.00% (6.94%) Partial Withdrawals 2.00% - 35.71% (2.72%) Non-Performance Spread 0.48% - 0.95% (0.75%) Option Cost 0.07% - 5.70% (2.68%) Contingent consideration 74 Discounted Cash Flow Risk-Adjusted Discount Rate 13.50% - 13.50% (13.50%) EBITDA Volatility 35% - 35% (35%) Counterparty Discount Rate 6.50% - 6.50% (6.50%) Market risk benefits liability 549 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.05%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.48% - 0.95% (0.75%) GMWB Utilization 50.00% - 75.00% (61.77%) Total financial liabilities at fair value $ 5,843 (a) Excludes $10,301 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above. Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2023 (In millions) December 31, 2023 Assets Asset-backed securities $ 57 Third-Party Valuation Discount Rate 5.09% - 6.95% (6.00%) Corporates 787 Third-Party Valuation Discount Rate 0.00% - 12.87% (6.91%) Corporates 8 Discounted Cash Flow Discount Rate 44.00% - 100.00% (75.20%) Municipals 32 Third-Party Valuation Discount Rate 6.25% - 6.25% (6.25%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.46% - 5.46% (5.46%) Foreign Governments 16 Third-Party Valuation Discount Rate 6.94% - 7.68% (7.45%) Investment in unconsolidated affiliates 285 Market Comparable Company Analysis EBITDA Multiple 4.4x - 31.8x (23.2x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% Equity securities 7 Discounted Cash Flow Discount rate 11.50% - 11.50% (11.50%) Other long-term investments: Available-for-sale embedded derivative 28 Black Scholes Model Market Value of Fund 100% Market risk benefits asset 88 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial assets at fair value (a) $ 1,312 Liabilities Derivatives: Indexed annuities/ IUL embedded derivatives, included in Contractholder funds $ 4,258 Discounted Cash Flow Market Value of Option 0.00% - 18.93% (2.63%) Swap Rates 3.84% - 5.26% (4.55%) Mortality Multiplier 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 70.00% (6.83%) Partial Withdrawals 2.00% - 34.48% (2.74%) Non-Performance Spread 0.38% - 1.10% 0.96% Option Cost 0.07% - 5.48% (2.38%) Market risk benefits liability 403 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% 2.50% Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial liabilities at fair value $ 4,661 (a) Assets of $8,365 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above. The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2024 and 2023, respectively. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended December 31, 2024 (in millions) Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 19 $ 128 $ 5,104 $ (2,825) $ (1,210) $ (195) $ 8,143 $ 130 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (3) 81 1,148 (100) (139) (9) 2,957 80 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — (1) — — (11) — 4 (1) Preferred securities 8 — — — — — — 8 — Equity securities 15 (5) — — — — — 10 — Interest rate swaps 57 (50) 3 — — — (7) 3 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — — — 65 — — — 65 — Short-term investments — — — 236 (190) (9) — 37 — Other long-term assets: Available-for-sale embedded derivative 27 — 5 — — — — 32 5 Credit linked note 10 1 — — — (11) — — — Prepaid expenses and other assets: Loan receivable (c) — — — 11 — — — 11 — Subtotal Level 3 assets at fair value $ 9,589 $ 41 $ 217 $ 6,623 $ (3,165) $ (1,380) $ (380) $ 11,545 $ 216 Market risk benefits asset (d)) 88 189 Total Level 3 assets at fair value $ 9,677 $ 11,734 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 45 $ — $ 1,351 $ — $ (434) $ — $ 5,220 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (e) — 26 — 48 — — — 74 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 99 $ — $ 1,399 $ — $ (434) $ (28) $ 5,294 $ — Market Risk benefits liability (d) 403 549 Total Level 3 liabilities at fair value $ 4,661 $ 5,843 (a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2 with the exception of (b) below. (b) The transfer out of investments in unconsolidated affiliates reflects F&G’s majority acquisition of PALH on July 18, 2024. Refer to Note B Acquisitions for details of the PALH majority acquisition. (c) Purchases represent advances on the loan commitment to Roar. Refer to Note H - Commitments and Contingencies for further details. (d) Refer to Note X Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability. (e) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note B Acquisitions for more information. Year ended December 31, 2023 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (53) $ 186 $ 1,830 $ (125) $ (738) $ (241) $ 7,122 $ 185 Commercial mortgage-backed securities 37 — 2 22 — — (43) 18 2 Corporates 1,440 (2) (21) 654 (1) (94) 3 1,979 (20) Municipals 29 — 20 — — — — 49 20 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 13 — 249 — — — 285 — Short-term investments — — — 204 (19) (185) — — — Derivative Instruments — 57 — — — — — 57 — Preferred securities 1 — — — — — 7 8 1 Equity securities 10 1 1 — — — 3 15 — Other long-term assets: Available-for-sale embedded derivative 23 — 4 — — — — 27 4 Credit linked note 15 — — — — (5) — 10 — Secured borrowing receivable 10 — — — — (10) — — — Subtotal Level 3 assets at fair value $ 8,169 $ 17 $ 199 $ 2,991 $ (145) $ (1,041) $ (601) $ 9,589 $ 199 Market risk benefits asset (b) 117 88 Total Level 3 assets at fair value $ 8,286 $ 9,677 Liabilities Indexed annuities embedded derivatives, included in contractholder funds $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Subtotal Total liabilities at Level 3 fair value $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Market risk benefits liability (b) 282 403 Total Level 3 liabilities at fair value $ 3,397 $ 4,661 ( a) The net transfers out of Level 3 during the year ended December 31, 2023, were to Level 2. (b) Refer to Note X Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. Mortgage Loans The fair value of mortgage loans is established using a discounted cash flow method based on internal credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The internal ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy. Investments in Unconsolidated affiliates In our F&G segment, the fair value of Investments in unconsolidated affiliates is determined using NAV as a practical expedient and are included in the NAV column in the table below. In our Title segment, Investments in unconsolidated affiliates are accounted for under the equity method of accounting. In our Title segment, Investments in unconsolidated affiliates were $166 million and $263 million as of December 31, 2024 and 2023, respectively. Policy Loans (included within Other long-term investments) Policy loans are reported at the unpaid principal balance and are fully collateralized by the cash surrender value of underlying insurance policies. The carrying value of the policy loans approximates the fair value and are classified as Level 3 in the fair value hierarchy. Company Owned Life Insurance (included within Other long-term investments) Company owned life insurance ("COLI") is a life insurance program used to finance certain employee benefit expenses. The fair value of COLI is based on net realizable value, which is generally cash surrender value. COLI is classified as Level 3 within the fair value hierarchy. Other Invested Assets (included within Other long-term investments) The fair value of bank loans is estimated using a discounted cash flow method with the discount rate based on weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end. Bank loans are classified as Level 3 within the fair value hierarchy. For cost method investments, our carrying value approximates fair value. Cost method investments are classified as Level 1 within the fair value hierarchy. Investment Contracts Investment contracts include deferred annuities (indexed annuities and fixed rate annuities), IUL policies, funding agreements and PRT, and immediate annuity contracts without life contingencies. The indexed annuities/IUL embedded derivatives, included in contractholder funds, are excluded as they are carried at fair value. The fair value of the deferred annuities (indexed annuities and fixed rate annuities) and IUL contracts is based on their cash surrender value (i.e., the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of funding agreements and PRT and immediate annuity contracts without life contingencies is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Other

Investments

Investments	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 <1.00 December 31, 2024 (Dollars in millions) LTV Ratios: Less than 50.00% $ 490 $ 34 $ — $ 524 19 % $ 501 21 % 50.00% to 59.99% 803 112 12 927 34 826 34 60.00% to 74.99% 1,238 16 — 1,254 46 1,060 44 75.00% to 84.99% 4 4 9 17 1 17 1 Total Commercial mortgage loans $ 2,535 $ 166 $ 21 $ 2,722 100 % $ 2,404 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 Total Commercial mortgage loans (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 66 $ 99 $ 19 $ 74 $ 189 $ 77 $ 524 50.00% to 59.99% 112 53 149 321 159 133 927 60.00% to 74.99% 91 71 113 858 121 — 1,254 75.00% to 84.99% 4 4 9 — — — 17 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 2,722 DSCR Greater than 1.25x $ 140 $ 215 $ 278 $ 1,241 $ 469 $ 192 $ 2,535 1.00x - 1.25x 133 12 3 — — 18 166 Less than 1.00x — — 9 12 — — 21 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 $ 2,722 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At December 31, 2024, we had one CML that was delinquent in principal or interest payments compared to none at December 31, 2023 as shown in the tables above. Residential Mortgage Loans RMLs represented approximately 5% of our total investments as of December 31, 2024 and 2023. Our residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: December 31, 2024 U.S. States: Amortized Cost (In millions) % of Total Florida $ 164 5 % All Other States (1) 3,110 95 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % Allowance for expected credit loss (53) Total residential mortgage loans, net of valuation allowance $ 3,221 (1) The individual concentration of each state is less than 5% as of December 31, 2024. December 31, 2023 U.S. States: Amortized Cost (In millions) % of Total Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (1) 2,431 84 Total residential mortgage loans, gross of valuation allowance $ 2,852 100 % Allowance for expected credit loss (54) Total residential mortgage loans, net of valuation allowance $ 2,798 (1) The individual concentration of each state is less than 5% as of December 31, 2023. RMLs have a primary credit quality indicator of either a performing or non-performing loan. We define non-performing RMLs as those that are 90 or more days past due or in non-accrual status, which is assessed monthly. The credit quality of RMLs was as follows: December 31, 2024 December 31, 2023 Performance indicators: Amortized Cost % of Total Amortized Cost % of Total (Dollars in millions) Performing $ 3,188 97 % $ 2,795 98 % Non-performing 86 3 57 2 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % $ 2,852 100 % Allowance for expected loan loss (53) — (54) — Total residential mortgage loans, net of valuation allowance $ 3,221 100 % $ 2,798 100 % There were no charge offs recorded for RMLs during the year ended December 31, 2024. RMLs segregated by aging of the loans (by year of origination) as of December 31, 2024 and 2023 were as follows, gross of valuation allowances: December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 610 $ 368 $ 911 $ 805 $ 162 $ 312 $ 3,168 30-89 days past due 1 6 4 6 1 3 21 90 days or more past due 3 2 13 29 13 25 85 Total residential mortgages $ 614 $ 376 $ 928 $ 840 $ 176 $ 340 $ 3,274 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852 Non-accrual loans by amortized cost as of December 31, 2024 and 2023 were as follows: Amortized cost of loans on non-accrual December 31, 2024 December 31, 2023 (In millions) Residential mortgage $ 85 $ 57 Commercial mortgage 9 — Total non-accrual mortgages $ 94 $ 57 Immaterial interest income was recognized on non-accrual financing receivables for the years ended December 31, 2024 and 2023. It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of December 31, 2024 and 2023, we had $94 million and $57 million, respectively, of mortgage loans that were over 90 days past due. As of December 31, 2024 and 2023 we had $81 million and $41 million, respectively, of residential mortgage loans that were in the process of foreclosure. Loan Modifications Under certain circumstances, modifications are granted to mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, payment deferrals, principal forgiveness or a combination of these concessions. We had an immaterial amount of mortgage loans modified during the years ended December 31, 2024 and 2023. Allowance for Expected Credit Loss We estimate expected credit losses for our CML and RML portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. The allowances for our mortgage loan portfolio are summarized as follows (in millions): Year ended December 31, 2024 Year ended December 31, 2023 Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (54) $ (12) $ (66) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 1 (5) (4) (22) (5) (27) Loans charged-off — — — — 3 3 Ending Balance $ (53) $ (17) $ (70) $ (54) $ (12) $ (66) An allowance for expected credit loss is not measured on accrued interest income for CMLs as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for RMLs and were immaterial as of December 31, 2024 and 2023. There were no purchases of purchased credit deteriorated mortgage loans during the years ended December 31, 2024 and 2023. As of December 31, 2024 and 2023, the accrued interest receivable balance on CMLs totaled $8 million and $7 million, respectively. As of December 31, 2024 and 2023, the accrued interest receivable on RMLs totaled $28 million and $24 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the Consolidated Balance Sheets. Interest and Investment Income The major sources of Interest and investment income reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Fixed maturity securities, available-for-sale $ 2,261 $ 1,911 $ 1,489 Equity securities 33 33 31 Preferred securities 34 52 67 Mortgage loans 273 229 186 Invested cash and short-term investments 238 151 61 Limited partnerships 326 231 110 Tax deferred property exchange income 133 166 103 Other investments 125 91 41 Gross investment income 3,423 2,864 2,088 Investment expense (299) (257) (197) Interest and investment income $ 3,124 $ 2,607 $ 1,891 The Company’s Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements, which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $636 million, $339 million, and $109 million for the years ended December 31, 2024, 2023 and 2022, respectively. Recognized Gains and Losses, Net Details underlying Recognized gains and losses, net reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (9) $ (155) $ (253) Net realized/unrealized gains (losses) on equity securities (1) 2 23 (386) Net realized/unrealized gains (losses) on preferred securities (2) 12 (1) (230) Realized gains (losses) on other invested assets 61 (25) (68) Change in allowance for expected credit losses (33) (36) (41) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 254 (211) (164) Unrealized (losses) gains on certain derivative instruments (184) 358 (693) Change in fair value of reinsurance related embedded derivatives (32) (128) 352 Change in fair value of other derivatives and embedded derivatives 12 11 (10) Realized gains (losses) on derivatives and embedded derivatives 50 30 (515) Recognized gains and losses, net $ 83 $ (164) $ (1,493) (1) Includes net valuation (losses) gains of $(131) million, $47 million and $(387) million for the years ended December 31, 2024, 2023, and 2022, respectively. (2) Includes net valuation gains (losses) of $13 million, $80 million, and $(198) million for the years ended December 31, 2024, 2023 and 2022, respectively. Recognized gains and losses is shown net of amounts attributable to certain funds withheld reinsurance agreements which are passed along to the reinsurer in accordance with the terms of these agreements. Recognized (losses) gains attributable to these agreements, and thus excluded from the totals in the table above, was $(30) million, $(123) million and $381 million for the years ended December 31, 2024, 2023 and 2022, respectively. The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Proceeds $ 4,414 $ 2,698 $ 3,264 Gross gains 45 18 14 Gross losses (80) (145) (252) Unconsolidated Variable Interest Entities The Company owns investments in VIEs that are not consolidated within our financial statements. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While the Company participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with the Company. It is for this reason that the Company is not considered the primary beneficiary for the VIE investments that are not consolidated. We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities and residential mortgage-backed securities included in fixed maturity securities available for sale on our Consolidated Balance Sheets. Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our Consolidated Balance Sheets for limited partnerships and the amortized costs of certain of our fixed maturity securities, in addition to any required unfunded commitments (also refer to Note H Commitments and Contingencies ). The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs: December 31, 2024 December 31, 2023 Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure (In millions) Investment in unconsolidated affiliates $ 3,565 $ 4,703 $ 3,071 $ 4,806 Fixed maturity securities 23,242 24,242 20,837 22,346 Total unconsolidated VIE investments $ 26,807 $ 28,945 $ 23,908 $ 27,152 " id="sjs-B4" xml:space="preserve">Investments Our investments in fixed maturity securities have been designated as AFS, and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings. Our consolidated investments are summarized as follows: December 31, 2024 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 15,784 $ (13) $ 202 $ (317) $ 15,656 Commercial mortgage-backed securities 5,379 (49) 53 (201) 5,182 Corporates 24,425 (5) 108 (2,832) 21,696 Hybrids 604 — 6 (29) 581 Municipals 1,638 — 3 (255) 1,386 Residential mortgage-backed securities 2,869 — 32 (105) 2,796 U.S. Government 645 — 2 (10) 637 Foreign Governments 337 — — (53) 284 Total available-for-sale securities $ 51,681 $ (67) $ 406 $ (3,802) $ 48,218 December 31, 2023 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 14,631 $ (11) $ 191 $ (469) $ 14,342 Commercial mortgage-backed/asset-backed securities 4,797 (22) 23 (323) 4,475 Corporates 20,133 (6) 186 (2,417) 17,896 Hybrids 668 — 3 (53) 618 Municipals 1,826 — 14 (229) 1,611 Residential mortgage-backed securities 2,507 (3) 29 (104) 2,429 U.S. Government 679 — 8 (9) 678 Foreign Governments 365 — 3 (44) 324 Total available-for-sale securities $ 45,606 $ (42) $ 457 $ (3,648) $ 42,373 Securities held on deposit with various state regulatory authorities had a fair value of $997 million and $141 million at December 31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, we held $32 million and $47 million of investments that were non-income producing for a period greater than twelve months, respectively. As of December 31, 2024 and 2023, the Company's accrued interest receivable balance, excluding accrued interest receivable balances related to mortgage loans discussed below under "Mortgage Loans", was $476 million and $450 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets In accordance with our FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $4,289 million and $4,345 million as of December 31, 2024 and 2023, respectively. The amortized cost and fair value of fixed maturity securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. December 31, 2024 December 31, 2023 (in millions) (in millions) Amortized Cost Fair Value Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 961 $ 955 $ 703 $ 687 Due after one year through five years 4,616 4,544 4,320 4,209 Due after five years through ten years 5,311 5,126 3,195 3,048 Due after ten years 16,761 13,959 15,453 13,183 27,649 24,584 23,671 21,127 Other securities, which provide for periodic payments: Asset-backed securities 15,784 15,656 14,631 14,342 Commercial mortgage-backed securities 5,379 5,182 4,797 4,475 Residential mortgage-backed securities 2,869 2,796 2,507 2,429 24,032 23,634 21,935 21,246 Total fixed maturity available-for-sale securities $ 51,681 $ 48,218 $ 45,606 $ 42,373 Allowance for Current Expected Credit Loss We regularly review AFS securities for declines in fair value that we determine to be credit related. For our fixed maturity securities, we generally consider the following in determining whether our unrealized losses are credit related, and if so, the magnitude of the credit loss: • The extent to which the fair value is less than the amortized cost basis; • The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening); • The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength); • Current delinquencies and non-performing assets of underlying collateral; • Expected future default rates; • Collateral value by vintage, geographic region, industry concentration or property type; • Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and • Contractual and regulatory cash obligations and the issuer's plans to meet such obligations. We recognize an allowance for current expected credit losses on fixed maturity securities in an unrealized loss position when it is determined, using the factors discussed above, a component of the unrealized loss is related to credit. We measure the credit loss using a discounted cash flow model that utilizes the single best estimate cash flow and the recognized credit loss is limited to the total unrealized loss on the security (i.e. the fair value floor). Cash flows are discounted using the implicit yield of bonds at their time of purchase and the current book yield for asset and mortgage backed securities as well as variable rate securities. We recognize the expected credit losses in Recognized gains and losses, net in the Consolidated Statements of Earnings, with an offset for the amount of non-credit impairments recognized in AOCI. We do not measure a credit loss allowance on accrued investment income because we write-off accrued interest through Interest and investment income when collectability concerns arise. We consider the following in determining whether write-offs of a security’s amortized cost is necessary: • We believe amounts related to securities have become uncollectible; or • We intend to sell a security; or • It is more likely than not that we will be required to sell a security prior to recovery. If we intend to sell a fixed maturity security or it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, we will write down the security to current fair value, with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. If we do not intend to sell a fixed maturity security or it is more likely than not that we will not be required to sell a fixed maturity security before recovery of its amortized cost basis but believe amounts related to a security are uncollectible , an impairment is deemed to have occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. The remainder of unrealized loss is held in AOCI. As of December 31, 2024 and 2023, our allowance for expected credit losses for AFS securities was $67 million and $42 million, respectively. The fair value and gross unrealized losses of available-for-sale securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost were as follows: December 31, 2024 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (Dollars in millions) Asset-backed securities $ 1,164 $ (30) $ 2,637 $ (276) $ 3,801 $ (306) Commercial mortgage-backed securities 727 (11) 1,513 (175) 2,240 (186) Corporates 6,831 (208) 9,866 (2,624) 16,697 (2,832) Hybrids 105 (4) 380 (25) 485 (29) Municipals 261 (12) 1,006 (243) 1,267 (255) Residential mortgage-backed securities 899 (16) 460 (89) 1,359 (105) U.S. Government 313 (4) 122 (5) 435 (9) Foreign Government 120 (5) 157 (48) 277 (53) Total available-for-sale securities $ 10,420 $ (290) $ 16,141 $ (3,485) $ 26,561 $ (3,775) Total number of available-for-sale securities in an unrealized loss position less than twelve months 2,005 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,305 Total number of available-for-sale securities in an unrealized loss position 4,310 December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities Asset-backed securities $ 1,707 $ (56) $ 5,835 $ (404) $ 7,542 $ (460) Commercial mortgage-backed securities 819 (53) 1,922 (235) 2,741 (288) Corporates 2,387 (134) 10,739 (2,283) 13,126 (2,417) Hybrids 60 (2) 483 (51) 543 (53) Municipals 399 (49) 920 (179) 1,319 (228) Residential mortgage-backed securities 336 (5) 662 (89) 998 (94) U.S. Government 84 — 159 (9) 243 (9) Foreign Government 49 (3) 188 (41) 237 (44) Total available-for-sale securities $ 5,841 $ (302) $ 20,908 $ (3,291) $ 26,749 $ (3,593) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,035 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,846 Total number of available-for-sale securities in an unrealized loss position 3,881 We determined the unrealized losses were caused by higher treasury rates compared to those at the time of the F&G acquisition or the purchase of the security if later. For securities in an unrealized loss position as of December 31, 2024, our allowance for expected credit loss was $67 million. We believe the unrealized loss position for which we have not recorded an allowance for expected credit loss as of December 31, 2024 was primarily attributable to interest rate increases, near-term illiquidity, and other macroeconomic uncertainties as opposed to issuer specific credit concerns. Mortgage Loans Our mortgage loans are collateralized by commercial and residential properties. Commercial Mortgage Loans CMLs represented approximately 4% of our total investments as of December 31, 2024 and 2023. The mortgage loans in our investment portfolio are generally comprised of high quality commercial first lien and mezzanine real estate loans. Mortgage loans are primarily on income producing properties including industrial properties, retail buildings, multifamily properties and office buildings. We diversify our CML portfolio by geographic region and property type to attempt to reduce concentration risk. We continuously evaluate CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: December 31, 2024 December 31, 2023 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: (Dollars in millions) Hotel $ 17 1 % $ 18 1 % Industrial 657 24 616 24 Mixed Use 11 — 11 — Multifamily 1,006 37 1,012 40 Office 349 13 316 13 Retail 98 4 102 4 Student Housing 83 3 83 3 Other 501 18 392 15 Total commercial mortgage loans, gross of valuation allowance $ 2,722 100 % $ 2,550 100 % Allowance for expected credit loss (17) (12) Total commercial mortgage loans, net of valuation allowance $ 2,705 $ 2,538 U.S. Region: East North Central $ 98 4 % $ 151 6 % East South Central 75 3 75 3 Middle Atlantic 354 13 354 14 Mountain 409 15 352 14 New England 164 6 168 6 Pacific 706 26 766 30 South Atlantic 683 25 563 22 West North Central 62 2 4 — West South Central 171 6 117 5 Total commercial mortgage loans, gross of valuation allowance $ 2,722 100 % $ 2,550 100 % Allowance for expected credit loss (17) (12) Total commercial mortgage loans, net of valuation allowance $ 2,705 $ 2,538 CMLs segregated by aging of the loans and charge offs (by year of origination) were as follows for the year ended December 31, 2024: December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total (In millions) Current (less than 30 days past due) $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 201 $ 2,713 30-89 days past due — — — — — — — 90 days or more past due — — — — — 9 9 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 $ 2,722 Charge offs $ — $ — $ — $ — $ — $ — $ — CMLs segregated by aging of loans (by year of origination) were as follows for the year ended December 31, 2023: December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total (In millions) Current (less than 30 days past due) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 30-89 days past due — — — — — — — 90 days or more past due — — — — — — — Total commercial mortgage loans(a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Charge offs $ — $ — $ — $ — $ — $ 3 $ 3 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation. The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios, gross of valuation allowances : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 <1.00 December 31, 2024 (Dollars in millions) LTV Ratios: Less than 50.00% $ 490 $ 34 $ — $ 524 19 % $ 501 21 % 50.00% to 59.99% 803 112 12 927 34 826 34 60.00% to 74.99% 1,238 16 — 1,254 46 1,060 44 75.00% to 84.99% 4 4 9 17 1 17 1 Total Commercial mortgage loans $ 2,535 $ 166 $ 21 $ 2,722 100 % $ 2,404 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 Total Commercial mortgage loans (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 66 $ 99 $ 19 $ 74 $ 189 $ 77 $ 524 50.00% to 59.99% 112 53 149 321 159 133 927 60.00% to 74.99% 91 71 113 858 121 — 1,254 75.00% to 84.99% 4 4 9 — — — 17 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 2,722 DSCR Greater than 1.25x $ 140 $ 215 $ 278 $ 1,241 $ 469 $ 192 $ 2,535 1.00x - 1.25x 133 12 3 — — 18 166 Less than 1.00x — — 9 12 — — 21 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 $ 2,722 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At December 31, 2024, we had one CML that was delinquent in principal or interest payments compared to none at December 31, 2023 as shown in the tables above. Residential Mortgage Loans RMLs represented approximately 5% of our total investments as of December 31, 2024 and 2023. Our residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: December 31, 2024 U.S. States: Amortized Cost (In millions) % of Total Florida $ 164 5 % All Other States (1) 3,110 95 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % Allowance for expected credit loss (53) Total residential mortgage loans, net of valuation allowance $ 3,221 (1) The individual concentration of each state is less than 5% as of December 31, 2024. December 31, 2023 U.S. States: Amortized Cost (In millions) % of Total Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (1) 2,431 84 Total residential mortgage loans, gross of valuation allowance $ 2,852 100 % Allowance for expected credit loss (54) Total residential mortgage loans, net of valuation allowance $ 2,798 (1) The individual concentration of each state is less than 5% as of December 31, 2023. RMLs have a primary credit quality indicator of either a performing or non-performing loan. We define non-performing RMLs as those that are 90 or more days past due or in non-accrual status, which is assessed monthly. The credit quality of RMLs was as follows: December 31, 2024 December 31, 2023 Performance indicators: Amortized Cost % of Total Amortized Cost % of Total (Dollars in millions) Performing $ 3,188 97 % $ 2,795 98 % Non-performing 86 3 57 2 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % $ 2,852 100 % Allowance for expected loan loss (53) — (54) — Total residential mortgage loans, net of valuation allowance $ 3,221 100 % $ 2,798 100 % There were no charge offs recorded for RMLs during the year ended December 31, 2024. RMLs segregated by aging of the loans (by year of origination) as of December 31, 2024 and 2023 were as follows, gross of valuation allowances: December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 610 $ 368 $ 911 $ 805 $ 162 $ 312 $ 3,168 30-89 days past due 1 6 4 6 1 3 21 90 days or more past due 3 2 13 29 13 25 85 Total residential mortgages $ 614 $ 376 $ 928 $ 840 $ 176 $ 340 $ 3,274 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852 Non-accrual loans by amortized cost as of December 31, 2024 and 2023 were as follows: Amortized cost of loans on non-accrual December 31, 2024 December 31, 2023 (In millions) Residential mortgage $ 85 $ 57 Commercial mortgage 9 — Total non-accrual mortgages $ 94 $ 57 Immaterial interest income was recognized on non-accrual financing receivables for the years ended December 31, 2024 and 2023. It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of December 31, 2024 and 2023, we had $94 million and $57 million, respectively, of mortgage loans that were over 90 days past due. As of December 31, 2024 and 2023 we had $81 million and $41 million, respectively, of residential mortgage loans that were in the process of foreclosure. Loan Modifications Under certain circumstances, modifications are granted to mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, payment deferrals, principal forgiveness or a combination of these concessions. We had an immaterial amount of mortgage loans modified during the years ended December 31, 2024 and 2023. Allowance for Expected Credit Loss We estimate expected credit losses for our CML and RML portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. The allowances for our mortgage loan portfolio are summarized as follows (in millions): Year ended December 31, 2024 Year ended December 31, 2023 Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (54) $ (12) $ (66) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 1 (5) (4) (22) (5) (27) Loans charged-off — — — — 3 3 Ending Balance $ (53) $ (17) $ (70) $ (54) $ (12) $ (66) An allowance for expected credit loss is not measured on accrued interest income for CMLs as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for RMLs and were immaterial as of December 31, 2024 and 2023. There were no purchases of purchased credit deteriorated mortgage loans during the years ended December 31, 2024 and 2023. As of December 31, 2024 and 2023, the accrued interest receivable balance on CMLs totaled $8 million and $7 million, respectively. As of December 31, 2024 and 2023, the accrued interest receivable on RMLs totaled $28 million and $24 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the Consolidated Balance Sheets. Interest and Investment Income The major sources of Interest and investment income reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Fixed maturity securities, available-for-sale $ 2,261 $ 1,911 $ 1,489 Equity securities 33 33 31 Preferred securities 34 52 67 Mortgage loans 273 229 186 Invested cash and short-term investments 238 151 61 Limited partnerships 326 231 110 Tax deferred property exchange income 133 166 103 Other investments 125 91 41 Gross investment income 3,423 2,864 2,088 Investment expense (299) (257) (197) Interest and investment income $ 3,124 $ 2,607 $ 1,891 The Company’s Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements, which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $636 million, $339 million, and $109 million for the years ended December 31, 2024, 2023 and 2022, respectively. Recognized Gains and Losses, Net Details underlying Recognized gains and losses, net reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (9) $ (155) $ (253) Net realized/unrealized gains (losses) on equity securities (1) 2 23 (386) Net realized/unrealized gains (losses) on preferred securities (2) 12 (1) (230) Realized gains (losses) on other invested assets 61 (25) (68) Change in allowance for expected credit losses (33) (36) (41) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 254 (211) (164) Unrealized (losses) gains on certain derivative instruments (184) 358 (693) Change in fair value of reinsurance related embedded derivatives (32) (128) 352 Change in fair value of other derivatives and embedded derivatives 12 11 (10) Realized gains (losses) on derivatives and embedded derivatives 50 30 (515) Recognized gains and losses, net $ 83 $ (164) $ (1,493) (1) Includes net valuation (losses) gains of $(131) million, $47 million and $(387) million for the years ended December 31, 2024, 2023, and 2022, respectively. (2) Includes net valuation gains (losses) of $13 million, $80 million, and $(198) million for the years ended December 31, 2024, 2023 and 2022, respectively. Recognized gains and losses is shown net of amounts attributable to certain funds withheld reinsurance agreements which are passed along to the reinsurer in accordance with the terms of these agreements. Recognized (losses) gains attributable to these agreements, and thus excluded from the totals in the table above, was $(30) million, $(123) million and $381 million for the years ended December 31, 2024, 2023 and 2022, respectively. The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Proceeds $ 4,414 $ 2,698 $ 3,264 Gross gains 45 18 14 Gross losses (80) (145) (252) Unconsolidated Variable Interest Entities The Company owns investments in VIEs that are not consolidated within our financial statements. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While the Company participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with the Company. It is for this reason that the Company is not considered the primary beneficiary for the VIE investments that are not consolidated. We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities and residential mortgage-backed securities included in fixed maturity securities available for sale on our Consolidated Balance Sheets. Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our Consolidated Balance Sheets for limited partnerships and the amortized costs of certain of our fixed maturity securities, in addition to any required unfunded commitments (also refer to Note H Commitments and Contingencies ). The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs: December 31, 2024 December 31, 2023 Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure (In millions) Investment in unconsolidated affiliates $ 3,565 $ 4,703 $ 3,071 $ 4,806 Fixed maturity securities 23,242 24,242 20,837 22,346 Total unconsolidated VIE investments $ 26,807 $ 28,945 $ 23,908 $ 27,152

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The notional and carrying amounts of derivative instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance is as follows: December 31, 2024 December 31, 2023 Notional Amount Carrying Amount Notional Amount Carrying Amount Assets: (In millions) Derivative investments: Equity options $ 29,594 $ 773 $ 27,263 $ 739 Interest rate swaps 2,445 19 2,705 57 Other derivative investments 157 3 137 1 Other long-term investments: Other embedded derivatives 32 28 Prepaid expenses and other assets: Reinsurance related embedded derivatives 109 152 Total $ 936 $ 977 Liabilities: Contractholder funds: Indexed annuities/IUL embedded derivatives $ 5,220 $ 4,258 Accounts payable and accrued liabilities: Equity Options — 1 — 1 Interest rate swaps $ 2,700 10 — Total $ 5,231 $ 4,259 The change in fair value of derivative instruments included within Recognized gains and losses, net, in the accompanying Consolidated Statements of Earnings is as follows: Year ended December 31, 2024 2023 2022 Net investment gains (losses): (In millions) Equity options $ 153 $ 98 $ (862) Interest rate swaps (103) 48 — Futures contracts 18 9 (7) Other derivative investments 10 (2) 12 Other embedded derivatives 4 5 (10) Reinsurance related embedded derivatives (32) (128) 352 Total net investment gains (losses) $ 50 $ 30 $ (515) Benefits and other changes in policy reserves: Indexed annuities/IUL embedded derivatives increase (decrease) $ 962 $ 1,143 $ (768) Additional Disclosures See descriptions of the fair value methodologies used for derivative financial instruments in Note D Fair Value of Financial Instruments . Indexed Annuities/IUL Embedded Derivative, Equity Options and Futures We have indexed annuities and IUL contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, such as the S&P 500 Index. This feature represents an embedded derivative under GAAP. The indexed annuities/IUL embedded derivatives are valued at fair value and included in the liability for contractholder funds in the Consolidated Balance Sheets with changes in fair value included as a component of Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. We purchase derivatives consisting of a combination of equity options and futures contracts (specifically for indexed annuity contracts) on the applicable market indices to fund the index credits due to indexed annuity/IUL contractholders. The equity options are one two three five six Other market exposures are hedged periodically depending on market conditions and our risk tolerance. Our indexed annuities/IUL hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and our risk tolerance changes. Interest Rate Swaps We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. With an interest rate swap, we agree with another party to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts tied to an agreed upon notional principal. The interest rate swaps are marked to fair value with the change in fair value, including accrued interest and related periodic cash flows received or paid, included as a component of Recognized gains and (losses), net, in the Consolidated Statements of Earnings. Reinsurance Related Embedded Derivatives F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurances that are segregated within the funds withheld account are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The fair value of the total return swaps is based on the change in fair value of the underlying assets held in the funds withheld account. These embedded derivatives are reported in Prepaid expenses and other assets if in a net gain position, or Accounts payable and accrued liabilities, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in Recognized gains and (losses), net, on the Consolidated Statements of Earnings. Credit Risk We are exposed to credit loss in the event of non-performance by our counterparties and reflect assumptions regarding this non-performance risk in the fair value of our derivatives. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. We maintain a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. We manage credit risk related to non-performance by our counterparties by (i) entering into derivative transactions with creditworthy counterparties; (ii) obtaining collateral, such as cash and securities when appropriate; (iii) establishing counterparty exposure limits, which are subject to periodic management review. Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below: Fair Value Collateral Net Credit Risk (In millions) December 31, 2024 $ 782 $ 771 $ 34 December 31, 2023 796 775 39 Collateral Agreements We are required to maintain minimum ratings as a matter of routine practice as part of our over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, we have agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by us or the counterparty would be dependent on the market value of the underlying contracts. Our current rating does not allow any counterparty the right to terminate ISDA agreements. In certain transactions, both us and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, the threshold is set to zero. As of December 31, 2024 and 2023, counterparties posted collateral of $771 million and $775 million, respectively, of which $679 million and $588 million, respectively, is included in Cash and cash equivalents with an associated payable for this collateral included in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Accordingly, the maximum amount of loss due to credit risk that we would incur if parties to the derivatives failed completely to perform according to the terms of the contracts was $34 million at December 31, 2024, and $39 million at December 31, 2023. We are required to pay our counterparties the effective federal funds interest rate each day for cash collateral posted to us. Cash collateral is reinvested in overnight investment sweep products, which are included in Cash and cash equivalents on the Consolidated Balance Sheets, to reduce the interest cost. Changes in cash collateral are included in the Change in derivative collateral liabilities in the Consolidated Statements of Cash Flow.

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Notes Payable	Notes Payable Notes payable consists of the following: December 31, 2024 December 31, 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving Credit Facility (4) (2) F&G Credit Agreement — 362 5.50% F&G Notes 301 561 7.40% F&G Notes, net of discount 497 495 7.95% F&G Notes, net of discount 336 336 6.50% F&G Notes, net of discount 545 — 6.25% F&G Notes, net of discount 492 — Other 22 7 $ 4,321 $ 3,887 On October 4, 2024, F&G issued $500 million of its 6.25% Senior Notes due 2034. The 6.25% F&G Notes were issued at 99.36% of face value, net of deferred issuance costs of approximately $8 million. The 6.25% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G's subsidiaries that are guarantors of F&G's obligations under its existing credit agreement. The 6.25% F&G Notes mature on October 4, 2034, and become callable on July 4, 2034. Interest is payable semi-annually at a fixed rate of 6.25%, and if the 6.25% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. A portion of the net proceeds were used to pay off the outstanding balance of $365 million on the F&G Credit Agreement described below. F&G intends to use the remaining net proceeds of this offering for general corporate purposes, including the support of organic growth opportunities. On June 4, 2024, F&G issued $550 million of its 6.50% Senior Notes due 2029. The 6.50% F&G Notes were issued at 99.74% of face value, net of deferred issuance costs of approximately $6 million. The 6.50% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G's subsidiaries that are guarantors of F&G's obligations under its existing credit agreement. The 6.50% F&G Notes mature on June 4, 2029, and become callable on May 4, 2029. Interest is payable semi-annually at a fixed rate of 6.50%, and if the 6.50% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. A portion of the net proceeds were used to finance a cash tender offer by its wholly owned subsidiary Fidelity & Guaranty Life Holdings, Inc. (“FGLH”) for an aggregate principal amount of $250 million of FGLH’s 5.50% Senior Notes due 2025 (the “5.50% F&G Notes”). F&G intends to use the remaining net proceeds of this offering for general corporate purposes, which may include the repurchase, redemption or repayment at maturity of outstanding indebtedness. On December 6, 2023, F&G issued $345 million of its 7.95% Senior Notes due 2053 (the "7.95% F&G Notes"). The 7.95% F&G Notes were issued at par, net of deferred issuance costs of approximately $9 million. The 7.95% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.95% F&G Notes mature on December 15, 2053, and become callable on or after December 15, 2028. Interest is payable quarterly at a fixed rate of 7.95%, and, if the 7.95% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. On January 13, 2023, F&G issued $500 million of its 7.40% F&G Notes due 2028 (the 7.40% F&G Notes"). The 7.40% F&G Notes were issued at par, net of deferred issuance costs of approximately $6 million. The 7.40% F&G Notes are senior, unsecured unsubordinated obligations of F&G and are fully and unconditionally guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.40% F&G Notes mature on January 13, 2028, and become callable on or after December 13, 2027. Interest is payable semi-annually at a fixed rate of 7.40%, and if, the 7.40% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. On April 20, 2018, Fidelity & Guaranty Life Holdings, Inc. (“FGLH”), F&G's indirect wholly owned subsidiary, completed a debt offering of $550 million of 5.50% F&G Notes due May 1, 2025 at 99.5% of face value for proceeds of $547 million. As a result of our acquisition of F&G in 2020, a premium of $39 million was established for these notes and is being amortized over the remaining life of the debt through 2025. In conjunction with the acquisition, we became a guarantor of FGLH's obligations under the 5.50% F&G Notes and agreed to fully and unconditionally guarantee the 5.50% F&G Notes, on a joint and several basis. A portion of the net proceeds of the 6.50% F&G Notes were used for a $250 million cash tender offer of the 5.50% F&G Notes in June 2024. Refer to Note A - Business and Summary of Significant Accounting Policies for a discussion of the redemption of the 5.50% F&G Notes on February 1, 2025. On November 22, 2022, F&G entered into the F&G Credit Agreement pursuant to which the Lenders have made available the F&G Credit Facility in an aggregate principal amount of $550 million to be used for working capital and general corporate purposes. On February 21, 2023, F&G entered into the Amended F&G Credit Agreement with the Lenders and the Administrative Agent, swing line lender and issuing bank. The Amended F&G Credit Agreement increased the aggregate principal amount of commitments under the F&G Credit Facility by $115 million to $665 million. On February 16, 2024, F&G entered into a Second Amended and Restated F&G Credit Agreement. Among other changes, the Second Amended and Restated F&G Credit Agreement amends the Amended F&G Credit Agreement to extend the maturity date to November 22, 2027, and increase the aggregate principal amount of commitments under the revolving credit facility to $750 million. Revolving loans under the Credit Agreement generally bear interest at a variable rate based on either (i) the base rate (which is the highest of (a) one-half of one percent in excess of the federal funds rate, (b) the Administrative Agent’s “prime rate”, or (c) the sum of one percent plus Term The Secured Overnight Financing Rate (“SOFR”) plus a margin of between 30.0 and 80.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G or (ii) Term SOFR plus a margin of between 130.0 and 180.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G. In addition, F&G pays a facility fee of between 20.0 and 45.0 basis points on the entire facility, also depending on the non-credit-enhanced, senior unsecured long-term debt ratings, which is payable quarterly in arrears. The average variable interest rate on the revolving credit facility for the period the debt was outstanding in 2024 was 7.06% compared to 7.11% for the year ended December 31, 2023. As of December 31, 2024 and 2023, $0 million and $365 million, respectively, of gross principal balance, was outstanding under the F&G Credit Agreement. As of December 31, 2024, we had $750 million of remaining borrowing availability. On September 17, 2021, we completed our underwritten public offering of $450 million aggregate principal amount of our 3.20% Notes due 2051, pursuant to our registration statement on Form S-3 ASR (File No. 333-239002) and the related prospectus supplement. The net proceeds from the registered offering of the 3.20% Notes were approximately $443 million, after deducting underwriting discounts, commissions and offering expenses. We plan to use the net proceeds from the offering for general corporate purposes. On October 29, 2020, we entered into the Fifth Restated Credit Agreement for our Amended Revolving Credit Facility with Bank of America, N.A., as administrative agent and the other agents party thereto. Among other changes, the Fifth Restated Credit Agreement amends the Fourth Restated Credit Agreement to extend the maturity date from April 27, 2022 to October 29, 2025. The material terms of the Fourth Restated Credit Agreement are set forth in our Annual Report for the year ended December 31, 2019. As of December 31, 2024, there was no principal outstanding, $4 million of unamortized debt issuance costs, and $800 million of available borrowing capacity under the Revolving Credit Facility. On February 16, 2024, we entered into a Sixth Amended and Restated Credit Agreement. Among other changes, the Sixth Amended and Restated Credit Agreement amends the Fifth Restated Credit Agreement to extend the maturity date from October 29, 2025 to February 16, 2029. On September 15, 2020, we completed our underwritten public offering of $600 million aggregate principal amount of our 2.45% Notes due March 15, 2031 (the "2.45% Notes") pursuant to an effective registration statement filed with the Securities and Exchange Commission ("SEC"). The net proceeds from the registered offering of the 2.45% Notes were approximately $593 million, after deducting underwriting discounts and commissions and offering expenses. We used the net proceeds from the offering (i) to repay the remaining $260 million outstanding indebtedness under our prior term loan credit agreement dated April 22, 2020, among us, as borrower, various lenders, and Bank of American N.A., as administrative agent (the "Term Loan"), which provided for an aggregate principal borrowing of $1.0 billion that we entered into to fund a portion of the acquisition of F&G and (ii) for general corporate purposes. On June 12, 2020, we completed our underwritten public offering of $650 million aggregate principal amount of the 3.40% Notes due 2030 (the “3.40% Notes”) pursuant to an effective registration statement filed with the SEC. The net proceeds from the registered offering of the 3.40% Notes were approximately $642 million, after deducting underwriting discounts, and commissions and offering expenses. We used the net proceeds from the offering (i) to repay $640 million of the then outstanding principal amount under the Term Loan, and (ii) for general corporate purposes. On August 13, 2018, we completed an offering of $450 million in aggregate principal amount of 4.50% notes due August 2028 (the "4.50% Notes"), pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.50% Notes were priced at 99.252% of par to yield 4.594% annual interest. We pay interest on the 4.50% Notes semi-annually on the 15th of February and August, beginning February 15, 2019. The 4.50% Notes contain customary covenants and events of default for investment grade public debt, which primarily relate to failure to make principal or interest payments. On May 16, 2019, we completed an offering to exchange the 4.50% Notes for substantially identical notes registered pursuant to Rule 424 under the Securities Act of 1933 (the "4.50% Notes Exchange"). There were no material changes to the terms of the 4.50% Notes as a result of the 4.50% Notes Exchange and all holders of the 4.50% Notes accepted the offer to exchange. Gross principal maturities of notes payable at December 31, 2024, are as follows: (In millions) 2025 $ 300 2026 22 2027 — 2028 950 2029 550 Thereafter 2,545 $ 4,367

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal and Regulatory Contingencies In the ordinary course of business, we are involved in various pending and threatened litigation matters related to our operations, some of which include claims for punitive or exemplary damages. With respect to our title insurance operations, this customary litigation includes but is not limited to a wide variety of cases arising out of or related to title and escrow claims, for which we make provisions through our loss reserves. See Note C Summary of Reserve for Title Claim Losses for further discussion. Additionally, like other companies, our ordinary course litigation includes a number of class action and purported class action lawsuits, which make allegations related to aspects of our operations. We believe that no actions, other than the matters discussed below, if any, depart from customary litigation incidental to our business. We review lawsuits and other legal and regulatory matters (collectively “legal proceedings”) on an ongoing basis when making accrual and disclosure decisions. When assessing reasonably possible and probable outcomes, management bases its decision on its assessment of the ultimate outcome assuming all appeals have been exhausted. For legal proceedings in which it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and that represents our best estimate has been recorded. Our accrual for legal and regulatory matters was $17 million and $10 million a s of December 31, 2024 and 2023, respectively . None of the amounts we have currently recorded are considered to be material to our financial condition individually or in the aggregate. Actual losses may materially differ from the amounts recorded and the ultimate outcome of our pending legal proceedings is generally not yet determinable. While some of these matters could be material to our operating results or cash flows for any particular period if an unfavorable outcome results, at present we do not believe that the ultimate resolution of currently pending legal proceedings, either individually or in the aggregate, will have a material adverse effect on our financial condition. F&G is a defendant in two putative class action lawsuits related that allege some customers’ personally identifiable information was disclosed due to a vulnerability in the MOVEit file transfer software. F&G’s vendor, Pension Benefit Information, LLC (“PBI”), used the MOVEit software in the course of providing audit and address research services to F&G and many other corporate customers. Miller v. F&G, No. 4:23-cv-00326 ("Miller"), was filed against F&G in the Southern District of Iowa on August 31, 2023. Miller alleges that he is a F&G customer whose personally identifiable information was disclosed in the MOVEit incident and brings common law tort and implied contract claims. Plaintiff seeks injunctive relief and damages. Cooper v. Progress Software Corp. , No. 1:23-cv-12067 ("Cooper"), was filed against F&G and five other defendants in the District of Massachusetts on September 7, 2023. Cooper also alleges that he is a F&G customer whose personally identifiable information was disclosed and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract. Plaintiff seeks declaratory and injunctive relief and damages. Well over 150 similar lawsuits have been filed against other entities impacted by the MOVEit incident including a number of such lawsuits related to PBI’s use of MOVEit. On October 4, 2023, the U.S. Judicial Panel on Multidistrict Litigation created a multidistrict litigation ("MDL") pursuant to 28 U.S.C. § 1407 to handle all litigation brought by individuals whose information was potentially compromised in connection with the alleged MOVEit vulnerability. Both Miller and Cooper have been transferred to the MDL and are proceeding under MDL Case No. 1:23-md-03083-ADB-PGL. Plaintiffs filed amendments to their complaints, and the Defendants filed their omnibus motion to dismiss for lack of Article III standing on July 23, 2024. The case is proceeding under a modified bellwether structure to decide critical issues and facilitate reciprocal discovery. At this time, we do not believe the incident will have a material impact on our business, operations, or financial results. In connection with the cybersecurity incident initially reported on November 21, 2023, the Company and/or its subsidiaries is a party to a consolidated putative nationwide class action, In Re: LoanCare Data Security Breach Litigation , Case No. 3:23cv1508, pending in the U.S. District Court for the Middle District of Florida and originating from the consolidation of putative class actions filed in the U.S. District Courts for the Middle District of Florida, the Central District of California, and the Western District of Missouri. On March 19, 2024, plaintiffs filed their consolidated class action complaint on behalf of a nationwide class, along with a California subclass and a Florida subclass, alleging common law tort and contract claims and certain state statutory claims. The parties mediated the case on July 25, 2024, and reached an agreement in principle to resolve the case on a class-wide basis. The parties have sought preliminary court approval of the class-wide settlement. If approved, once the settlement administrator disburses all the funds, final court approval of the settlement will be sought, and the case dismissed. On May 28, 2024, a stockholder derivative lawsuit styled, Roofers Local 149 Pension Fund v. Fidelity National Financial Inc., William P. Foley, F&G Annuities & Life Inc. , C.A. No. 2024-0562-LWW, was filed in the Chancery Court of the State of Delaware against defendants Fidelity National Financial, Inc. (“FNF”), in its capacity as F&G Annuities & Life Inc.’s (“F&G”) controlling stockholder, and William P. Foley, Executive Chairman of F&G and Chairman of FNF, alleging breach of fiduciary duty related to F&G’s January 11, 2024 sale of $250 million of 6.875% Series A Mandatory Convertible Preferred Stock to FNF. Plaintiff alleges that, based upon the unfair process and unfair price, the preferred stock investment was advantageous to FNF and unfair to F&G. Plaintiff seeks to recover damages on behalf of F&G for the alleged unfair preferred stock investment and the adoption of certain corporate governance measures. On July 24, 2024, F&G filed its answer and the remaining defendants, including FNF, filed their motion to dismiss Plaintiff’s complaint. On September 23, 2024, Plaintiff voluntarily dismissed its action against William P. Foley, leaving FNF’s motion to dismiss fully briefed and a decision pending with the court. On February 4, 2025, FNF argued the motion to dismiss before the court. The remaining defendants will vigorously contest the Plaintiff’s claims in the action. Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) is a defendant in a lawsuit filed in U.S. District Court for the Southern District of Texas styled, Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company , Case No. 3:23-cv-00126. Plaintiff, which provides consulting services to independent marketing organizations (IMOs), alleges FGL Insurance failed to pay commissions owed to Plaintiff and diverted commissions from one of Plaintiff’s IMO customers, Syncis, to another IMO, Freedom Equity Group, LLC (“Freedom Equity”). Further, Plaintiff alleges after FGL Insurance purportedly purchased a partial ownership interest in Syncis and Freedom Equity, Plaintiff offered to sell its interests in its contracts with Syncis but FGL Insurance declined, leading Plaintiff to allege a statutory violation of 42 U.S.C. §1981 for discrimination where Plaintiff’s sole member is a racial minority. Plaintiff claims its damages for breach of contract from FGL Insurance’s purported failure to pay commissions are more than $162 million and its damages from FGL Insurance’s declining to purchase Plaintiff’s interest in its contracts with Syncis are over $11 million. FGL Insurance denies the allegations and denies any contract or agreement existed with Plaintiff to pay commissions. Dispositive motions are due April 21, 2025, and the case is expected to be set for trial in the summer of 2025. FGL Insurance will vigorously contest the Plaintiff’s claims in the action. As this case continues to evolve, it is not possible to reasonably estimate the probability that Plaintiff will ultimately prevail on its claims or that FGL Insurance will be held liable for the dispute. At this time, we do not believe the lawsuit will have a material impact on our business, operations, or financial results. From time to time, we receive inquiries and requests for information from state insurance departments, attorneys general, and other regulatory agencies about various matters relating to our business. Sometimes these take the form of civil investigative demands or subpoenas. We cooperate with all such inquiries, and we have responded to or are currently responding to inquiries from multiple governmental agencies. Also, regulators and courts have been dealing with issues arising from foreclosures and related processes and documentation. Various governmental entities are studying the title insurance product, market, pricing, and business practices, and potential regulatory and legislative changes, which may materially affect our business and operations. From time to time, we are assessed fines for violations of regulations or other matters or enter into settlements with such authorities, which may require us to pay fines or claims or take other actions. We do not anticipate such fines and settlements, either individually or in the aggregate, will have a material adverse effect on our business, operations, or financial results. Escrow Balances In conducting our operations, we routinely hold customers’ assets in escrow, pending completion of real estate transactions, and are respon sible for the proper disposition of these balances for our customers. Certain of these amounts are maintained in segregated bank accounts and have not been included in the accompanying Consolidated Balance Sheets, consistent with GAAP and industry practice. These balances amounted t o $14.4 billion a nd $13.5 billion at December 31, 2024 and 2023, respectively. As a result of holding these customers’ assets in escrow, we have ongoing programs for realizing economic benefits during the year through favorable borrowing and vendor arrangements with various banks. There were no investments or loans outstanding as of December 31, 2024 and 2023 related to these arrangements. F&G Commitments In our F&G segment, we have unfunded investment commitments as of December 31, 2024 based upon the timing of when investments and agreements are executed or signed compared to when the actual investments and agreements are funded or closed. Some investments require that funding occur over a period of months or years. A summary of unfunded commitments by commitment type is included below: December 31, 2024 Commitment Type (In millions) Unconsolidated VIEs: Limited partnerships $ 1,138 Whole loans 278 Fixed maturity securities, ABS 338 Direct Lending 1,618 Other fixed maturity securities, AFS 70 Other assets 162 Commercial mortgage loans 116 Residential mortgage loans 35 Other invested assets 134 Total $ 3,889 Concurrent with the Roar purchase agreement, we executed a separate loan agreement with the sellers of Roar for us to lend up to $40 million. The loan matures on August 5, 2027. The principal balance outstanding as of December 31, 2024 was $11 million and is included in Prepaid expenses and other assets on the Consolidated Balance Sheet. Changes in fair value are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Interest income is recorded in Interest and investment income in the Consolidated Statements of Earnings and recognized when earned. The remainder of the unfunded loan commitment is included in the unfunded commitments table above in the “Other assets” line item. Refer to Note B Acquisitions for more information on the Roar acquisition, and refer to Note D Fair Value of Financial Instruments for information regarding the fair value calculation of this loan receivable. Contingent Consideration Under the terms of the purchase agreement for Roar, we have agreed to make cash payments of up to approximately $90 million over a three-year period upon the achievement by Roar of certain EBITDA milestones. The contingent consideration is recorded at fair value in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Refer to Note B Acquisitions for more information on the Roar purchase and refer to Note D Fair Value of Financial Instruments for more information regarding the fair value of the contingent consideration. See Note A Business and Summary of Significant Accounting Policies , for discussion of funding agreements that have been issued pursuant to the FABN Program as well as to the FHLB that are included in Contractholder funds. The Company leases office space under operating leases. The largest leases expire in 2030. Rent expense and minimum rental commitments under all leases are immaterial.

Dividends

Dividends	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Dividends	Dividends On February 20, 2025, our Board of Directors declared cash dividends of $0.50 per share, payable on March 31, 2025, to FNF common shareholders of record as of March 17, 2025. During the years ended December 31, 2024, 2023 and 2022, we declared dividends on our common stock of $1.94, $1.83 and $1.77, respectively.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The tables below summarize the result of operations by segment that are provided to the Chief Operating Decision Maker ("CODM"), who is the Company's Chief Executive Officer. The Company's primary methods of measuring profitability and performance on a reportable segment basis are Revenues and Net earnings from continuing operations which are also measures used by the CODM to evaluate segment results and are factors in determining capital allocation among the segments. Summarized financial information concerning our reportable segments is shown in the following tables. The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. As of and for the year ended December 31, 2024: Title F&G Corporate and Other Elimination Total Segment revenues: (In millions) Direct title insurance premiums $ 2,200 $ — $ — $ — $ 2,200 Agency title insurance premiums 2,953 — — — 2,953 Escrow, title related and other fees 2,196 2,941 184 — 5,321 Interest and investment income 359 2,719 154 (108) 3,124 Recognized gains and losses, net (6) 84 5 — 83 Total segment revenues 7,702 5,744 343 (108) 13,681 Significant segment expenses: Personnel costs 2,695 296 157 — 3,148 Agent commissions 2,287 — — — 2,287 Other operating expenses 1,251 203 104 — 1,558 Benefits and other changes in policy reserves — 3,791 — — 3,791 Total significant segment expenses 6,233 4,290 261 — 10,784 Other segment items: Depreciation and amortization 141 569 29 — 739 Provision for title claim losses 232 — — — 232 Market risk benefit gains — (25) — — (25) Interest expense — 132 77 — 209 Total other segment items 373 676 106 — 1,155 Total segment expenses 6,606 4,966 367 — 11,939 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 1,096 778 (24) (108) 1,742 Income tax expense (benefit) 265 136 (34) — 367 Earnings (loss) before equity in earnings (loss) of unconsolidated affiliates 831 642 10 (108) 1,375 Equity in earnings of unconsolidated affiliates 16 — — — 16 Net earnings (loss) from continuing operations $ 847 $ 642 $ 10 $ (108) $ 1,391 Assets $ 7,627 $ 85,047 $ 2,698 $ — $ 95,372 Goodwill 2,799 2,179 293 — 5,271 As of and for the year ended December 31, 2023: Title F&G Corporate and Other Elimination Total Segment revenues: (In millions) Direct title insurance premiums $ 1,982 $ — $ — $ — $ 1,982 Agency title insurance premiums 2,610 — — — 2,610 Escrow, title related and other fees 2,117 2,413 187 — 4,717 Interest and investment income 338 2,211 123 (65) 2,607 Recognized gains and losses, net (9) (124) (31) — (164) Total segment revenues 7,038 4,500 279 (65) 11,752 Significant segment expenses: Personnel costs 2,544 232 132 — 2,908 Agent commissions 2,008 — — — 2,008 Other operating expenses 1,242 146 133 — 1,521 Benefits and other changes in policy reserves — 3,553 — — 3,553 Total significant segment expenses 5,794 3,931 265 — 9,990 Other segment items: Depreciation and amortization 154 412 27 — 593 Provision for title claim losses 207 — — — 207 Market risk benefit losses — 95 — — 95 Interest expense — 97 77 — 174 Total other segment items 361 604 104 — 1,069 Total segment expense 6,155 4,535 369 — 11,059 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 883 (35) (90) (65) 693 Income tax expense (benefit) 181 23 (12) — 192 Earnings (loss) before equity in earnings of unconsolidated affiliates 702 (58) (78) (65) 501 Equity in earnings of unconsolidated affiliates 17 — — — 17 Net earnings (loss) $ 719 $ (58) $ (78) $ (65) $ 518 Assets $ 7,949 $ 70,186 $ 2,479 $ — $ 80,614 Goodwill 2,789 1,749 292 — 4,830 As of and for the year ended December 31, 2022: Title F&G Corporate and Other Total Segment revenues: (In millions) Direct title insurance premiums $ 2,858 $ — $ — $ 2,858 Agency title insurance premiums 3,976 — — 3,976 Escrow, title related and other fees 2,502 1,704 127 4,333 Interest and investment income 213 1,655 23 1,891 Recognized gains and losses, net (443) (1,010) (40) (1,493) Total segment revenues 9,106 2,349 110 11,565 Significant segment expenses: Personnel costs 2,987 157 48 3,192 Agent commissions 3,064 — — 3,064 Other operating expenses 1,515 102 104 1,721 Benefits and other changes in policy reserves — 1,126 — 1,126 Total significant segment expenses 7,566 1,385 152 9,103 Other segment items: Depreciation and amortization 142 324 25 491 Provision for title claims losses 308 — — 308 Market risk benefit gains — (182) — (182) Interest expense — 29 86 115 Total other segment items 450 171 111 732 Total segment expenses 8,016 1,556 263 9,835 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 1,090 793 (153) 1,730 Income tax expense (benefit) 298 158 (17) 439 Earnings (loss) before equity in earnings of unconsolidated affiliates 792 635 (136) 1,291 Equity in earnings of unconsolidated affiliates 15 — — 15 Net earnings (loss) $ 807 $ 635 $ (136) $ 1,306 Assets $ 8,295 $ 54,637 $ 2,211 $ 65,143 Goodwill 2,620 1,749 266 4,635 The activities in our segments include the following: Title. This segment consists of the operations of our title insurance underwriters and related businesses. This segment provides core title insurance and escrow and other title-related services including loan sub-servicing, valuations, default services and home warranty. F&G . This segment primarily consists of the operations of our annuities and life insurance related businesses. This segment issues a broad portfolio of annuity and life products, including deferred annuities (fixed indexed and fixed rate annuities), immediate annuities and indexed universal life insurance. This segment also provides funding agreements and pension risk transfer solutions. Corporate and Other. This segment consists of the operations of the parent holding company, our real estate technology subsidiaries and our remaining real estate brokerage businesses. This segment also includes certain other unallocated corporate overhead expenses and eliminations of revenues and expenses between it and our Title segment. Refer to Note L Revenue Recognition for a description of our accounting for our various revenue streams.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities. Year Ended December 31, 2024 2023 2022 Cash paid for: (In millions) Interest $ 200 $ 157 $ 125 Income taxes 237 216 387 Deferred sales inducements 319 168 87 Non-cash investing and financing activities: Distribution of 15% of the common stock of F&G — — 421 Investments received from pension risk transfer premiums 129 464 — Change in proceeds of sales of investments available for sale receivable in period (59) 32 96 Change in purchases of investments available for sale payable in period 82 20 (25) Lease liabilities recognized in exchange for lease right-of-use assets 55 40 70 Remeasurement of lease liabilities 67 75 60 Liabilities assumed in connection with acquisitions Fair value of assets acquired 789 304 266 Less: Total Purchase price 586 299 180 Liabilities and noncontrolling interests assumed $ 203 $ 5 $ 86

Revenue Recognition

Revenue Recognition	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Our revenue consists of: Year Ended December 31, 2024 2023 2022 Revenue Stream Income Statement Classification Segment Total Revenue Revenue from insurance contracts: (In millions) Direct title insurance premiums Direct title insurance premiums Title $ 2,200 $ 1,982 $ 2,858 Agency title insurance premiums Agency title insurance premiums Title 2,953 2,610 3,976 Life insurance premiums, insurance and investment product fees, and other (1) Escrow, title-related and other fees F&G 2,941 2,413 1,704 Home warranty Escrow, title-related and other fees Title 146 143 165 Total revenue from insurance contracts 8,240 7,148 8,703 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Title 824 766 980 Other title-related fees and income Escrow, title-related and other fees Title 642 633 752 ServiceLink, excluding title premiums, escrow fees, and subservicing fees Escrow, title-related and other fees Title 318 313 342 Real estate technology Escrow, title-related and other fees Corporate and other 140 151 158 Total revenue from contracts with customers 1,924 1,863 2,232 Other revenue: Loan subservicing revenue Escrow, title-related and other fees Title 266 262 263 Other Escrow, title-related and other fees Corporate and other 44 36 (31) Interest and investment income Interest and investment income Various 3,124 2,607 1,891 Recognized gains and losses, net Recognized gains and losses, net Various 83 (164) (1,493) Total revenues Total revenues $ 13,681 $ 11,752 $ 11,565 (1) Includes $2,217, $1,964 and $1,362 of life-contingent pension risk transfer premiums in 2024, 2023 and 2022, respectively. Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete. Revenues from our home warranty business are generated from contracts with customers to provide warranty for major home appliances. Substantially all of our home warranty contracts are one year in length and revenue is recognized ratably over the term of the contract. Escrow fees and Other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing. Revenues from ServiceLink, excluding its title premiums, escrow fees and loan subservicing fees primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete. Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on indexed annuities policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholders' allowable penalty-free amounts. We have ceded the majority of our traditional life business to unaffiliated third-party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Other income related to riders is earned when elected by the policyholder. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of DAC, DSI, and VOBA, other operating costs and expenses, and income taxes. Premiums, annuity deposits (net of reinsurance and reinsurance recoverable) and funding agreements, which are not included as revenues in the accompanying Consolidated Statements of Earnings, collected by product type were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 Product Type (In millions) Fixed indexed annuities $ 5,828 $ 4,738 $ 4,483 Fixed rate annuities 1,277 1,147 1,522 Funding agreements (FABN/FHLB) 2,404 1,256 1,891 Life insurance and other (a) 638 646 446 Total $ 10,147 $ 7,787 $ 8,342 (a) Life insurance and other primarily includes indexed universal life insurance. Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Subscriptions are only offered on a month-by-month basis and fees are billed monthly. Revenue is recognized in the month services are provided. Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860. Interest and investment income consists primarily of interest payments received on fixed maturity security holdings and dividends received on equity and preferred security holdings along with the investment income of limited partnerships. We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed. Contract Balances The following table provides information about trade receivables and deferred revenue: December 31, 2024 December 31, 2023 (In millions) Trade receivables $ 362 $ 317 Deferred revenue (contract liabilities) 92 91 Deferred revenue is recorded primarily for our home warranty contracts. Revenues from home warranty products are recognized over the life of the policy, which is primarily one year. The unrecognized portion is recorded as deferred revenue in Accounts payable and other accrued liabilities in the Consolidated Balance Sheets. During the years ended December 31, 2024 and 2023, we recognized $80 million and $84 million of revenue, respectively, which was included in deferred revenue at the beginning of the respective period.

Other Intangible Assets

Other Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Other Intangible Assets	Other Intangible Assets The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2024 and 2023: December 31, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 435 $ 174 VOBA 1,349 1,446 DAC 3,036 2,215 DSI 625 346 Value of distribution asset 74 86 Computer software 277 266 Trademarks, tradenames, and other 180 94 Total Other intangible assets, net $ 5,976 $ 4,627 The following tables roll forward VOBA by product for the years ended December 31, 2024 and 2023: Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance at January 1, 2024 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446 Amortization (133) (5) (7) (8) (7) (160) Actuarial model updates and refinements (a) — — — — 63 63 Balance at December 31, 2024 $ 892 $ 22 $ 184 $ 126 $ 125 $ 1,349 (a) net of amortization of ($15 million). Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance at January 1, 2023 $ 1,166 $ 32 $ 201 $ 143 $ 73 $ 1,615 Amortization (141) (5) (10) (9) (4) (169) Balance at December 31, 2023 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446 VOBA amortization expense of $175 million, $169 million, and $180 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2024, 2023, and 2022, respectively. The following tables roll forward DAC by product for the years ended December 31, 2024 and 2023: Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance at January 1, 2024 $ 1,378 $ 288 $ 545 $ 2,211 Capitalization 652 174 274 1,100 Amortization (156) (86) (38) (280) Balance at December 31, 2024 $ 1,874 $ 376 $ 781 $ 3,031 Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance at January 1, 2023 $ 971 $ 83 $ 348 $ 1,402 Capitalization 510 177 229 916 Amortization (103) (51) (32) (186) Reinsurance related adjustments — 79 — 79 Balance at December 31, 2023 $ 1,378 $ 288 $ 545 $ 2,211 (a) Excludes insignificant amounts of DAC related to FABN and PRT. DAC amortization expense of $280 million, $186 million, and $99 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the year s ended December 31, 2024, 2023 and 2022, respectively, excluding insignificant amounts related to FABN and PRT. The following table presents a reconciliation of DAC to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2024 and 2023: December 31, 2024 December 31, 2023 (In millions) Indexed Annuities $ 1,874 $ 1,378 Fixed Rate Annuities 376 288 Universal Life 781 545 Funding Agreements 4 4 PRT 1 — Total $ 3,036 $ 2,215 The following tables roll forward DSI for our indexed annuity products for the years ended December 31, 2024 and 2023: Years Ended December 31, 2024 2023 (In millions) Balance at January 1, $ 346 $ 200 Capitalization 319 168 Amortization (40) (22) Balance at December 31, $ 625 $ 346 DSI amortization expense of $40 million, $22 million, and $14 million, was recorded in Depreciation and amortization on the Consolidated Statements of Earnings for the years ended December 31, 2024, 2023 and 2022, respectively. The cash flow assumptions used to amortize VOBA and DAC were consistent with the assumptions used to estimate the FPB for life contingent immediate annuities, and will be reviewed and unlocked, if applicable, in the same period as those balances. For nonparticipating traditional life contracts, the VOBA amortization is straight-line, without the use of cash flow assumptions. For indexed annuity contracts, the cash flow assumptions used to amortize VOBA, DAC, and DSI were consistent with the assumptions used to estimate the value of the embedded derivative and MRBs, and will be reviewed and unlocked, if applicable, in the same period as those balances. For fixed rate annuities and IUL the cash flow assumptions used to amortize VOBA, DAC and DSI reflect the Company’s best estimates for policyholder behavior, consistent with the development of assumptions for indexed annuities and immediate annuities. Refer to Note A Business and Summary of Significant Accounting Policies for further information about accounting policies for amortization of VOBA, DAC and DSI. F&G reviews cash flow assumptions annually, generally in the third quarter. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to deferred annuity (indexed annuity and fixed rate annuity) and IUL products. For the year ended December 31, 2024, F&G updated assumptions including surrender rates, GMWB election timing, premium persistency, mortality improvement and option budgets. For the year ended December 31, 2023, F&G updated assumptions including surrender rates, GMWB election timing, premium persistency, and option budgets. All updates to these assumptions brought F&G more in line with our company and overall industry experience since the prior assumption update. For the in-force liabilities as of December 31, 2024, the estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year (In millions) 2025 $ 145 2026 132 2027 121 2028 110 2029 100 Thereafter 741 Total $ 1,349 Definite and Indefinite Lived Other Intangible Assets Other intangible assets as of December 31, 2024, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts (a) $ 795 $ (360) $ 435 10 to 20 Computer software 723 (446) 277 2 to 10 Value of distribution asset (VODA) 140 (66) 74 15 Trademarks, tradenames, and other 234 (54) 180 Varies Total $ 966 (a) Includes intangible assets acquired with ROAR and PALH. Refer to Note B Acquisitions for further details. Other intangible assets as of December 31, 2023, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts $ 948 $ (774) $ 174 10 to 20 Computer software 651 (385) 266 2 to 10 Value of distribution Asset (VODA) 140 (54) 86 15 Trademarks, tradenames, and other 146 (52) 94 Varies Total $ 620 Amortization expense for amortizable intangible assets, which consist primarily of VODA, customer relationships, computer software and definite lived trademarks, tradenames and other, was $187 million, $152 million, and $134 million for the years ended December 31, 2024, 2023 and 2022, respectively. For the amortizable intangible assets as of December 31, 2024, the estimated amortization expense in future fiscal periods is $172 million in 2025, $140 million in 2026, $112 million in 2027, $85 million in 2028 and $72 million in 2029.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill A summary of the changes in Goo dwill consists of the following: Title F&G Corporate and Other Total (In millions) Balance, December 31, 2022 $ 2,620 $ 1,749 $ 266 $ 4,635 Goodwill associated with acquisitions 168 — 27 195 Balance, December 31, 2023 $ 2,788 $ 1,749 $ 293 $ 4,830 Goodwill associated with acquisitions 11 430 — 441 Balance, December 31, 2024 $ 2,799 $ 2,179 $ 293 $ 5,271

F&G Reinsurance

F&G Reinsurance	12 Months Ended
	Dec. 31, 2024
Reinsurance Disclosures [Abstract]
F&G Reinsurance	F&G Reinsurance The company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the company's retention limit is reinsured. The company primarily seeks reinsurance coverage in order to manage loss exposures, to enhance our capital position, to diversify risks and earnings, and to manage new business volume. The company follows reinsurance accounting when the treaty adequately transfers insurance risk and any acquisition cost reimbursements reduce policy acquisition costs deferred and maintenance expense reimbursements reduce direct expenses incurred. Otherwise, the company follows deposit accounting if there is inadequate transfer of insurance risk or if the underlying policy for which risk is being transferred is an investment contract that does not contain insurance risk. Refer to Note A Business and Summary of Significant Accounting Policies for more information over our accounting policy for reinsurance agreements. As of December 31, 2024, we had an immaterial amount of COR included in Prepaid expenses and other assets on the Consolidated Balance Sheets compared to none as of December 31, 2023. The effects of reinsurance on net premiums earned and net benefits incurred (benefits paid and reserve changes) for the years ended December 31, 2024, 2023 and 2022 respectively, were as follows: Year Ended December 31, 2024 December 31, 2023 December 31, 2022 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred (In millions) Direct $ 2,346 $ 3,987 $ 2,112 $ 3,728 $ 1,522 $ 3,640 Ceded (94) (196) (105) (175) (128) (2,514) Net $ 2,252 $ 3,791 $ 2,007 $ 3,553 $ 1,394 $ 1,126 Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. No policies issued by the company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Reinsurance Transactions The following summarizes significant changes to third-party reinsurance agreements for the years ended December 31, 2024 and 2023: Somerset: Effective July 1, 2024, F&G amended the existing flow reinsurance agreement with Somerset Reinsurance Ltd. (“Somerset”), a third-party reinsurer, to additionally cede the base contract benefits and GMWB riders attached under certain FIA policies on a coinsurance funds withheld quota share basis. Kubera: F&G has a reinsurance agreement with Kubera Insurance (SAC) Ltd. (“Kubera”), an unaffiliated reinsurer, to cede certain FIA statutory reserves on a coinsurance funds withheld quota share basis, net of applicable existing reinsurance. This agreement has been amended several times to include additional FIA policies, with the latest amendment effective December 1, 2024. Everlake and Somerset: F&G executed flow reinsurance agreements with Everlake Life Insurance Company (“Everlake”) and Somerset, third-party reinsurers, to cede certain MYGA business written effective September 1, 2023, and December 1, 2023, respectively, on a coinsurance quota share basis. Canada Life: Effective May 1, 2020, F&G entered into an indemnity reinsurance agreement with Canada Life Assurance Company (“Canada Life”) United States Branch, a third-party reinsurer, to reinsure FIA policies with GMWB riders. In accordance with the terms of this agreement, F&G cedes a quota share percentage of the net retention of guaranteed payments in excess of account value for GMWB. Effective December 31, 2023, we entered a Recapture and Termination Agreement with Canada Life whereby 100% of the liabilities and obligations were recaptured. The following summarizes significant changes to third-party reinsurance agreements subsequent to the year ended December 31, 2024: Everlake Reinsurance Amendment Effective January 1, 2025, F&G amended the existing flow reinsurance agreement with Everlake to cede future additional MYGA business for agreed upon periods to Everlake pursuant to an offer and acceptance process, rather than on a flow basis. The amendment included a cession of an inforce block of certain MYGA policies on a coinsurance quota share basis. The following summarizes our reinsurance recoverable (in millions) as of December 31, 2024 and 2023: Parent Company/ Reinsurance Recoverable (a) Agreement Type Products Accounting December 31, 2024 December 31, 2023 Aspida Life Re Ltd $ 7,844 $ 6,128 Coinsurance Funds Withheld Certain MYGA (b) Deposit Somerset (c) 2,822 716 Coinsurance Funds Withheld Certain MYGA (b) and deferred annuities Deposit Coinsurance Funds Withheld Certain FIA Reinsurance Everlake 1,168 509 Coinsurance Certain MYGA (b) (d) Deposit Wilton Reassurance Company 1,066 1,092 Coinsurance Block of traditional, IUL, and UL (e) Reinsurance Other (f) 489 536 Reinsurance recoverable, gross of allowance for credit losses 13,389 8,981 Allowance for expected credit loss (20) (21) Reinsurance recoverable, net of allowance for credit losses $ 13,369 $ 8,960 (a) Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies. (b) The combined quota share flow reinsurance amongst all reinsurers for 2024 varied between 30% and 90%. As of December 31, 2024, the combined quota share flow reinsurance amongst all reinsurers was 90%. (c) The balance represents the total reinsurance recoverable for all reinsurance agreements with Somerset. (d) Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit. (e) Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX. (f) Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable As of December 31, 2024, and 2023, the company had a deposit asset of $11,039 million and $7,481 million, respectively, which is reported in the Reinsurance recoverable, net of allowance for credit losses on the Consolidated Balance Sheet. The company incurred risk charge fees of $42 million, $39 million, and $36 million during the years ended December 31, 2024, 2023, and 2022, respectively, in relation to reinsurance agreements. Credit Losses The company estimates expected credit losses on reinsurance recoverables using a probability of default/loss given default model. Significant inputs to the model include the reinsurer's credit risk, expected timing of recovery, industry-wide historical default experience, senior unsecured bond recovery rates, and credit enhancement features. The expected credit loss reserves were as follows: Years Ended December 31, 2024 December 31, 2023 (In millions) Balance at Beginning of Period $ (21) $ (10) Changes in the expected credit loss reserve 1 (11) Balance at End of Period $ (20) $ (21) Concentration of Reinsurance Risk As indicated above, F&G has a significant concentration of reinsurance risk with third party reinsurers, Aspida Life Re Ltd. (“Aspida Re”), Wilton Reassurance (“Wilton Re”), Somerset, and Everlake that could have a material impact on our financial position in the event that any of these reinsurers fails to perform its obligations under the various reinsurance treaties. We monitor the financial condition and financial strength of individual reinsurers using public ratings (refer to table below) and ratings reports of individual reinsurers to attempt to reduce the risk of default by such reinsurers. In addition, the risk of non-performance is further mitigated with various forms of collateral or collateral arrangements, including secured trusts, funds withheld accounts and irrevocable letters of credit. We believe that all amounts due from Aspida Re, Wilton Re, Somerset, and Everlake for periodic treaty settlements, net of any applicable credit loss reserves, are collectible as of December 31, 2024. The following table presents financial strength ratings as of December 31, 2024: Parent Company/Principal Reinsurers Financial Strength Rating AM Best S&P Fitch Moody's Aspida Re A- — — — Somerset A- BBB+ — — Everlake A — — — Wilton Re A+ — A- — “—” indicates not rated Intercompany Reinsurance Agreements The Company executes various intercompany reinsurance agreements between its insurance subsidiaries, including off shore entities, for purposes of managing regulatory statutory capital and risk. Since these agreements are intercompany, the financial impacts are eliminated in the preparation of the Consolidated Financial Statements included within this Annual Report on Form 10-K. Some of these intercompany transactions are executed with wholly owned reinsurance subsidiaries, Corbeau Re, Inc. (“Corbeau Re”), Raven Reinsurance Company (“Raven Re”) and F&G Cayman Re (“Cayman Re”), to finance the portion of statutory reserves considered to be non-economic. The financing arrangements involve Fidelity & Guaranty Life Insurance Company reinsuring certain annuity products and their related rider benefits to the captives and the captives executing third-party financing facilities that are classified as capital for statutory purposes.

Regulation and Equity

Regulation and Equity	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Regulation and Equity	Summary of Reserve for Title Claim Losses A summary of the reserve for title claim losses follows: Year Ended December 31, 2024 2023 2022 (Dollars in millions) Beginning balance $ 1,770 $ 1,810 $ 1,883 Change in insurance recoverable (10) 15 (128) Claim loss provision related to: Current year 232 207 308 Prior years — — — Total title claim loss provision 232 207 308 Claims paid, net of recoupments related to: Current year (25) (22) (21) Prior years (254) (240) (232) Total title claims paid, net of recoupments (279) (262) (253) Ending balance of claim loss reserve for title insurance $ 1,713 $ 1,770 $ 1,810 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 % 4.5 % Several lawsuits were filed by various parties against Chicago Title Company and Chicago Title Insurance Company as its principal (collectively, the “Named Companies”) by plaintiffs claiming they were investors who were solicited by Gina Champion-Cain through her former company, ANI Development LLC (“ANI”), or other affiliates to provide funds placed in an escrow account that purportedly were to be used for high-interest, short-term loans to parties seeking to acquire California alcoholic beverage licenses. Plaintiffs further alleged that employees of Chicago Title Company assisted Ms. Champion-Cain and her entities in diverting the funds placed into an escrow account maintained by Chicago Title Company into which some of the plaintiffs’ funds were deposited. In connection with the alcoholic beverage license scheme, the SEC filed a civil enforcement proceeding asserting claims for securities fraud against Champion-Cain and ANI in a lawsuit styled, Securities and Exchange Commission v. Gina Champion-Cain and ANI Development, LLC , pending in the United States District Court for the Southern District of California. The receiver, who was appointed by the court to preserve the assets of the defendant affiliated entities, then filed a lawsuit in San Diego County Superior Court against the Named Companies seeking damages in a lawsuit styled, Krista Freitag v. Chicago Title Co. and Chicago Title Ins. Co. The Named Companies reached a global settlement with the receiver and several other investor claimants and jointly sought court approval of the global settlement and entry of an order barring any claims against the Named Companies related to the alcoholic beverage license scheme. On November 23, 2022, the federal court overruled any objections by non-joining investors and entered an order approving the global settlement barring further claims against the Named Companies (“Settlement and Bar Order”). After her receipt of the settlement funds, the receiver dismissed the lawsuit against the Named Companies. Some of the non-joining investor claimants who objected to entry of the Settlement and Bar Order appealed the decision to the United States Court of Appeals for the Ninth Circuit by (Cases 22-56206, 22-56208, and 23-55083). On February 20, 2025, the Ninth Circuit affirmed the district court's Settlement and Bar Order, barring all ongoing and future litigation against CTC stemming from the scheme operated by Ms. Champion-Cain. If appellants wish to seek further review of the Ninth Circuit's decision, they have a limited time to file a petition for rehearing or rehearing en banc , and/or a petition for review with the U.S. Supreme Court. Once the appellate decision is final, the remaining lawsuits pending in the Superior Court of San Diego County for the State of California involving claimants/investors who objected to CTC's settlement with the receiver are expected to be dismissed as to CTC. Chicago Title Company has also resolved a number of other pre-suit claims and previously-disclosed lawsuits from both individual and groups of alleged investors under confidential terms. Based on the facts and circumstances of the remaining claims, including the settlements already reached, we have recorded reserves included in our reserve for title claim losses, which we believe are adequate to cover losses related to this matter, and believe that our reserves for title claim losses are adequate. We continually update loss reserve estimates as new information becomes known, new loss patterns emerge or as other contributing factors are considered and incorporated into the analysis of reserve for claim losses. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims and other factors. Due to the uncertainty inherent in the process and to the judgment used by management, the ultimate liability may be greater or less than our current reserves. If actual claims loss development varies from what is currently expected and is not offset by other factors, it is possible that additional reserve adjustments may be required in future periods in order to maintain our recorded reserve within a reasonable range of our actuary's central estimate. Regulation Title Our insurance subsidiaries, including title insurers, underwritten title companies and insurance agencies, are subject to extensive regulation under applicable state laws. Each of the insurance underwriters is subject to a holding company act in its state of domicile that regulates, among other matters, the ability to pay dividends and enter into transactions with affiliates. The laws of most states in which we transact business establish supervisory agencies with broad administrative powers relating to issuing and revoking licenses to transact business, regulating trade practices, licensing agents, approving policy forms, accounting practices, financial practices, establishing reserve and capital and surplus as regards policyholders (“capital and surplus”) requirements, defining suitable investments for reserves and capital and surplus and approving rate schedules. The process of state regulation of changes in rates ranges from states that set rates, to states where individual companies or associations of companies prepare rate filings that are submitted for approval, to a few states in which rate changes do not need to be filed for approval. Since we are regulated by both state and federal governments and the applicable insurance laws and regulations are constantly subject to change, it is not possible to predict the potential effects on our insurance operations, particularly the Title segment, of any laws or regulations that may become more restrictive in the future or if new restrictive laws will be enacted. Statutory-basis financial statements are prepared in accordance with accounting practices prescribed or permitted by the various state insurance regulatory authorities. The National Association of Insurance Commissioners' Accounting Practices and Procedures manual (“NAIC SAP”) has been adopted as a component of prescribed or permitted practices by each of the states that regulate us. Each of our states of domicile for our title insurance underwriter subsidiaries have adopted a material prescribed accounting practice that differs from that found in NAIC SAP. Specifically, in both years, the timing of amounts released from the statutory unearned premium reserve under NAIC SAP differs from the states' required practice. Statutory surplus at December 31, 2024 and 2023 was lower by approximately $33 million and $34 million than if we had reported such amounts in accordance with NAIC SAP. Pursuant to statutory accounting requirements of the various states in which our insurers are domiciled, these insurers must defer a portion of premiums earned as an unearned premium reserve for the protection of policyholders and must maintain qualified assets in an amount equal to the statutory requirements. The level of unearned premium reserve required to be maintained at any time is determined by statutory formula based upon either the age, number of policies and dollar amount of policy liabilities underwritten, or the age and dollar amount of statutory premiums written. As of December 31, 2024, the combined statutory unearned premium reserve required and reported for our title insurers was $1,608 million. In addition to statutory unearned premium reserves, each of our insurers maintains reserves for known claims and surplus funds for policyholder protection and business operations. Each of our insurance subsidiaries is regulated by the insurance regulatory authority in its respective state of domicile, as well as that of each state in which it is licensed. The insurance commissioners of their respective states of domicile are the primary regulators of our title insurance subsidiaries. Each of the insurers is subject to periodic regulatory financial examination by regulatory authorities. Our insurance subsidiaries are subject to regulations that restrict their ability to pay dividends or make other distributions of cash or property to their immediate par ent company without prior approval from the Department of Insurance of their respective states of domicile. As of December 31, 2024, $1,141 million of our net assets are restricted from dividend payments without prior approval from the Departments of Insurance. During 2025, our title insurers can pay or make distributions to us of approximately $498 million, without prior approval. The combined statutory capital and surplus of our title insurers was approximately $1,223 million and $1,225 million as of December 31, 2024 and 2023, respectively. The combined statutory net earnings of our title insurance subsidiaries were $587 million, $503 million, and $778 million for the years ended December 31, 2024, 2023 and 2022, respectively. As a condition to continued authority to underwrite policies in the states in which our insurers conduct their business, the insurers are required to pay certain fees and file information regarding their officers, directors and financial condition. In addition, our escrow and trust business is subject to regulation by various state banking authorities. Pursuant to statutory requirements of the various states in which our insurers are domiciled, such insurers must maintain certain levels of minimum capital and surplus. Required levels of minimum capital and surplus are not significant to the insurers individually or in the aggregate. Each of our insurers has complied with the minimum statutory requirements as of December 31, 2024. Our underwritten title companies, primarily those domiciled in California, are also subject to certain regulation by insurance regulatory or banking authorities relating to their net worth and working capital. Minimum net worth and working capital requirements for each underwritten title company is less than $1 million. These companies were in compliance with their respective minimum net worth and working capital requirements at December 31, 2024. There are no restrictions on our retained earnings regarding our ability to pay dividends to shareholders although there are limits on the ability of certain subsidiaries to pay dividends to us, as described above. F&G Through our majority owned F&G subsidiary, our insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, except for Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed but approved by state regulators. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G's non-U.S. insurance subsidiaries, F&G Life Re (Bermuda) and F&G Cayman Re (Cayman Islands) file financial statements with their respective regulators. In our F&G segment, our principal insurance subsidiaries' statutory financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows: Subsidiary (state of domicile) (a) FGL Insurance (IA) FGL NY Insurance (NY) Raven Re (VT) Corbeau Re (VT) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ 150 $ 8 $ 54 $ (458) Year ended December 31, 2023 (462) 5 60 (644) Year ended December 31, 2022 (243) (15) (111) — Statutory Capital and Surplus: December 31, 2024 $ 1,654 $ 97 $ 168 $ 178 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Regulation - U.S. Companies FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re’s respective statutory capital and surplus satisfy the applicable minimum regulatory requirements. To enhance the regulation of insurers’ solvency, the NAIC adopted a model law to implement risk-based capital ("RBC") requirements for life, health and property and casualty insurance companies. All states have adopted the NAIC’s model law or a substantially similar law. RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk, and (iv) business risk. As of the most recent annual statutory financial statements filed with insurance regulators, the RBC ratios for each of our U.S Insurance Companies exceeded the minimum RBC requirements. Dividends The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively. FGL Insurance dividends are paid as declared by its Board of Directors. Pursuant to Iowa insurance law, any proposed payment of a dividend is classified as an "extraordinary dividend" if it, together with the aggregate fair market value of other dividends or distributions made during the preceding twelve months, exceeds the greater of (i) 10% of capital and surplus as of the preceding December 31 or (ii) net gain from operations before realized capital gains or losses for twelve month period ending December 31 of the preceding year. No extraordinary dividends may be paid without prior approval of the IID. In addition, no ordinary dividends may be paid except from the earned profits arising from FGL Insurance's business, which does not include contributed capital or contributed surplus. FGL Insurance did not pay dividends to its parent, Fidelity & Guaranty Life Holdings, Inc. ("FGLH"), for the years ended December 31, 2024, 2023, and 2022. Pursuant to the limitations described above, it is estimated that FGL Insurance's maximum ordinary dividend capacity for 2025 is $0. Each year, FGL NY Insurance may pay a certain limited amount of ordinary dividends or other distributions without being required to obtain the prior consent of the New York State Department of Financial Services (“NYDFS”). However, to pay any dividends or distributions in a calendar year immediately following a calendar year in which the FGL NY's net gain from operations, not including realized capital gains, was negative, approval from the NY Superintendent is required. FGL NY Insurance has historically not paid dividends. Based on the limitations described above, it's estimated that the maximum amount of ordinary dividends FGL NY Insurance will be permitted to distribute during 2025 is approximately $10 million. Raven Re and Corbeau Re dividends are paid as declared by their Board of Directors. Under the laws of the State of Vermont, no captive insurance company may pay a dividend out of, or other distribution with respect to, capital or surplus, without prior approval. Based on the limitations described above, no dividends may be paid in 2025 by either Raven Re or Corbeau Re without prior regulatory approval. Prescribed and permitted practices FGL Insurance - FGL Insurance applies Iowa-prescribed accounting practices prescribed by Iowa Administrative Code (" IAC ") Chapter 97, “Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve”, for its indexed annuities and IUL products. Under these alternative accounting practices, the equity option derivative instruments that hedge the growth in interest credited on index products are accounted for at amortized cost with the corresponding amortization recorded as a decrease to net investment income and indexed annuity reserves are calculated based on Standard Valuation Law and Actuarial Guideline XXXV assuming the market value of the equity options associated with the current index term is zero regardless of the observable market value for such options. In addition, based on a permitted practice received from the IID, FGL Insurance carries one of its limited partnership interests which qualifies for accounting under SSAP No. 48, “Investments in Joint Ventures, Partnerships and Limited Liability Companies”, on a net asset value per share basis. This is a departure from SSAP No. 48 which requires such investments to be carried based on the investees underlying GAAP equity (prior to any impairment considerations). This limited partnership investment was redeemed as of December 31, 2024. In addition, the financial statements of Raven Re and Corbeau Re include certain permitted practices approved by the Vermont Department of Financial Regulations. Without these permitted practices, the carry value of these two entities would be zero. The prescribed and permitted practices resulted in increases to statutory capital and surplus of $454 million and $194 million at December 31, 2024 and 2023, respectively. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset, which increased Raven Re’s statutory capital and surplus by $175 million and $200 million at December 31, 2024 and 2023, respectively. In addition, FGL Insurance’s statutory carrying value of Corbeau Re reflects the effect of permitted practices Corbeau Re received to treat the excess of loss as an admitted asset, which increased Corbeau Re’s statutory capital and surplus by $1,230 million and $765 million at December 31, 2024 and 2023, respectively. Refer to Note O - F&G Reinsurance for a discussion of the XOL and letter of credit. Raven Re - Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance and also has approval to include as an admitted asset the value of a letter of credit serving as collateral for reinsurance credit taken by FGL Insurance. Without such permitted statutory accounting practices, Raven Re’s statutory capital and surplus (deficit) would be $(13) million and $(89) million as of December 31, 2024 and 2023, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent (refer to discussion of letter of credit in Note O F&G Reinsurance ). FGL Insurance’s statutory carrying value of Raven Re was $168 million and $140 million at December 31, 2024 and 2023, respectively. Corbeau Re - Corbeau Re has four permitted practices pursuant to Vermont Statute, Title 8, Chapter 141 – (8 V.S.A. § 6048k(a)(2), whereby the Vermont Department authorizes the Company to (i) account for the amount equal to the excess of loss amount (“XOL Asset”) as an asset on its statutory financial statements; (ii) calculate the reserves with respect to the Retirement Pro Contracts in accordance with the following reserving methodology: the reserves are calculated as the present value of reinsured benefits when account value equals zero less the present value of reinsurance premiums from the winning integrated stream, floored at zero and capped as necessary to keep the net statutory reserve at the net cash surrender value. For benefits associated with all other contracts (“the GMWB Riders”), the reserves are calculated as the statutory reserves for the entire contract (i.e., the base contracts plus the GMWB Riders) minus the statutory reserves for the base contracts only (“Reserve Calculation Permitted Practice”); (iii) calculate its company action level risk-based capital as defined in Section 8301(13)(A) and, calculated using the risk-based capital factors and formulas prescribed by the NAIC, applying a factor of 0.62% to the XOL Asset Value; and (iv) annually perform a total company solvency analysis in lieu of cash flow testing and actuarial opinion and memorandum under Section 2010-2 of the Vermont Administrative Code. In addition, Corbeau Re assumes reserves that are equal to the reserves ceded by FGL Insurance which includes application of IAC Insurance 191, Chapter 97, "Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve". Without such permitted statutory accounting practices, the Company’s statutory capital and surplus (deficit) would be $(1,052) million and $(594) million as of December 31, 2024 and 2023, respectively, and its risk-based capital would fall below the minimum regulatory requirements. FGL Insurance’s statutory carrying value of Corbeau Re was $178 million and $171 million at December 31, 2024 and 2023, respectively. FGL NY Insurance - As of December 31, 2024 and 2023, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices. Non-U.S. Companies F&G's non-U.S. insurance subsidiaries, F&G Cayman Re and F&G Life Re, file financial statements with their respective regulators. For the annual period ended December 31, 2023, F&G Cayman Re began to file financial statements that are prepared in accordance with SAP prescribed or permitted by such authorities, which may vary materially from GAAP. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G Cayman Re has two permitted practices which have been approved by the Cayman Islands Monetary Authority (“CIMA”). F&G Cayman Re has a permitted practice approved by CIMA to include, as an admitted asset, the value of the letters of credit (“LOCs”) acquired to support reinsurance transactions. Also, F&G Cayman Re has a permitted practice, approved by CIMA, for PRT reinsurance transactions to use U.S. statutory book value adjusted for best estimate reserve calculations (consistent with GAAP prior to ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts). These reserve calculations will be subject to annual assumption reviews consistent with other GAAP liability balances. If F&G Cayman Re had not been permitted to calculate PRT assumed reserves using best estimate reserve calculations or include the value of the LOCs as an admitted asset, statutory surplus would be $(64) million and $102 million as of December 31, 2024 and December 31, 2023, respectively. Without such permitted statutory accounting practices, F&G Cayman Re’s risk-based capital would fall below the minimum regulatory requirements as of December 31, 2024 and December 31, 2023. F&G Life Re files financial statements based on GAAP. Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows: Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ (11) $ 139 Year ended December 31, 2023 133 151 Year ended December 31, 2022 71 (339) Statutory Capital and Surplus (Deficit): December 31, 2024 $ 734 $ 123 December 31, 2023 543 11 Regulation - Bermuda F&G Life Re is a Bermuda exempted company incorporated under the Companies Act 1981, as amended (the “Bermuda Companies Act”) and registered as a Class E insurer under the Insurance Act 1978, as amended, and its related regulations (the “Bermuda Insurance Act”). F&G Life Re is regulated by the Bermuda Monetary Authority (“BMA”). In addition to the requirements under the Bermuda Companies Act (as discussed below), the Bermuda Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re without prior regulatory approval. F&G Life Re is prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. If F&G Life Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA. In addition, as a Class E insurer, F&G Life Re must not declare or pay a dividend to any person other than a policyholder unless the value of the assets of such insurer, as certified by the insurer’s approved actuary, exceeds its liabilities (as so certified) by the greater of its margin of solvency or ECR. In the event a dividend complies with the above, F&G Life Re must ensure the amount of any such dividend does not exceed that excess. Furthermore, as a Class E insurer, F&G Life Re must not declare or pay a dividend in any financial year which would exceed 25% of its total statutory capital and surplus, as set out in its previous year’s Bermuda statutory financial statements, unless at least seven days before payment of such dividend F&G Life Re files with the BMA an affidavit signed by at least two directors of F&G Life Re and its principal representative under the Bermuda Insurance Act stating that, in the opinion of those signing, declaration of such dividend has not caused the insurer to fail to meet its relevant margins. The Bermuda Companies Act also limits F&G Life Re’s ability to pay dividends and make distributions to its shareholders. F&G Life Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities. F&G Life Re’s ability to pay dividends in 2025 is subject to the limitations described above. Regulation - Cayman Islands F&G Cayman Re is a Cayman Islands exempted company incorporated under the Companies Act, as amended (2023 Revision) and licensed as a Class D insurer in the Cayman Islands under the Insurance Act, 2010 as amended and its related regulation (the “Cayman Islands Insurance Act”). F&G Cayman Re is regulated by CIMA. F&G Cayman Re dividends are paid as declared by its Board of Directors. The dividends will be in accordance with CIMA regulatory requirements and contractual obligations and any dividends require approval by CIMA. F&G Cayman Re can only request approval for dividends if (i) the ending capital, including considerations for future business plans, will maintain a surplus over the CIMA approved and permitted target modified RBC, and (ii) contractual language pursuant to the PRT reinsurance agreement requiring a US RBC above specified target is met. As of the most recent annual financial statement filed with CIMA, the RBC ratios for F&G Cayman Re exceeded these minimum requirements. Pursuant to the limitations described above, no dividends may be paid in 2025 by F&G Cayman Re without prior regulatory approval. The prescribed and permitted statutory accounting practices have no impact on our audited Consolidated Financial Statements, which are prepared in accordance with GAAP. Equity On August 3, 2021, our Board of Directors approved the 2021 Repurchase Program under which we may purchase up to 25 million shares of our FNF common stock through July 31, 2024 (the "2021 Repurchase Program"). On July 31, 2024, our Board of Directors approved a new three-year stock repurchase program effective July 31, 2024 (the "2024 Repurchase Program") under which we are authorized to purchase up to 25 million shares of our FNF common stock through July 31, 2027. We may make repurchases from time to time in the open market, in block purchases or in privately negotiated transactions, depending on market conditions and other factors. During the year ended December 31, 2023, we repurchased a total of 100,000 FNF common shares for an aggregate of $4 million or an average of $38.45 per share under the 2021 Repurchase Program. During the year ended December 31, 2024, we did not repurchase any FNF common stock under the 2021 Repurchase Program or the 2024 Repurchase Program. Subsequent to December 31, 2024 and through market close on February 21, 2025, we did not repurchase any FNF common stock under the 2024 Repurchase Program.

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases Right-of-use assets and lease liabilities related to operating leases under ASC Topic 842 are recorded when we are party to a contract, which conveys the right for us to control an asset for a specified period of time. Substantially all of our operating lease arrangements relate to rented office space and real estate for our title operations. We generally are not a party to any material contracts considered finance leases. Right-of-use assets and lease liabilities under ASC Topic 842 are recorded as Lease assets and Lease liabilities, respectively, on the Consolidated Balance Sheet as of December 31, 2024. Our operating leases range in term from one Our lease agreements do not contain material variable lease payments, buyout options, residual value guarantees or restrictive covenants. Most of our leases include one or more options to renew, with renewal terms that can extend the lease term by varying amounts. The exercise of lease renewal options is at our sole discretion. We do not include options to renew in our measurement of lease assets and lease liabilities as they are not considered reasonably assured of exercise. Our operating lease liability is determined by discounting future lease payments using a discount rate based on our incremental borrowing rate for similar collateralized borrowing. The discount rate is calculated as an average of the current yield on our unsecured notes payable and 140 basis points in excess of the current five year SOFR swap rate. As of December 31, 2024, the weighted-average discount rate used to determine our operating lease liability was 4.7%. We do not separate lease components from non-lease components for any of our right-of-use assets. Our lease costs are included in Other operating expenses on the Consolidated Statements of Earnings and was $134 million, $137 million and $142 million for the years ended December 31, 2024, 2023 and 2022, respectively. We do not have any material short term lease costs, variable lease costs, or sublease income. Future payments under operating lease arrangements accounted for under ASC Topic 842 as of December 31, 2024, are as follows (in millions): 2025 $ 133 2026 108 2027 77 2028 52 2029 32 Thereafter 24 Total operating lease payments, undiscounted $ 426 Less: present value discount 41 Lease liability, at present value $ 385 See Note K Supplementary Cash Flow Information for certain information on noncash investing and financing activities related to our operating lease arrangements.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment consist of the following: December 31, 2024 2023 (In millions) Furniture, fixtures and equipment $ 161 $ 163 Data processing equipment 155 145 Leasehold improvements 126 121 Buildings 93 95 Land 14 14 Other 8 6 Total property and equipment, gross 557 544 Accumulated depreciation and amortization (384) (376) Total property and equipment, net $ 173 $ 168 Depreciation expense on property and equipment was $53 million, $55 million and $59 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Accounts Payable and Other Accr

Accounts Payable and Other Accrued Liabilities	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Accounts Payable and Other Accrued Liabilities	Accounts Payable and Other Accrued Liabilities Accounts payable and other accrued liabilities consist of the following: December 31, 2024 2023 (In millions) Salaries and incentives $ 433 $ 373 Accrued benefits 454 437 URL 401 270 Deferred revenue 92 91 Contingent consideration - acquisitions 110 49 Trade accounts payable 191 339 Accrued recording fees and transfer taxes 7 15 Accrued premium taxes 30 3 Liability for policy and contract claims 102 92 Retained asset account 60 81 Remittances and items not allocated 224 284 Option collateral liabilities 680 588 Other accrued liabilities 465 387 $ 3,249 $ 3,009 The following tables roll forward URL for the universal life product for the years ended December 31, 2024 and 2023: December 31, 2024 2023 (In millions) Balance at January 1, $ 270 $ 166 Capitalization 151 119 Amortization (20) (15) Balance at December 31, $ 401 $ 270

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income tax expense (benefit) on continuing operations consists of the following: Year Ended December 31, 2024 2023 2022 (In millions) Current $ 360 $ 241 $ 331 Deferred 7 (49) 108 $ 367 $ 192 $ 439 Total income tax expense was allocated as follows: Year Ended December 31, 2024 2023 2022 (In millions) Net earnings from continuing operations $ 367 $ 192 $ 439 Other comprehensive earnings (loss): Unrealized (loss) gain on investments and other financial instruments (35) 275 (1,198) Unrealized (loss) gain on foreign currency translation and cash flow hedging (6) 2 (4) Changes in current discount rate - future policy benefits 59 (50) 203 Changes in instrument - specific credit risk - market risk benefits 1 (9) 18 F&G 15% Distribution (3) (35) 9 Minimum pension liability adjustment — — 2 Total income tax expense (benefit) allocated to other comprehensive earnings 16 183 (970) Total income tax expense (benefit) $ 383 $ 375 $ (531) A reconciliation of the federal statutory rate to our effective tax rate is as follows: Year Ended December 31, 2024 2023 2022 Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 1.8 2.4 2.0 Stock compensation (0.5) (0.2) (0.1) Tax credits (0.7) (1.8) (0.7) Valuation allowance for deferred tax assets (1.0) 5.0 5.4 Benefit on Capital Loss Carryback — — (1.3) Officers Compensation 0.8 1.2 0.4 Non-deductible expenses and other, net (0.3) 0.1 (1.3) Effective tax rate 21.1 % 27.7 % 25.4 % The significant components of deferred tax assets and liabilities consist of the following: December 31, 2024 2023 (In millions) Deferred Tax Assets: Employee benefit accruals $ 129 $ 116 Net operating loss carryforwards 115 84 Tax credits 204 119 Investment securities 775 686 Capital loss carryover 19 38 Life insurance and claim related adjustments 451 547 Funds held under reinsurance agreements 822 500 Market Risk Benefits 56 61 Bermuda corporate income tax net operating loss carryforward 10 24 Other 42 26 Total gross deferred tax asset 2,623 2,201 Less: valuation allowance 164 197 Total deferred tax asset $ 2,459 $ 2,004 Deferred Tax Liabilities: Title plant $ (53) $ (53) Amortization of goodwill and intangible assets (71) (98) Other (11) (25) Depreciation (24) (29) Partnerships (198) (152) Value of business acquired (283) (304) Deferred acquisition costs (543) (361) Funds held under reinsurance agreements (945) (621) Title Insurance reserve discounting (16) (18) Total deferred tax liability $ (2,144) $ (1,661) Net deferred tax asset $ 315 $ 343 Our net deferred tax asset was $315 million and $343 million as of December 31, 2024 and 2023, respectively. The significant changes in the deferred taxes are as follows: the deferred tax asset for investment securities increased by $89 million primarily due to unrealized losses recorded for investment securities, of which $26 million was related to unrealized losses in our Title segment and $63 million was related to unrealized losses in our F&G segment's life insurance business. The deferred tax liability related to deferred acquisition costs increased by $182 million, which is consistent with the growth in sales in our F&G segment. The reinsurance receivable deferred tax asset increased by $322 million and the reinsurance receivable deferred tax liability increased by $324 million, both due to the increase in the Modco reinsurance in the F&G segment. The deferred tax asset relating to life insurance receivables decreased by $96 million primarily due to tax reserves increasing more than GAAP reserves by F&G. The tax credits deferred tax asset increased by $85 million, primarily due to additional corporate alternative minimum tax credits at the F&G segment’s life insurance business offset by utilization of low-income housing tax credits at the F&G segment’s life insurance business. As of December 31, 2024, we have net operating losses ("NOLs") on a pretax basis of $547 million, of which $44 million relates to our Title segment and $503 million relates to our F&G segment's life insurance business, which are available to carryforward and offset future federal taxable income. The Title segment NOLs are U.S. federal NOLs arising from acquisitions made since 2012, including Buyers Protection Group, Inc., Digital Insurance Holdings, Inc. and THL Corporations (ServiceLink). Most of the NOLs are subject to an annual Internal Revenue Code Section 382 limitation. These losses will begin to expire in year 2034 and we fully anticipate utilizing the Title segment losses prior to expiration with the exception of $25 million of gross net operating losses that are offset by a $25 million valuation allowance in the Title segment. The F&G NOLs are indefinite life U.S. federal NOLs arising from the life insurance business. As of December 31, 2024 and 2023, we had $204 million and $119 million of tax credits, respectively, some of which have expiration dates and will begin to expire between 2029 and 2044. The credits primarily consist of general business credits and corporate alternative minimum tax credits, including $164 million associated with our F&G segment's life insurance business. The F&G segment's corporate alternative minimum tax credit has an indefinite life. We anticipate the remainder of the credits will be utilized prior to expiration with the exception of $30 million relating to general business credits in our Title segment which have a corresponding $30 million valuation allowance recorded. As of December 31, 2024, a full valuation allowance on the net deferred tax asset related to the Bermuda corporate income tax net operating loss carryforward of $10 million was recorded. The net change in the Bermuda corporate income tax net loss operating carryforward valuation allowance was a $14 million decrease for the year ended December 31, 2024. As of December 31, 2024, a valuation allowance of $119 million on the net deferred tax asset for capital losses was recorded, of which $71 million related to the Title segment and $48 million related to the F&G segment. The net change in the capital loss valuation allowance was a $20 million decrease for the year ended December 31, 2024. This decrease to the valuation allowance was primarily due to fluctuations in the bond and equity markets, and to capital gains and losses generated in 2024. As of December 31, 2024 and 2023, there were no unrecognized tax benefits. F&G's life insurance subsidiaries, as well as certain F&G non-life subsidiaries file separate tax returns from the FNF consolidated group. Prepaid expenses and other assets in the accompanying Consolidated Balance Sheets as of December 31, 2024, includes: $20 million of deferred tax assets related to the FNF consolidated group as well as $6 million of tax receivables and $295 million of deferred tax assets related to F&G subsidiaries who file separate tax returns. As of December 31, 2023, prepaid expenses and other assets included $26 million of tax receivables related to the FNF consolidated group as well as $28 million of tax receivables and $372 million of deferred tax assets related to the F&G subsidiaries. We continue to be a participant in the Internal Revenue Service (“IRS”) Compliance Assurance Process that is a real-time audit. The 2024 U.S. federal income tax return remains open to examination by the IRS. We file income tax returns in various foreign and US state jurisdictions. Our state income tax returns for the 2020 through 2024 tax years remain subject to examination by state jurisdictions. The F&G life insurance group files a separate consolidated return with the IRS. The F&G federal income tax returns for 2020 through the current period remain open to examination by the IRS. The Organization for Economic Cooperation and Development has developed guidance known as the Global Anti-Base Erosion Pillar Two minimum tax rules, or Pillar Two, which generally provide for a minimum effective tax rate of 15% and are intended to apply to tax years beginning in 2024. As of December 31, 2024, based on the countries in which we do business that have enacted legislation, the Company does not expect these rules to have a material impact on our income tax provision. The Company considers its non-U.S. earnings to be indefinitely reinvested outside of the U.S. to the extent these earnings are not subject to the U.S. income tax under an anti-deferral tax regime. Given our intent to reinvest these earnings for an indefinite period of time, the Company has not accrued a deferred tax liability on these earnings. A determination of an unrecognized deferred tax liability related to these earnings is not practicable.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Employee Benefit Plans	Employee Benefit Plans Stock Purchase Plan During the three-year period ended December 31, 2024, our eligible employees could voluntarily participate in our employee stock purchase plan (“ESPP”) sponsored by us. Pursuant to the ESPP, employees may contribute an amount between 3% and 15% of their base salary and certain commissions. We contribute varying amounts as specified in the ESPP. We contribu ted $34 million, $30 million and $36 million to the ESPP in the years ended December 31, 2024 , 2023 and 2022, respectively, in accordance with our matching contribution. FNF 401(k) Profit Sharing Plan During the three-year period ended December 31, 2024 , we have offered our employees the opportunity to participate in our 401(k) profit sharing plan (the “401(k) Plan”), a qualified voluntary contributory savings plan that is available to substantially all of our employees. Eligible employees may contribute up to 40% of their pre-tax annual compensation, up to the amount allowed pursuant to the Internal Revenue Code. During the year ended December 31, 2024, 2023 and 2022, we made an employer match on the 401(k) Plan of $0.50 on each $1.00 contributed up to the first 6% of eligible earnings contributed to the 401(k) Plan by employees. The employer match was $46 million, $45 million and $50 million for the years ended December 31, 2024, 2023 and 2022, respectively, and was credited based on the participant's individual investment elections in the FNF 401(k) Plan. Omnibus Incentive Plan In 2005, we established the FNT 2005 Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) authorizing the issuance of up to 8 million shares of common stock, subject to the terms of the Omnibus Plan. On October 23, 2006; May 29, 2008; May 25, 2011; May 22, 2013; and June 15, 2016, the shareholders of FNF approved amendments to increase the number of shares for issuance under the Omnibus Plan by 16 million, 11 million, 6 million, 6 million and 10 million shares, respectively. The primary purpose of the increases were to assure that we had adequate means to provide equity incentive compensation to our employees on a going-forward basis. The Omnibus Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and performance shares, performance units, other cash and stock-based awards and dividend equivalents. As of December 31, 2024, there were 2,357,220 shares of restricted stock and no stock options outstanding under the Omnibus Plan. Awards granted are approved by the Compensation Committee of the Board of Directors. F&G Omnibus Incentive Plan On June 1, 2020, in connection with the acquisition of F&G, we assumed the shares that remained available for future awards under the FGL Holdings 2017 Omnibus Incentive Plan, as amended and restated (the “F&G Omnibus Plan”) and converted such shares into 2,096,429 shares of FNF common stock that may be issued pursuant to future awards granted under the F&G Omnibus Plan and 2,411,585 sh ares of FNF common stock that may be issued pursuant to outstanding stock options under the F&G Omnibus Plan. Each unvested stock option assumed under the F&G Omnibus Plan was converted into an FNF stock option and vests solely on the passage of time without any ongoing performance-vesting conditions. The options vest over a 3 year period, based on the option's initial grant date, and have a contractual life of 7 years. As of December 31, 2024, there were no shares of restricted stock and 100,000 stock options outstanding under the F&G Omnibus Plan. FNF stock option transactions under the Omnibus Plan for 2024 , 2023, and 2022 are as follows: Options Weighted Average Exercisable Balance, January 1, 2022 996,113 $ 25.53 996,113 Exercised (996,113) 25.53 Balance, December 31, 2022 — $ — — FNF stock option transactions under the F&G Omnibus Plan for 2024, 2023 , and 2022 are as follows: Options Weighted Average Exercisable Balance January 1, 2022 1,527,936 $ 35.97 1,072,584 Exercised (352,614) 38.79 Canceled (2,715) 28.00 Balance, December 31, 2022 1,172,607 $ 35.15 1,172,607 Exercised (502,414) 30.31 Canceled (26,570) 38.07 Balance, December 31, 2023 643,623 $ 38.80 643,623 Exercised (543,623) 38.74 Balance, December 31, 2024 100,000 $ 39.10 100,000 FNF restricted stock transactions under the Omnibus Plan in 2024 , 2023 and 2022 are as follows: Shares Weighted Average Grant Date Fair Value Balance, December 31, 2021 1,639,226 $ 41.97 Granted 994,548 40.83 Vested (792,230) 41.44 Balance, December 31, 2022 1,841,544 $ 41.59 Granted 966,093 44.44 Canceled (23,975) 41.42 Vested (908,267) 40.26 Balance, December 31, 2023 1,875,395 $ 43.69 Granted 1,604,119 60.23 Canceled (16,603) 45.92 Vested (1,105,691) 47.21 Balance, December 31, 2024 2,357,220 $ 53.28 FNF restricted stock transactions under the F&G Omnibus Plan in 2024, 2023 and 2022 are as follows: Shares Weighted Average Grant Date Fair Value Balance, January 1, 2022 718,641 $ 40.24 Granted — — Canceled (78,551) 37.79 Vested (138,542) 34.11 Balance, December 31, 2022 501,548 $ 42.31 Granted — — Canceled (15,965) 45.63 Vested (304,104) 42.87 Balance, December 31, 2023 181,479 $ 41.08 Granted — — Canceled (13,082) 48.28 Vested (168,397) 40.53 Balance, December 31, 2024 — $ — The following table summarizes information related to stock options outstanding and exercisable as of December 31, 2024 : Options Outstanding Options Exercisable Weighted Weighted Average Weighted Average Weighted Remaining Average Remaining Average Range of Number of Contractual Exercise Intrinsic Number of Contractual Exercise Intrinsic Exercise Prices Options Life Price Value Options Life Price Value (In years) (In millions) (In years) (In millions) $0.00 - $39.10 100,000 0.97 $ 39.10 $ 2 100,000 0.97 $ 39.10 $ 2 100,000 $ 2 100,000 $ 2 We account for stock-based compensation plans in accordance with GAAP on share-based payments, which requires that compensation cost relating to share-based payments be recognized in the consolidated financial statements based on the fair value of each award. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date and recognized over the service period. Fair value of restricted stock awards and units is based on the grant date value of the underlying stock derived from quoted market prices. In 2024, we issued a $50 million restricted stock grant to our chairman, of which one quarter of the grant vested immediately, with the remaining three quarters vesting in equal installments over a period of three years on each anniversary of the grant date. The total fair value of restricted stock awards granted in the years ended December 31, 2024 , 2023 and 2022 was $97 million, $43 million and $41 million, respectively. The total fair value of restricted stock awards, which vested in the years ended December 31, 2024 , 2023 and 2022 was $76 million, $51 million and $38 million, respectively. Option awards are measured at fair value on the grant date using the Black Scholes Option Pricing Model. The intrinsic value of options exercised in the years ended December 31, 2024 , 2023 and 2022 was $9 million, $8 million and $16 million, respectively. Net earnings attributable to FNF Shareholders reflects stock-based compensation expense amounts of $82 million for the year ended December 31, 2024, $60 million for the year ended December 31, 2023 and $49 million for the year ended December 31, 2022 , which are included in personnel costs in the reported financial results of each period. At December 31, 2024 Pension Plan In 2000, FNF merged with Chicago Title Corporation ("CTC"). In connection with the merger, we assumed CTC’s noncontributory defined contribution plan and noncontributory defined benefit pension plan (the “Pension Plan”). The Pension Plan covers certain CTC employees. The benefits are based on years of service and the employee’s average monthly compensation in the highest 60 consecutive calendar months during the 120 months ending at retirement or termination. Effective December 31, 2000, the Pension Plan was frozen and there will be no future credit given for years of service or changes in salary. The accumulated benefit obligation is the same as the projected benefit obligation due to the pension plan being frozen as of December 31, 2000. Pursuant to GAAP on employers’ accounting for defined benefit pension and other post-retirement plans, the measurement date is December 31. On May 1, 2023, we elected to terminate the Pension Plan, subject to approval by the Pension Benefit Guarantee Corporation and the receipt of a favorable determination letter from the IRS. Upon termination, the account balance of each participant in the Pension Plan shall become fully vested. Each remaining participant or beneficiary in the Pension Plan shall be given one of the following options with respect to termination of the Pension Plan: (i) a lump-sum distribution of the participant's account balance; or (ii) an annuity benefit equal to the participant’s account balance. During the year ended December 31, 2024, we distributed substantially all of the Pension Plan assets to the participants or beneficiaries of the Pension Plan. As of December 31, 2024, the project benefit obligation and fair value of plan assets were immaterial. The discount rate used to determine the benefit obligation as of December 31, 2023 wa s 4.67% . As of December 31, 2023, the projected benefit obligation was $64 million and the fair value of plan assets was $54 million. The net pension liability and net periodic expense included in our financial position and results of operations relating to the Pension Plan is not considered material for any period presented.

Financial Instruments with Off-

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk	12 Months Ended
	Dec. 31, 2024
Risks and Uncertainties [Abstract]
Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk	Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk In the normal course of business, we and certain of our subsidiaries enter into off-balance sheet credit arrangements associated with certain aspects of the title insurance business and other activities. We generate a significant amount of title insurance premiums in Texas, California, Florida, Pennsylvania and Illinois. Title insurance premiums as a percentage of the total title insurance premiums written from those five states are detailed as follows: 2024 2023 2022 Texas 13.8 % 14.3 % 15.0 % California 12.9 % 13.0 % 12.0 % Florida 10.2 % 10.7 % 10.6 % Illinois 5.8 % 6.0 % 5.3 % Pennsylvania 5.2 % 4.9 % 5.2 % Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, short-term investments, and trade receivables. We place cash equivalents and short-term investments with high credit quality financial institutions and, by policy, limit the amount of credit exposure with any one financial institution. Investments in commercial paper of industrial firms and financial institutions are rated investment grade by nationally recognized rating agencies. Concentrations of credit risk with respect to trade receivables are limited because a large number of geographically diverse customers make up our customer base, thus spreading the trade receivables credit risk. We control credit risk through monitoring procedures.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements Adopted Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the CODM and included in each reported measure of a segment’s profit or loss. In addition, the amendments enhance interim disclosure requirements that are currently required annually, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and contain other disclosure requirements. The amendments in this update are incremental to the current requirements of Topic 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. We adopted this standard using the retrospective approach for all periods presented as required. Refer to Note J Segment Information for additional information. In March 2023, the FASB issued ASU 2023-02, Accounting for Investments in Tax Credit Structure Using the Proportional Amortization Method (a consensus of the Emerging Issues Task Force). The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. We adopted this standard on January 1, 2024, as required, and there was no material impact to our audited Condensed Consolidated Financial Statements. Refer to Note T Income Taxes for further information. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update affect all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction and clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. Additionally, the amendments require the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet, the nature and remaining duration of the restriction(s), and the circumstances that could cause a lapse in the restriction(s). The amendments in this update do not change the principles of fair value measurement, rather, they clarify those principles when measuring the fair value of an equity security subject to a contractual sale restriction and improve current GAAP by reducing diversity in practice, reducing the cost and complexity in measuring fair value, and increasing comparability of financial information across reporting entities that hold those investments. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We adopted this standard as of January 1, 2024, and it did not have a material impact on our unaudited Condensed Consolidated Financial Statements and related disclosures upon adoption. Pronouncements Not Yet Adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied on a prospective basis, and, retrospective application is permitted. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this update enhance transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel costs, depreciation, and amortization. The amendments also require disclosure of qualitative description of amounts remaining in relevant expense captions that are not separately disaggregated. The amendments in this update are effective for all public companies for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We do not expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption.

Market Risk Benefits

Market Risk Benefits	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Market Risk Benefits	Market Risk Benefits The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the years ended December 31, 2024 and 2023: December 31, 2024 December 31, 2023 Indexed Annuities Fixed rate annuities Indexed Annuities Fixed rate annuities (Dollars in millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 109 — (10) — Attributed fees collected and interest accrual 147 — 131 — Actual policyholder behavior different from expected (5) — 27 — Changes in assumptions and other 24 — 29 — Effects of market related movements (162) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk $ 322 $ 1 $ 209 $ 1 Effect of changes in the instrument-specific credit risk 98 — 105 — Balance, end of period, net liability $ 420 $ 1 $ 314 $ 1 Less: reinsured market risk benefits 61 — — — Balance, end of period, net of reinsurance $ 359 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 67.98 72.58 68.28 72.59 Net amount at risk $ 1,327 $ 2 $ 1,059 $ 2 The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets: December 31, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB Asset Indexed annuities $ 128 $ 61 $ 189 $ 88 $ — $ 88 Fixed rate annuities — — — — — — Total MRB Asset $ 128 $ 61 $ 189 $ 88 $ — $ 88 MRB Liability Indexed annuities $ 548 $ — $ 548 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 549 $ — $ 549 $ 403 $ — $ 403 The net MRB liability increased for the year ended December 31, 2024, primarily as a result of collection of attributed fees, interest accrual, MRB reserves for contracts issued within the period, and changes in actuarial assumptions. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2024, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and an increase in the rider benefit utilization assumption, leading to an unfavorable change in the value of the associated MRBs. The net MRB liability increased for the year ended December 31, 2023, primarily as a result of attributed fees collected, increases as a result of actual policyholder behavior different than expected and changes in assumptions as discussed below. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2023, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and F&G’s credit spread decreased, lead to a corresponding unfavorable change in the MRBs associated with both indexed annuities and fixed rate annuities. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuities (indexed annuities and fixed rate annuities) with MRBs. For the year ended December 31, 2024, we updated assumptions including surrender rates, rider benefit election utilization, mortality improvement, and option budgets. For the year ended December 31, 2023, we updated assumptions including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our Company and overall industry experience since the prior assumption updates. These updates, in total, led to increases in the net MRB liability for the years ended December 31, 2024 and 2023. The following tables summarize balances of and changes in contractholder funds’ account balances: December 31, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 6,649 5,125 208 600 1,804 Premiums received 120 1 495 — — Policy charges (a) (195) — (315) — — Surrenders and withdrawals (3,832) (1,479) (101) — — Benefit payments (495) (315) (18) (820) (1,606) Interest credited 821 667 157 71 117 Other 3 — — (1) (2) Balance, end of year 30,235 17,442 2,817 2,463 2,852 Embedded derivative adjustment (c) 219 — 79 — — Gross liability, end of period 30,454 17,442 2,896 2,463 2,852 Less: Reinsurance recoverable 861 11,009 877 — — Net liability, after reinsurance recoverable $ 29,593 $ 6,433 $ 2,019 $ 2,463 $ 2,852 Weighted-average crediting rate 2.90 % 4.42 % 6.20 % N/A N/A Net amount at risk (d) N/A N/A $ 74,279 N/A N/A Cash surrender value (e) $ 27,865 $ 16,266 $ 2,177 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance December 31, 2023 Indexed Annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of year 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance recoverable 17 7,520 894 — — Net liability, after reinsurance recoverable $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheets: December 31, 2024 2023 (In millions) Indexed annuities $ 30,454 $ 27,407 Fixed rate annuities 17,442 13,443 Immediate annuities 286 311 Universal life 2,896 2,475 Traditional life 5 5 Funding Agreement-FABN 2,463 2,613 FHLB 2,852 2,539 PRT 6 5 Total $ 56,404 $ 48,798 Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2024 and for the year ended December 31, 2024, based on policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $89 million for the year ended December 31, 2024. During the third quarter of 2023 and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million for the year ended December 31, 2023. The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: December 31, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,540 $ 1,236 $ 492 $ 1,846 $ 27,114 1.51%-2.50% 875 1 684 1,242 2,802 Greater than 2.50% 303 2 — 14 319 Total $ 24,718 $ 1,239 $ 1,176 $ 3,102 $ 30,235 Fixed Rate Annuities 0.00%-1.50% $ 57 $ 20 $ 773 $ 14,407 $ 15,257 1.51%-2.50% 4 7 20 462 493 Greater than 2.50% 804 2 5 881 1,692 Total $ 865 $ 29 $ 798 $ 15,750 $ 17,442 Universal Life 0.00%-1.50% $ 2,421 $ 7 $ — $ 24 $ 2,452 1.51%-2.50% — — — — — Greater than 2.50% 364 — 1 — 365 Total $ 2,785 $ 7 $ 1 $ 24 $ 2,817 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 1.51%-2.50% — — — — — Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Contractholder Funds

Contractholder Funds	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Contractholder Funds	Market Risk Benefits The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the years ended December 31, 2024 and 2023: December 31, 2024 December 31, 2023 Indexed Annuities Fixed rate annuities Indexed Annuities Fixed rate annuities (Dollars in millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 109 — (10) — Attributed fees collected and interest accrual 147 — 131 — Actual policyholder behavior different from expected (5) — 27 — Changes in assumptions and other 24 — 29 — Effects of market related movements (162) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk $ 322 $ 1 $ 209 $ 1 Effect of changes in the instrument-specific credit risk 98 — 105 — Balance, end of period, net liability $ 420 $ 1 $ 314 $ 1 Less: reinsured market risk benefits 61 — — — Balance, end of period, net of reinsurance $ 359 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 67.98 72.58 68.28 72.59 Net amount at risk $ 1,327 $ 2 $ 1,059 $ 2 The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets: December 31, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB Asset Indexed annuities $ 128 $ 61 $ 189 $ 88 $ — $ 88 Fixed rate annuities — — — — — — Total MRB Asset $ 128 $ 61 $ 189 $ 88 $ — $ 88 MRB Liability Indexed annuities $ 548 $ — $ 548 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 549 $ — $ 549 $ 403 $ — $ 403 The net MRB liability increased for the year ended December 31, 2024, primarily as a result of collection of attributed fees, interest accrual, MRB reserves for contracts issued within the period, and changes in actuarial assumptions. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2024, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and an increase in the rider benefit utilization assumption, leading to an unfavorable change in the value of the associated MRBs. The net MRB liability increased for the year ended December 31, 2023, primarily as a result of attributed fees collected, increases as a result of actual policyholder behavior different than expected and changes in assumptions as discussed below. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2023, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and F&G’s credit spread decreased, lead to a corresponding unfavorable change in the MRBs associated with both indexed annuities and fixed rate annuities. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuities (indexed annuities and fixed rate annuities) with MRBs. For the year ended December 31, 2024, we updated assumptions including surrender rates, rider benefit election utilization, mortality improvement, and option budgets. For the year ended December 31, 2023, we updated assumptions including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our Company and overall industry experience since the prior assumption updates. These updates, in total, led to increases in the net MRB liability for the years ended December 31, 2024 and 2023. The following tables summarize balances of and changes in contractholder funds’ account balances: December 31, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 6,649 5,125 208 600 1,804 Premiums received 120 1 495 — — Policy charges (a) (195) — (315) — — Surrenders and withdrawals (3,832) (1,479) (101) — — Benefit payments (495) (315) (18) (820) (1,606) Interest credited 821 667 157 71 117 Other 3 — — (1) (2) Balance, end of year 30,235 17,442 2,817 2,463 2,852 Embedded derivative adjustment (c) 219 — 79 — — Gross liability, end of period 30,454 17,442 2,896 2,463 2,852 Less: Reinsurance recoverable 861 11,009 877 — — Net liability, after reinsurance recoverable $ 29,593 $ 6,433 $ 2,019 $ 2,463 $ 2,852 Weighted-average crediting rate 2.90 % 4.42 % 6.20 % N/A N/A Net amount at risk (d) N/A N/A $ 74,279 N/A N/A Cash surrender value (e) $ 27,865 $ 16,266 $ 2,177 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance December 31, 2023 Indexed Annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of year 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance recoverable 17 7,520 894 — — Net liability, after reinsurance recoverable $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheets: December 31, 2024 2023 (In millions) Indexed annuities $ 30,454 $ 27,407 Fixed rate annuities 17,442 13,443 Immediate annuities 286 311 Universal life 2,896 2,475 Traditional life 5 5 Funding Agreement-FABN 2,463 2,613 FHLB 2,852 2,539 PRT 6 5 Total $ 56,404 $ 48,798 Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2024 and for the year ended December 31, 2024, based on policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $89 million for the year ended December 31, 2024. During the third quarter of 2023 and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million for the year ended December 31, 2023. The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: December 31, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,540 $ 1,236 $ 492 $ 1,846 $ 27,114 1.51%-2.50% 875 1 684 1,242 2,802 Greater than 2.50% 303 2 — 14 319 Total $ 24,718 $ 1,239 $ 1,176 $ 3,102 $ 30,235 Fixed Rate Annuities 0.00%-1.50% $ 57 $ 20 $ 773 $ 14,407 $ 15,257 1.51%-2.50% 4 7 20 462 493 Greater than 2.50% 804 2 5 881 1,692 Total $ 865 $ 29 $ 798 $ 15,750 $ 17,442 Universal Life 0.00%-1.50% $ 2,421 $ 7 $ — $ 24 $ 2,452 1.51%-2.50% — — — — — Greater than 2.50% 364 — 1 — 365 Total $ 2,785 $ 7 $ 1 $ 24 $ 2,817 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 1.51%-2.50% — — — — — Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Future Policy Benefits

Future Policy Benefits	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Future Policy Benefits	Future Policy Benefits The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts: Traditional life December 31, 2024 December 31, 2023 Expected net premiums (In millions) Balance, beginning of year $ 722 $ 797 Beginning balance at original discount rate 874 974 Effect of actual variances from expected experience (4) (1) Balance adjusted for variances from expectation 870 973 Interest accrual 17 19 Net premiums collected (107) (118) Ending Balance at original discount rate 780 874 Effect of changes in discount rate assumptions (149) (152) Balance, end of year $ 631 $ 722 Expected FPB Balance, beginning of year $ 2,071 $ 2,151 Beginning balance at original discount rate 2,492 2,665 Effect of actual variances from expected experience 44 (24) Balance adjusted for variances from expectation 2,536 2,641 Interest accrual 54 56 Benefits payments (222) (205) Ending Balance at original discount rate 2,368 2,492 Effect of changes in discount rate assumptions (435) (421) Balance, end of year $ 1,933 $ 2,071 Net liability for future policy benefits $ 1,302 $ 1,349 Less: Reinsurance recoverable 513 413 Net liability for future policy benefits, after reinsurance recoverable $ 789 $ 936 Weighted-average duration of liability for future policyholder benefits (years) 6.28 7.36 The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts: PRT December 31, 2024 December 31, 2023 (In millions) Balance, beginning of year $ 4,189 $ 2,165 Beginning balance at original discount rate 4,351 2,475 Effect of changes in cash flow assumptions (3) (9) Effect of actual variances from expected experience (11) (7) Balance adjusted for variances from expectation 4,337 2,459 Issuances 2,324 2,041 Interest accrual 240 109 Benefits payments (484) (258) Ending Balance at original discount rate 6,417 4,351 Effect of changes in discount rate assumptions (363) (162) Balance, end of year $ 6,054 $ 4,189 Net liability for future policy benefits, after reinsurance recoverable $ 6,054 $ 4,189 Weighted-average duration of liability for future policyholder benefits (years) 7.78 8.23 Immediate annuities December 31, 2024 December 31, 2023 (In millions) Balance, beginning of year $ 1,415 $ 1,429 Beginning balance at original discount rate 1,788 1,858 Effect of changes in cash flow assumptions — — Effect of actual variances from expected experience (27) (15) Balance adjusted for variances from expectation 1,761 1,843 Issuances 30 22 Interest accrual 59 51 Benefits payments (118) (128) Ending Balance at original discount rate 1,732 1,788 Effect of changes in discount rate assumptions (435) (373) Balance, end of year $ 1,297 $ 1,415 Net liability for future policy benefits $ 1,297 $ 1,415 Less: Reinsurance recoverable 109 116 Net liability for future policy benefits, after reinsurance recoverable $ 1,188 $ 1,299 Weighted-average duration of liability for future policyholder benefits (years) 12.63 12.47 The following tables summarize balances and changes in the liability for DPL for limited-payment contracts: December 31, 2024 December 31, 2023 Immediate annuities PRT Immediate annuities PRT (In millions) Balance, beginning of year $ 87 $ 10 $ 69 $ 4 Effect of modeling changes — — 4 — Effect of changes in cash flow assumptions — (8) — 1 Effect of actual variances from expected experience 8 — 16 5 Balance adjusted for variances from expectation 95 2 89 10 Issuances 3 1 3 — Interest accrual 1 4 2 1 Amortization (9) (1) (7) (1) Balance, end of year $ 90 $ 6 $ 87 $ 10 The following table reconciles the net FPB to the FPB in the Consolidated Balance Sheets. The DPL for Immediate Annuities and PRT is presented together with the FPB in the Consolidated Balance Sheets and has been included as a reconciling item in the table below: December 31, 2024 2023 (In millions) Traditional life $ 1,302 $ 1,349 Immediate annuities 1,297 1,415 PRT 6,054 4,189 Immediate annuities DPL 90 87 PRT DPL 6 10 Total $ 8,749 $ 7,050 The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts: Undiscounted Discounted December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Traditional life (In millions) Expected future benefit payments $ 2,705 $ 2,935 $ 1,948 $ 2,075 Expected future gross premiums 914 1,082 681 789 Immediate annuities Expected future benefit payments $ 3,189 $ 3,291 $ 1,297 $ 1,413 Expected future gross premiums — — — — PRT Expected future benefit payments $ 10,038 $ 6,709 $ 6,054 $ 4,350 Expected future gross premiums — — — — The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the Consolidated Statements of Earnings: Gross Premiums (a) Interest Expense (b) December 31, December 31, 2024 2023 2022 2024 2023 2022 (In millions) Traditional life $ 111 $ 123 $ 137 $ 37 $ 37 $ 39 Immediate annuities 18 24 23 59 51 60 PRT 2,217 1,964 1,362 240 109 50 Total $ 2,346 $ 2,111 $ 1,522 $ 336 $ 197 $ 149 (a) Included in Life insurance premiums and other fees on the Consolidated Statements of Earnings. (b) Included in Benefits and other changes in policy reserves (remeasurement gains (losses) (a)) on the Consolidated Statements of Earnings. The following table presents the weighted-average interest rate: December 31, 2024 2023 2022 Traditional life Interest accretion rate 2.34 % 2.33 % 2.32 % Current discount rate 5.44 % 5.03 % 5.37 % Immediate annuities Interest accretion rate 3.17 % 3.14 % 3.07 % Current discount rate 5.45 % 4.98 % 5.21 % PRT Interest accretion rate 4.72 % 4.61 % 3.20 % Current discount rate 5.54 % 5.03 % 5.40 % The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB: December 31, 2024 Traditional life Immediate annuities PRT Mortality Actual experience 1.4 % 2.7 % 2.7 % Expected experience 1.5 % 1.9 % 2.5 % Lapses Actual experience 0.1 % — % — % Expected experience 0.5 % — % — % December 31, 2023 Traditional life Immediate annuities PRT Mortality Actual experience 1.7 % 3.2 % 3.2 % Expected experience 1.4 % 1.8 % 2.3 % Lapses Actual experience — % — % — % Expected experience 0.3 % — % — % December 31, 2022 Traditional life Immediate annuities PRT Mortality Actual experience 1.5 % 3.0 % 1.9 % Expected experience 1.3 % 1.9 % 2.5 % Lapses Actual experience — % — % — % Expected experience 0.3 % — % — % The following table provides additional information for periods in which a cohort has a net premium ratio (“NPR”) greater than 100% (and therefore capped at 100%) (dollars in millions): December 31, 2024 Cohort X Description NPR before capping 108 % Term with return of premium Non-NY Cohort Reserves before NPR capping $ 1,147 Term with return of premium Non-NY Cohort Reserves after NPR capping 1,174 Term with return of premium Non-NY Cohort Loss Expense 27 Term with return of premium Non-NY Cohort F&G realized actual-to-expected experience variances and made changes to assumptions during the years ended December 31, 2024 and 2023 as follows: Traditional life The traditional life line of business primarily consists of policies that were sold prior to 2010. As this line of business continues to age, benefit payments made from these contracts will be the primary driver of the emergence of reserves, decreasing the reserve balance. Significant assumption inputs to the calculation of the FPB for traditional life include mortality, lapses (including lapses due to nonpayment of premium and surrenders for cash surrender value), and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2024, F&G made an adjustment to the calculation to reflect additional actuarial precision, unrelated to the assumptions, driving an increase to the FPB liability. In 2023, F&G undertook a review of all significant assumptions and revised the lapse assumption, resulting in a slight decrease to the FPB. There have been no other significant changes. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB. Market data that underlies current discount rates was updated in 2023 from that utilized in 2022, resulting in decreased discount rates that drove a material increase to the FPB. Immediate annuities (life contingent) Significant assumption inputs to the calculation of the FPB for immediate annuities (life contingent) include mortality and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2024 and 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB. Market data that underlies current discount rates was updated in 2023 from that utilized in 2022, resulting in decreased discount rates that drove a material increase to the FPB. PRT (life contingent) The PRT line of business has issued a significant volume of contracts for both 2024 and 2023, which is the primary impact in increasing the reserve balance in each of those periods. Significant assumption inputs to the calculation of the FPB for PRT (life contingent) include mortality and discount rates (both accretion and current). Additionally, for PRT contracts with deferred payment streams retirement age and elected payment form are significant assumptions. We review the cash flow assumptions annually, typically in the third quarter. In 2024 and 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in increased discount rates that drove a decrease to the FPB. Market data that underlies current discount rates was updated in 2023 from that utilized in 2022, resulting in decreased discount rates that drove a material increase to the FPB. Premium deficiency testing

Schedule II - Condensed Financi

Schedule II - Condensed Financial Information	12 Months Ended
	Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Schedule II - Condensed Financial Information	SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) BALANCE SHEETS (In millions) December 31, 2024 2023 ASSETS Cash $ 534 $ 397 Short-term investments 252 487 Investment in unconsolidated affiliates 3 3 Notes receivable 212 268 Investments in and amounts due from subsidiaries 8,882 7,949 Property and equipment, net 2 3 Prepaid expenses and other assets 433 318 Total assets $ 10,318 $ 9,425 LIABILITIES AND EQUITY Liabilities: Accounts payable and other accrued liabilities $ 385 $ 358 Income taxes payable 51 — Deferred tax liability — 29 Notes payable 2,128 2,126 Total liabilities 2,564 2,513 Equity: FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2024 and 2023; outstanding of 275 and 273 as of December 31, 2024 and 2023, respectively, and issued of 331 and 329 as of December 31, 2024 and 2023, respectively — — Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none — — Additional paid-in capital 5,976 5,913 Retained earnings 5,982 5,244 Accumulated other comprehensive earnings (2,052) (2,119) Less: Treasury stock, 56 shares as of December 31, 2024 and 2023, at cost (2,152) (2,126) Total equity of Fidelity National Financial, Inc. common shareholders 7,754 6,912 Total liabilities and equity $ 10,318 $ 9,425 SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) STATEMENTS OF EARNINGS AND RETAINED EARNINGS Year Ended December 31, 2024 2023 2022 (In millions, except per share data) Revenues: Other fees and revenue $ 38 $ 33 $ (37) Interest and investment income and realized gains 76 74 43 Recognized gains and losses, net 2 (31) (42) Total revenues 116 76 (36) Expenses: Personnel expenses 94 70 (11) Other operating expenses 28 47 15 Interest expense 76 77 92 Total expenses 198 194 96 Losses before income tax benefit and equity in earnings of subsidiaries (82) (118) (132) Income tax benefit (20) (29) (33) Losses before equity in earnings of subsidiaries (62) (89) (99) Equity in earnings of subsidiaries 1,332 606 1,393 Net earnings attributable to Fidelity National Financial, Inc. common shareholders $ 1,270 $ 517 $ 1,294 Retained earnings, beginning of year $ 5,244 $ 5,225 $ 4,818 Dividends declared (532) (498) (490) Distribution of F&G to FNF common shareholders — — (397) Net earnings attributable to Fidelity National Financial, Inc. common shareholders 1,270 517 1,294 Retained earnings, end of year $ 5,982 $ 5,244 $ 5,225 SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) STATEMENTS OF CASH FLOWS Year Ended December 31, 2024 2023 2022 (In millions) Cash Flows From Operating Activities: Net earnings $ 1,270 $ 517 $ 1,294 Adjustments to reconcile net earnings to net cash provided by operating activities: Equity in earnings of subsidiaries (1,332) (606) (1,393) Depreciation and amortization 1 1 1 Stock-based compensation 82 57 48 Net change in income taxes 5 (262) 748 Net (increase) decrease in prepaid expenses and other assets (113) (72) 41 Net increase (decrease) in accounts payable and other accrued liabilities 27 70 (51) Net cash (used in) provided by operating activities (60) (295) 688 Cash Flows From Investing Activities: Purchase of F&G preferred stock (250) — — Net proceeds from (purchases of) short-term investment activities 235 82 (509) Additions to notes receivable (1) (12) (87) Collection of notes receivable 55 47 79 Net cash provided by (used in) investing activities 39 117 (517) Cash Flows From Financing Activities: Debt service payments — — (400) Dividends paid (532) (500) (489) Purchases of treasury stock — (6) (553) Exercise of stock options 21 15 39 Payment for shares withheld for taxes and in treasury (22) (17) (15) Additional investments in non-controlling interests (12) (12) (2) Net dividends from subsidiaries 703 689 140 Net cash provided by (used in) financing activities 158 169 (1,280) Net change in cash and cash equivalents 137 (9) (1,109) Cash at beginning of year 397 406 1,515 Cash at end of year $ 534 $ 397 $ 406 See Notes to Financial Statements SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) NOTES TO FINANCIAL STATEMENTS A. Summary of Significant Accounting Policies Fidelity National Financial, Inc. transacts substantially all of its business through its subsidiaries. The Parent Company Financial Statements should be read in connection with the aforementioned Consolidated Financial Statements and Notes thereto included elsewhere herein. B. Notes Payable Notes payable consist of the following: December 31, 2024 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving credit facility (4) (2) $ 2,128 $ 2,126 C. Supplemental Cash Flow Information Year Ended December 31, 2024 2023 2022 (In millions) Cash paid during the year: Interest paid $ 73 $ 73 $ 95 Income tax payments 229 213 459 D. Cash Dividends Received We have received cash dividends from our title insurance underwriters and F&G o f $0.6 billion , $0.4 billion, and $0.8 billion during the years ended December 31, 2024, 2023 and 2022, respectively.

Schedule III - F&G Supplementar

Schedule III - F&G Supplementary Insurance Information	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Schedule III - F&G Supplementary Insurance Information	Schedule III FIDELITY NATIONAL FINANCIAL, INC. F&G Supplementary Insurance Information (in millions) Year Ended December 31, 2024 December 31, 2023 December 31, 2021 F&G Segment: Deferred acquisition costs $ 3,036 $ 2,215 $ 1,411 Future policy benefits, losses, claims and loss expenses 8,749 7,050 5,021 Other policy claims and benefits payable 102 92 109 Life insurance premiums and other fees 2,860 2,413 1,704 Interest and investment income 2,719 2,211 1,655 Benefits, claims, losses and settlement expenses (3,791) (3,553) (1,126) Amortization of deferred policy acquisition costs (280) (191) (99) Other operating expenses, net of deferrals (203) (146) (102)

Schedule IV - F&G Reinsurance

Schedule IV - F&G Reinsurance	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV - F&G Reinsurance	Schedule IV FIDELITY NATIONAL FINANCIAL, INC. F&G Reinsurance (In millions) For the year ended December 31, 2024 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed to net Life insurance in force $ 10,906 $ (1,370) $ — $ 9,536 — % Premiums and other considerations: Traditional life insurance premiums 129 (94) — 35 — Life-contingent PRT premiums 2,217 — — 2,217 — Annuity product charges and other fees 655 (47) — 608 — Total premiums and other considerations $ 3,001 $ (141) $ — $ 2,860 — % For the year ended December 31, 2023 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed to net Life insurance in force $ 8,448 $ (1,436) $ — $ 7,012 — % Premiums and other considerations: Traditional life insurance premiums 148 (105) — 43 — Life-contingent PRT premiums 1,964 — — 1,964 — Annuity product charges and other fees 455 (49) — 406 — Total premiums and other considerations $ 2,567 $ (154) $ — $ 2,413 — % For the year ended December 31, 2022 Gross Amount Ceded to other companies Assumed from other companies Net Amount Percentage of amount assumed to net Life insurance in force $ 6,296 $ (1,524) $ — $ 4,772 — % Premiums and other considerations: Traditional life insurance premiums 160 (128) — 32 — Life-contingent PRT premiums 1,362 — — 1,362 — Annuity product charges and other fees 360 (50) — 310 — Total premiums and other considerations $ 1,882 $ (178) $ — $ 1,704 — %

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net earnings attributable to FNF common shareholders	$ 1,270	$ 517	$ 1,294

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Dec. 31, 2024 shares	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted		false
Rule 10b5-1 Arrangement Terminated		false
Non-Rule 10b5-1 Arrangement Terminated		false
Sandra D. Morgan [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 24, 2024, Sandra D. Morgan, a Director on our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the "Morgan Rule 10b5-1 trading agreement") that was intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). The Morgan Rule 10b5-1 trading agreement was entered into during an open trading window and in accordance with our insider trading policies. Ms. Morgan was not aware of any material, nonpublic information concerning us or our securities upon adoption of the Morgan Rule 10b5-1 trading arrangement. The Morgan Rule 10b5-1 trading arrangement provided for the sale, on December 24, 2024, of 35% of an aggregate 5,979 of FNF common stock, or 2,092 shares, which were received by Ms. Morgan upon the vesting of restricted stock awards in November 2024. The Morgan Rule 10b5-1 trading arrangement terminated upon the execution of all trades as defined in the Morgan Rule 10b5-1 trading arrangement.
Name	Ms. Morgan
Title	Director on our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 24, 2024
Expiration Date	December 24, 2024
Arrangement Duration	53 days
Aggregate Available	2,092	2,092
Ms. Morgan Trading Arrangement, Common Stock [Member] | Sandra D. Morgan [Member]
Trading Arrangements, by Individual
Aggregate Available	5,979	5,979

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	We assess, identify and manage cybersecurity risks through various processes within our Enterprise Risk Management Program and Information Security Program. We focus on all areas of cybersecurity, including threat and vulnerability management, security monitoring, identity and access management, phishing awareness, risk oversight, third-party risk management, disaster recovery and continuity management. We have established policies, including those related to privacy, information security and cybersecurity, and we employ a broad and diversified set of cybersecurity risk monitoring and risk mitigation techniques. Internal audits, external audits and self-assessments are conducted to assess the effectiveness and maturity of our Enterprise Risk Management Program and Information Security Program. Our employees are one of our strongest assets in protecting our customers' information and mitigating cybersecurity risk. We maintain comprehensive and tailored training programs that focus on applicable privacy and cybersecurity requirements. Additionally, we make strategic investments in cybersecurity to protect our customers and information systems, including both capital expenditures and operating expenses for hardware, software, personnel and consulting services. Our processes to assess, identify and manage cybersecurity risks, including cybersecurity risks related to the use of third-party service providers, are fully integrated into our Enterprise Risk Management Program. In some circumstances we use third-party service providers to provide expertise and to monitor utilization of specific cyber tools, and in certain cases, to supplement staffing services. Through our vendor risk management process, these vendors undergo various assessments such as financial, reputational, contractual and informational security. These assessments are performed to ascertain that these vendors meet our policy requirements relative to the services they perform on our behalf. To further reduce the residual risk associated with cybersecurity, we maintain Miscellaneous Professional Liability Insurance, which provides coverage for cybersecurity incidents. The deductible limits on these policies are determined by a corporate insurance risk management group and executive management at least on an annual basis. This group determines appropriate coverage levels and deductibles for each policy based on tolerance and weighs the coverage against the premium for the policy.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We assess, identify and manage cybersecurity risks through various processes within our Enterprise Risk Management Program and Information Security Program. We focus on all areas of cybersecurity, including threat and vulnerability management, security monitoring, identity and access management, phishing awareness, risk oversight, third-party risk management, disaster recovery and continuity management. We have established policies, including those related to privacy, information security and cybersecurity, and we employ a broad and diversified set of cybersecurity risk monitoring and risk mitigation techniques. Internal audits, external audits and self-assessments are conducted to assess the effectiveness and maturity of our Enterprise Risk Management Program and Information Security Program. Our employees are one of our strongest assets in protecting our customers' information and mitigating cybersecurity risk. We maintain comprehensive and tailored training programs that focus on applicable privacy and cybersecurity requirements. Additionally, we make strategic investments in cybersecurity to protect our customers and information systems, including both capital expenditures and operating expenses for hardware, software, personnel and consulting services.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Management's Role in Assessing and Managing Cybersecurity Risk Our Corporate Information Security Group is led by our Chief Information Security Officer ("CISO") who is responsible for our information security strategy. This strategy includes policy management, security engineering, identity and access management, vulnerability management and cyber threat detection and response through our Security Operations Center. Our CISO has extensive information technology and program management experience as do many of our employees in our information security group. Our CISO, as well as others in our information security group, hold certifications such the Certified Information System Security Professional certification. We believe cybersecurity is a shared responsibility throughout the organization and thus we also manage cybersecurity risks, through a cross-functional committee of members of senior management known as the Enterprise Risk Steering Committee, which includes the CISO. The diversity of this group allows for identification of key enterprise risks from strategic, operational, financial, legal, information technology and compliance perspectives. These individuals receive reporting on our cybersecurity programs and also participate in table-top exercises relating to potential security incidents. The CISO is also the primary point of contact for reporting information security incidents and for coordinating information security activities including incident response and digital forensics. Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space. Board Oversight of Cybersecurity Our board has a strong focus on cybersecurity. Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis. See Item 1A Risk Factors for discussion of material risks faced by the Company, including risks related to cybersecurity. 2023 Cybersecurity Incident On November 19, 2023, we became aware of a cybersecurity incident that impacted certain of our systems. We promptly commenced an investigation, retained leading experts to assist the Company, notified law enforcement authorities, regulatory authorities and other stakeholders and followed our incident response plans. In addition, we took containment measures such as blocking access to certain of our systems resulting in varying levels of disruption to our businesses. The incident was contained on November 26, 2023. We completed our forensic investigation on December 13, 2023. We determined that an unauthorized third-party accessed certain of our systems, deployed a type of malware that is not self-propagating and exfiltrated certain data. We have no evidence that any customer-owned system was directly impacted in the incident, and no customer has reported that this has occurred. The last confirmed date of unauthorized third-party activity in our network occurred on November 20, 2023. We have identified and analyzed the nature and scope of the affected systems and data. We have notified our affected customers and applicable state attorneys general and regulators, and approximately 1.3 million potentially impacted consumers; are providing credit monitoring, web monitoring and identity theft restoration services; and are fielding questions from customers. We are continuing to coordinate with law enforcement, our customers, regulators, advisors and other stakeholders. We have been named as a defendant in several lawsuits related to this incident. The Company will vigorously defend itself against any litigation filed related to this incident. This incident did not have a material impact on the Company.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Role of Management [Text Block]	Our Corporate Information Security Group is led by our Chief Information Security Officer ("CISO") who is responsible for our information security strategy. This strategy includes policy management, security engineering, identity and access management, vulnerability management and cyber threat detection and response through our Security Operations Center. Our CISO has extensive information technology and program management experience as do many of our employees in our information security group. Our CISO, as well as others in our information security group, hold certifications such the Certified Information System Security Professional certification. We believe cybersecurity is a shared responsibility throughout the organization and thus we also manage cybersecurity risks, through a cross-functional committee of members of senior management known as the Enterprise Risk Steering Committee, which includes the CISO. The diversity of this group allows for identification of key enterprise risks from strategic, operational, financial, legal, information technology and compliance perspectives. These individuals receive reporting on our cybersecurity programs and also participate in table-top exercises relating to potential security incidents. The CISO is also the primary point of contact for reporting information security incidents and for coordinating information security activities including incident response and digital forensics. Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our CISO reports to our Chief Security Officer who also has extensive experience in the information security space.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our board has a strong focus on cybersecurity. Our approaches to cybersecurity and privacy risk are overseen by the audit committee. At each regular meeting of the audit committee of our Board of Directors, our Chief Risk Officer, Chief Compliance Officer, Chief Security Officer, Chief Information Security Officer and Chief Audit Officer provide reports relating to existing and emerging cyber and data security risks, as well as reports on the Company’s risk assessments and security incidents. Our audit committee chairman reports on these discussions to our board of directors on a quarterly basis.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation and Basis of Presentation	Principles of Consolidation and Basis of Presentation The Consolidated Financial Statements are prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and include our accounts as well as our wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany profits, transactions and balances have been eliminated. Non-controlling interests recorded on the Consolidated Statements of Earnings represent the portion of a majority-owned subsidiary's net earnings or loss that is owned by non-controlling shareholders of the subsidiary. Non-controlling interests recorded on the Consolidated Balance Sheets represent the portion of equity in a consolidated subsidiary owned by non-controlling shareholders. We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. We assess our relationships with VIEs to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our Consolidated Financial Statements. See Note E Investments for additional information on our investments in VIEs.
Investments	I nvestments Fixed Maturity Securities Available-for-Sale Fixed maturity securities are purchased to support our investment strategies, which are developed based on factors including rate of return, maturity, credit risk, duration, tax considerations and regulatory requirements. Our investments in fixed maturity securities have been designated as available-for-sale ("AFS") and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Fair values for fixed maturity securities are principally a function of current market conditions and are primarily valued based on quoted prices in markets that are not active or model inputs that are observable or unobservable. We recognize investment income on fixed maturities based on the effective interest method, which results in the recognition of a constant rate of return on the investment equal to the prevailing rate at the time of purchase or at the time of subsequent adjustments of book value. In our title segment, realized gains and losses on sales of our fixed maturity securities are determined on the basis of the cost of the specific investments sold and are credited or charged to income on a trade date basis. Our F&G segment uses first-in first-out cost basis and generally records security transactions on a trade date basis except for private placements, which are recorded on a settlement date basis. Realized gains and losses on sales of fixed maturity securities are reported within Recognized gains and losses, net in the accompanying Consolidated Statements of Earnings. Fixed maturity securities AFS are subject to an allowance for credit loss and changes in the allowance are reported in net earnings as a component of Recognized gains and losses, net. For details on our policy around allowance for expected credit losses on AFS securities, refer to Note E Investments. Preferred and Equity Securities Preferred and equity securities held are carried at fair value as of the balance sheet dates. Changes in fair value and realized gains and losses on sales of our preferred and equity securities are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. Realized gains and losses on sales of our preferred and equity securities are determined on the first in first out cost basis and are credited or charged to earnings on a trade date basis unless the security is a private placement in which case settlement date basis is used. Interest and dividend income from these investments is reported in Interest and investment income in the Consolidated Statements of Earnings.
Derivative Financial Instruments	Derivative Financial Instruments In our F&G segment, we hedge certain portions of our exposure to product related equity market risk by entering into derivative transactions (primarily equity options). We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. All such derivative instruments are recognized as either assets or liabilities in the Consolidated Balance Sheets at fair value. The changes in fair value are reported within Recognized gains and losses, net in the Consolidated Statements of Earnings. The change in the fair value of derivative instruments is included in (Gain) loss on sales of investments and other assets and asset impairments, net, in the Consolidated Statements of Cash Flow.
Mortgage Loans	Mortgage Loans Our investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less allowance for expected credit losses. For details on our policy around allowance for expected credit losses on mortgage loans, refer to Note E Investments . Commercial mortgage loans ("CMLs") are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors. CMLs are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below certain thresholds and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. We define delinquent mortgage loans as 30 days past due, consistent with industry practice. Residential mortgage loans ("RMLs") have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming RMLs as those that are 90 or more days past due and/or in nonaccrual status, which is assessed monthly. Generally, nonperforming RMLs have a higher risk of experiencing a credit loss. We consider residential mortgage loans that are 90 or more days past due and have an LTV greater than 90% to be foreclosure probable. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Interest income, amortization of premiums and discounts, prepayment fees, and loan commitment fees are reported in Interest and investment income in the accompanying Consolidated Statements of Earnings.
Short-term Investments	Short-term investments
Investments in Unconsolidated Affiliates	Investments in Unconsolidated Affiliates In our F&G segment, we account for our investments in unconsolidated affiliates using the equity method or by electing the fair value option. Initial investments are recorded at cost. For investments subsequently measured using the equity method (primarily limited partnerships), adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by net asset value ("NAV") in the unconsolidated affiliates’ financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. Our pro rata share of NAV adjustments are reported in Interest and investment income and realized gains and losses on sales are reported in Recognized gains and (losses), net in the Consolidated Statements of Earnings. Distributions received from investments measured using the equity method are recorded as a decrease in the investment balance. Recognition of income and adjustments to the carrying amount can be delayed due to the availability of the related financial statements, which are obtained from the general partner or managing member generally on a one to three-month delay. Management inquires quarterly with the general partner or managing member to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter NAV adjustments and investment income. For investments subsequently measured using the fair value option, adjustments to the carrying amount reflecting the change in fair value of the investment and realized gains and losses on sales are reported in Recognized gains and (losses), net in the Consolidated Statements of Earnings. Distributions received from investments measured using the fair value option are reported within Interest and investment income in the Consolidated Statements of Earnings. For descriptions of the fair value methodologies used for our investments, refer to Note D Fair Value of Financial Instruments . In our title segment, we account for our investments in unconsolidated affiliates using the equity method of accounting and earnings on our investments in unconsolidated affiliates are recorded within Equity in earnings of unconsolidated affiliates within the Consolidated Statements of Earnings. We classify distributions received from unconsolidated affiliates in our Consolidated Statements of Cash Flows using the cumulative earnings approach. Under the cumulative earnings approach, distributions are considered returns on investment and classified as cash inflows from operating activities unless the Company’s cumulative distributions from an investee received exceed the cumulative equity in earnings of such investee. When cumulative distributions from an investee exceed cumulative equity in earnings of the investee, such excess is considered a return of investment and is classified as a cash inflow from investing activities.
Interest and Investment Income	Interest and investment income Dividends and interest income are recorded in Interest and investment income and recognized when earned. Income or losses upon call or prepayment of fixed maturity securities are recognized in Interest and investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in Interest and investment income over the contractual terms of the investments, and for callable investments at a premium, based on the earliest call date of the investments, in a manner that produces a constant effective yield. For mortgage-backed and asset-backed securities, included in the fixed maturity securities portfolios, one of two models may be used to recognize interest income. For higher rated securities, interest income will be estimated based on an effective yield that considers cash flows received to date plus current expectations of future cash flows. For all other securities, interest income will be estimated based upon an effective yield that considers current expectations of future cash flows. For both interest income models, the estimated future cash flows include assumptions regarding the performance of the underlying collateral pool.
Cash and Cash Equivalents	Cash and Cash Equivalents
Trade and Notes Receivables	Trade and Notes Receivables The carrying values reported in the Consolidated Balance Sheets for trade and notes receivables approximate their fair value. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete and reported to us. Premium revenues from agency operations and related commissions include an accrual based on estimated historical transaction volume data for policies that have closed in a particular period in which premiums have not yet been reported to us. Historically, the time lag between the closing of these transactions by our agents and the reporting of these policies, or premiums, to us has been up to 15 months, with 61% - 92% reported within three months following closing, an additional 7% - 29% reported within the next three months and the remainder within seven fifteen
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair values of financial instruments presented in the Consolidated Financial Statements are estimates of the fair values at the balance sheet date using available market information and appropriate valuation methodologies. These estimates are subjective in nature and involve uncertainties and significant judgment in the interpretation of current market data. See a description of the fair value methodology used in Note D Fair Value of Financial Instruments
Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations	Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations
Goodwill	Goodwill Goodwill represents the excess of cost over fair value of identifiable net assets acquired and assumed in a business combination. Goodwill and other intangible assets with indefinite useful lives are reviewed for impairment at the reporting unit level on an annual basis or more frequently if circumstances indicate potential impairment, through a comparison of fair value to the carrying amount. In evaluating the recoverability of goodwill, we perform a qualitative analysis at the reporting unit level to determine whether there are any events or circumstances that would indicate it is more likely than not that the fair value of our recorded goodwill exceeds its carrying value, prior to performing a full fair-value assessment. We complete annual goodwill impairment analyses in the fourth quarter of each period presented using a September 30 measurement date. For the years ended December 31, 2024,
VOBA, DAC, DSI, URL and Other Intangible Assets	Other Intangible Assets We have other intangible assets, not including goodwill, VOBA, DAC or DSI, which consist primarily of customer relationships and contracts, the value of distribution network acquired ("VODA"), trademarks and tradenames, state licenses, and computer software, which are generally recorded in connection with business combinations at their fair value . Intangible assets with estimable lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In general, customer relationships are amortized over their estimated useful lives using an accelerated method, which takes into consideration expected customer attrition rates. VODA is an intangible asset that represents the value of an acquired distribution network and is amortized using the sum of years digits method. Contractual relationships are generally amortized over their contractual life. Trademarks and tradenames are generally amortized over ten years. Capitalized computer software includes the fair value of software acquired in business combinations, purchased software and capitalized software development costs. Purchased software is recorded at cost and amortized using the straight-line method over its estimated useful life. Software acquired in business combinations is recorded at its fair value and amortized using straight-line or accelerated methods over its estimated useful life. For internal-use computer software products, internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred during the application development stage are capitalized and amortized on a product-by-product basis commencing on the date the software is ready for its intended use. We do not capitalize any costs once the software is ready for its intended use. We review VOBA, DSI and other intangible assets for impairment annually or when events or circumstances occur that indicate a potential change in the underlying basis. F or further information, refer to Note M Intangibles for details of impairment expense. Title Plants Title plants are recorded at the cost incurred to construct or obtain and organize historical title information to the point it can be used to perform title searches. Costs incurred to maintain, update and operate title plants are expensed as incurred. Title plants are not amortized as they are considered to have an indefinite life, if maintained. Sales of title plants are reported at the
Property and Equipment	Property and Equipment Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is computed primarily using the straight-line method based on the estimated useful lives of the related assets: twenty three recorded $2 million of impairment expense related to property and equipment in our title segment in the year ended December 31, 2022 . We did not record any impairment expense related to property and equipment in the years ended December 31, 2024 and 2023.
Contractholder Funds	Contractholder Funds Contractholder funds include deferred annuities (indexed annuities and fixed rate annuities), IULs, funding agreements and non-life contingent ("NLC") immediate annuities (which includes NLC pension risk transfer ("PRT") annuities). The liabilities for contractholder funds for fixed rate annuities, funding agreements and NLC immediate annuities consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for indexed annuities and IUL policies consist of the value of the host contract plus the fair value of the indexed crediting feature of the policy, which is accounted for as an embedded derivative. The embedded derivative liability is carried at fair value in Contractholder funds in the Consolidated Balance Sheets with changes in fair value reported in Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. See a description of the fair value methodology used in Note D Fair Value of Financial Instruments .
Future Policy Benefits	Future Policy Benefits The FPB are determined as the present value of future policy benefits and related claims expenses to be paid to or on behalf of the policyholder less the present value of future net premiums to be collected from policyholders. The FPB for traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities) are estimated using current assumptions that include discount rate, mortality and surrender/lapse terminations for traditional life insurance policies only, and expenses. The expense assumption is locked-in at contract issuance and not subsequently reviewed or updated. The initial assumptions are based on generally accepted actuarial methods and a combination of internal and industry experience. Policies are terminated through surrenders, lapses and maturities, where surrenders represent the voluntary terminations of policies by policyholders, lapses represent cancellations by us due to nonpayment of premiums, and maturities are determined by policy contract terms. For traditional life policies and life-contingent immediate annuity policies, contracts are grouped into cohorts by product type, legal entity, and issue year, or acquisition year for cohorts established as of the F&G acquisition date, June 1, 2020. Life-contingent PRT annuities are grouped into cohorts by deal and legal entity. At contract inception, a net premium ratio ("NPR") is determined, which is calculated based on discounted future cash flows projected using best estimate assumptions and is capped at 100%, as net premiums cannot exceed gross premiums. Cohorts with NPRs less than 100% are not used to offset cohorts with NPRs greater than 100%. The NPR is adjusted for changes in cash flow assumptions and for differences between actual and expected experience. We assess the appropriateness of all future cash flow assumptions, excluding the expense assumption, on a quarterly basis and perform an in-depth review of future cash flow assumptions in the third quarter of each year. Updates are made when evidence suggests a revision is necessary. Updates for actual experience, which includes actual cash flows and insurance in-force, are performed on a quarterly basis. These updated cash flows are used to calculate a revised NPR, which is used to derive an updated liability as of the beginning of the current reporting period, discounted at the original contract issuance date. The updated liability is compared with the carrying amount of the liability as of that same date before the revised NPR. The difference between these amounts is the remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. In subsequent periods, the revised NPR is used to measure the FPB, subject to future revisions. If the NPR is greater than 100%, and therefore capped at 100%, the liability is increased and expensed immediately to reflect the amount necessary for net premiums to equal gross premiums. As the liability assumptions are reviewed and updated, if deemed necessary, at least annually, if conditions improve whereby the contracts are no longer expected to have net premiums in excess of gross premiums, the improvements would be captured in the remeasurement process and reflected in the Consolidated Statements of Earnings in the period of improvement. For traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities), the discount rate assumption is an equivalent single rate that is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. We selected fixed-income instruments that have been A-rated by Bloomberg. In order to reflect the duration characteristics of the liability, we will use an implied forward yield curve and linear interpolation will be used for durations that have limited or no market observable points on the curve. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in the accompanying Consolidated Statements of Comprehensive Earnings. Deferred Profit Liability For life-contingent immediate annuity policies, gross premiums received in excess of net premiums are deferred at initial recognition as a DPL. Premiums are measured using assumptions consistent with those used in the measurement of the related liability for FPBs, including discount rate, mortality, and expenses. The DPL is amortized and recognized as premium revenue with the amount of expected future benefit payments, discounted using the same discount rate determined and locked-in at contract issuance that is used in the measurement of the related FPB. Interest is accreted on the balance of the DPL using this same discount rate. We periodically review and update our estimates using the actual historical experience and updated cash flows for the DPL at the same time as the estimates of cash flows for the FPB. When cash flows are updated, the updated estimates are used to recalculate the initial DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, with any differences recognized as a remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. The DPL is recorded as a component of the Future policy benefits in the Consolidated Balance Sheets. Market Risk Benefits ("MRBs") MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on indexed annuities products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit ("GMDB"), guaranteed minimum withdrawal benefit ("GMWB") riders and guaranteed minimum accumulation benefit ("GMAB") riders. In certain reinsurance transactions, the underlying risks ceded to a reinsurer contain MRBs. MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread which reflects the credit of the reinsurer. MRBs can either be in an asset or liability position and are presented separately on the Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value, net, are recognized in Market risk benefit (gains) losses in the Consolidated Statements of Earnings, except for the change in fair value due to a change in the instrument-specific credit risk, which is recognized in the Consolidated Statements of Comprehensive Earnings. See a description of the fair value methodology used in Note D Fair Value of Financial Instruments and Note X Market Risk Benefits .
Reserve for Title Claims Losses	Reserve for Title Claim Losses Our reserve for title claim losses includes known claims as well as losses we expect to incur, net of recoupments. Each known claim is reserved based on our review as to the estimated amount of the claim and the costs required to settle the claim. Reserves for claims, which are incurred but not reported are established at the time premium revenue is recognized based on historical loss experience and also take into consideration other factors, including industry trends, claim loss history, current leg al environment, geographic considerations and the type of policy written. The reserve for title claim losses also includes reserves for losses arising from closing and disbursement functions due to frau d or operational error. If a loss is r elated to a policy issued by an independent agent, we may proceed against the independent agent pursuant to the terms of the agency agreement. In any event, we may proceed against third parties who are responsible for any loss under th e title insurance policy under rights of subrogation.
Secured Trust Deposits	Secured Trust Deposits In the state of Illinois, a trust company is permitted to commingle and invest customers’ assets with its own assets, pending completion of real estate transactions. Accordingly, our Consolidated Balance Sheets reflect a secured trust deposit liability of $551 million a nd $731 million at December 31, 2024 and 2023, respectively, representing customers’ assets held by us and corresponding assets including cash and investments pledged as security for those trust balances.
Income Taxes	Income Taxes We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities and expected benefits of utilizing net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The impact on deferred taxes of changes in tax rates and laws, if any, is applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period enacted.
Reinsurance	Reinsurance Title In our Title segment, in a limited number of situations, we limit our maximum loss exposure by reinsuring certain risks with other title insurers. We also earn a small amount of additional income, which is reflected in our direct premiums, by assuming reinsurance for certain risks of other title insurers. We cede a portion of certain policy and other liabilities under agent fidelity, excess of loss and case-by-case reinsurance agreements. Reinsurance agreements provide that in the event of a loss (including costs, attorneys’ fees and expenses) exceeding the retained amounts, the reinsurer is liable for the excess amount assumed. However, the ceding company remains primarily liable in the event the reinsurer does not meet its contractual obligations. F&G In our F&G segment, our insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. In certain arrangements that are not accounted for as reinsurance, the right of offset may be applied resulting in all balances and activity associated with the agreement being presented on a net basis in the Consolidated Balance Sheets and Statements of Earnings, respectively. When the right of offset is not applied, the arrangement is reflected on a gross basis in the Consolidated Balance Sheets and Statements of Earnings. This results in the recognition of a Reinsurance recoverable for amounts due from the reinsurer. For arrangements accounted for as reinsurance, the Reinsurance recoverable balance reflects the reserve balance of the policies ceded. For arrangements not accounted for as reinsurance, deposit accounting is applied. As a result, the deposit asset presented as a Reinsurance recoverable on the Consolidated Balance Sheets, is based on the actual and expected cash flows due from the reinsurer where the interest method is used to accrete the deposit asset using an effective yield based on changes in actual and expected cash flows. For coinsurance of FIA and IUL policies, the Reinsurance recoverable will incorporate the fair value of the indexed crediting feature, which is accounted for as an embedded derivative. Changes in the Reinsurance recoverable balance are reported as Benefits and other changes in policy reserves in the Consolidated Statements of Earnings. Cost of Reinsurance Amounts received from or paid to reinsurers in excess of reimbursements or liabilities ceded, respectively, represents COR. If the net COR balance is in a deferred gain position, it is included within Accounts payable and accrued liabilities with the related amortization reflected within Life insurance premiums and other fees and, if in a deferred loss position, is included within the Prepaid expenses and other assets with the related amortization reflected within Other operating expenses, in the Consolidated Balance Sheets and Statements of Earnings, respectively. Premiums and expenses are recorded net of reinsurance ceded. Funds Withheld Arrangements F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurance that are segregated within the funds withheld account are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance agreement and thus require bifurcation. The fair value of the total return swaps is based on the change in fair value of the underlying assets held in the funds withheld account. These
Benefits and Other Changes in Policy Reserves	Benefits and Other Changes in Policy Reserves Benefit expenses for deferred annuities (indexed annuities and fixed rate annuities), IUL policies and funding agreements include interest credited to contractholder account balances. For indexed annuities and IUL, the benefits expense includes the change in fair value of the embedded derivatives associated with the equity crediting rates. Benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy or strategies. All changes in the Reinsurance recoverable balance that need to be reflected in earnings are included within Benefits and other changes in policy reserves on the Consolidated Statements of Operations. For reinsurance arrangements that apply reinsurance accounting, this primarily relates to changes in the reserve balance ceded. For reinsurance arrangements that apply deposit accounting, this primarily relates to accretion of the deposit asset balance. Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and life-contingent immediate annuities (which includes PRT annuities with life contingencies), policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries. Remeasurement gains or losses on the related FPB and DPL balances are presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Earnings.
Stock-Based Compensation Plans	Stock-Based Compensation Plans We accou nt for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date using quoted market prices, and recognized over the service period.
Earnings Per Share	Earnings Per Share Basic earnings per share, as presented on the Consolidated Statement of Earnings, is computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding plus the impact of assumed conversions of potentially dilutive securities. For periods when we recognize a net loss, diluted earnings per share is equal to basic earnings per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive. We have granted certain stock options, shares of restricted stock, convertible debt instruments and certain other convertible share-based payments, which have been treated as common share equivalents for purposes of calculating diluted earnings per share for periods in which positive earnings have been reported. The net earnings of F&G in our calculation of diluted earnings per share is adjusted for dilution related to certain F&G restricted stock granted to F&G's employees in accordance with ASC 260-10-55-20. We calculate the ratio of the shares of F&G we own to the total weighted average diluted shares of F&G outstanding and multiply the ratio by F&G's net earnings. The result is used for F&G's net earnings attributable to FNF included in our consolidated net earnings in the numerator for our diluted EPS calculation.
Comprehensive Earnings (Loss)	Comprehensive Earnings (Loss) We report Comprehensive earnings (loss) in accordance with GAAP on the Consolidated Statements of Comprehensive Earnings. Total comprehensive earnings are defined as all changes in shareholders' equity during a period, other than those resulting from investments by and distributions to shareholders. While total comprehensive earnings is the activity in a period and is largely driven by net earnings in that period, accumulated other comprehensive earnings or loss represents the cumulative balance of other comprehensive earnings, net of tax, as of the balance sheet date. Amounts reclassified to net earnings relate to the realized gains (losses) on our investments and other financial instruments, excluding investments in unconsolidated
Management Estimates	Management Estimates The preparation of these Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Periodically, and at least annually, typically in the third quarter, we review the assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2024 and for the year ended December 31, 2024, based on policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $89 million for the year ended December 31, 2024. During the third quarter of 2023 and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain indexed annuities assumptions to calculate the fair value of the embedded derivative component within the contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million. During the fourth quarter of 2022, based on increases in interest rates and pricing changes during 2022, we updated certain indexed annuities assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and the fair value of market risk benefits. These changes, taken together, resulted in an increase in contractholder funds and market risk benefits of $99 million .
Revenue Recognition	Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete.
Revenue Recognition, Other	Interest and investment income consists primarily of interest payments received on fixed maturity security holdings and dividends received on equity and preferred security holdings along with the investment income of limited partnerships. We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.
Revenue Recognition, Services, Real Estate Transactions	Escrow fees and Other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing. Revenues from ServiceLink, excluding its title premiums, escrow fees and loan subservicing fees primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete. Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on indexed annuities policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholders' allowable penalty-free amounts. We have ceded the majority of our traditional life business to unaffiliated third-party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Other income related to riders is earned when elected by the policyholder. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of DAC, DSI, and VOBA, other operating costs and expenses, and income taxes. Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Subscriptions are only offered on a month-by-month basis and fees are billed monthly. Revenue is recognized in the month services are provided. Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860.
Recent Accounting Pronouncements Adopted and Not Yet Adopted	Adopted Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the CODM and included in each reported measure of a segment’s profit or loss. In addition, the amendments enhance interim disclosure requirements that are currently required annually, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and contain other disclosure requirements. The amendments in this update are incremental to the current requirements of Topic 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. We adopted this standard using the retrospective approach for all periods presented as required. Refer to Note J Segment Information for additional information. In March 2023, the FASB issued ASU 2023-02, Accounting for Investments in Tax Credit Structure Using the Proportional Amortization Method (a consensus of the Emerging Issues Task Force). The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. We adopted this standard on January 1, 2024, as required, and there was no material impact to our audited Condensed Consolidated Financial Statements. Refer to Note T Income Taxes for further information. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update affect all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction and clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. Additionally, the amendments require the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet, the nature and remaining duration of the restriction(s), and the circumstances that could cause a lapse in the restriction(s). The amendments in this update do not change the principles of fair value measurement, rather, they clarify those principles when measuring the fair value of an equity security subject to a contractual sale restriction and improve current GAAP by reducing diversity in practice, reducing the cost and complexity in measuring fair value, and increasing comparability of financial information across reporting entities that hold those investments. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We adopted this standard as of January 1, 2024, and it did not have a material impact on our unaudited Condensed Consolidated Financial Statements and related disclosures upon adoption. Pronouncements Not Yet Adopted In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied on a prospective basis, and, retrospective application is permitted. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amendments in this update enhance transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel costs, depreciation, and amortization. The amendments also require disclosure of qualitative description of amounts remaining in relevant expense captions that are not separately disaggregated. The amendments in this update are effective for all public companies for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted, and the amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We do not expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption.

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Changes in Other Comprehensive Earnings (Loss)	Changes in the balance of Other comprehensive earnings (loss) for the years ended December 31, 2024, 2023 and 2022, by component are as follows: Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates) Change in current discount rate - future policy benefits Change in instrument-specific credit risk - market risk benefits Other Total Accumulated Other Comprehensive Earnings (Loss) (In millions) Balance January 1, 2022 $ 986 $ (1) $ (116) $ 9 $ 878 Reclassification adjustments 181 — — (8) 173 Other comprehensive earnings (4,783) 764 67 (4) (3,956) Non-controlling interest 33 — 1 1 35 Balance December 31, 2022 (3,583) 763 (48) (2) (2,870) Reclassification adjustments 137 — — (11) 126 Other comprehensive earnings 961 (189) (34) 21 759 Non-controlling interest (170) 31 6 (1) (134) Balance December 31, 2023 (2,655) 605 (76) 7 (2,119) Reclassification adjustments 3 — — (11) (8) Other comprehensive earnings (157) 224 5 10 82 Non-controlling interest 14 (21) — — (7) Balance December 31, 2024 $ (2,795) $ 808 $ (71) $ 6 $ (2,052)

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Business Acquisitions, by Acquisition	The initial purchase price is as follows (in millions): Cash paid for 70% majority interest of Roar shares $ 269 Less: Cash acquired net of non-controlling interests 1 Net cash paid for 70% majority interest of Roar 268 Initial fair value of contingent consideration 48 Total initial consideration $ 316 The initial purchase price is as follows: (In millions) Cash paid $ 215 Less: Cash acquired 1 Net cash paid 214 Settlement of prepaid asset 8 Acquisition date fair value of previously held interests 92 Total consideration $ 314
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 268 Prepaid expenses and other assets 3 Other intangible assets 183 Total assets acquired 454 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Non-controlling interests (fair value determined using income approach) 136 Total liabilities assumed and non-controlling interests 138 Net assets acquired $ 316 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 162 Prepaid expenses and other assets 5 Other intangible assets 149 Total assets acquired 316 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Net assets acquired $ 314
Schedule of Gross Carrying Value and Weighted Average Estimated Useful Lives of Other Intangible Assets Acquired	The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the Roar acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 179 12 Definite lived trademarks, tradenames, and other 4 10 Total Other intangible assets $ 183 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the PALH acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 131 20 Definite lived trademarks, tradenames, and other 18 5 to 10 Total Other intangible assets $ 149

Summary of Reserve for Title _2

Summary of Reserve for Title Claim Losses (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Summary of the Reserve for Title Claim Losses	A summary of the reserve for title claim losses follows: Year Ended December 31, 2024 2023 2022 (Dollars in millions) Beginning balance $ 1,770 $ 1,810 $ 1,883 Change in insurance recoverable (10) 15 (128) Claim loss provision related to: Current year 232 207 308 Prior years — — — Total title claim loss provision 232 207 308 Claims paid, net of recoupments related to: Current year (25) (22) (21) Prior years (254) (240) (232) Total title claims paid, net of recoupments (279) (262) (253) Ending balance of claim loss reserve for title insurance $ 1,713 $ 1,770 $ 1,810 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 % 4.5 %

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Carrying Amounts of Assets and Liabilities and Estimated at Fair Value on Recurring Basis	Our assets and liabilities measured and carried at fair value on a recurring basis, summarized according to the hierarchy previously described, are as follows: December 31, 2024 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 3,479 $ — $ — $ — $ 3,479 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,513 8,143 — 15,656 Commercial mortgage-backed securities — 5,182 — — 5,182 Corporates 41 18,698 2,957 — 21,696 Hybrids 35 546 — — 581 Municipals — 1,386 — — 1,386 Residential mortgage-backed securities — 2,793 3 — 2,796 U.S. Government 631 6 — — 637 Foreign Governments — 280 4 — 284 Short term investments 2,995 18 37 — 3,050 Preferred securities 189 246 8 — 443 Equity securities 575 — 10 57 642 Derivative investments — 791 3 — 794 Investment in unconsolidated affiliates — — 272 — 272 Loan receivable, included in Prepaid expenses and other assets — — 11 — 11 Reinsurance related embedded derivative, included in other assets — 109 — — 109 Market risk benefits asset — — 189 — 189 Other assets — — 65 — 65 Other long-term investments — — 32 — 32 Total financial assets at fair value $ 7,945 $ 37,568 $ 11,734 $ 57 $ 57,304 Liabilities Derivatives: Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in Contractholder funds $ — $ — $ 5,220 $ — $ 5,220 Interest rate swaps — 10 — — 10 Equity options 1 — — — 1 Contingent consideration obligation — — 74 — 74 Market risk benefits liability — — 549 — 549 Total financial liabilities at fair value $ 1 $ 10 $ 5,843 $ — $ 5,854 December 31, 2023 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 2,767 $ — $ — $ — $ 2,767 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,220 7,122 — 14,342 Commercial mortgage-backed securities — 4,457 18 — 4,475 Corporates 25 15,892 1,979 — 17,896 Hybrids 95 523 — — 618 Municipals — 1,562 49 — 1,611 Residential mortgage-backed securities — 2,426 3 — 2,429 U.S. Government 662 16 — — 678 Foreign Governments — 308 16 — 324 Preferred securities 214 399 8 — 621 Equity securities 692 — 15 59 766 Derivative investments — 740 57 — 797 Investment in unconsolidated affiliates — — 285 — 285 Short-term investments 2,111 8 — — 2,119 Reinsurance related embedded derivative, included in other assets — 152 — — 152 Other long-term investments — — 37 — 37 Market risk benefits asset — — 88 — 88 Total financial assets at fair value $ 6,566 $ 33,703 $ 9,677 $ 59 $ 50,005 Liabilities Derivatives: Indexed annuities/IUL embedded derivatives, included in Contractholder funds $ — $ — $ 4,258 $ — $ 4,258 Market risk benefits liability — — 403 — 403 Equity options 1 — — — 1 Total financial liabilities at fair value $ 1 $ — $ 4,661 $ — $ 4,662 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the accompanying Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. December 31, 2024 (in millions) Level 1 Level 2 Level 3 NAV Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 153 $ — $ — $ 153 $ 153 Commercial mortgage loans — — 2,404 — 2,404 2,705 Residential mortgage loans — — 2,916 — 2,916 3,221 Investments in unconsolidated affiliates — — 5 3,288 3,293 3,293 Policy loans — — 104 — 104 104 Other invested assets 42 — — 48 90 90 Company-owned life insurance — — 431 — 431 431 Trade and notes receivables, net of allowance — — 471 — 471 471 Total $ 42 $ 153 $ 6,331 $ 3,336 $ 9,862 $ 10,468 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 46,339 $ — $ 46,339 $ 51,184 Debt — 3,781 — — 3,781 4,321 Total $ — $ 3,781 $ 46,339 $ — $ 50,120 $ 55,505 December 31, 2023 (in millions) Level 1 Level 2 Level 3 NAV Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 138 $ — $ — $ 138 $ 138 Commercial mortgage loans — — 2,253 — 2,253 2,538 Residential mortgage loans — — 2,545 — 2,545 2,798 Investments in unconsolidated affiliates — — 7 2,779 2,786 2,786 Policy loans — — 71 — 71 71 Other invested assets 17 — — 42 59 59 Company-owned life insurance — — 397 — 397 397 Trade and notes receivables, net of allowance — — 442 — 442 442 Total $ 17 $ 138 $ 5,715 $ 2,821 $ 8,691 $ 9,229 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 40,229 $ — $ 40,229 $ 44,540 Debt — 3,568 — — 3,568 3,887 Total $ — $ 3,568 $ 40,229 $ — $ 43,797 $ 48,427
Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2024 and 2023, excluding assets and liabilities for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2024 (in millions) December 31, 2024 Assets Asset-backed securities $ 95 Third-Party Valuation Discount Rate 4.83% - 7.15% (6.33%) Corporates 7 Discounted Cash Flow Discount Rate 13.33% - 100.00% (96.45%) Corporates 750 Third-Party Valuation Discount Rate 2.00% - 22.53% (6.76%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.89%-5.89% (5.89%) Foreign Governments 4 Third-Party Valuation Discount Rate 12.14% - 12.14% (12.14%) Investment in unconsolidated affiliates 272 Market Comparable Company Analysis EBITDA Multiple 8.7x - 23.6x (14.6x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% - 100.00% (100.00%) Equity securities 4 Discounted Cash Flow Discount rate 4.80% - 14.10% (9.40%) Market Comparable Company Analysis EBITDA multiple 5.8x - 7.5x (7.0x) Other assets 65 Discounted Cash Flow Discount Rate 10.60% - 12.00% (11.30%) Conditional Prepayment Rate 6.24% -11.99% (9.12%) Other long-term investments: Available-for-sale embedded derivative 32 Black Scholes Model Market Value of AnchorPath Fund 100.00% Prepaid expenses and other assets: Loan receivable 11 Discounted Cash Flow Risk-Adjusted Discount Rate 7.22% - 7.22% (7.22%) Collateral Volatility 35.00% - 35.00% (35.00%) Market risk benefits asset 189 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.05%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.48% - 0.95% (0.75%) GMWB Utilization 50.00% - 75.00% (61.77%) Total financial assets at fair value (a) $ 1,433 Liabilities Derivatives: Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 5,220 Discounted Cash Flow Market Value of Option 0.00% - 20.81% (2.92%) Mortality Multiplier 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 50.00% (6.94%) Partial Withdrawals 2.00% - 35.71% (2.72%) Non-Performance Spread 0.48% - 0.95% (0.75%) Option Cost 0.07% - 5.70% (2.68%) Contingent consideration 74 Discounted Cash Flow Risk-Adjusted Discount Rate 13.50% - 13.50% (13.50%) EBITDA Volatility 35% - 35% (35%) Counterparty Discount Rate 6.50% - 6.50% (6.50%) Market risk benefits liability 549 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.05%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.48% - 0.95% (0.75%) GMWB Utilization 50.00% - 75.00% (61.77%) Total financial liabilities at fair value $ 5,843 (a) Excludes $10,301 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above. Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2023 (In millions) December 31, 2023 Assets Asset-backed securities $ 57 Third-Party Valuation Discount Rate 5.09% - 6.95% (6.00%) Corporates 787 Third-Party Valuation Discount Rate 0.00% - 12.87% (6.91%) Corporates 8 Discounted Cash Flow Discount Rate 44.00% - 100.00% (75.20%) Municipals 32 Third-Party Valuation Discount Rate 6.25% - 6.25% (6.25%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.46% - 5.46% (5.46%) Foreign Governments 16 Third-Party Valuation Discount Rate 6.94% - 7.68% (7.45%) Investment in unconsolidated affiliates 285 Market Comparable Company Analysis EBITDA Multiple 4.4x - 31.8x (23.2x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% Equity securities 7 Discounted Cash Flow Discount rate 11.50% - 11.50% (11.50%) Other long-term investments: Available-for-sale embedded derivative 28 Black Scholes Model Market Value of Fund 100% Market risk benefits asset 88 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial assets at fair value (a) $ 1,312 Liabilities Derivatives: Indexed annuities/ IUL embedded derivatives, included in Contractholder funds $ 4,258 Discounted Cash Flow Market Value of Option 0.00% - 18.93% (2.63%) Swap Rates 3.84% - 5.26% (4.55%) Mortality Multiplier 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 70.00% (6.83%) Partial Withdrawals 2.00% - 34.48% (2.74%) Non-Performance Spread 0.38% - 1.10% 0.96% Option Cost 0.07% - 5.48% (2.38%) Market risk benefits liability 403 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% 2.50% Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial liabilities at fair value $ 4,661 (a) Assets of $8,365 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above.
Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2024 and 2023, respectively. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended December 31, 2024 (in millions) Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 19 $ 128 $ 5,104 $ (2,825) $ (1,210) $ (195) $ 8,143 $ 130 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (3) 81 1,148 (100) (139) (9) 2,957 80 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — (1) — — (11) — 4 (1) Preferred securities 8 — — — — — — 8 — Equity securities 15 (5) — — — — — 10 — Interest rate swaps 57 (50) 3 — — — (7) 3 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — — — 65 — — — 65 — Short-term investments — — — 236 (190) (9) — 37 — Other long-term assets: Available-for-sale embedded derivative 27 — 5 — — — — 32 5 Credit linked note 10 1 — — — (11) — — — Prepaid expenses and other assets: Loan receivable (c) — — — 11 — — — 11 — Subtotal Level 3 assets at fair value $ 9,589 $ 41 $ 217 $ 6,623 $ (3,165) $ (1,380) $ (380) $ 11,545 $ 216 Market risk benefits asset (d)) 88 189 Total Level 3 assets at fair value $ 9,677 $ 11,734 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 45 $ — $ 1,351 $ — $ (434) $ — $ 5,220 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (e) — 26 — 48 — — — 74 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 99 $ — $ 1,399 $ — $ (434) $ (28) $ 5,294 $ — Market Risk benefits liability (d) 403 549 Total Level 3 liabilities at fair value $ 4,661 $ 5,843 (a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2 with the exception of (b) below. (b) The transfer out of investments in unconsolidated affiliates reflects F&G’s majority acquisition of PALH on July 18, 2024. Refer to Note B Acquisitions for details of the PALH majority acquisition. (c) Purchases represent advances on the loan commitment to Roar. Refer to Note H - Commitments and Contingencies for further details. (d) Refer to Note X Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability. (e) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note B Acquisitions for more information. Year ended December 31, 2023 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (53) $ 186 $ 1,830 $ (125) $ (738) $ (241) $ 7,122 $ 185 Commercial mortgage-backed securities 37 — 2 22 — — (43) 18 2 Corporates 1,440 (2) (21) 654 (1) (94) 3 1,979 (20) Municipals 29 — 20 — — — — 49 20 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 13 — 249 — — — 285 — Short-term investments — — — 204 (19) (185) — — — Derivative Instruments — 57 — — — — — 57 — Preferred securities 1 — — — — — 7 8 1 Equity securities 10 1 1 — — — 3 15 — Other long-term assets: Available-for-sale embedded derivative 23 — 4 — — — — 27 4 Credit linked note 15 — — — — (5) — 10 — Secured borrowing receivable 10 — — — — (10) — — — Subtotal Level 3 assets at fair value $ 8,169 $ 17 $ 199 $ 2,991 $ (145) $ (1,041) $ (601) $ 9,589 $ 199 Market risk benefits asset (b) 117 88 Total Level 3 assets at fair value $ 8,286 $ 9,677 Liabilities Indexed annuities embedded derivatives, included in contractholder funds $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Subtotal Total liabilities at Level 3 fair value $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Market risk benefits liability (b) 282 403 Total Level 3 liabilities at fair value $ 3,397 $ 4,661 ( a) The net transfers out of Level 3 during the year ended December 31, 2023, were to Level 2. (b) Refer to Note X Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability.
Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2024 and 2023, respectively. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Year ended December 31, 2024 (in millions) Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 19 $ 128 $ 5,104 $ (2,825) $ (1,210) $ (195) $ 8,143 $ 130 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (3) 81 1,148 (100) (139) (9) 2,957 80 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — (1) — — (11) — 4 (1) Preferred securities 8 — — — — — — 8 — Equity securities 15 (5) — — — — — 10 — Interest rate swaps 57 (50) 3 — — — (7) 3 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — — — 65 — — — 65 — Short-term investments — — — 236 (190) (9) — 37 — Other long-term assets: Available-for-sale embedded derivative 27 — 5 — — — — 32 5 Credit linked note 10 1 — — — (11) — — — Prepaid expenses and other assets: Loan receivable (c) — — — 11 — — — 11 — Subtotal Level 3 assets at fair value $ 9,589 $ 41 $ 217 $ 6,623 $ (3,165) $ (1,380) $ (380) $ 11,545 $ 216 Market risk benefits asset (d)) 88 189 Total Level 3 assets at fair value $ 9,677 $ 11,734 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 45 $ — $ 1,351 $ — $ (434) $ — $ 5,220 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (e) — 26 — 48 — — — 74 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 99 $ — $ 1,399 $ — $ (434) $ (28) $ 5,294 $ — Market Risk benefits liability (d) 403 549 Total Level 3 liabilities at fair value $ 4,661 $ 5,843 (a) The net transfers out of Level 3 during the year ended December 31, 2024 were exclusively to Level 2 with the exception of (b) below. (b) The transfer out of investments in unconsolidated affiliates reflects F&G’s majority acquisition of PALH on July 18, 2024. Refer to Note B Acquisitions for details of the PALH majority acquisition. (c) Purchases represent advances on the loan commitment to Roar. Refer to Note H - Commitments and Contingencies for further details. (d) Refer to Note X Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability. (e) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note B Acquisitions for more information. Year ended December 31, 2023 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Incl in OCI Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (53) $ 186 $ 1,830 $ (125) $ (738) $ (241) $ 7,122 $ 185 Commercial mortgage-backed securities 37 — 2 22 — — (43) 18 2 Corporates 1,440 (2) (21) 654 (1) (94) 3 1,979 (20) Municipals 29 — 20 — — — — 49 20 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 13 — 249 — — — 285 — Short-term investments — — — 204 (19) (185) — — — Derivative Instruments — 57 — — — — — 57 — Preferred securities 1 — — — — — 7 8 1 Equity securities 10 1 1 — — — 3 15 — Other long-term assets: Available-for-sale embedded derivative 23 — 4 — — — — 27 4 Credit linked note 15 — — — — (5) — 10 — Secured borrowing receivable 10 — — — — (10) — — — Subtotal Level 3 assets at fair value $ 8,169 $ 17 $ 199 $ 2,991 $ (145) $ (1,041) $ (601) $ 9,589 $ 199 Market risk benefits asset (b) 117 88 Total Level 3 assets at fair value $ 8,286 $ 9,677 Liabilities Indexed annuities embedded derivatives, included in contractholder funds $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Subtotal Total liabilities at Level 3 fair value $ 3,115 $ 257 $ — $ 1,049 $ — $ (163) $ — $ 4,258 $ — Market risk benefits liability (b) 282 403 Total Level 3 liabilities at fair value $ 3,397 $ 4,661 ( a) The net transfers out of Level 3 during the year ended December 31, 2023, were to Level 2. (b) Refer to Note X Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Consolidated Investments	Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings. Our consolidated investments are summarized as follows: December 31, 2024 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 15,784 $ (13) $ 202 $ (317) $ 15,656 Commercial mortgage-backed securities 5,379 (49) 53 (201) 5,182 Corporates 24,425 (5) 108 (2,832) 21,696 Hybrids 604 — 6 (29) 581 Municipals 1,638 — 3 (255) 1,386 Residential mortgage-backed securities 2,869 — 32 (105) 2,796 U.S. Government 645 — 2 (10) 637 Foreign Governments 337 — — (53) 284 Total available-for-sale securities $ 51,681 $ (67) $ 406 $ (3,802) $ 48,218 December 31, 2023 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 14,631 $ (11) $ 191 $ (469) $ 14,342 Commercial mortgage-backed/asset-backed securities 4,797 (22) 23 (323) 4,475 Corporates 20,133 (6) 186 (2,417) 17,896 Hybrids 668 — 3 (53) 618 Municipals 1,826 — 14 (229) 1,611 Residential mortgage-backed securities 2,507 (3) 29 (104) 2,429 U.S. Government 679 — 8 (9) 678 Foreign Governments 365 — 3 (44) 324 Total available-for-sale securities $ 45,606 $ (42) $ 457 $ (3,648) $ 42,373
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturity securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. December 31, 2024 December 31, 2023 (in millions) (in millions) Amortized Cost Fair Value Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 961 $ 955 $ 703 $ 687 Due after one year through five years 4,616 4,544 4,320 4,209 Due after five years through ten years 5,311 5,126 3,195 3,048 Due after ten years 16,761 13,959 15,453 13,183 27,649 24,584 23,671 21,127 Other securities, which provide for periodic payments: Asset-backed securities 15,784 15,656 14,631 14,342 Commercial mortgage-backed securities 5,379 5,182 4,797 4,475 Residential mortgage-backed securities 2,869 2,796 2,507 2,429 24,032 23,634 21,935 21,246 Total fixed maturity available-for-sale securities $ 51,681 $ 48,218 $ 45,606 $ 42,373
Fair Value and Gross Unrealized Losses of Available-for-sale Securities	The fair value and gross unrealized losses of available-for-sale securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost were as follows: December 31, 2024 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (Dollars in millions) Asset-backed securities $ 1,164 $ (30) $ 2,637 $ (276) $ 3,801 $ (306) Commercial mortgage-backed securities 727 (11) 1,513 (175) 2,240 (186) Corporates 6,831 (208) 9,866 (2,624) 16,697 (2,832) Hybrids 105 (4) 380 (25) 485 (29) Municipals 261 (12) 1,006 (243) 1,267 (255) Residential mortgage-backed securities 899 (16) 460 (89) 1,359 (105) U.S. Government 313 (4) 122 (5) 435 (9) Foreign Government 120 (5) 157 (48) 277 (53) Total available-for-sale securities $ 10,420 $ (290) $ 16,141 $ (3,485) $ 26,561 $ (3,775) Total number of available-for-sale securities in an unrealized loss position less than twelve months 2,005 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,305 Total number of available-for-sale securities in an unrealized loss position 4,310 December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities Asset-backed securities $ 1,707 $ (56) $ 5,835 $ (404) $ 7,542 $ (460) Commercial mortgage-backed securities 819 (53) 1,922 (235) 2,741 (288) Corporates 2,387 (134) 10,739 (2,283) 13,126 (2,417) Hybrids 60 (2) 483 (51) 543 (53) Municipals 399 (49) 920 (179) 1,319 (228) Residential mortgage-backed securities 336 (5) 662 (89) 998 (94) U.S. Government 84 — 159 (9) 243 (9) Foreign Government 49 (3) 188 (41) 237 (44) Total available-for-sale securities $ 5,841 $ (302) $ 20,908 $ (3,291) $ 26,749 $ (3,593) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,035 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,846 Total number of available-for-sale securities in an unrealized loss position 3,881
Schedule of Distribution of CMLs, Gross Valuation by Property Type and Geographic Region	The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: December 31, 2024 December 31, 2023 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: (Dollars in millions) Hotel $ 17 1 % $ 18 1 % Industrial 657 24 616 24 Mixed Use 11 — 11 — Multifamily 1,006 37 1,012 40 Office 349 13 316 13 Retail 98 4 102 4 Student Housing 83 3 83 3 Other 501 18 392 15 Total commercial mortgage loans, gross of valuation allowance $ 2,722 100 % $ 2,550 100 % Allowance for expected credit loss (17) (12) Total commercial mortgage loans, net of valuation allowance $ 2,705 $ 2,538 U.S. Region: East North Central $ 98 4 % $ 151 6 % East South Central 75 3 75 3 Middle Atlantic 354 13 354 14 Mountain 409 15 352 14 New England 164 6 168 6 Pacific 706 26 766 30 South Atlantic 683 25 563 22 West North Central 62 2 4 — West South Central 171 6 117 5 Total commercial mortgage loans, gross of valuation allowance $ 2,722 100 % $ 2,550 100 % Allowance for expected credit loss (17) (12) Total commercial mortgage loans, net of valuation allowance $ 2,705 $ 2,538
Loans Segregated by Risk Rating Exposure	CMLs segregated by aging of the loans and charge offs (by year of origination) were as follows for the year ended December 31, 2024: December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total (In millions) Current (less than 30 days past due) $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 201 $ 2,713 30-89 days past due — — — — — — — 90 days or more past due — — — — — 9 9 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 $ 2,722 Charge offs $ — $ — $ — $ — $ — $ — $ — CMLs segregated by aging of loans (by year of origination) were as follows for the year ended December 31, 2023: December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total (In millions) Current (less than 30 days past due) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 30-89 days past due — — — — — — — 90 days or more past due — — — — — — — Total commercial mortgage loans(a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Charge offs $ — $ — $ — $ — $ — $ 3 $ 3 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 610 $ 368 $ 911 $ 805 $ 162 $ 312 $ 3,168 30-89 days past due 1 6 4 6 1 3 21 90 days or more past due 3 2 13 29 13 25 85 Total residential mortgages $ 614 $ 376 $ 928 $ 840 $ 176 $ 340 $ 3,274 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios, gross of valuation allowances : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 <1.00 December 31, 2024 (Dollars in millions) LTV Ratios: Less than 50.00% $ 490 $ 34 $ — $ 524 19 % $ 501 21 % 50.00% to 59.99% 803 112 12 927 34 826 34 60.00% to 74.99% 1,238 16 — 1,254 46 1,060 44 75.00% to 84.99% 4 4 9 17 1 17 1 Total Commercial mortgage loans $ 2,535 $ 166 $ 21 $ 2,722 100 % $ 2,404 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 Total Commercial mortgage loans (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023. December 31, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 66 $ 99 $ 19 $ 74 $ 189 $ 77 $ 524 50.00% to 59.99% 112 53 149 321 159 133 927 60.00% to 74.99% 91 71 113 858 121 — 1,254 75.00% to 84.99% 4 4 9 — — — 17 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 2,722 DSCR Greater than 1.25x $ 140 $ 215 $ 278 $ 1,241 $ 469 $ 192 $ 2,535 1.00x - 1.25x 133 12 3 — — 18 166 Less than 1.00x — — 9 12 — — 21 Total commercial mortgage loans $ 273 $ 227 $ 290 $ 1,253 $ 469 $ 210 $ 2,722 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total LTV Ratios: (In millions) Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total commercial mortgage loans (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023.
Schedule of Residential Mortgage Loans by State	The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: December 31, 2024 U.S. States: Amortized Cost (In millions) % of Total Florida $ 164 5 % All Other States (1) 3,110 95 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % Allowance for expected credit loss (53) Total residential mortgage loans, net of valuation allowance $ 3,221 (1) The individual concentration of each state is less than 5% as of December 31, 2024. December 31, 2023 U.S. States: Amortized Cost (In millions) % of Total Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (1) 2,431 84 Total residential mortgage loans, gross of valuation allowance $ 2,852 100 % Allowance for expected credit loss (54) Total residential mortgage loans, net of valuation allowance $ 2,798 (1) The individual concentration of each state is less than 5% as of December 31, 2023.
Schedule of Loans with Credit Quality Indicators, Performing or Nonperforming	The credit quality of RMLs was as follows: December 31, 2024 December 31, 2023 Performance indicators: Amortized Cost % of Total Amortized Cost % of Total (Dollars in millions) Performing $ 3,188 97 % $ 2,795 98 % Non-performing 86 3 57 2 Total residential mortgage loans, gross of valuation allowance $ 3,274 100 % $ 2,852 100 % Allowance for expected loan loss (53) — (54) — Total residential mortgage loans, net of valuation allowance $ 3,221 100 % $ 2,798 100 %
Schedule of Nonaccrual Loans by Amortized Cost	Non-accrual loans by amortized cost as of December 31, 2024 and 2023 were as follows: Amortized cost of loans on non-accrual December 31, 2024 December 31, 2023 (In millions) Residential mortgage $ 85 $ 57 Commercial mortgage 9 — Total non-accrual mortgages $ 94 $ 57
Changes in Allowance for Expected Credit Losses on Loans	The allowances for our mortgage loan portfolio are summarized as follows (in millions): Year ended December 31, 2024 Year ended December 31, 2023 Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (54) $ (12) $ (66) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 1 (5) (4) (22) (5) (27) Loans charged-off — — — — 3 3 Ending Balance $ (53) $ (17) $ (70) $ (54) $ (12) $ (66)
Schedule of Sources of Net Investment Income Reported	The major sources of Interest and investment income reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Fixed maturity securities, available-for-sale $ 2,261 $ 1,911 $ 1,489 Equity securities 33 33 31 Preferred securities 34 52 67 Mortgage loans 273 229 186 Invested cash and short-term investments 238 151 61 Limited partnerships 326 231 110 Tax deferred property exchange income 133 166 103 Other investments 125 91 41 Gross investment income 3,423 2,864 2,088 Investment expense (299) (257) (197) Interest and investment income $ 3,124 $ 2,607 $ 1,891
Recognized Gains and Losses, net	Details underlying Recognized gains and losses, net reported on the accompanying Consolidated Statements of Earnings were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (9) $ (155) $ (253) Net realized/unrealized gains (losses) on equity securities (1) 2 23 (386) Net realized/unrealized gains (losses) on preferred securities (2) 12 (1) (230) Realized gains (losses) on other invested assets 61 (25) (68) Change in allowance for expected credit losses (33) (36) (41) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 254 (211) (164) Unrealized (losses) gains on certain derivative instruments (184) 358 (693) Change in fair value of reinsurance related embedded derivatives (32) (128) 352 Change in fair value of other derivatives and embedded derivatives 12 11 (10) Realized gains (losses) on derivatives and embedded derivatives 50 30 (515) Recognized gains and losses, net $ 83 $ (164) $ (1,493) (1) Includes net valuation (losses) gains of $(131) million, $47 million and $(387) million for the years ended December 31, 2024, 2023, and 2022, respectively.
Proceeds from Sale of Fixed Maturity Available-for-sale Securities	The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 (In millions) Proceeds $ 4,414 $ 2,698 $ 3,264 Gross gains 45 18 14 Gross losses (80) (145) (252)
Schedule of Carrying Value and Maximum Loss Exposure, Unconsolidated VIEs	The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs: December 31, 2024 December 31, 2023 Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure (In millions) Investment in unconsolidated affiliates $ 3,565 $ 4,703 $ 3,071 $ 4,806 Fixed maturity securities 23,242 24,242 20,837 22,346 Total unconsolidated VIE investments $ 26,807 $ 28,945 $ 23,908 $ 27,152

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The notional and carrying amounts of derivative instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance is as follows: December 31, 2024 December 31, 2023 Notional Amount Carrying Amount Notional Amount Carrying Amount Assets: (In millions) Derivative investments: Equity options $ 29,594 $ 773 $ 27,263 $ 739 Interest rate swaps 2,445 19 2,705 57 Other derivative investments 157 3 137 1 Other long-term investments: Other embedded derivatives 32 28 Prepaid expenses and other assets: Reinsurance related embedded derivatives 109 152 Total $ 936 $ 977 Liabilities: Contractholder funds: Indexed annuities/IUL embedded derivatives $ 5,220 $ 4,258 Accounts payable and accrued liabilities: Equity Options — 1 — 1 Interest rate swaps $ 2,700 10 — Total $ 5,231 $ 4,259
Derivative Instruments, Gain (Loss)	The change in fair value of derivative instruments included within Recognized gains and losses, net, in the accompanying Consolidated Statements of Earnings is as follows: Year ended December 31, 2024 2023 2022 Net investment gains (losses): (In millions) Equity options $ 153 $ 98 $ (862) Interest rate swaps (103) 48 — Futures contracts 18 9 (7) Other derivative investments 10 (2) 12 Other embedded derivatives 4 5 (10) Reinsurance related embedded derivatives (32) (128) 352 Total net investment gains (losses) $ 50 $ 30 $ (515) Benefits and other changes in policy reserves: Indexed annuities/IUL embedded derivatives increase (decrease) $ 962 $ 1,143 $ (768)
Information Regarding Exposure to Credit Loss on Call Options Held	Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below: Fair Value Collateral Net Credit Risk (In millions) December 31, 2024 $ 782 $ 771 $ 34 December 31, 2023 796 775 39

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Notes Payable	Notes payable consists of the following: December 31, 2024 December 31, 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving Credit Facility (4) (2) F&G Credit Agreement — 362 5.50% F&G Notes 301 561 7.40% F&G Notes, net of discount 497 495 7.95% F&G Notes, net of discount 336 336 6.50% F&G Notes, net of discount 545 — 6.25% F&G Notes, net of discount 492 — Other 22 7 $ 4,321 $ 3,887 B. Notes Payable Notes payable consist of the following: December 31, 2024 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving credit facility (4) (2) $ 2,128 $ 2,126
Schedule of Principal Maturities of Notes Payable	Gross principal maturities of notes payable at December 31, 2024, are as follows: (In millions) 2025 $ 300 2026 22 2027 — 2028 950 2029 550 Thereafter 2,545 $ 4,367

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of Unfunded Commitments	A summary of unfunded commitments by commitment type is included below: December 31, 2024 Commitment Type (In millions) Unconsolidated VIEs: Limited partnerships $ 1,138 Whole loans 278 Fixed maturity securities, ABS 338 Direct Lending 1,618 Other fixed maturity securities, AFS 70 Other assets 162 Commercial mortgage loans 116 Residential mortgage loans 35 Other invested assets 134 Total $ 3,889

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Segment Information	The tables below summarize the result of operations by segment that are provided to the Chief Operating Decision Maker ("CODM"), who is the Company's Chief Executive Officer. The Company's primary methods of measuring profitability and performance on a reportable segment basis are Revenues and Net earnings from continuing operations which are also measures used by the CODM to evaluate segment results and are factors in determining capital allocation among the segments. Summarized financial information concerning our reportable segments is shown in the following tables. The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM. As of and for the year ended December 31, 2024: Title F&G Corporate and Other Elimination Total Segment revenues: (In millions) Direct title insurance premiums $ 2,200 $ — $ — $ — $ 2,200 Agency title insurance premiums 2,953 — — — 2,953 Escrow, title related and other fees 2,196 2,941 184 — 5,321 Interest and investment income 359 2,719 154 (108) 3,124 Recognized gains and losses, net (6) 84 5 — 83 Total segment revenues 7,702 5,744 343 (108) 13,681 Significant segment expenses: Personnel costs 2,695 296 157 — 3,148 Agent commissions 2,287 — — — 2,287 Other operating expenses 1,251 203 104 — 1,558 Benefits and other changes in policy reserves — 3,791 — — 3,791 Total significant segment expenses 6,233 4,290 261 — 10,784 Other segment items: Depreciation and amortization 141 569 29 — 739 Provision for title claim losses 232 — — — 232 Market risk benefit gains — (25) — — (25) Interest expense — 132 77 — 209 Total other segment items 373 676 106 — 1,155 Total segment expenses 6,606 4,966 367 — 11,939 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 1,096 778 (24) (108) 1,742 Income tax expense (benefit) 265 136 (34) — 367 Earnings (loss) before equity in earnings (loss) of unconsolidated affiliates 831 642 10 (108) 1,375 Equity in earnings of unconsolidated affiliates 16 — — — 16 Net earnings (loss) from continuing operations $ 847 $ 642 $ 10 $ (108) $ 1,391 Assets $ 7,627 $ 85,047 $ 2,698 $ — $ 95,372 Goodwill 2,799 2,179 293 — 5,271 As of and for the year ended December 31, 2023: Title F&G Corporate and Other Elimination Total Segment revenues: (In millions) Direct title insurance premiums $ 1,982 $ — $ — $ — $ 1,982 Agency title insurance premiums 2,610 — — — 2,610 Escrow, title related and other fees 2,117 2,413 187 — 4,717 Interest and investment income 338 2,211 123 (65) 2,607 Recognized gains and losses, net (9) (124) (31) — (164) Total segment revenues 7,038 4,500 279 (65) 11,752 Significant segment expenses: Personnel costs 2,544 232 132 — 2,908 Agent commissions 2,008 — — — 2,008 Other operating expenses 1,242 146 133 — 1,521 Benefits and other changes in policy reserves — 3,553 — — 3,553 Total significant segment expenses 5,794 3,931 265 — 9,990 Other segment items: Depreciation and amortization 154 412 27 — 593 Provision for title claim losses 207 — — — 207 Market risk benefit losses — 95 — — 95 Interest expense — 97 77 — 174 Total other segment items 361 604 104 — 1,069 Total segment expense 6,155 4,535 369 — 11,059 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 883 (35) (90) (65) 693 Income tax expense (benefit) 181 23 (12) — 192 Earnings (loss) before equity in earnings of unconsolidated affiliates 702 (58) (78) (65) 501 Equity in earnings of unconsolidated affiliates 17 — — — 17 Net earnings (loss) $ 719 $ (58) $ (78) $ (65) $ 518 Assets $ 7,949 $ 70,186 $ 2,479 $ — $ 80,614 Goodwill 2,789 1,749 292 — 4,830 As of and for the year ended December 31, 2022: Title F&G Corporate and Other Total Segment revenues: (In millions) Direct title insurance premiums $ 2,858 $ — $ — $ 2,858 Agency title insurance premiums 3,976 — — 3,976 Escrow, title related and other fees 2,502 1,704 127 4,333 Interest and investment income 213 1,655 23 1,891 Recognized gains and losses, net (443) (1,010) (40) (1,493) Total segment revenues 9,106 2,349 110 11,565 Significant segment expenses: Personnel costs 2,987 157 48 3,192 Agent commissions 3,064 — — 3,064 Other operating expenses 1,515 102 104 1,721 Benefits and other changes in policy reserves — 1,126 — 1,126 Total significant segment expenses 7,566 1,385 152 9,103 Other segment items: Depreciation and amortization 142 324 25 491 Provision for title claims losses 308 — — 308 Market risk benefit gains — (182) — (182) Interest expense — 29 86 115 Total other segment items 450 171 111 732 Total segment expenses 8,016 1,556 263 9,835 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 1,090 793 (153) 1,730 Income tax expense (benefit) 298 158 (17) 439 Earnings (loss) before equity in earnings of unconsolidated affiliates 792 635 (136) 1,291 Equity in earnings of unconsolidated affiliates 15 — — 15 Net earnings (loss) $ 807 $ 635 $ (136) $ 1,306 Assets $ 8,295 $ 54,637 $ 2,211 $ 65,143 Goodwill 2,620 1,749 266 4,635

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities. Year Ended December 31, 2024 2023 2022 Cash paid for: (In millions) Interest $ 200 $ 157 $ 125 Income taxes 237 216 387 Deferred sales inducements 319 168 87 Non-cash investing and financing activities: Distribution of 15% of the common stock of F&G — — 421 Investments received from pension risk transfer premiums 129 464 — Change in proceeds of sales of investments available for sale receivable in period (59) 32 96 Change in purchases of investments available for sale payable in period 82 20 (25) Lease liabilities recognized in exchange for lease right-of-use assets 55 40 70 Remeasurement of lease liabilities 67 75 60 Liabilities assumed in connection with acquisitions Fair value of assets acquired 789 304 266 Less: Total Purchase price 586 299 180 Liabilities and noncontrolling interests assumed $ 203 $ 5 $ 86 Year Ended December 31, 2024 2023 2022 (In millions) Cash paid during the year: Interest paid $ 73 $ 73 $ 95 Income tax payments 229 213 459

Revenue Recognition (Tables)

Revenue Recognition (Tables) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Our revenue consists of: Year Ended December 31, 2024 2023 2022 Revenue Stream Income Statement Classification Segment Total Revenue Revenue from insurance contracts: (In millions) Direct title insurance premiums Direct title insurance premiums Title $ 2,200 $ 1,982 $ 2,858 Agency title insurance premiums Agency title insurance premiums Title 2,953 2,610 3,976 Life insurance premiums, insurance and investment product fees, and other (1) Escrow, title-related and other fees F&G 2,941 2,413 1,704 Home warranty Escrow, title-related and other fees Title 146 143 165 Total revenue from insurance contracts 8,240 7,148 8,703 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Title 824 766 980 Other title-related fees and income Escrow, title-related and other fees Title 642 633 752 ServiceLink, excluding title premiums, escrow fees, and subservicing fees Escrow, title-related and other fees Title 318 313 342 Real estate technology Escrow, title-related and other fees Corporate and other 140 151 158 Total revenue from contracts with customers 1,924 1,863 2,232 Other revenue: Loan subservicing revenue Escrow, title-related and other fees Title 266 262 263 Other Escrow, title-related and other fees Corporate and other 44 36 (31) Interest and investment income Interest and investment income Various 3,124 2,607 1,891 Recognized gains and losses, net Recognized gains and losses, net Various 83 (164) (1,493) Total revenues Total revenues $ 13,681 $ 11,752 $ 11,565 (1) Includes $2,217, $1,964 and $1,362 of life-contingent pension risk transfer premiums in 2024, 2023 and 2022, respectively.
Premium, Annuity Deposits and Funding Agreements (Net of Reinsurance) By Type	Premiums, annuity deposits (net of reinsurance and reinsurance recoverable) and funding agreements, which are not included as revenues in the accompanying Consolidated Statements of Earnings, collected by product type were as follows: Year ended December 31, 2024 December 31, 2023 December 31, 2022 Product Type (In millions) Fixed indexed annuities $ 5,828 $ 4,738 $ 4,483 Fixed rate annuities 1,277 1,147 1,522 Funding agreements (FABN/FHLB) 2,404 1,256 1,891 Life insurance and other (a) 638 646 446 Total $ 10,147 $ 7,787 $ 8,342 (a) Life insurance and other primarily includes indexed universal life insurance.
Information about Trade Receivables and Deferred Revenue	The following table provides information about trade receivables and deferred revenue: December 31, 2024 December 31, 2023 (In millions) Trade receivables $ 362 $ 317 Deferred revenue (contract liabilities) 92 91
Revenue from contract with customer	$ 1,924	$ 1,863	$ 2,232

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Definite and Indefinite Lived Other Intangible Assets	The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2024 and 2023: December 31, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 435 $ 174 VOBA 1,349 1,446 DAC 3,036 2,215 DSI 625 346 Value of distribution asset 74 86 Computer software 277 266 Trademarks, tradenames, and other 180 94 Total Other intangible assets, net $ 5,976 $ 4,627 Other intangible assets as of December 31, 2024, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts (a) $ 795 $ (360) $ 435 10 to 20 Computer software 723 (446) 277 2 to 10 Value of distribution asset (VODA) 140 (66) 74 15 Trademarks, tradenames, and other 234 (54) 180 Varies Total $ 966 (a) Includes intangible assets acquired with ROAR and PALH. Refer to Note B Acquisitions for further details. Other intangible assets as of December 31, 2023, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts $ 948 $ (774) $ 174 10 to 20 Computer software 651 (385) 266 2 to 10 Value of distribution Asset (VODA) 140 (54) 86 15 Trademarks, tradenames, and other 146 (52) 94 Varies Total $ 620
Schedule of Indefinite-Lived Intangible Assets	The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2024 and 2023: December 31, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 435 $ 174 VOBA 1,349 1,446 DAC 3,036 2,215 DSI 625 346 Value of distribution asset 74 86 Computer software 277 266 Trademarks, tradenames, and other 180 94 Total Other intangible assets, net $ 5,976 $ 4,627 Other intangible assets as of December 31, 2024, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts (a) $ 795 $ (360) $ 435 10 to 20 Computer software 723 (446) 277 2 to 10 Value of distribution asset (VODA) 140 (66) 74 15 Trademarks, tradenames, and other 234 (54) 180 Varies Total $ 966 (a) Includes intangible assets acquired with ROAR and PALH. Refer to Note B Acquisitions for further details. Other intangible assets as of December 31, 2023, consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) (In millions) Customer relationships and contracts $ 948 $ (774) $ 174 10 to 20 Computer software 651 (385) 266 2 to 10 Value of distribution Asset (VODA) 140 (54) 86 15 Trademarks, tradenames, and other 146 (52) 94 Varies Total $ 620
Rollforward of Value of Business Acquired	The following tables roll forward VOBA by product for the years ended December 31, 2024 and 2023: Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance at January 1, 2024 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446 Amortization (133) (5) (7) (8) (7) (160) Actuarial model updates and refinements (a) — — — — 63 63 Balance at December 31, 2024 $ 892 $ 22 $ 184 $ 126 $ 125 $ 1,349 (a) net of amortization of ($15 million). Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance at January 1, 2023 $ 1,166 $ 32 $ 201 $ 143 $ 73 $ 1,615 Amortization (141) (5) (10) (9) (4) (169) Balance at December 31, 2023 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446
Rollforward of Deferred Policy Acquisition Costs	The following tables roll forward DAC by product for the years ended December 31, 2024 and 2023: Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance at January 1, 2024 $ 1,378 $ 288 $ 545 $ 2,211 Capitalization 652 174 274 1,100 Amortization (156) (86) (38) (280) Balance at December 31, 2024 $ 1,874 $ 376 $ 781 $ 3,031 Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance at January 1, 2023 $ 971 $ 83 $ 348 $ 1,402 Capitalization 510 177 229 916 Amortization (103) (51) (32) (186) Reinsurance related adjustments — 79 — 79 Balance at December 31, 2023 $ 1,378 $ 288 $ 545 $ 2,211 (a) Excludes insignificant amounts of DAC related to FABN and PRT.
Schedule of Reconciliation of Deferred Policy Acquisition Cost to Statement of Financial Position	The following table presents a reconciliation of DAC to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2024 and 2023: December 31, 2024 December 31, 2023 (In millions) Indexed Annuities $ 1,874 $ 1,378 Fixed Rate Annuities 376 288 Universal Life 781 545 Funding Agreements 4 4 PRT 1 — Total $ 3,036 $ 2,215
Rollforward of Deferred Sale Inducement Cost	The following tables roll forward DSI for our indexed annuity products for the years ended December 31, 2024 and 2023: Years Ended December 31, 2024 2023 (In millions) Balance at January 1, $ 346 $ 200 Capitalization 319 168 Amortization (40) (22) Balance at December 31, $ 625 $ 346
Estimated Amortization Expense for VOBA in Future Fiscal Periods	For the in-force liabilities as of December 31, 2024, the estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year (In millions) 2025 $ 145 2026 132 2027 121 2028 110 2029 100 Thereafter 741 Total $ 1,349

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	A summary of the changes in Goo dwill consists of the following: Title F&G Corporate and Other Total (In millions) Balance, December 31, 2022 $ 2,620 $ 1,749 $ 266 $ 4,635 Goodwill associated with acquisitions 168 — 27 195 Balance, December 31, 2023 $ 2,788 $ 1,749 $ 293 $ 4,830 Goodwill associated with acquisitions 11 430 — 441 Balance, December 31, 2024 $ 2,799 $ 2,179 $ 293 $ 5,271

F&G Reinsurance (Tables)

F&G Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2024
Reinsurance Disclosures [Abstract]
Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effects of reinsurance on net premiums earned and net benefits incurred (benefits paid and reserve changes) for the years ended December 31, 2024, 2023 and 2022 respectively, were as follows: Year Ended December 31, 2024 December 31, 2023 December 31, 2022 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred (In millions) Direct $ 2,346 $ 3,987 $ 2,112 $ 3,728 $ 1,522 $ 3,640 Ceded (94) (196) (105) (175) (128) (2,514) Net $ 2,252 $ 3,791 $ 2,007 $ 3,553 $ 1,394 $ 1,126
Schedule of Reinsurance Recoverable	The following summarizes our reinsurance recoverable (in millions) as of December 31, 2024 and 2023: Parent Company/ Reinsurance Recoverable (a) Agreement Type Products Accounting December 31, 2024 December 31, 2023 Aspida Life Re Ltd $ 7,844 $ 6,128 Coinsurance Funds Withheld Certain MYGA (b) Deposit Somerset (c) 2,822 716 Coinsurance Funds Withheld Certain MYGA (b) and deferred annuities Deposit Coinsurance Funds Withheld Certain FIA Reinsurance Everlake 1,168 509 Coinsurance Certain MYGA (b) (d) Deposit Wilton Reassurance Company 1,066 1,092 Coinsurance Block of traditional, IUL, and UL (e) Reinsurance Other (f) 489 536 Reinsurance recoverable, gross of allowance for credit losses 13,389 8,981 Allowance for expected credit loss (20) (21) Reinsurance recoverable, net of allowance for credit losses $ 13,369 $ 8,960 (a) Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies. (b) The combined quota share flow reinsurance amongst all reinsurers for 2024 varied between 30% and 90%. As of December 31, 2024, the combined quota share flow reinsurance amongst all reinsurers was 90%. (c) The balance represents the total reinsurance recoverable for all reinsurance agreements with Somerset. (d) Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit. (e) Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX. (f) Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable
Reinsurance Recoverable, Expected Credit Loss Reserves	The expected credit loss reserves were as follows: Years Ended December 31, 2024 December 31, 2023 (In millions) Balance at Beginning of Period $ (21) $ (10) Changes in the expected credit loss reserve 1 (11) Balance at End of Period $ (20) $ (21)
Schedule Of Credit Ratings Of Principal Reinsurers	The following table presents financial strength ratings as of December 31, 2024: Parent Company/Principal Reinsurers Financial Strength Rating AM Best S&P Fitch Moody's Aspida Re A- — — — Somerset A- BBB+ — — Everlake A — — — Wilton Re A+ — A- —

Regulation and Equity (Tables)

Regulation and Equity (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Statutory Accounting Practices Disclosure	Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows: Subsidiary (state of domicile) (a) FGL Insurance (IA) FGL NY Insurance (NY) Raven Re (VT) Corbeau Re (VT) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ 150 $ 8 $ 54 $ (458) Year ended December 31, 2023 (462) 5 60 (644) Year ended December 31, 2022 (243) (15) (111) — Statutory Capital and Surplus: December 31, 2024 $ 1,654 $ 97 $ 168 $ 178 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows: Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory Net income (loss): (In millions) Year ended December 31, 2024 $ (11) $ 139 Year ended December 31, 2023 133 151 Year ended December 31, 2022 71 (339) Statutory Capital and Surplus (Deficit): December 31, 2024 $ 734 $ 123 December 31, 2023 543 11

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Future Payments Under Operating Lease Arrangements	Future payments under operating lease arrangements accounted for under ASC Topic 842 as of December 31, 2024, are as follows (in millions): 2025 $ 133 2026 108 2027 77 2028 52 2029 32 Thereafter 24 Total operating lease payments, undiscounted $ 426 Less: present value discount 41 Lease liability, at present value $ 385

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and equipment consist of the following: December 31, 2024 2023 (In millions) Furniture, fixtures and equipment $ 161 $ 163 Data processing equipment 155 145 Leasehold improvements 126 121 Buildings 93 95 Land 14 14 Other 8 6 Total property and equipment, gross 557 544 Accumulated depreciation and amortization (384) (376) Total property and equipment, net $ 173 $ 168

Accounts Payable and Other Ac_2

Accounts Payable and Other Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Other Accrued Liabilities	Accounts payable and other accrued liabilities consist of the following: December 31, 2024 2023 (In millions) Salaries and incentives $ 433 $ 373 Accrued benefits 454 437 URL 401 270 Deferred revenue 92 91 Contingent consideration - acquisitions 110 49 Trade accounts payable 191 339 Accrued recording fees and transfer taxes 7 15 Accrued premium taxes 30 3 Liability for policy and contract claims 102 92 Retained asset account 60 81 Remittances and items not allocated 224 284 Option collateral liabilities 680 588 Other accrued liabilities 465 387 $ 3,249 $ 3,009
Roll Forward of URL	The following tables roll forward URL for the universal life product for the years ended December 31, 2024 and 2023: December 31, 2024 2023 (In millions) Balance at January 1, $ 270 $ 166 Capitalization 151 119 Amortization (20) (15) Balance at December 31, $ 401 $ 270

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Income tax expense (benefit) on continuing operations consists of the following: Year Ended December 31, 2024 2023 2022 (In millions) Current $ 360 $ 241 $ 331 Deferred 7 (49) 108 $ 367 $ 192 $ 439
Schedule of Components of Income Tax Expense (Benefit)	Total income tax expense was allocated as follows: Year Ended December 31, 2024 2023 2022 (In millions) Net earnings from continuing operations $ 367 $ 192 $ 439 Other comprehensive earnings (loss): Unrealized (loss) gain on investments and other financial instruments (35) 275 (1,198) Unrealized (loss) gain on foreign currency translation and cash flow hedging (6) 2 (4) Changes in current discount rate - future policy benefits 59 (50) 203 Changes in instrument - specific credit risk - market risk benefits 1 (9) 18 F&G 15% Distribution (3) (35) 9 Minimum pension liability adjustment — — 2 Total income tax expense (benefit) allocated to other comprehensive earnings 16 183 (970) Total income tax expense (benefit) $ 383 $ 375 $ (531)
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the federal statutory rate to our effective tax rate is as follows: Year Ended December 31, 2024 2023 2022 Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal benefit 1.8 2.4 2.0 Stock compensation (0.5) (0.2) (0.1) Tax credits (0.7) (1.8) (0.7) Valuation allowance for deferred tax assets (1.0) 5.0 5.4 Benefit on Capital Loss Carryback — — (1.3) Officers Compensation 0.8 1.2 0.4 Non-deductible expenses and other, net (0.3) 0.1 (1.3) Effective tax rate 21.1 % 27.7 % 25.4 %
Schedule of Deferred Tax Assets and Liabilities	The significant components of deferred tax assets and liabilities consist of the following: December 31, 2024 2023 (In millions) Deferred Tax Assets: Employee benefit accruals $ 129 $ 116 Net operating loss carryforwards 115 84 Tax credits 204 119 Investment securities 775 686 Capital loss carryover 19 38 Life insurance and claim related adjustments 451 547 Funds held under reinsurance agreements 822 500 Market Risk Benefits 56 61 Bermuda corporate income tax net operating loss carryforward 10 24 Other 42 26 Total gross deferred tax asset 2,623 2,201 Less: valuation allowance 164 197 Total deferred tax asset $ 2,459 $ 2,004 Deferred Tax Liabilities: Title plant $ (53) $ (53) Amortization of goodwill and intangible assets (71) (98) Other (11) (25) Depreciation (24) (29) Partnerships (198) (152) Value of business acquired (283) (304) Deferred acquisition costs (543) (361) Funds held under reinsurance agreements (945) (621) Title Insurance reserve discounting (16) (18) Total deferred tax liability $ (2,144) $ (1,661) Net deferred tax asset $ 315 $ 343

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Stock Options Transactions	FNF stock option transactions under the Omnibus Plan for 2024 , 2023, and 2022 are as follows: Options Weighted Average Exercisable Balance, January 1, 2022 996,113 $ 25.53 996,113 Exercised (996,113) 25.53 Balance, December 31, 2022 — $ — — FNF stock option transactions under the F&G Omnibus Plan for 2024, 2023 , and 2022 are as follows: Options Weighted Average Exercisable Balance January 1, 2022 1,527,936 $ 35.97 1,072,584 Exercised (352,614) 38.79 Canceled (2,715) 28.00 Balance, December 31, 2022 1,172,607 $ 35.15 1,172,607 Exercised (502,414) 30.31 Canceled (26,570) 38.07 Balance, December 31, 2023 643,623 $ 38.80 643,623 Exercised (543,623) 38.74 Balance, December 31, 2024 100,000 $ 39.10 100,000
Schedule of Restricted Stock Transactions	FNF restricted stock transactions under the Omnibus Plan in 2024 , 2023 and 2022 are as follows: Shares Weighted Average Grant Date Fair Value Balance, December 31, 2021 1,639,226 $ 41.97 Granted 994,548 40.83 Vested (792,230) 41.44 Balance, December 31, 2022 1,841,544 $ 41.59 Granted 966,093 44.44 Canceled (23,975) 41.42 Vested (908,267) 40.26 Balance, December 31, 2023 1,875,395 $ 43.69 Granted 1,604,119 60.23 Canceled (16,603) 45.92 Vested (1,105,691) 47.21 Balance, December 31, 2024 2,357,220 $ 53.28 FNF restricted stock transactions under the F&G Omnibus Plan in 2024, 2023 and 2022 are as follows: Shares Weighted Average Grant Date Fair Value Balance, January 1, 2022 718,641 $ 40.24 Granted — — Canceled (78,551) 37.79 Vested (138,542) 34.11 Balance, December 31, 2022 501,548 $ 42.31 Granted — — Canceled (15,965) 45.63 Vested (304,104) 42.87 Balance, December 31, 2023 181,479 $ 41.08 Granted — — Canceled (13,082) 48.28 Vested (168,397) 40.53 Balance, December 31, 2024 — $ —
Schedule of Stock Options Outstanding and Exercisable	The following table summarizes information related to stock options outstanding and exercisable as of December 31, 2024 : Options Outstanding Options Exercisable Weighted Weighted Average Weighted Average Weighted Remaining Average Remaining Average Range of Number of Contractual Exercise Intrinsic Number of Contractual Exercise Intrinsic Exercise Prices Options Life Price Value Options Life Price Value (In years) (In millions) (In years) (In millions) $0.00 - $39.10 100,000 0.97 $ 39.10 $ 2 100,000 0.97 $ 39.10 $ 2 100,000 $ 2 100,000 $ 2

Financial Instruments with Of_2

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk (Tables)	12 Months Ended
	Dec. 31, 2024
Risks and Uncertainties [Abstract]
Schedules of Title Insurance Premiums as a Percentage of Total Title Insurance Premiums Written	Title insurance premiums as a percentage of the total title insurance premiums written from those five states are detailed as follows: 2024 2023 2022 Texas 13.8 % 14.3 % 15.0 % California 12.9 % 13.0 % 12.0 % Florida 10.2 % 10.7 % 10.6 % Illinois 5.8 % 6.0 % 5.3 % Pennsylvania 5.2 % 4.9 % 5.2 %

Market Risk Benefits (Tables)

Market Risk Benefits (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Balances and Changes in Market Risk Benefit	The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the years ended December 31, 2024 and 2023: December 31, 2024 December 31, 2023 Indexed Annuities Fixed rate annuities Indexed Annuities Fixed rate annuities (Dollars in millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 109 — (10) — Attributed fees collected and interest accrual 147 — 131 — Actual policyholder behavior different from expected (5) — 27 — Changes in assumptions and other 24 — 29 — Effects of market related movements (162) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk $ 322 $ 1 $ 209 $ 1 Effect of changes in the instrument-specific credit risk 98 — 105 — Balance, end of period, net liability $ 420 $ 1 $ 314 $ 1 Less: reinsured market risk benefits 61 — — — Balance, end of period, net of reinsurance $ 359 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 67.98 72.58 68.28 72.59 Net amount at risk $ 1,327 $ 2 $ 1,059 $ 2 The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets: December 31, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB Asset Indexed annuities $ 128 $ 61 $ 189 $ 88 $ — $ 88 Fixed rate annuities — — — — — — Total MRB Asset $ 128 $ 61 $ 189 $ 88 $ — $ 88 MRB Liability Indexed annuities $ 548 $ — $ 548 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 549 $ — $ 549 $ 403 $ — $ 403

Contractholder Funds (Tables)

Contractholder Funds (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Summary of Balances and Changes in Contractholder Funds	The following tables summarize balances of and changes in contractholder funds’ account balances: December 31, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 6,649 5,125 208 600 1,804 Premiums received 120 1 495 — — Policy charges (a) (195) — (315) — — Surrenders and withdrawals (3,832) (1,479) (101) — — Benefit payments (495) (315) (18) (820) (1,606) Interest credited 821 667 157 71 117 Other 3 — — (1) (2) Balance, end of year 30,235 17,442 2,817 2,463 2,852 Embedded derivative adjustment (c) 219 — 79 — — Gross liability, end of period 30,454 17,442 2,896 2,463 2,852 Less: Reinsurance recoverable 861 11,009 877 — — Net liability, after reinsurance recoverable $ 29,593 $ 6,433 $ 2,019 $ 2,463 $ 2,852 Weighted-average crediting rate 2.90 % 4.42 % 6.20 % N/A N/A Net amount at risk (d) N/A N/A $ 74,279 N/A N/A Cash surrender value (e) $ 27,865 $ 16,266 $ 2,177 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance December 31, 2023 Indexed Annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of year 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance recoverable 17 7,520 894 — — Net liability, after reinsurance recoverable $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance
Schedule Of Reconciliation Of Policyholder Account Balances To Statement Of Financial Position	The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheets: December 31, 2024 2023 (In millions) Indexed annuities $ 30,454 $ 27,407 Fixed rate annuities 17,442 13,443 Immediate annuities 286 311 Universal life 2,896 2,475 Traditional life 5 5 Funding Agreement-FABN 2,463 2,613 FHLB 2,852 2,539 PRT 6 5 Total $ 56,404 $ 48,798
Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: December 31, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,540 $ 1,236 $ 492 $ 1,846 $ 27,114 1.51%-2.50% 875 1 684 1,242 2,802 Greater than 2.50% 303 2 — 14 319 Total $ 24,718 $ 1,239 $ 1,176 $ 3,102 $ 30,235 Fixed Rate Annuities 0.00%-1.50% $ 57 $ 20 $ 773 $ 14,407 $ 15,257 1.51%-2.50% 4 7 20 462 493 Greater than 2.50% 804 2 5 881 1,692 Total $ 865 $ 29 $ 798 $ 15,750 $ 17,442 Universal Life 0.00%-1.50% $ 2,421 $ 7 $ — $ 24 $ 2,452 1.51%-2.50% — — — — — Greater than 2.50% 364 — 1 — 365 Total $ 2,785 $ 7 $ 1 $ 24 $ 2,817 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 1.51%-2.50% — — — — — Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Future Policy Benefits (Tables)

Future Policy Benefits (Tables)	12 Months Ended
	Dec. 31, 2024
Insurance [Abstract]
Summary Balances and Changes in the Present Value of Expected Net Premiums and Present Value	The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts: Traditional life December 31, 2024 December 31, 2023 Expected net premiums (In millions) Balance, beginning of year $ 722 $ 797 Beginning balance at original discount rate 874 974 Effect of actual variances from expected experience (4) (1) Balance adjusted for variances from expectation 870 973 Interest accrual 17 19 Net premiums collected (107) (118) Ending Balance at original discount rate 780 874 Effect of changes in discount rate assumptions (149) (152) Balance, end of year $ 631 $ 722 Expected FPB Balance, beginning of year $ 2,071 $ 2,151 Beginning balance at original discount rate 2,492 2,665 Effect of actual variances from expected experience 44 (24) Balance adjusted for variances from expectation 2,536 2,641 Interest accrual 54 56 Benefits payments (222) (205) Ending Balance at original discount rate 2,368 2,492 Effect of changes in discount rate assumptions (435) (421) Balance, end of year $ 1,933 $ 2,071 Net liability for future policy benefits $ 1,302 $ 1,349 Less: Reinsurance recoverable 513 413 Net liability for future policy benefits, after reinsurance recoverable $ 789 $ 936 Weighted-average duration of liability for future policyholder benefits (years) 6.28 7.36 The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts: PRT December 31, 2024 December 31, 2023 (In millions) Balance, beginning of year $ 4,189 $ 2,165 Beginning balance at original discount rate 4,351 2,475 Effect of changes in cash flow assumptions (3) (9) Effect of actual variances from expected experience (11) (7) Balance adjusted for variances from expectation 4,337 2,459 Issuances 2,324 2,041 Interest accrual 240 109 Benefits payments (484) (258) Ending Balance at original discount rate 6,417 4,351 Effect of changes in discount rate assumptions (363) (162) Balance, end of year $ 6,054 $ 4,189 Net liability for future policy benefits, after reinsurance recoverable $ 6,054 $ 4,189 Weighted-average duration of liability for future policyholder benefits (years) 7.78 8.23 Immediate annuities December 31, 2024 December 31, 2023 (In millions) Balance, beginning of year $ 1,415 $ 1,429 Beginning balance at original discount rate 1,788 1,858 Effect of changes in cash flow assumptions — — Effect of actual variances from expected experience (27) (15) Balance adjusted for variances from expectation 1,761 1,843 Issuances 30 22 Interest accrual 59 51 Benefits payments (118) (128) Ending Balance at original discount rate 1,732 1,788 Effect of changes in discount rate assumptions (435) (373) Balance, end of year $ 1,297 $ 1,415 Net liability for future policy benefits $ 1,297 $ 1,415 Less: Reinsurance recoverable 109 116 Net liability for future policy benefits, after reinsurance recoverable $ 1,188 $ 1,299 Weighted-average duration of liability for future policyholder benefits (years) 12.63 12.47
Summary of Changes in Liability for Deferred Profit Liability	The following tables summarize balances and changes in the liability for DPL for limited-payment contracts: December 31, 2024 December 31, 2023 Immediate annuities PRT Immediate annuities PRT (In millions) Balance, beginning of year $ 87 $ 10 $ 69 $ 4 Effect of modeling changes — — 4 — Effect of changes in cash flow assumptions — (8) — 1 Effect of actual variances from expected experience 8 — 16 5 Balance adjusted for variances from expectation 95 2 89 10 Issuances 3 1 3 — Interest accrual 1 4 2 1 Amortization (9) (1) (7) (1) Balance, end of year $ 90 $ 6 $ 87 $ 10
Schedule Of Reconciliation Of Future Policy Benefits To Statement Of Financial Position	The following table reconciles the net FPB to the FPB in the Consolidated Balance Sheets. The DPL for Immediate Annuities and PRT is presented together with the FPB in the Consolidated Balance Sheets and has been included as a reconciling item in the table below: December 31, 2024 2023 (In millions) Traditional life $ 1,302 $ 1,349 Immediate annuities 1,297 1,415 PRT 6,054 4,189 Immediate annuities DPL 90 87 PRT DPL 6 10 Total $ 8,749 $ 7,050
Schedule Of Liability For Future Policy Benefit Expected Future Policy Benefit Undiscounted Before Reinsurance	The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts: Undiscounted Discounted December 31, 2024 December 31, 2023 December 31, 2024 December 31, 2023 Traditional life (In millions) Expected future benefit payments $ 2,705 $ 2,935 $ 1,948 $ 2,075 Expected future gross premiums 914 1,082 681 789 Immediate annuities Expected future benefit payments $ 3,189 $ 3,291 $ 1,297 $ 1,413 Expected future gross premiums — — — — PRT Expected future benefit payments $ 10,038 $ 6,709 $ 6,054 $ 4,350 Expected future gross premiums — — — —
Revenue from External Customers by Products and Services	The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the Consolidated Statements of Earnings: Gross Premiums (a) Interest Expense (b) December 31, December 31, 2024 2023 2022 2024 2023 2022 (In millions) Traditional life $ 111 $ 123 $ 137 $ 37 $ 37 $ 39 Immediate annuities 18 24 23 59 51 60 PRT 2,217 1,964 1,362 240 109 50 Total $ 2,346 $ 2,111 $ 1,522 $ 336 $ 197 $ 149 (a) Included in Life insurance premiums and other fees on the Consolidated Statements of Earnings. (b) Included in Benefits and other changes in policy reserves (remeasurement gains (losses) (a)) on the Consolidated Statements of Earnings.
Schedule Of Liability For Future Policy Benefit, Weighted Average Discount Rates	The following table presents the weighted-average interest rate: December 31, 2024 2023 2022 Traditional life Interest accretion rate 2.34 % 2.33 % 2.32 % Current discount rate 5.44 % 5.03 % 5.37 % Immediate annuities Interest accretion rate 3.17 % 3.14 % 3.07 % Current discount rate 5.45 % 4.98 % 5.21 % PRT Interest accretion rate 4.72 % 4.61 % 3.20 % Current discount rate 5.54 % 5.03 % 5.40 %
Schedule Of Liability for Future Policy Benefit, Mortality And Lapse, Actual And Expected Experience	The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB: December 31, 2024 Traditional life Immediate annuities PRT Mortality Actual experience 1.4 % 2.7 % 2.7 % Expected experience 1.5 % 1.9 % 2.5 % Lapses Actual experience 0.1 % — % — % Expected experience 0.5 % — % — % December 31, 2023 Traditional life Immediate annuities PRT Mortality Actual experience 1.7 % 3.2 % 3.2 % Expected experience 1.4 % 1.8 % 2.3 % Lapses Actual experience — % — % — % Expected experience 0.3 % — % — % December 31, 2022 Traditional life Immediate annuities PRT Mortality Actual experience 1.5 % 3.0 % 1.9 % Expected experience 1.3 % 1.9 % 2.5 % Lapses Actual experience — % — % — % Expected experience 0.3 % — % — %
Liability For Future Policy Benefits, Additional Information	The following table provides additional information for periods in which a cohort has a net premium ratio (“NPR”) greater than 100% (and therefore capped at 100%) (dollars in millions): December 31, 2024 Cohort X Description NPR before capping 108 % Term with return of premium Non-NY Cohort Reserves before NPR capping $ 1,147 Term with return of premium Non-NY Cohort Reserves after NPR capping 1,174 Term with return of premium Non-NY Cohort Loss Expense 27 Term with return of premium Non-NY Cohort

Schedule II - Condensed Finan_2

Schedule II - Condensed Financial Information (Tables)	12 Months Ended
	Dec. 31, 2024
Condensed Financial Information Disclosure [Abstract]
Balance Sheets	SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) BALANCE SHEETS (In millions) December 31, 2024 2023 ASSETS Cash $ 534 $ 397 Short-term investments 252 487 Investment in unconsolidated affiliates 3 3 Notes receivable 212 268 Investments in and amounts due from subsidiaries 8,882 7,949 Property and equipment, net 2 3 Prepaid expenses and other assets 433 318 Total assets $ 10,318 $ 9,425 LIABILITIES AND EQUITY Liabilities: Accounts payable and other accrued liabilities $ 385 $ 358 Income taxes payable 51 — Deferred tax liability — 29 Notes payable 2,128 2,126 Total liabilities 2,564 2,513 Equity: FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2024 and 2023; outstanding of 275 and 273 as of December 31, 2024 and 2023, respectively, and issued of 331 and 329 as of December 31, 2024 and 2023, respectively — — Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none — — Additional paid-in capital 5,976 5,913 Retained earnings 5,982 5,244 Accumulated other comprehensive earnings (2,052) (2,119) Less: Treasury stock, 56 shares as of December 31, 2024 and 2023, at cost (2,152) (2,126) Total equity of Fidelity National Financial, Inc. common shareholders 7,754 6,912 Total liabilities and equity $ 10,318 $ 9,425
Statement of Earnings and Retained Earnings	SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) STATEMENTS OF EARNINGS AND RETAINED EARNINGS Year Ended December 31, 2024 2023 2022 (In millions, except per share data) Revenues: Other fees and revenue $ 38 $ 33 $ (37) Interest and investment income and realized gains 76 74 43 Recognized gains and losses, net 2 (31) (42) Total revenues 116 76 (36) Expenses: Personnel expenses 94 70 (11) Other operating expenses 28 47 15 Interest expense 76 77 92 Total expenses 198 194 96 Losses before income tax benefit and equity in earnings of subsidiaries (82) (118) (132) Income tax benefit (20) (29) (33) Losses before equity in earnings of subsidiaries (62) (89) (99) Equity in earnings of subsidiaries 1,332 606 1,393 Net earnings attributable to Fidelity National Financial, Inc. common shareholders $ 1,270 $ 517 $ 1,294 Retained earnings, beginning of year $ 5,244 $ 5,225 $ 4,818 Dividends declared (532) (498) (490) Distribution of F&G to FNF common shareholders — — (397) Net earnings attributable to Fidelity National Financial, Inc. common shareholders 1,270 517 1,294 Retained earnings, end of year $ 5,982 $ 5,244 $ 5,225
Statements of Cash Flows	SCHEDULE II FIDELITY NATIONAL FINANCIAL, INC. (Parent Company) STATEMENTS OF CASH FLOWS Year Ended December 31, 2024 2023 2022 (In millions) Cash Flows From Operating Activities: Net earnings $ 1,270 $ 517 $ 1,294 Adjustments to reconcile net earnings to net cash provided by operating activities: Equity in earnings of subsidiaries (1,332) (606) (1,393) Depreciation and amortization 1 1 1 Stock-based compensation 82 57 48 Net change in income taxes 5 (262) 748 Net (increase) decrease in prepaid expenses and other assets (113) (72) 41 Net increase (decrease) in accounts payable and other accrued liabilities 27 70 (51) Net cash (used in) provided by operating activities (60) (295) 688 Cash Flows From Investing Activities: Purchase of F&G preferred stock (250) — — Net proceeds from (purchases of) short-term investment activities 235 82 (509) Additions to notes receivable (1) (12) (87) Collection of notes receivable 55 47 79 Net cash provided by (used in) investing activities 39 117 (517) Cash Flows From Financing Activities: Debt service payments — — (400) Dividends paid (532) (500) (489) Purchases of treasury stock — (6) (553) Exercise of stock options 21 15 39 Payment for shares withheld for taxes and in treasury (22) (17) (15) Additional investments in non-controlling interests (12) (12) (2) Net dividends from subsidiaries 703 689 140 Net cash provided by (used in) financing activities 158 169 (1,280) Net change in cash and cash equivalents 137 (9) (1,109) Cash at beginning of year 397 406 1,515 Cash at end of year $ 534 $ 397 $ 406 See Notes to Financial Statements
Schedule of Notes Payable	Notes payable consists of the following: December 31, 2024 December 31, 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving Credit Facility (4) (2) F&G Credit Agreement — 362 5.50% F&G Notes 301 561 7.40% F&G Notes, net of discount 497 495 7.95% F&G Notes, net of discount 336 336 6.50% F&G Notes, net of discount 545 — 6.25% F&G Notes, net of discount 492 — Other 22 7 $ 4,321 $ 3,887 B. Notes Payable Notes payable consist of the following: December 31, 2024 2023 (In millions) 4.50% Notes, net of discount $ 447 $ 446 3.40% Notes, net of discount 646 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving credit facility (4) (2) $ 2,128 $ 2,126
Schedule of Supplemental Cash Flow Information	The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities. Year Ended December 31, 2024 2023 2022 Cash paid for: (In millions) Interest $ 200 $ 157 $ 125 Income taxes 237 216 387 Deferred sales inducements 319 168 87 Non-cash investing and financing activities: Distribution of 15% of the common stock of F&G — — 421 Investments received from pension risk transfer premiums 129 464 — Change in proceeds of sales of investments available for sale receivable in period (59) 32 96 Change in purchases of investments available for sale payable in period 82 20 (25) Lease liabilities recognized in exchange for lease right-of-use assets 55 40 70 Remeasurement of lease liabilities 67 75 60 Liabilities assumed in connection with acquisitions Fair value of assets acquired 789 304 266 Less: Total Purchase price 586 299 180 Liabilities and noncontrolling interests assumed $ 203 $ 5 $ 86 Year Ended December 31, 2024 2023 2022 (In millions) Cash paid during the year: Interest paid $ 73 $ 73 $ 95 Income tax payments 229 213 459

Business and Summary of Signi_4

Business and Summary of Significant Accounting Policies - Recent Developments (Details)

Feb. 01, 2025 USD ($)

Oct. 04, 2024 USD ($)

Jul. 18, 2024 USD ($)

Jul. 17, 2024 USD ($)

Jan. 12, 2024 USD ($) $ / shares shares

Jan. 11, 2024

Jan. 02, 2024 USD ($)

Jan. 13, 2025 USD ($)

Dec. 31, 2024 USD ($) $ / shares

Jun. 04, 2024 USD ($)

Feb. 16, 2024 USD ($)

Feb. 15, 2024 USD ($)

Dec. 31, 2023 USD ($) $ / shares

Feb. 21, 2023 USD ($)

Nov. 22, 2022 USD ($)

Apr. 20, 2018 USD ($)

Business Acquisition [Line Items]

Preferred stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.0001

$ 0.0001

Contingent consideration - acquisitions

$ 110,000,000

$ 49,000,000

6.875% Series A Mandatory Convertible Preferred Stock

Business Acquisition [Line Items]

Preferred stock, dividend rate, percentage

6.875%

F&G | 6.875% Series A Mandatory Convertible Preferred Stock

Business Acquisition [Line Items]

Purchase of F&G preferred stock

$ 250,000,000

Preferred stock investment, shares issued in transaction (in shares) | shares

5,000,000

Preferred stock, dividend rate, percentage

6.875%

Preferred stock, par or stated value per share (in dollars per share) | $ / shares

$ 0.001

Preferred stock, liquidation preference (in usd per share) | $ / shares

$ 50

F&G | 6.875% Series A Mandatory Convertible Preferred Stock | Maximum

Business Acquisition [Line Items]

Preferred stock, convertible, conversion ratio

1.1111

F&G | 6.875% Series A Mandatory Convertible Preferred Stock | Minimum

Business Acquisition [Line Items]

Preferred stock, convertible, conversion ratio

0.9456

PALH LLC

Business Acquisition [Line Items]

Ownership interest including subsequent acquisition, percentage

100%

Ownership interest prior to acquisition

30%

Consideration transferred

$ 314,000,000

Cash paid for acquisition

215,000,000

Settlement of prepaid asset

8,000,000

Acquisition date fair value of previously held interests

92,000,000

Less: Cash acquired net of non-controlling interests

$ 1,000,000

PALH LLC | F&G

Business Acquisition [Line Items]

Ownership interest including subsequent acquisition, percentage

100%

Ownership interest prior to acquisition

30%

Acquisition date fair value of previously held interests

$ 92,000,000

PALH LLC | PALH LLC

Business Acquisition [Line Items]

Redeemable non-controlling interest, ownership percentage

70%

PALH LLC | PALH LLC | F&G

Business Acquisition [Line Items]

Redeemable non-controlling interest, ownership percentage

70%

Roar Joint Venture, LLC

Business Acquisition [Line Items]

Consideration transferred

$ 316,000,000

Cash paid for acquisition

269,000,000

Less: Cash acquired net of non-controlling interests

$ 1,000,000

Contingent consideration liability payment period

3 years

Roar Joint Venture, LLC | F&G

Business Acquisition [Line Items]

Cash paid for acquisition

$ 269,000,000

Percentage of outstanding equity acquired

70%

Contingent consideration - acquisitions

$ 48,000,000

Contingent consideration obligation, payments (up to)

$ 90,000,000

Contingent consideration liability payment period

3 years

5.50% F&G Senior Notes due May 2025 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

5.50%

Aggregate principal amount

$ 250,000,000

$ 550,000,000

6.25% Senior Notes due 2034 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

6.25%

6.25%

Aggregate principal amount

$ 500,000,000

6.25% Senior Notes due 2034 | Senior Notes | F&G

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

6.25%

Aggregate principal amount

$ 500,000,000

6.50% F&G Notes, net of discount | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

6.50%

6.50%

Aggregate principal amount

$ 550,000,000

5.50% Senior Notes due 2025 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

Aggregate principal amount

$ 250,000,000

Revolving Credit Facility | 6.25% Senior Notes due 2034 | Senior Notes | F&G

Business Acquisition [Line Items]

Repayments of debt

$ 365,000,000

Revolving Credit Facility | Revolving Credit Facility | Line of Credit

Business Acquisition [Line Items]

Line of credit facility

$ 800,000,000

Revolving Credit Facility | F&G Credit Agreement | Line of Credit

Business Acquisition [Line Items]

Line of credit facility

$ 750,000,000

$ 665,000,000

$ 665,000,000

$ 550,000,000

Subsequent Event | 5.50% F&G Senior Notes due May 2025 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

Repurchased amount

$ 300,000,000

Redemption percentage

100%

Subsequent Event | 7.30% Junior Subordinated Notes due 2065 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

7.30%

Aggregate principal amount

$ 375,000,000

Business and Summary of Signi_5

Business and Summary of Significant Accounting Policies - Trade and Notes Receivable (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenue Recognition, Milestone Method [Line Items]
Insurance commissions as percentage of agent premiums	77.40%	76.90%	77.10%
Premium due from agents, net of accrued sales commissions	$ 40	$ 35
Minimum
Revenue Recognition, Milestone Method [Line Items]
Accrual for agency premiums reported within three months, percent	61%
Accrual for agency premiums reported within next three months, percent	7%
Accrual for agency premiums, remaining period	7 months
Maximum
Revenue Recognition, Milestone Method [Line Items]
Accrual for agency premiums reported within three months, percent	92%
Accrual for agency premiums reported within next three months, percent	29%
Accrual for agency premiums, remaining period	15 months

Business and Summary of Signi_6

Business and Summary of Significant Accounting Policies - Goodwill, Intangible Assets and Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Impairment related to property and equipment	$ 0	$ 0	$ 2,000,000
Minimum | Buildings
Goodwill [Line Items]
Property and equipment, useful life (in years)	20 years
Minimum | Furniture Fixture and Equipment
Goodwill [Line Items]
Property and equipment, useful life (in years)	3 years
Maximum | Buildings
Goodwill [Line Items]
Property and equipment, useful life (in years)	30 years
Maximum | Furniture Fixture and Equipment
Goodwill [Line Items]
Property and equipment, useful life (in years)	25 years
Title Plant
Goodwill [Line Items]
Impairment of indefinite-lived intangible asset	$ 2,000,000	$ 0	$ 1,000,000
Trademarks, tradenames, and other
Goodwill [Line Items]
Finite-lived intangible asset, useful life (years)	10 years

Business and Summary of Signi_7

Business and Summary of Significant Accounting Policies - Contract Holder Funds, Future Policy Benefits and Secured Trust Deposits (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
NPR, capped percentage	100%
Market risk benefit, attributed fee ratio capped percentage	100%
Secured trust deposits	$ 551	$ 731

Business and Summary of Signi_8

Business and Summary of Significant Accounting Policies - Earnings Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	1,000,000	1,000,000

Business and Summary of Signi_9

Business and Summary of Significant Accounting Policies - Schedule of Changes in Other Comprehensive Earnings (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		$ 6,908
Reclassification adjustments		(8)	$ 126	$ 173
Other comprehensive earnings		82	759	(3,956)
Non-controlling interest	[1]	(7)	(134)	35
Stockholders' equity attributable to parent, ending balance		7,754	6,908
Unrealized gain (loss) on investments and other financial instruments, net (excluding investments in unconsolidated affiliates)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		(2,655)	(3,583)	986
Reclassification adjustments		3	137	181
Other comprehensive earnings		(157)	961	(4,783)
Non-controlling interest		14	(170)	33
Stockholders' equity attributable to parent, ending balance		(2,795)	(2,655)	(3,583)
Change in current discount rate - future policy benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		605	763	(1)
Reclassification adjustments		0	0	0
Other comprehensive earnings		224	(189)	764
Non-controlling interest		(21)	31	0
Stockholders' equity attributable to parent, ending balance		808	605	763
Change in instrument-specific credit risk - market risk benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		(76)	(48)	(116)
Reclassification adjustments		0	0	0
Other comprehensive earnings		5	(34)	67
Non-controlling interest		0	6	1
Stockholders' equity attributable to parent, ending balance		(71)	(76)	(48)
Other
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		7	(2)	9
Reclassification adjustments		(11)	(11)	(8)
Other comprehensive earnings		10	21	(4)
Non-controlling interest		0	(1)	1
Stockholders' equity attributable to parent, ending balance		6	7	(2)
Total Accumulated Other Comprehensive Earnings (Loss)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stockholders' equity attributable to parent, beginning balance		(2,119)	(2,870)	878
Stockholders' equity attributable to parent, ending balance		$ (2,052)	$ (2,119)	$ (2,870)
[1] Net of income tax (benefit) expense of $(3) million, $(35) million and $9 million for the years ended December 31, 2024, and 2023, and 2022, respectively.

Business and Summary of Sign_10

Business and Summary of Significant Accounting Policies - Management Estimates (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Accounting Policies [Abstract]
Change in total benefits and other changes in policy reserves (decrease) increase	$ 99	$ 89	$ 73

Business and Summary of Sign_11

Business and Summary of Significant Accounting Policies - Owned Distribution Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Commissions	$ 2,287	$ 2,008	$ 3,064
Affiliate
Related Party Transaction [Line Items]
Commissions	$ 119	$ 154	$ 74

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Millions				12 Months Ended
	Jul. 18, 2024	Jul. 17, 2024	Jan. 02, 2024	Dec. 31, 2024
Roar Joint Venture, LLC
Business Acquisition [Line Items]
Contingent consideration liability payment period			3 years
Roar Joint Venture, LLC | F&G
Business Acquisition [Line Items]
Percentage of outstanding equity acquired			70%
Contingent consideration arrangements, payments			$ 90
Contingent consideration liability payment period			3 years
Revenue of acquiree				$ 78
Earnings of acquiree				6
PALH LLC
Business Acquisition [Line Items]
Revenue of acquiree				3
Earnings of acquiree				(6)
Ownership interest including subsequent acquisition, percentage	100%
Ownership interest prior to acquisition	30%
Acquisition date fair value of previously held interests	$ 92
PALH LLC | F&G
Business Acquisition [Line Items]
Ownership interest including subsequent acquisition, percentage	100%
Ownership interest prior to acquisition		30%
Acquisition date fair value of previously held interests		$ 92
Remeasurement gain				$ 2
PALH LLC | PALH LLC
Business Acquisition [Line Items]
Redeemable non-controlling interest, ownership percentage	70%
PALH LLC | PALH LLC | F&G
Business Acquisition [Line Items]
Redeemable non-controlling interest, ownership percentage		70%

Acquisitions - Schedule of Init

Acquisitions - Schedule of Initial Purchase Price - Roar (Details) - Roar Joint Venture, LLC $ in Millions	Jan. 02, 2024 USD ($)
Business Acquisition [Line Items]
Cash paid for majority interest	$ 269
Less: Cash acquired net of non-controlling interests	1
Net cash paid	268
Initial fair value of contingent consideration	48
Total initial consideration	$ 316
F&G
Business Acquisition [Line Items]
Percentage of outstanding equity acquired	70%
Cash paid for majority interest	$ 269

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Fair Value Amounts for Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jul. 18, 2024	Jan. 02, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill	$ 5,271			$ 4,830	$ 4,635
Roar Joint Venture, LLC
Business Acquisition [Line Items]
Goodwill			$ 268
Prepaid expenses and other assets			3
Other intangible assets			183
Total assets acquired			454
Accounts payable and accrued liabilities			2
Total liabilities assumed			2
Non-controlling interests (fair value determined using income approach)			136
Total liabilities assumed and non-controlling interests			138
Net assets acquired			$ 316
PALH LLC
Business Acquisition [Line Items]
Goodwill		$ 162
Prepaid expenses and other assets		5
Other intangible assets		149
Total assets acquired		316
Accounts payable and accrued liabilities		2
Total liabilities assumed		2
Net assets acquired		$ 314

Acquisitions - Carrying Value a

Acquisitions - Carrying Value and Estimated Useful Lives (Details) - USD ($) $ in Millions	Jul. 18, 2024	Jan. 02, 2024
Roar Joint Venture, LLC
Property, Plant and Equipment [Line Items]
Other intangible assets		$ 183
Roar Joint Venture, LLC | Customer relationships
Property, Plant and Equipment [Line Items]
Other intangible assets		$ 179
Weighted average useful life (years)		12 years
Roar Joint Venture, LLC | Trademarks, tradenames, and other
Property, Plant and Equipment [Line Items]
Other intangible assets		$ 4
Weighted average useful life (years)		10 years
PALH LLC
Property, Plant and Equipment [Line Items]
Other intangible assets	$ 149
PALH LLC | Customer relationships
Property, Plant and Equipment [Line Items]
Other intangible assets	$ 131
Weighted average useful life (years)	20 years
PALH LLC | Trademarks, tradenames, and other
Property, Plant and Equipment [Line Items]
Other intangible assets	$ 18
PALH LLC | Trademarks, tradenames, and other | Minimum
Property, Plant and Equipment [Line Items]
Weighted average useful life (years)	5 years
PALH LLC | Trademarks, tradenames, and other | Maximum
Property, Plant and Equipment [Line Items]
Weighted average useful life (years)	10 years

Acquisitions - Schedule of In_2

Acquisitions - Schedule of Initial Purchase Price - PAHL (Details) - PALH LLC $ in Millions	Jul. 18, 2024 USD ($)
Business Acquisition [Line Items]
Cash paid	$ 215
Less: Cash acquired	1
Net cash paid	214
Settlement of prepaid asset	8
Acquisition date fair value of previously held interests	92
Total consideration	$ 314

Summary of Reserve for Title _3

Summary of Reserve for Title Claim Losses - Summary of the Reserve for Title Claim Losses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Change in insurance recoverable	$ 13	$ (78)	$ (276)
Title
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	1,770	1,810	1,883
Change in insurance recoverable	(10)	15	(128)
Claim loss provision related to:
Current year	232	207	308
Prior years	0	0	0
Total title claim loss provision	232	207	308
Claims paid, net of recoupments related to:
Current year	(25)	(22)	(21)
Prior years	(254)	(240)	(232)
Total title claims paid, net of recoupments	(279)	(262)	(253)
Ending balance of claim loss reserve for title insurance	$ 1,713	$ 1,770	$ 1,810
Provision for title insurance claim losses as a percentage of title insurance premiums	4.50%	4.50%	4.50%

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Carrying Amounts of Assets and Liabilities at Estimated Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Assets
Fixed maturity securities available-for-sale	$ 48,218	$ 42,373
Derivative investments	794	797
Market risk benefits asset	189	88
Total financial assets at fair value	1,433	1,312
Derivatives:
Contingent consideration - acquisitions	110	49
Market risk benefits liability	549	403
Level 1
Assets
Cash and cash equivalents	3,479	2,767
Short term investments	2,995	2,111
Derivative investments	0	0
Investment in unconsolidated affiliates		0
Loan receivable, included in Prepaid expenses and other assets	0
Market risk benefits asset	0	0
Other assets	0
Total financial assets at fair value	7,945	6,566
Derivatives:
Contingent consideration - acquisitions	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	1	1
Level 2
Assets
Cash and cash equivalents	0	0
Short term investments	18	8
Derivative investments	791	740
Investment in unconsolidated affiliates		0
Loan receivable, included in Prepaid expenses and other assets	0
Market risk benefits asset	0	0
Other assets	0
Total financial assets at fair value	37,568	33,703
Derivatives:
Contingent consideration - acquisitions	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	10	0
Level 3
Assets
Cash and cash equivalents	0	0
Short term investments	37	0
Derivative investments	3	57
Investment in unconsolidated affiliates		285
Loan receivable, included in Prepaid expenses and other assets	11
Market risk benefits asset	189	37
Other assets	65
Total financial assets at fair value	11,734	9,677
Derivatives:
Contingent consideration - acquisitions	74
Market risk benefits liability	549	403
Total financial liabilities at fair value	5,843	4,661
NAV
Assets
Total financial assets at fair value	57	59
Total Estimated Fair Value
Assets
Cash and cash equivalents	3,479	2,767
Short term investments	3,050	2,119
Derivative investments	794	797
Investment in unconsolidated affiliates		285
Loan receivable, included in Prepaid expenses and other assets	11
Market risk benefits asset	189	37
Other assets	65
Total financial assets at fair value	57,304	50,005
Derivatives:
Contingent consideration - acquisitions	74
Market risk benefits liability	549	403
Total financial liabilities at fair value	5,854	4,662
Reinsurance related embedded derivative, included in other assets | Level 1
Assets
Derivative investments	0	0
Reinsurance related embedded derivative, included in other assets | Level 2
Assets
Derivative investments	109	152
Reinsurance related embedded derivative, included in other assets | Level 3
Assets
Derivative investments	0	0
Reinsurance related embedded derivative, included in other assets | Total Estimated Fair Value
Assets
Derivative investments	109	152
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Level 1
Derivatives:
Derivative liability	0	0
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Level 2
Derivatives:
Derivative liability	0	0
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Level 3
Derivatives:
Derivative liability	5,220	4,258
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Total Estimated Fair Value
Derivatives:
Derivative liability	5,220	4,258
Interest rate swaps | Level 1
Derivatives:
Derivative liability	0
Interest rate swaps | Level 2
Derivatives:
Derivative liability	10
Interest rate swaps | Level 3
Derivatives:
Derivative liability	0
Interest rate swaps | Total Estimated Fair Value
Derivatives:
Derivative liability	10
Equity options | Level 1
Derivatives:
Derivative liability	1	1
Equity options | Level 2
Derivatives:
Derivative liability	0	0
Equity options | Level 3
Derivatives:
Derivative liability	0	0
Equity options | Total Estimated Fair Value
Derivatives:
Derivative liability	1	1
Asset-backed securities
Assets
Fixed maturity securities available-for-sale	15,656	14,342
Asset-backed securities | Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Asset-backed securities | Level 2
Assets
Fixed maturity securities available-for-sale	7,513	7,220
Asset-backed securities | Level 3
Assets
Fixed maturity securities available-for-sale	8,143	7,122
Asset-backed securities | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	15,656	14,342
Commercial mortgage-backed securities
Assets
Fixed maturity securities available-for-sale	5,182	4,475
Commercial mortgage-backed securities | Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Commercial mortgage-backed securities | Level 2
Assets
Fixed maturity securities available-for-sale	5,182	4,457
Commercial mortgage-backed securities | Level 3
Assets
Fixed maturity securities available-for-sale	0	18
Commercial mortgage-backed securities | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	5,182	4,475
Corporates
Assets
Fixed maturity securities available-for-sale	21,696	17,896
Corporates | Level 1
Assets
Fixed maturity securities available-for-sale	41	25
Corporates | Level 2
Assets
Fixed maturity securities available-for-sale	18,698	15,892
Corporates | Level 3
Assets
Fixed maturity securities available-for-sale	2,957	1,979
Corporates | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	21,696	17,896
Hybrids
Assets
Fixed maturity securities available-for-sale	581	618
Hybrids | Level 1
Assets
Fixed maturity securities available-for-sale	35	95
Hybrids | Level 2
Assets
Fixed maturity securities available-for-sale	546	523
Hybrids | Level 3
Assets
Fixed maturity securities available-for-sale	0	0
Hybrids | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	581	618
Municipals
Assets
Fixed maturity securities available-for-sale	1,386	1,611
Municipals | Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Municipals | Level 2
Assets
Fixed maturity securities available-for-sale	1,386	1,562
Municipals | Level 3
Assets
Fixed maturity securities available-for-sale	0	49
Municipals | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	1,386	1,611
Residential mortgage-backed securities
Assets
Fixed maturity securities available-for-sale	2,796	2,429
Residential mortgage-backed securities | Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Residential mortgage-backed securities | Level 2
Assets
Fixed maturity securities available-for-sale	2,793	2,426
Residential mortgage-backed securities | Level 3
Assets
Fixed maturity securities available-for-sale	3	3
Residential mortgage-backed securities | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	2,796	2,429
U.S. Government
Assets
Fixed maturity securities available-for-sale	637	678
U.S. Government | Level 1
Assets
Fixed maturity securities available-for-sale	631	662
U.S. Government | Level 2
Assets
Fixed maturity securities available-for-sale	6	16
U.S. Government | Level 3
Assets
Fixed maturity securities available-for-sale	0	0
U.S. Government | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	637	678
Foreign Governments
Assets
Fixed maturity securities available-for-sale	284	324
Foreign Governments | Level 1
Assets
Fixed maturity securities available-for-sale	0	0
Foreign Governments | Level 2
Assets
Fixed maturity securities available-for-sale	280	308
Foreign Governments | Level 3
Assets
Fixed maturity securities available-for-sale	4	16
Foreign Governments | Total Estimated Fair Value
Assets
Fixed maturity securities available-for-sale	284	324
Preferred securities
Assets
Equity securities, at fair value	443	621
Preferred securities | Level 1
Assets
Equity securities, at fair value	189	214
Preferred securities | Level 2
Assets
Equity securities, at fair value	246	399
Preferred securities | Level 3
Assets
Equity securities, at fair value	8	8
Preferred securities | Total Estimated Fair Value
Assets
Equity securities, at fair value	443	621
Equity securities | Level 1
Assets
Equity securities, at fair value	575	692
Equity securities | Level 2
Assets
Equity securities, at fair value	0	0
Equity securities | Level 3
Assets
Equity securities, at fair value	10	15
Equity securities | NAV
Assets
Equity securities, at fair value	57	59
Equity securities | Total Estimated Fair Value
Assets
Equity securities, at fair value	642	766
Investment in unconsolidated affiliates | Level 1
Assets
Investment in unconsolidated affiliates	0
Investment in unconsolidated affiliates | Level 2
Assets
Investment in unconsolidated affiliates	0
Investment in unconsolidated affiliates | Level 3
Assets
Investment in unconsolidated affiliates	272
Investment in unconsolidated affiliates | Total Estimated Fair Value
Assets
Investment in unconsolidated affiliates	272
Other long-term investments | Level 1
Assets
Other long-term investments	0	0
Other long-term investments | Level 2
Assets
Other long-term investments	0	0
Other long-term investments | Level 3
Assets
Other long-term investments	32	88
Other long-term investments | Total Estimated Fair Value
Assets
Other long-term investments	$ 32	$ 88

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Narrative (Details) $ in Millions	Dec. 31, 2024 USD ($) $ / Contract	Dec. 31, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 3,731	$ 3,334
Outstanding principal	4,367
F&G Credit Agreement | Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Outstanding principal	0	365
Title
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 166	$ 263
Credit Linked Note | Income Approach
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract	0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Quantitative Information of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Details) $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1,433	$ 1,312
Liabilities, fair value	5,843	4,661
Market Comparable Company Analysis | Broker quoted/Market Comparable
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	10,301	8,365
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 5,220	$ 4,258
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0025	0.0025
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.5000	0.7000
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0694	0.0683
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawal Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0200	0.0200
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawal Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.3571	0.3448
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawal Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0272	0.0274
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0048	0.0038
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0095	0.0110
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0075	0.0096
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0	0
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.2081	0.1893
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0292	0.0263
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Swap rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability		0.0384
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Swap rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability		0.0526
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Swap rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability		0.0455
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.8000	1
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	1.1500	1
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	1	1
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0007	0.0007
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0570	0.0548
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0268	0.0238
Asset-backed securities | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 95	$ 57
Asset-backed securities | Third-Party Valuation | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0483	0.0509
Asset-backed securities | Third-Party Valuation | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0715	0.0695
Asset-backed securities | Third-Party Valuation | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0633	0.0600
Corporates | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 750	$ 787
Corporates | Third-Party Valuation | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0200	0
Corporates | Third-Party Valuation | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.2253	0.1287
Corporates | Third-Party Valuation | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0676	0.0691
Corporates | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 7	$ 8
Corporates | Discounted Cash Flow | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.1333	0.4400
Corporates | Discounted Cash Flow | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	1	1
Corporates | Discounted Cash Flow | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.9645	0.7520
Municipals | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 32
Municipals | Third-Party Valuation | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Municipals | Third-Party Valuation | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Municipals | Third-Party Valuation | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Residential mortgage-backed securities | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 3	$ 3
Residential mortgage-backed securities | Third-Party Valuation | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0589	0.0546
Residential mortgage-backed securities | Third-Party Valuation | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0589	0.0546
Residential mortgage-backed securities | Third-Party Valuation | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0589	0.0546
Foreign Governments | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 4	$ 16
Foreign Governments | Third-Party Valuation | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.1214	0.0694
Foreign Governments | Third-Party Valuation | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.1214	0.0768
Foreign Governments | Third-Party Valuation | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.1214	0.0745
Investment in unconsolidated affiliates | Market Comparable Company Analysis
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 272	$ 285
Investment in unconsolidated affiliates | Market Comparable Company Analysis | EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	8.7	0.044
Investment in unconsolidated affiliates | Market Comparable Company Analysis | EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	23.6	0.318
Investment in unconsolidated affiliates | Market Comparable Company Analysis | EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	14.6	0.232
Preferred securities | Affiliate | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1	$ 1
Preferred securities | Affiliate | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities		1
Preferred securities | Affiliate | Discounted Cash Flow | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	1
Preferred securities | Affiliate | Discounted Cash Flow | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	1
Preferred securities | Affiliate | Discounted Cash Flow | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	1
Equity securities | Market Comparable Company Analysis | EBITDA Multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	5.8
Equity securities | Market Comparable Company Analysis | EBITDA Multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	7.5
Equity securities | Market Comparable Company Analysis | EBITDA Multiple | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	7
Equity securities | Affiliate | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 4	$ 7
Equity securities | Affiliate | Discounted Cash Flow | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	0.0480	0.1150
Equity securities | Affiliate | Discounted Cash Flow | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	0.1410	0.1150
Equity securities | Affiliate | Discounted Cash Flow | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity / Preferred securities	0.0940	0.1150
Other assets | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 65
Other assets | Discounted Cash Flow | Discount rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1060
Other assets | Discounted Cash Flow | Discount rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1200
Other assets | Discounted Cash Flow | Discount rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1130
Other assets | Discounted Cash Flow | Conditional Prepayment Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.0624
Other assets | Discounted Cash Flow | Conditional Prepayment Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1199
Other assets | Discounted Cash Flow | Conditional Prepayment Rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.0912
Available-for-sale embedded derivative | Black Scholes model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 32	$ 28
Available-for-sale embedded derivative | Black Scholes model | Market Value of AnchorPath Fund
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative asset	1	1
Loan receivable | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 11
Loan receivable | Discounted Cash Flow | Risk-Adjusted Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.0722
Loan receivable | Discounted Cash Flow | Risk-Adjusted Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.0722
Loan receivable | Discounted Cash Flow | Risk-Adjusted Discount Rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.0722
Loan receivable | Discounted Cash Flow | Collateral Volatility | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.3500
Loan receivable | Discounted Cash Flow | Collateral Volatility | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.3500
Loan receivable | Discounted Cash Flow | Collateral Volatility | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Loan receivable	0.3500
Market risk benefits asset | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 189	$ 88
Market risk benefits asset | Discounted Cash Flow | Mortality | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.8000	1
Market risk benefits asset | Discounted Cash Flow | Mortality | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1.1500	1
Market risk benefits asset | Discounted Cash Flow | Mortality | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1	1
Market risk benefits asset | Discounted Cash Flow | Surrender Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0025	0.0025
Market risk benefits asset | Discounted Cash Flow | Surrender Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.3000	0.1000
Market risk benefits asset | Discounted Cash Flow | Surrender Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0505	0.0522
Market risk benefits asset | Discounted Cash Flow | Partial Withdrawal Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0200	0
Market risk benefits asset | Discounted Cash Flow | Partial Withdrawal Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.2439	0.2326
Market risk benefits asset | Discounted Cash Flow | Partial Withdrawal Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0248	0.0250
Market risk benefits asset | Discounted Cash Flow | Non-Performance Spread | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0048	0.0038
Market risk benefits asset | Discounted Cash Flow | Non-Performance Spread | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0095	0.0110
Market risk benefits asset | Discounted Cash Flow | Non-Performance Spread | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0075	0.0096
Market risk benefits asset | Discounted Cash Flow | GMWB Utilization | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5000	0.5000
Market risk benefits asset | Discounted Cash Flow | GMWB Utilization | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.7500	0.6000
Market risk benefits asset | Discounted Cash Flow | GMWB Utilization | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.6177	0.5081
Contingent consideration | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 74
Contingent consideration | Discounted Cash Flow | Risk-Adjusted Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1350
Contingent consideration | Discounted Cash Flow | Risk-Adjusted Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1350
Contingent consideration | Discounted Cash Flow | Risk-Adjusted Discount Rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1350
Contingent consideration | Discounted Cash Flow | EBITDA Volatility | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.35
Contingent consideration | Discounted Cash Flow | EBITDA Volatility | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.35
Contingent consideration | Discounted Cash Flow | EBITDA Volatility | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.35
Contingent consideration | Discounted Cash Flow | Counterparty Discount Rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0650
Contingent consideration | Discounted Cash Flow | Counterparty Discount Rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0650
Contingent consideration | Discounted Cash Flow | Counterparty Discount Rate | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0650
Market risk benefits liability | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 549	$ 403
Market risk benefits liability | Discounted Cash Flow | Mortality | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.8000	1
Market risk benefits liability | Discounted Cash Flow | Mortality | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1.1500	1
Market risk benefits liability | Discounted Cash Flow | Mortality | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1	1
Market risk benefits liability | Discounted Cash Flow | Surrender Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0025	0.0025
Market risk benefits liability | Discounted Cash Flow | Surrender Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.3000	0.1000
Market risk benefits liability | Discounted Cash Flow | Surrender Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0505	0.0522
Market risk benefits liability | Discounted Cash Flow | Partial Withdrawal Rates | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0200	0
Market risk benefits liability | Discounted Cash Flow | Partial Withdrawal Rates | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.2439	0.2326
Market risk benefits liability | Discounted Cash Flow | Partial Withdrawal Rates | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0248	0.0250
Market risk benefits liability | Discounted Cash Flow | Non-Performance Spread | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0048	0.0038
Market risk benefits liability | Discounted Cash Flow | Non-Performance Spread | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0095	0.0110
Market risk benefits liability | Discounted Cash Flow | Non-Performance Spread | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0075	0.0096
Market risk benefits liability | Discounted Cash Flow | GMWB Utilization | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5000	0.5000
Market risk benefits liability | Discounted Cash Flow | GMWB Utilization | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.7500	0.6000
Market risk benefits liability | Discounted Cash Flow | GMWB Utilization | Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.6177	0.5081

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Liabilities
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Recognized gains and losses, net	Recognized gains and losses, net
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]	Unrealized (loss) gain on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)	Unrealized (loss) gain on investments and other financial instruments, net of adjustments to intangible assets and unearned revenue (excluding investments in unconsolidated affiliates)
Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	$ 9,677	$ 8,286
Balance at End of Period	11,734	9,677
Liabilities
Balance at Beginning of Period	4,661	3,397
Balance at End of Period	5,843	4,661
Indexed annuity/ IUL embedded derivatives, included in contractholder funds
Liabilities
Balance at Beginning of Period	4,258	3,115
Liabilities, Total Gains (Losses) Included in Earnings	45	257
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	1,351	1,049
Liabilities, Sales	0	0
Liabilities, Settlements	(434)	(163)
Liabilities, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	5,220	4,258
Change in Unrealized Incl in OCI	0	0
Interest rate swaps
Liabilities
Balance at Beginning of Period	0
Liabilities, Total Gains (Losses) Included in Earnings	28
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	0
Liabilities, Net transfer In (Out) of Level 3	(28)
Balance at End of Period	0	0
Change in Unrealized Incl in OCI	0
Contingent consideration
Liabilities
Balance at Beginning of Period	0
Liabilities, Total Gains (Losses) Included in Earnings	26
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	48
Liabilities, Sales	0
Liabilities, Settlements	0
Liabilities, Net transfer In (Out) of Level 3	0
Balance at End of Period	74	0
Change in Unrealized Incl in OCI	0
Asset-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	7,122	6,263
Assets, Total Gains (Losses) Included in Earnings	19	(53)
Assets, Total Gains (Losses) Included in AOCI	128	186
Assets, Purchases	5,104	1,830
Assets, Sales	(2,825)	(125)
Assets, Settlements	(1,210)	(738)
Assets, Net transfer In (Out) of Level 3	(195)	(241)
Balance at End of Period	8,143	7,122
Change in Unrealized Incl in OCI	130	185
Commercial mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	18	37
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	2
Assets, Purchases	58	22
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(76)	(43)
Balance at End of Period	0	18
Change in Unrealized Incl in OCI	0	2
Corporates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	1,979	1,440
Assets, Total Gains (Losses) Included in Earnings	(3)	(2)
Assets, Total Gains (Losses) Included in AOCI	81	(21)
Assets, Purchases	1,148	654
Assets, Sales	(100)	(1)
Assets, Settlements	(139)	(94)
Assets, Net transfer In (Out) of Level 3	(9)	3
Balance at End of Period	2,957	1,979
Change in Unrealized Incl in OCI	80	(20)
Municipals
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	49	29
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	1	20
Assets, Purchases	0	0
Assets, Sales	(50)	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	0	49
Change in Unrealized Incl in OCI	1	20
Residential mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	3	302
Assets, Total Gains (Losses) Included in Earnings	0	1
Assets, Total Gains (Losses) Included in AOCI	0	7
Assets, Purchases	1	32
Assets, Sales	0	0
Assets, Settlements	0	(9)
Assets, Net transfer In (Out) of Level 3	(1)	(330)
Balance at End of Period	3	3
Change in Unrealized Incl in OCI	0	7
Foreign Governments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	16	16
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	(1)	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	(11)	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	4	16
Change in Unrealized Incl in OCI	(1)	0
Preferred securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8	1
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	7
Balance at End of Period	8	8
Change in Unrealized Incl in OCI	0	1
Equity securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	15	10
Assets, Total Gains (Losses) Included in Earnings	(5)	1
Assets, Total Gains (Losses) Included in AOCI	0	1
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	3
Balance at End of Period	10	15
Change in Unrealized Incl in OCI	0	0
Interest rate swaps
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	57
Assets, Total Gains (Losses) Included in Earnings	(50)
Assets, Total Gains (Losses) Included in AOCI	3
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	(7)
Balance at End of Period	3	57
Change in Unrealized Incl in OCI	1
Investment in unconsolidated affiliates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	285	23
Assets, Total Gains (Losses) Included in Earnings	79	13
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	249
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	(92)	0
Balance at End of Period	272	285
Change in Unrealized Incl in OCI	0	0
Other assets
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	65
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	65	0
Change in Unrealized Incl in OCI	0
Short-term investments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0	0
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	236	204
Assets, Sales	(190)	(19)
Assets, Settlements	(9)	(185)
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	37	0
Change in Unrealized Incl in OCI	0	0
Derivative Instruments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	57	0
Assets, Total Gains (Losses) Included in Earnings		57
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		57
Change in Unrealized Incl in OCI		0
Available-for-sale embedded derivative
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	27	23
Assets, Total Gains (Losses) Included in Earnings	0	0
Assets, Total Gains (Losses) Included in AOCI	5	4
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	0	0
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	32	27
Change in Unrealized Incl in OCI	5	4
Credit linked note
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	10	15
Assets, Total Gains (Losses) Included in Earnings	1	0
Assets, Total Gains (Losses) Included in AOCI	0	0
Assets, Purchases	0	0
Assets, Sales	0	0
Assets, Settlements	(11)	(5)
Assets, Net transfer In (Out) of Level 3	0	0
Balance at End of Period	0	10
Change in Unrealized Incl in OCI	0	0
Secured borrowing receivable
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0	10
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		(10)
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		0
Change in Unrealized Incl in OCI		0
Loan receivable
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	0
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	11
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	11	0
Change in Unrealized Incl in OCI	0
Subtotal Level 3 assets at fair value
Fixed maturity securities available-for-sale:
Assets, Total Gains (Losses) Included in Earnings	41
Assets, Total Gains (Losses) Included in AOCI	217
Assets, Purchases	6,623
Assets, Sales	(3,165)
Assets, Settlements	(1,380)
Assets, Net transfer In (Out) of Level 3	(380)
Change in Unrealized Incl in OCI	216
Subtotal Level 3 assets at fair value | Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	9,589	8,169
Assets, Total Gains (Losses) Included in Earnings		17
Assets, Total Gains (Losses) Included in AOCI		199
Assets, Purchases		2,991
Assets, Sales		(145)
Assets, Settlements		(1,041)
Assets, Net transfer In (Out) of Level 3		(601)
Balance at End of Period	11,545	9,589
Change in Unrealized Incl in OCI		199
Market risk benefits asset | Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	88	117
Balance at End of Period	189	88
Subtotal Level 3 liabilities at fair value
Liabilities
Balance at Beginning of Period	4,258	3,115
Liabilities, Total Gains (Losses) Included in Earnings	99	257
Liabilities, Total Gains (Losses) Included in AOCI	0	0
Liabilities, Purchases	1,399	1,049
Liabilities, Sales	0	0
Liabilities, Settlements	(434)	(163)
Liabilities, Net transfer In (Out) of Level 3	(28)	0
Balance at End of Period	5,294	4,258
Change in Unrealized Incl in OCI	0	0
Market risk benefits liability | Level 3
Liabilities
Balance at Beginning of Period	403	282
Balance at End of Period	$ 549	$ 403

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Assets
Investments in unconsolidated affiliates	$ 3,731	$ 3,334
Trade and notes receivables, net of allowance	471	442
Total Estimated Fair Value
Assets
FHLB common stock	153	138
Commercial mortgage loans	2,404	2,253
Residential mortgage loans	2,916	2,545
Investments in unconsolidated affiliates	3,293	2,786
Policy loans	104	71
Other invested assets	90	59
Company-owned life insurance	431	397
Trade and notes receivables, net of allowance	471	442
Total	9,862	8,691
Liabilities
Investment contracts, included in contractholder funds	46,339	40,229
Debt	3,781	3,568
Total	50,120	43,797
Carrying Amount
Assets
FHLB common stock	153	138
Commercial mortgage loans	2,705	2,538
Residential mortgage loans	3,221	2,798
Investments in unconsolidated affiliates	3,293	2,786
Policy loans	104	71
Other invested assets	90	59
Company-owned life insurance	431	397
Trade and notes receivables, net of allowance	471	442
Total	10,468	9,229
Liabilities
Investment contracts, included in contractholder funds	51,184	44,540
Debt	4,321	3,887
Total	55,505	48,427
Level 1
Assets
FHLB common stock	0	0
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	42	17
Company-owned life insurance	0	0
Trade and notes receivables, net of allowance	0	0
Total	42	17
Liabilities
Investment contracts, included in contractholder funds	0	0
Debt	0	0
Total	0	0
Level 2
Assets
FHLB common stock	153	138
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	0	0
Company-owned life insurance	0	0
Trade and notes receivables, net of allowance	0	0
Total	153	138
Liabilities
Investment contracts, included in contractholder funds	0	0
Debt	3,781	3,568
Total	3,781	3,568
Level 3
Assets
FHLB common stock	0	0
Commercial mortgage loans	2,404	2,253
Residential mortgage loans	2,916	2,545
Investments in unconsolidated affiliates	5	7
Policy loans	104	71
Other invested assets	0	0
Company-owned life insurance	431	397
Trade and notes receivables, net of allowance	471	442
Total	6,331	5,715
Liabilities
Investment contracts, included in contractholder funds	46,339	40,229
Debt	0	0
Total	46,339	40,229
NAV
Assets
Investments in unconsolidated affiliates	3,288	2,779
Other invested assets	48	42
Total	$ 3,336	$ 2,821

Investments - Consolidated Inve

Investments - Consolidated Investments (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Available-for-sale securities
Amortized Cost	$ 51,681	$ 45,606
Allowance for Expected Credit Losses	(67)	(42)
Gross Unrealized Gains	406	457
Gross Unrealized Losses	(3,802)	(3,648)
Fair Value	48,218	42,373
Asset-backed securities
Available-for-sale securities
Amortized Cost	15,784	14,631
Allowance for Expected Credit Losses	(13)	(11)
Gross Unrealized Gains	202	191
Gross Unrealized Losses	(317)	(469)
Fair Value	15,656	14,342
Commercial mortgage-backed securities
Available-for-sale securities
Amortized Cost	5,379	4,797
Allowance for Expected Credit Losses	(49)	(22)
Gross Unrealized Gains	53	23
Gross Unrealized Losses	(201)	(323)
Fair Value	5,182	4,475
Corporates
Available-for-sale securities
Amortized Cost	24,425	20,133
Allowance for Expected Credit Losses	(5)	(6)
Gross Unrealized Gains	108	186
Gross Unrealized Losses	(2,832)	(2,417)
Fair Value	21,696	17,896
Hybrids
Available-for-sale securities
Amortized Cost	604	668
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	6	3
Gross Unrealized Losses	(29)	(53)
Fair Value	581	618
Municipals
Available-for-sale securities
Amortized Cost	1,638	1,826
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	3	14
Gross Unrealized Losses	(255)	(229)
Fair Value	1,386	1,611
Residential mortgage-backed securities
Available-for-sale securities
Amortized Cost	2,869	2,507
Allowance for Expected Credit Losses	0	(3)
Gross Unrealized Gains	32	29
Gross Unrealized Losses	(105)	(104)
Fair Value	2,796	2,429
U.S. Government
Available-for-sale securities
Amortized Cost	645	679
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	2	8
Gross Unrealized Losses	(10)	(9)
Fair Value	637	678
Foreign Governments
Available-for-sale securities
Amortized Cost	337	365
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	0	3
Gross Unrealized Losses	(53)	(44)
Fair Value	$ 284	$ 324

Investments - Narrative (Detail

Investments - Narrative (Details)	12 Months Ended
	Dec. 31, 2024 USD ($) loan	Dec. 31, 2023 USD ($) loan	Dec. 31, 2022 USD ($)
Debt Securities, Available-for-sale [Line Items]
Non-income producing investment fair value	$ 32,000,000	$ 47,000,000
Accrued interest receivable	476,000,000	450,000,000
FHLB collateral pledged	4,289,000,000	4,345,000,000
Available for sale securities, allowance for credit losses	67,000,000	$ 42,000,000
Available-for-sale, securities in unrealized loss position, allowance for credit loss	$ 0
Commercial mortgage loans, percentage of investments	4%	4%
DSC ratio, amortization period	25 years
Mortgage loans past due 90 days	$ 94,000,000	$ 57,000,000
Purchased mortgage loans with credit deterioration	0	0
Gross investment income	3,423,000,000	2,864,000,000	$ 2,088,000,000
Reinsurance agreement, recognized gains (losses)	$ (30,000,000)	(123,000,000)	381,000,000
Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other assets
Funds Withheld for Reinsurance
Debt Securities, Available-for-sale [Line Items]
Gross investment income	$ 636,000,000	$ 339,000,000	$ 109,000,000
90 days or more past due
Debt Securities, Available-for-sale [Line Items]
Mortgage loans in process of foreclosure	$ 81,000,000
United States
Debt Securities, Available-for-sale [Line Items]
Residential mortgage loans, location percentage	100%
Residential mortgage
Debt Securities, Available-for-sale [Line Items]
Percentage of total investments	5%	5%
Loan charge offs	$ 0
Mortgage loans past due 90 days	85,000,000	$ 57,000,000
Interest receivable	$ 28,000,000	$ 24,000,000
Commercial mortgage
Debt Securities, Available-for-sale [Line Items]
Number of loans delinquent in principal or interest payments | loan	1	0
Mortgage loans past due 90 days	$ 9,000,000	$ 0
Interest receivable	$ 8,000,000	7,000,000
Mortgage loans | 90 days or more past due
Debt Securities, Available-for-sale [Line Items]
Mortgage loans in process of foreclosure		41,000,000
Mortgage loans | Residential mortgage
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, forecast period	2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period	3 years
Mortgage loans | Commercial mortgage
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, forecast period	2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period	3 years
Fixed maturity securities, available-for-sale
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators	$ 997,000,000	$ 141,000,000

Investments - Amortized Cost an

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Due in one year or less, Amortized Cost	$ 961	$ 703
Due after one year through five years, Amortized Cost	4,616	4,320
Due after five years through ten years, Amortized Cost	5,311	3,195
Due after ten years, Amortized Cost	16,761	15,453
Subtotal, Amortized Cost	27,649	23,671
Other securities which provide for periodic payments, Amortized Cost	24,032	21,935
Due in one year or less, Fair Value	955	687
Due after one year through five years, Fair Value	4,544	4,209
Due after five years through ten years, Fair Value	5,126	3,048
Due after ten years, Fair Value	13,959	13,183
Subtotal, Fair Value	24,584	21,127
Other securities which provide for periodic payments, Fair Value	23,634	21,246
Amortized Cost	51,681	45,606
Fair Value	48,218	42,373
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	15,784	14,631
Other securities which provide for periodic payments, Fair Value	15,656	14,342
Amortized Cost	15,784	14,631
Fair Value	15,656	14,342
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,379	4,797
Other securities which provide for periodic payments, Fair Value	5,182	4,475
Amortized Cost	5,379	4,797
Fair Value	5,182	4,475
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,869	2,507
Other securities which provide for periodic payments, Fair Value	$ 2,796	$ 2,429

Investments - Fair Value and Gr

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details) $ in Millions	Dec. 31, 2024 USD ($) security	Dec. 31, 2023 USD ($) security
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	$ 10,420	$ 5,841
Gross Unrealized Losses Less than 12 months	(290)	(302)
Fair Value, 12 Months or longer	16,141	20,908
Gross Unrealized Losses, 12 months or longer	(3,485)	(3,291)
Total Fair Value	26,561	26,749
Total Gross Unrealized Losses	$ (3,775)	$ (3,593)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | security	2,005	1,035
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | security	2,305	2,846
Total number of available-for-sale securities in an unrealized loss position | security	4,310	3,881
Asset-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	$ 1,164	$ 1,707
Gross Unrealized Losses Less than 12 months	(30)	(56)
Fair Value, 12 Months or longer	2,637	5,835
Gross Unrealized Losses, 12 months or longer	(276)	(404)
Total Fair Value	3,801	7,542
Total Gross Unrealized Losses	(306)	(460)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	727	819
Gross Unrealized Losses Less than 12 months	(11)	(53)
Fair Value, 12 Months or longer	1,513	1,922
Gross Unrealized Losses, 12 months or longer	(175)	(235)
Total Fair Value	2,240	2,741
Total Gross Unrealized Losses	(186)	(288)
Corporates
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	6,831	2,387
Gross Unrealized Losses Less than 12 months	(208)	(134)
Fair Value, 12 Months or longer	9,866	10,739
Gross Unrealized Losses, 12 months or longer	(2,624)	(2,283)
Total Fair Value	16,697	13,126
Total Gross Unrealized Losses	(2,832)	(2,417)
Hybrids
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	105	60
Gross Unrealized Losses Less than 12 months	(4)	(2)
Fair Value, 12 Months or longer	380	483
Gross Unrealized Losses, 12 months or longer	(25)	(51)
Total Fair Value	485	543
Total Gross Unrealized Losses	(29)	(53)
Municipals
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	261	399
Gross Unrealized Losses Less than 12 months	(12)	(49)
Fair Value, 12 Months or longer	1,006	920
Gross Unrealized Losses, 12 months or longer	(243)	(179)
Total Fair Value	1,267	1,319
Total Gross Unrealized Losses	(255)	(228)
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	899	336
Gross Unrealized Losses Less than 12 months	(16)	(5)
Fair Value, 12 Months or longer	460	662
Gross Unrealized Losses, 12 months or longer	(89)	(89)
Total Fair Value	1,359	998
Total Gross Unrealized Losses	(105)	(94)
U.S. Government
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	313	84
Gross Unrealized Losses Less than 12 months	(4)	0
Fair Value, 12 Months or longer	122	159
Gross Unrealized Losses, 12 months or longer	(5)	(9)
Total Fair Value	435	243
Total Gross Unrealized Losses	(9)	(9)
Foreign Governments
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Values, Less than 12 months	120	49
Gross Unrealized Losses Less than 12 months	(5)	(3)
Fair Value, 12 Months or longer	157	188
Gross Unrealized Losses, 12 months or longer	(48)	(41)
Total Fair Value	277	237
Total Gross Unrealized Losses	$ (53)	$ (44)

Investments - Schedule of Comme

Investments - Schedule of Commercial Mortgage Loan, Gross of Valuation Allowance, By Property Type and Region (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Allowance for expected credit loss	$ (70)	$ (66)	$ (42)
Loans, net	5,926	5,336
Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	2,722	2,550
Allowance for expected credit loss	(17)	(12)	$ (10)
Loans, net	$ 2,705	$ 2,538
% of Total	100%	100%
East North Central | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 98	$ 151
% of Total	4%	6%
East South Central | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 75	$ 75
% of Total	3%	3%
Middle Atlantic | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 354	$ 354
% of Total	13%	14%
Mountain | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 409	$ 352
% of Total	15%	14%
New England | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 164	$ 168
% of Total	6%	6%
Pacific | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 706	$ 766
% of Total	26%	30%
South Atlantic | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 683	$ 563
% of Total	25%	22%
West North Central | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 62	$ 4
% of Total	2%	0%
West South Central | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 171	$ 117
% of Total	6%	5%
Hotel | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 17	$ 18
% of Total	1%	1%
Industrial | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 657	$ 616
% of Total	24%	24%
Mixed Use | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 11	$ 11
% of Total	0%	0%
Multifamily | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 1,006	$ 1,012
% of Total	37%	40%
Office | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 349	$ 316
% of Total	13%	13%
Retail | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 98	$ 102
% of Total	4%	4%
Student Housing | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 83	$ 83
% of Total	3%	3%
Other | Commercial mortgage
Schedule of Investments [Line Items]
Gross Carrying Value	$ 501	$ 392
% of Total	18%	15%

Investments - Commercial Mortga

Investments - Commercial Mortgage Loans Segregated by Aging of Loans and Charge Offs by Year of Origination (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Charge offs
Year one	$ 0	$ 0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Total charge-offs	0	3
Loans under development, amortized cost		22
Loans under development, fair value		22
Commercial mortgage
Credit Quality Indicator Current Year [Abstract]
2024	273	213
2023	227	288
2022	290	1,256
2021	1,253	512
2020	469	0
Prior	210	259
Total	2,722	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	273	213
2022	227	288
2021	290	1,256
2020	1,253	512
2019	469	0
Prior	210	259
Total	2,722	2,528
Charge offs
Prior	0	3
Total charge-offs	0	3
Commercial mortgage | Current (less than 30 days past due)
Credit Quality Indicator Current Year [Abstract]
2024	273	213
2023	227	288
2022	290	1,256
2021	1,253	512
2020	469	0
Prior	201	259
Total	2,713	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	273	213
2022	227	288
2021	290	1,256
2020	1,253	512
2019	469	0
Prior	201	259
Total	2,713	2,528
Commercial mortgage | 30-89 days past due
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	0	0
2022	0	0
2021	0	0
2020	0	0
Prior	0	0
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	0	0
2021	0	0
2020	0	0
2019	0	0
Prior	0	0
Total	0	0
Commercial mortgage | 90 days or more past due
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	0	0
2022	0	0
2021	0	0
2020	0	0
Prior	9	0
Total	9	0
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	0	0
2021	0	0
2020	0	0
2019	0	0
Prior	9	0
Total	$ 9	$ 0

Investments - Schedule of Inves

Investments - Schedule of Investment in CMLs by Loan to Value and Debt Service Coverage Ratios (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Credit Quality Indicator Prior Year [Abstract]
Loans under development, amortized cost		$ 22
Loans under development, fair value		22
Commercial mortgage
Schedule of Investments [Line Items]
Loans	$ 2,722	$ 2,528
% of Total	100%	100%
Credit Quality Indicator Current Year [Abstract]
2024	$ 273	$ 213
2023	227	288
2022	290	1,256
2021	1,253	512
2020	469	0
Prior	210	259
Total	2,722	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	273	213
2022	227	288
2021	290	1,256
2020	1,253	512
2019	469	0
Prior	210	259
Total	2,722	2,528
Commercial mortgage | Total Estimated Fair Value
Schedule of Investments [Line Items]
Loans	$ 2,404	$ 2,231
% of Total	100%	100%
Credit Quality Indicator Current Year [Abstract]
Total	$ 2,404	$ 2,231
Credit Quality Indicator Prior Year [Abstract]
Total	2,404	2,231
Commercial mortgage | Less than 50.00%
Schedule of Investments [Line Items]
Loans	$ 524	$ 533
% of Total	19%	21%
Credit Quality Indicator Current Year [Abstract]
2024	$ 66	$ 85
2023	99	17
2022	19	77
2021	74	232
2020	189	0
Prior	77	122
Total	524	533
Credit Quality Indicator Prior Year [Abstract]
2023	66	85
2022	99	17
2021	19	77
2020	74	232
2019	189	0
Prior	77	122
Total	524	533
Commercial mortgage | Less than 50.00% | Total Estimated Fair Value
Schedule of Investments [Line Items]
Loans	$ 501	$ 510
% of Total	21%	23%
Credit Quality Indicator Current Year [Abstract]
Total	$ 501	$ 510
Credit Quality Indicator Prior Year [Abstract]
Total	501	510
Commercial mortgage | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	$ 927	$ 764
% of Total	34%	30%
Credit Quality Indicator Current Year [Abstract]
2024	$ 112	$ 53
2023	53	149
2022	149	267
2021	321	158
2020	159	0
Prior	133	137
Total	927	764
Credit Quality Indicator Prior Year [Abstract]
2023	112	53
2022	53	149
2021	149	267
2020	321	158
2019	159	0
Prior	133	137
Total	927	764
Commercial mortgage | 50.00% to 59.99% | Total Estimated Fair Value
Schedule of Investments [Line Items]
Loans	$ 826	$ 679
% of Total	34%	30%
Credit Quality Indicator Current Year [Abstract]
Total	$ 826	$ 679
Credit Quality Indicator Prior Year [Abstract]
Total	826	679
Commercial mortgage | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	$ 1,254	$ 1,216
% of Total	46%	48%
Credit Quality Indicator Current Year [Abstract]
2024	$ 91	$ 69
2023	71	113
2022	113	912
2021	858	122
2020	121	0
Prior	0	0
Total	1,254	1,216
Credit Quality Indicator Prior Year [Abstract]
2023	91	69
2022	71	113
2021	113	912
2020	858	122
2019	121	0
Prior	0	0
Total	1,254	1,216
Commercial mortgage | 60.00% to 74.99% | Total Estimated Fair Value
Schedule of Investments [Line Items]
Loans	$ 1,060	$ 1,028
% of Total	44%	46%
Credit Quality Indicator Current Year [Abstract]
Total	$ 1,060	$ 1,028
Credit Quality Indicator Prior Year [Abstract]
Total	1,060	1,028
Commercial mortgage | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	$ 17	$ 15
% of Total	1%	1%
Credit Quality Indicator Current Year [Abstract]
2024	$ 4	$ 6
2023	4	9
2022	9	0
2021	0	0
2020	0	0
Prior	0	0
Total	17	15
Credit Quality Indicator Prior Year [Abstract]
2023	4	6
2022	4	9
2021	9	0
2020	0	0
2019	0	0
Prior	0	0
Total	17	15
Commercial mortgage | 75.00% to 84.99% | Total Estimated Fair Value
Schedule of Investments [Line Items]
Loans	$ 17	$ 14
% of Total	1%	1%
Credit Quality Indicator Current Year [Abstract]
Total	$ 17	$ 14
Credit Quality Indicator Prior Year [Abstract]
Total	17	14
Greater than 1.25 | Commercial mortgage
Schedule of Investments [Line Items]
Loans	2,535	2,443
Credit Quality Indicator Current Year [Abstract]
2024	140	154
2023	215	276
2022	278	1,256
2021	1,241	512
2020	469	0
Prior	192	245
Total	2,535	2,443
Credit Quality Indicator Prior Year [Abstract]
2023	140	154
2022	215	276
2021	278	1,256
2020	1,241	512
2019	469	0
Prior	192	245
Total	2,535	2,443
Greater than 1.25 | Commercial mortgage | Less than 50.00%
Schedule of Investments [Line Items]
Loans	490	519
Credit Quality Indicator Current Year [Abstract]
Total	490	519
Credit Quality Indicator Prior Year [Abstract]
Total	490	519
Greater than 1.25 | Commercial mortgage | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	803	764
Credit Quality Indicator Current Year [Abstract]
Total	803	764
Credit Quality Indicator Prior Year [Abstract]
Total	803	764
Greater than 1.25 | Commercial mortgage | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	1,238	1,160
Credit Quality Indicator Current Year [Abstract]
Total	1,238	1,160
Credit Quality Indicator Prior Year [Abstract]
Total	1,238	1,160
Greater than 1.25 | Commercial mortgage | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	4	0
Credit Quality Indicator Current Year [Abstract]
Total	4	0
Credit Quality Indicator Prior Year [Abstract]
Total	4	0
Greater than 1.00 but less than 1.25 | Commercial mortgage
Schedule of Investments [Line Items]
Loans	166	66
Credit Quality Indicator Current Year [Abstract]
2024	133	59
2023	12	3
2022	3	0
2021	0	0
2020	0	0
Prior	18	4
Total	166	66
Credit Quality Indicator Prior Year [Abstract]
2023	133	59
2022	12	3
2021	3	0
2020	0	0
2019	0	0
Prior	18	4
Total	166	66
Greater than 1.00 but less than 1.25 | Commercial mortgage | Less than 50.00%
Schedule of Investments [Line Items]
Loans	34	4
Credit Quality Indicator Current Year [Abstract]
Total	34	4
Credit Quality Indicator Prior Year [Abstract]
Total	34	4
Greater than 1.00 but less than 1.25 | Commercial mortgage | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	112	0
Credit Quality Indicator Current Year [Abstract]
Total	112	0
Credit Quality Indicator Prior Year [Abstract]
Total	112	0
Greater than 1.00 but less than 1.25 | Commercial mortgage | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	16	56
Credit Quality Indicator Current Year [Abstract]
Total	16	56
Credit Quality Indicator Prior Year [Abstract]
Total	16	56
Greater than 1.00 but less than 1.25 | Commercial mortgage | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	4	6
Credit Quality Indicator Current Year [Abstract]
Total	4	6
Credit Quality Indicator Prior Year [Abstract]
Total	4	6
Greater than 1.00 | Commercial mortgage
Schedule of Investments [Line Items]
Loans	21	19
Credit Quality Indicator Current Year [Abstract]
Total	21	19
Credit Quality Indicator Prior Year [Abstract]
Total	21	19
Greater than 1.00 | Commercial mortgage | Less than 50.00%
Schedule of Investments [Line Items]
Loans	0	10
Credit Quality Indicator Current Year [Abstract]
Total	0	10
Credit Quality Indicator Prior Year [Abstract]
Total	0	10
Greater than 1.00 | Commercial mortgage | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	12	0
Credit Quality Indicator Current Year [Abstract]
Total	12	0
Credit Quality Indicator Prior Year [Abstract]
Total	12	0
Greater than 1.00 | Commercial mortgage | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	0	0
Credit Quality Indicator Current Year [Abstract]
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
Total	0	0
Greater than 1.00 | Commercial mortgage | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	9	9
Credit Quality Indicator Current Year [Abstract]
Total	9	9
Credit Quality Indicator Prior Year [Abstract]
Total	9	9
Less than 1.00 | Commercial mortgage
Schedule of Investments [Line Items]
Loans	21	19
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	0	9
2022	9	0
2021	12	0
2020	0	0
Prior	0	10
Total	21	19
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	0	9
2021	9	0
2020	12	0
2019	0	0
Prior	0	10
Total	$ 21	$ 19

Investments - Schedule of Resid

Investments - Schedule of Residential Mortgage Loan by State (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Allowance for expected credit loss	$ (70)	$ (66)	$ (42)
Loans, net	5,926	5,336
Residential mortgage
Loans	3,274	2,852
Allowance for expected credit loss	$ (53)	$ (54)	$ (32)
% of Total	100%	100%
Loans, net	$ 3,221	$ 2,798
Florida | Residential mortgage
Loans	$ 164	$ 163
% of Total	5%	6%
New York | Residential mortgage
Loans		$ 129
% of Total		5%
Texas | Residential mortgage
Loans		$ 129
% of Total		5%
All other states | Residential mortgage
Loans	$ 3,110	$ 2,431
% of Total	95%	84%

Investments - Credit Quality of

Investments - Credit Quality of RMLs (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Financing Receivable, Credit Quality Indicator [Line Items]
Allowance for expected credit loss	$ (70)	$ (66)	$ (42)
Loans, net	5,926	5,336
Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	3,274	2,852
Allowance for expected credit loss	(53)	(54)	$ (32)
Loans, net	$ 3,221	$ 2,798
% of Total	100%	100%
Allowance for expected loan loss, % of Total	0%	0%
Total residential mortgage loans, % of Total	100%	100%
Residential mortgage | Performing
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	$ 3,188	$ 2,795
% of Total	97%	98%
Residential mortgage | Non-performing
Financing Receivable, Credit Quality Indicator [Line Items]
Gross Carrying Value	$ 86	$ 57
% of Total	3%	2%

Investments - Schedule of Res_2

Investments - Schedule of Residential Loans Segregated by Risk Rating Exposure and Non-accrual Loans by Amortized Cost (Details) - Residential mortgage - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Credit Quality Indicator Current Year [Abstract]
2024	$ 614	$ 373
2023	376	995
2022	928	877
2021	840	208
2020	176	204
Prior	340	195
Total	3,274	2,852
Credit Quality Indicator Prior Year [Abstract]
2023	614	373
2022	376	995
2021	928	877
2020	840	208
2019	176	204
Prior	340	195
Total	3,274	2,852
Current (less than 30 days past due)
Credit Quality Indicator Current Year [Abstract]
2024	610	373
2023	368	985
2022	911	854
2021	805	192
2020	162	183
Prior	312	192
Total	3,168	2,779
Credit Quality Indicator Prior Year [Abstract]
2023	610	373
2022	368	985
2021	911	854
2020	805	192
2019	162	183
Prior	312	192
Total	3,168	2,779
30-89 days past due
Credit Quality Indicator Current Year [Abstract]
2024	1	0
2023	6	4
2022	4	7
2021	6	3
2020	1	0
Prior	3	2
Total	21	16
Credit Quality Indicator Prior Year [Abstract]
2023	1	0
2022	6	4
2021	4	7
2020	6	3
2019	1	0
Prior	3	2
Total	21	16
90 days or more past due
Credit Quality Indicator Current Year [Abstract]
2024	3	0
2023	2	6
2022	13	16
2021	29	13
2020	13	21
Prior	25	1
Total	85	57
Credit Quality Indicator Prior Year [Abstract]
2023	3	0
2022	2	6
2021	13	16
2020	29	13
2019	13	21
Prior	25	1
Total	$ 85	$ 57

Investments - Amortized Costs o

Investments - Amortized Costs of Non-accrual Loans (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost of loans on non-accrual	$ 94	$ 57
Residential mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost of loans on non-accrual	85	57
Commercial mortgage
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost of loans on non-accrual	$ 9	$ 0

Investments - Changes in Allowa

Investments - Changes in Allowance for Expected Credit Losses on Mortgage Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ 66	$ 42
Provision (expense) benefit for loan losses	(4)	(27)
Loans charged-off	0	3
Ending Balance	70	66
Residential Mortgage
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	54	32
Provision (expense) benefit for loan losses	1	(22)
Loans charged-off	0	0
Ending Balance	53	54
Commercial Mortgage
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	12	10
Provision (expense) benefit for loan losses	(5)	(5)
Loans charged-off	0	3
Ending Balance	$ 17	$ 12

Investments - Major Sources of

Investments - Major Sources of Interest and Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Gross investment income	$ 3,423	$ 2,864	$ 2,088
Investment expense	(299)	(257)	(197)
Interest and investment income	3,124	2,607	1,891
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	2,261	1,911	1,489
Equity securities
Schedule of Investments [Line Items]
Gross investment income	33	33	31
Preferred securities
Schedule of Investments [Line Items]
Gross investment income	34	52	67
Mortgage loans
Schedule of Investments [Line Items]
Gross investment income	273	229	186
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	238	151	61
Limited partnerships
Schedule of Investments [Line Items]
Gross investment income	326	231	110
Tax deferred property exchange income
Schedule of Investments [Line Items]
Gross investment income	133	166	103
Other investments
Schedule of Investments [Line Items]
Gross investment income	$ 125	$ 91	$ 41

Investments - Investment Gains

Investments - Investment Gains (Losses) Net (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Net realized (losses) gains on fixed maturity available-for-sale securities	$ (9)	$ (155)	$ (253)
Realized gains (losses) on other invested assets	61	(25)	(68)
Change in allowance for expected credit losses	(33)	(36)	(41)
Realized gains (losses) on certain derivative instruments	254	(211)	(164)
Unrealized (losses) gains on certain derivative instruments	(184)	358	(693)
Change in fair value of reinsurance related embedded derivatives	(32)	(128)	352
Change in fair value of other derivatives and embedded derivatives	12	11	(10)
Realized gains (losses) on derivatives and embedded derivatives	50	30	(515)
Recognized gains and losses, net	83	(164)	(1,493)
Equity securities
Schedule of Investments [Line Items]
Net realized/unrealized gains (losses) on equity and preferred equity securities	2	23	(386)
Valuation (losses) gains	(131)	47	(387)
Preferred securities
Schedule of Investments [Line Items]
Net realized/unrealized gains (losses) on equity and preferred equity securities	12	(1)	(230)
Valuation (losses) gains	$ 13	$ 80	$ (198)

Investments - Proceeds From the

Investments - Proceeds From the Sale of Fixed-Maturity Available-For-Sale Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 4,414	$ 2,698	$ 3,264
Gross gains	45	18	14
Gross losses	$ (80)	$ (145)	$ (252)

Investments - Carrying Value an

Investments - Carrying Value and Maximum Loss Exposure of Unconsolidated VIEs (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Carrying Value	$ 26,807	$ 23,908
Maximum Loss Exposure	28,945	27,152
Investment in unconsolidated affiliates
Schedule of Investments [Line Items]
Carrying Value	3,565	3,071
Maximum Loss Exposure	4,703	4,806
Fixed maturity securities
Schedule of Investments [Line Items]
Carrying Value	23,242	20,837
Maximum Loss Exposure	$ 24,242	$ 22,346

Derivative Financial Instrume_3

Derivative Financial Instruments - Carrying Amounts of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	$ 936	$ 977
Derivatives liabilities, carrying amount	5,231	4,259
Equity options | Derivative Investments
Derivative [Line Items]
Derivative asset, notional amount	29,594	27,263
Equity options | Derivative Investments | Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	773	739
Equity options | Accounts payable and accrued liabilities: | Carrying Amount
Derivative [Line Items]
Derivatives liabilities, carrying amount	1	1
Interest rate swaps | Derivative Investments
Derivative [Line Items]
Derivative asset, notional amount	2,445	2,705
Interest rate swaps | Derivative Investments | Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	19	57
Interest rate swaps | Accounts payable and accrued liabilities:
Derivative [Line Items]
Derivative liability, notional amount	2,700
Interest rate swaps | Accounts payable and accrued liabilities: | Carrying Amount
Derivative [Line Items]
Derivatives liabilities, carrying amount	10	0
Other derivative investments | Derivative Investments
Derivative [Line Items]
Derivative asset, notional amount	157	137
Other derivative investments | Derivative Investments | Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	3	1
Other embedded derivatives | Other long-term investments | Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	32	28
Reinsurance related embedded derivatives | Prepaid expenses and other assets: | Carrying Amount
Derivative [Line Items]
Derivative asset, carrying amount	109	152
Indexed annuities/IUL embedded derivatives | Contractholder funds: | Carrying Amount
Derivative [Line Items]
Derivatives liabilities, carrying amount	$ 5,220	$ 4,258

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative gains (losses)	$ (32)	$ (128)	$ 352
Equity options
Derivative [Line Items]
Derivative gains (losses)	153	98	(862)
Interest rate swaps
Derivative [Line Items]
Derivative gains (losses)	(103)	48	0
Futures contracts
Derivative [Line Items]
Derivative gains (losses)	18	9	(7)
Other derivative investments
Derivative [Line Items]
Derivative gains (losses)	10	(2)	12
Other embedded derivatives
Derivative [Line Items]
Derivative gains (losses)	4	5	(10)
Reinsurance related embedded derivatives
Derivative [Line Items]
Derivative gains (losses)	(32)	(128)	352
Total net investment gains (losses)
Derivative [Line Items]
Derivative gains (losses)	50	30	(515)
Indexed annuities/IUL embedded derivatives increase (decrease)
Derivative [Line Items]
Derivative gains (losses)	$ 962	$ 1,143	$ (768)

Derivative Financial Instrume_5

Derivative Financial Instruments - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) contract counterparty	Dec. 31, 2023 USD ($) contract
Derivative [Line Items]
Number of counterparties, net exposure threshold set to zero | counterparty	1
All counterparties except one
Derivative [Line Items]
Counterparties, collateral required threshold	0%
Other embedded derivatives
Derivative [Line Items]
Term of contract, term one	1 year
Term of contract, term two	2 years
Term of contract, term three	3 years
Term of contract, term five	5 years
Term of contract, term six	6 years
Call options and interest rate swaps | Derivatives for Trading and Investment | Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral posted	$ 771	$ 775
Net Credit Risk	34	39
Call options and interest rate swaps | Cash and Cash Equivalents | Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral posted	$ 679	$ 588
Futures contracts
Derivative [Line Items]
Number of instruments held | contract	527	439
Collateral held	$ 7	$ 4

Derivative Financial Instrume_6

Derivative Financial Instruments - Schedule of Exposure to Credit Loss on Call Options Held (Details) - Not Designated as Hedging Instrument - Derivative instruments excluding futures contracts - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Fair Value	$ 782	$ 796
Collateral	771	775
Net Credit Risk	$ 34	$ 39

Notes Payable - Schedule of Lon

Notes Payable - Schedule of Long Term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Oct. 04, 2024	Jun. 04, 2024	Dec. 31, 2023	Dec. 06, 2023	Jan. 13, 2023	Sep. 17, 2021	Sep. 15, 2020	May 16, 2019	Aug. 13, 2018
Debt Instrument [Line Items]
Notes payable	$ 4,321			$ 3,887
4.50% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage									4.50%	4.50%
4.50% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.50%								4.50%	4.50%
Notes payable	$ 447			446
3.40% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.40%
Notes payable	$ 646			644
2.45% Senior Notes Due March 2031 | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	2.45%							2.45%
Notes payable	$ 595			594
3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage							3.20%
3.20% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.20%
Notes payable	$ 444			444
Revolving Credit Facility | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Notes payable	4			2
F&G Credit Agreement | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Notes payable	$ 0			362
5.50% F&G Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	5.50%
Notes payable	$ 301			561
7.40% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.40%					7.40%
Notes payable	$ 497			495
7.95% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.95%				7.95%
Notes payable	$ 336			336
6.50% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.50%		6.50%
Notes payable	$ 545			0
6.25% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.25%	6.25%
Notes payable	$ 492			0
Other
Debt Instrument [Line Items]
Notes payable	$ 22			$ 7

Notes Payable - Narrative (Deta

Notes Payable - Narrative (Details) - USD ($)

12 Months Ended

Oct. 04, 2024

Feb. 21, 2023

Nov. 22, 2022

Sep. 17, 2021

Sep. 15, 2020

Jun. 12, 2020

Apr. 20, 2018

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2022

Jun. 04, 2024

Feb. 16, 2024

Feb. 15, 2024

Dec. 06, 2023

Jan. 13, 2023

Apr. 22, 2020

May 16, 2019

Aug. 13, 2018

Debt Instrument [Line Items]

Outstanding principal

$ 4,367,000,000

Repayment of principal borrowed

$ 250,000,000

$ 0

$ 400,000,000

Senior Notes

Debt Instrument [Line Items]

Debt instrument, unamortized premium

$ 39,000,000

6.25% Senior Notes due 2034 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Debt instrument, interest rate, stated percentage

6.25%

6.25%

Price as percent of par on offering of unsecured Notes

99.36%

Debt issuance costs, net

$ 8,000,000

6.50% F&G Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 550,000,000

Debt instrument, interest rate, stated percentage

6.50%

6.50%

Price as percent of par on offering of unsecured Notes

99.74%

Debt issuance costs, net

$ 6,000,000

7.95% F&G Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 345,000,000

Debt instrument, interest rate, stated percentage

7.95%

7.95%

Debt issuance costs, net

$ 9,000,000

7.40% F&G Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Debt instrument, interest rate, stated percentage

7.40%

7.40%

Debt issuance costs, net

$ 6,000,000

5.50% F&G Senior Notes due May 2025 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 550,000,000

$ 250,000,000

Debt instrument, interest rate, stated percentage

5.50%

5.50%

Price as percent of par on offering of unsecured Notes

99.50%

Proceeds from issuance of senior notes

$ 547,000,000

5.50% F&G Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

5.50% F&G Notes | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 250,000,000

F&G Credit Agreement | Revolving Credit Facility

Debt Instrument [Line Items]

Outstanding principal

$ 0

365,000,000

F&G Credit Agreement | Line of Credit

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility

Debt Instrument [Line Items]

Line of credit facility

$ 665,000,000

$ 550,000,000

$ 750,000,000

$ 665,000,000

Credit facility increase in borrowing capacity

$ 115,000,000

Basis spread on variable rate (as percent)

0.50%

Revolving credit outstanding

0

$ 365,000,000

Remaining borrowing capacity

$ 750,000,000

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Minimum | Condition One

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

0.30%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Minimum | Condition Two

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1.30%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Maximum | Condition One

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

0.80%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Maximum | Condition Two

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1.80%

Credit Agreement November 2022 | Line of Credit | Revolving Credit Facility

Debt Instrument [Line Items]

Repayment of remaining outstanding principal

$ 365,000,000

Average variable interest rate

7.06%

7.11%

Credit Agreement November 2022 | Line of Credit | Revolving Credit Facility | Minimum

Debt Instrument [Line Items]

Facility fee, rate

0.20%

Credit Agreement November 2022 | Line of Credit | Revolving Credit Facility | Maximum

Debt Instrument [Line Items]

Facility fee, rate

0.45%

3.20% Notes, net of discount

Debt Instrument [Line Items]

Aggregate principal amount

$ 450,000,000

Debt instrument, interest rate, stated percentage

3.20%

Proceeds from issuance debt

$ 443,000,000

3.20% Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

3.20%

Revolving Credit Facility Due April 2022 | Line of Credit | Revolving Credit Facility

Debt Instrument [Line Items]

Line of credit facility

$ 800,000,000

Basis spread on variable rate (as percent)

1.40%

Remaining borrowing capacity

$ 800,000,000

Outstanding principal

0

Unamortized debt issuance costs

$ 4,000,000

2.45% Senior Notes Due March 2031

Debt Instrument [Line Items]

Proceeds from issuance debt

$ 593,000,000

2.45% Senior Notes Due March 2031 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 600,000,000

Debt instrument, interest rate, stated percentage

2.45%

2.45%

Term Loan Credit Agreement | Term Loan

Debt Instrument [Line Items]

Line of credit facility

$ 1,000,000,000

Repayments of all outstanding indebtedness under term loan credit agreement

$ 260,000,000

Repayment of principal borrowed

$ 640,000,000

3.40% Notes due June 15, 2030 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 650,000,000

Debt instrument, interest rate, stated percentage

3.40%

Proceeds from issuance debt

$ 642,000,000

4.50 % Notes due August 2028

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

4.50%

4.50%

4.50 % Notes due August 2028 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 450,000,000

Debt instrument, interest rate, stated percentage

4.50%

4.50%

4.50%

Price as percent of par on offering of unsecured Notes

99.252%

Annual interest rate

4.594%

Notes Payable - Principal Matur

Notes Payable - Principal Maturities of Notes Payable (Details) $ in Millions	Dec. 31, 2024 USD ($)
Maturities of Long-term Debt [Abstract]
2025	$ 300
2026	22
2027	0
2028	950
2029	550
Thereafter	2,545
Total long term debt	$ 4,367

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions					12 Months Ended
	Jan. 12, 2024	Jan. 11, 2024 USD ($)	Jan. 02, 2024 USD ($)	Sep. 07, 2023 defendant	Dec. 31, 2024 USD ($) lawsuit	Dec. 31, 2023 USD ($)	Oct. 31, 2021 USD ($)
Other Commitments [Line Items]
Estimated litigation liability					$ 17	$ 10
Escrow balances					14,400	$ 13,500
Kubera
Other Commitments [Line Items]
Note funding, maximum							$ 300
Roar Joint Venture, LLC
Other Commitments [Line Items]
Contingent consideration liability payment period			3 years
Roar Joint Venture, LLC | F&G
Other Commitments [Line Items]
Contingent consideration obligation, payments (up to)			$ 90
Contingent consideration liability payment period			3 years
Roar Joint Venture, LLC | Loan Commitment
Other Commitments [Line Items]
Loan principal outstanding					11
Roar Joint Venture, LLC | Maximum | Loan Commitment
Other Commitments [Line Items]
Loan agreement with seller (up to)					$ 40
6.875% Series A Mandatory Convertible Preferred Stock
Other Commitments [Line Items]
Issuance of preferred stock		$ 250
Preferred stock, dividend rate, percentage		6.875%
6.875% Series A Mandatory Convertible Preferred Stock | F&G
Other Commitments [Line Items]
Preferred stock, dividend rate, percentage	6.875%
Cooper v. Progress Software Corp., No. 1:23-cv-12067
Other Commitments [Line Items]
Number of defendants | defendant				5
Damages from Product Defects
Other Commitments [Line Items]
Number of similar lawsuits filed against other entities (over) | lawsuit					150
Breach Of Contract | Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company
Other Commitments [Line Items]
Plaintiffs claim losses amount					$ 162
Failure To Purchase Interest In Contracts | Insurance Distribution Consulting, LLC v. Fidelity & Guaranty Life Insurance Company
Other Commitments [Line Items]
Plaintiffs claim losses amount					$ 11
Pending Litigation | Damages from Product Defects
Other Commitments [Line Items]
Number of class action lawsuits | lawsuit					2

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Unfunded Commitments by Invested Asset Class (Details) $ in Millions	Dec. 31, 2024 USD ($)
Limited partnerships
Other Commitments [Line Items]
Unfunded investment commitment	$ 1,138
Whole loans
Other Commitments [Line Items]
Unfunded investment commitment	278
Fixed maturity securities, ABS
Other Commitments [Line Items]
Unfunded investment commitment	338
Direct Lending
Other Commitments [Line Items]
Unfunded investment commitment	1,618
Other fixed maturity securities, AFS
Other Commitments [Line Items]
Unfunded investment commitment	70
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	162
Commercial mortgage loans
Other Commitments [Line Items]
Unfunded investment commitment	116
Residential mortgage loans
Other Commitments [Line Items]
Unfunded investment commitment	35
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	134
Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	$ 3,889

Dividends (Details)

Dividends (Details) - $ / shares		12 Months Ended
	Feb. 20, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Cash dividend per common share (in dollars per share)		$ 1.94	$ 1.83	$ 1.77
Subsequent Event
Subsequent Event [Line Items]
Cash dividend per common share (in dollars per share)	$ 0.50

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Direct title insurance premiums	$ 2,200	$ 1,982	$ 2,858
Agency title insurance premiums	2,953	2,610	3,976
Escrow, title-related and other fees	5,321	4,717	4,333
Interest and investment income	3,124	2,607	1,891
Recognized gains and losses, net	83	(164)	(1,493)
Total revenues	13,681	11,752	11,565
Personnel costs	3,148	2,908	3,192
Agent commissions	2,287	2,008	3,064
Other operating expenses	1,558	1,521	1,721
Benefits and other changes in policy reserves	3,791	3,553	1,126
Total significant segment expenses	10,784	9,990	9,103
Depreciation and amortization	739	593	491
Provision for title claim losses	232	207	308
Market risk benefit (gains) losses	(25)	95	(182)
Interest expense	209	174	115
Total other segment items	1,155	1,069	732
Total expenses	11,939	11,059	9,835
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,742	693	1,730
Income tax expense (benefit)	367	192	439
Earnings before equity in earnings of unconsolidated affiliates	1,375	501	1,291
Equity in earnings of unconsolidated affiliates	16	17	15
Net earnings from continuing operations	1,391	518	1,306
Assets	95,372	80,614	65,143
Goodwill	5,271	4,830	4,635
Operating Segments | Title
Segment Reporting Information [Line Items]
Direct title insurance premiums	2,200	1,982	2,858
Agency title insurance premiums	2,953	2,610	3,976
Escrow, title-related and other fees	2,196	2,117	2,502
Interest and investment income	359	338	213
Recognized gains and losses, net	(6)	(9)	(443)
Total revenues	7,702	7,038	9,106
Personnel costs	2,695	2,544	2,987
Agent commissions	2,287	2,008	3,064
Other operating expenses	1,251	1,242	1,515
Benefits and other changes in policy reserves	0	0	0
Total significant segment expenses	6,233	5,794	7,566
Depreciation and amortization	141	154	142
Provision for title claim losses	232	207	308
Market risk benefit (gains) losses	0	0	0
Interest expense	0	0	0
Total other segment items	373	361	450
Total expenses	6,606	6,155	8,016
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	1,096	883	1,090
Income tax expense (benefit)	265	181	298
Earnings before equity in earnings of unconsolidated affiliates	831	702	792
Equity in earnings of unconsolidated affiliates	16	17	15
Net earnings from continuing operations	847	719	807
Assets	7,627	7,949	8,295
Goodwill	2,799	2,789	2,620
Operating Segments | F&G
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0	0
Agency title insurance premiums	0	0	0
Escrow, title-related and other fees	2,941	2,413	1,704
Interest and investment income	2,719	2,211	1,655
Recognized gains and losses, net	84	(124)	(1,010)
Total revenues	5,744	4,500	2,349
Personnel costs	296	232	157
Agent commissions	0	0	0
Other operating expenses	203	146	102
Benefits and other changes in policy reserves	3,791	3,553	1,126
Total significant segment expenses	4,290	3,931	1,385
Depreciation and amortization	569	412	324
Provision for title claim losses	0	0	0
Market risk benefit (gains) losses	(25)	95	(182)
Interest expense	132	97	29
Total other segment items	676	604	171
Total expenses	4,966	4,535	1,556
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	778	(35)	793
Income tax expense (benefit)	136	23	158
Earnings before equity in earnings of unconsolidated affiliates	642	(58)	635
Equity in earnings of unconsolidated affiliates	0	0	0
Net earnings from continuing operations	642	(58)	635
Assets	85,047	70,186	54,637
Goodwill	2,179	1,749	1,749
Operating Segments | Corporate and Other
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0	0
Agency title insurance premiums	0	0	0
Escrow, title-related and other fees	184	187	127
Interest and investment income	154	123	23
Recognized gains and losses, net	5	(31)	(40)
Total revenues	343	279	110
Personnel costs	157	132	48
Agent commissions	0	0	0
Other operating expenses	104	133	104
Benefits and other changes in policy reserves	0	0	0
Total significant segment expenses	261	265	152
Depreciation and amortization	29	27	25
Provision for title claim losses	0	0	0
Market risk benefit (gains) losses	0	0	0
Interest expense	77	77	86
Total other segment items	106	104	111
Total expenses	367	369	263
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(24)	(90)	(153)
Income tax expense (benefit)	(34)	(12)	(17)
Earnings before equity in earnings of unconsolidated affiliates	10	(78)	(136)
Equity in earnings of unconsolidated affiliates	0	0	0
Net earnings from continuing operations	10	(78)	(136)
Assets	2,698	2,479	2,211
Goodwill	293	292	$ 266
Consolidation, Eliminations
Segment Reporting Information [Line Items]
Direct title insurance premiums	0	0
Agency title insurance premiums	0	0
Escrow, title-related and other fees	0	0
Interest and investment income	(108)	(65)
Recognized gains and losses, net	0	0
Total revenues	(108)	(65)
Personnel costs	0	0
Agent commissions	0	0
Other operating expenses	0	0
Benefits and other changes in policy reserves	0	0
Total significant segment expenses	0	0
Depreciation and amortization	0	0
Provision for title claim losses	0	0
Market risk benefit (gains) losses	0	0
Interest expense	0	0
Total other segment items	0	0
Total expenses	0	0
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(108)	(65)
Income tax expense (benefit)	0	0
Earnings before equity in earnings of unconsolidated affiliates	(108)	(65)
Equity in earnings of unconsolidated affiliates	0	0
Net earnings from continuing operations	(108)	(65)
Assets	0	0
Goodwill	$ 0	$ 0

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash paid for:
Interest	$ 200	$ 157	$ 125
Income taxes	237	216	387
Deferred sales inducements	319	168	87
Non-cash investing and financing activities:
Distribution of 15% of the common stock of F&G	0	0	421
Investments received from pension risk transfer premiums	129	464	0
Change in proceeds of sales of investments available for sale receivable in period	(59)	32	96
Change in purchases of investments available for sale payable in period	82	20	(25)
Lease liabilities recognized in exchange for lease right-of-use assets	55	40	70
Remeasurement of lease liabilities	67	75	60
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	789	304	266
Less: Total Purchase price	586	299	180
Liabilities and noncontrolling interests assumed	$ 203	$ 5	$ 86

Supplemental Cash Flow Inform_4

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information - Narrative (Details)		12 Months Ended
	Dec. 01, 2022	Dec. 31, 2023	Dec. 31, 2022
Dividends Payable [Line Items]
Dividend to shareholders, pro rata percentage of common stock		15%	15%
F&G | Fidelity National Financial Inc.
Dividends Payable [Line Items]
Dividend to shareholders, pro rata percentage of common stock	15%

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	$ 1,924	$ 1,863	$ 2,232
Interest and investment income	3,124	2,607	1,891
Recognized gains and losses, net	83	(164)	(1,493)
Total revenues	13,681	11,752	11,565
Title
Disaggregation of Revenue [Line Items]
Loan subservicing revenue	266	262	263
Title | Direct title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,200	1,982	2,858
Title | Agency title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,953	2,610	3,976
Title | Home warranty
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	146	143	165
Title | Insurance contracts
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	8,240	7,148	8,703
Title | Escrow fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	824	766	980
Title | Other title-related fees and income
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	642	633	752
Title | ServiceLink, excluding title premiums, escrow fees, and subservicing fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	318	313	342
F&G | Life insurance premiums, insurance and investment product fees, and other
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,941	2,413	1,704
F&G | Life insurance premiums, insurance and investment product fees, other, pension risk transfer
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	2,217	1,964	1,362
Corporate and other | Real estate technology
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	140	151	158
Corporate and other | Other
Disaggregation of Revenue [Line Items]
Other Income	$ 44	$ 36	$ (31)

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details)	12 Months Ended
	Dec. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]
Home warranty contract, period	1 year

Revenue Recognition - Premium a

Revenue Recognition - Premium and Annuity Deposits (Details) - F&G - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	$ 10,147	$ 7,787	$ 8,342
Fixed indexed annuities
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	5,828	4,738	4,483
Fixed rate annuities
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	1,277	1,147	1,522
Funding agreements (FABN/FHLB)
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	2,404	1,256	1,891
Life insurance and other
Disaggregation of Revenue [Line Items]
Premium and annuity deposits, net of reinsurance	$ 638	$ 646	$ 446

Revenue Recognition - Contract

Revenue Recognition - Contract Balances, Information about Receivables and Deferred Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Disaggregation of Revenue [Line Items]
Trade receivables	$ 362	$ 317
Policy period	1 year
Revenue recognized	$ 80	84
Deferred revenue
Disaggregation of Revenue [Line Items]
Deferred revenue (contract liabilities)	$ 92	$ 91

Other Intangible Assets - Recon

Other Intangible Assets - Reconciliation of Other Intangibles to Balance Sheet (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
VOBA	$ 1,349	$ 1,446	$ 1,615
DAC	3,036	2,215
DSI	625	346	$ 200
Definite lived	966	620
Total	5,976	4,627
Customer relationships and contracts
Finite-Lived Intangible Assets [Line Items]
Definite lived	435	174
Value of distribution asset
Finite-Lived Intangible Assets [Line Items]
Definite lived	74	86
Computer software
Finite-Lived Intangible Assets [Line Items]
Definite lived	277	266
Trademarks, tradenames, and other
Finite-Lived Intangible Assets [Line Items]
Definite lived	$ 180	$ 94

Other Intangible Assets - VOBA

Other Intangible Assets - VOBA (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
VOBA
VOBA at beginning of period	$ 1,446	$ 1,615
Amortization	(160)	(169)	$ (180)
Actuarial model updates and refinements	63
VOBA at end of period	1,349	1,446	1,615
Amortization	(15)
Indexed Annuities
VOBA
VOBA at beginning of period	1,025	1,166
Amortization	(133)	(141)
Actuarial model updates and refinements	0
VOBA at end of period	892	1,025	1,166
Fixed rate annuities
VOBA
VOBA at beginning of period	27	32
Amortization	(5)	(5)
Actuarial model updates and refinements	0
VOBA at end of period	22	27	32
Immediate Annuities
VOBA
VOBA at beginning of period	191	201
Amortization	(7)	(10)
Actuarial model updates and refinements	0
VOBA at end of period	184	191	201
Universal Life
VOBA
VOBA at beginning of period	134	143
Amortization	(8)	(9)
Actuarial model updates and refinements	0
VOBA at end of period	126	134	143
Traditional life
VOBA
VOBA at beginning of period	69	73
Amortization	(7)	(4)
Actuarial model updates and refinements	63
VOBA at end of period	$ 125	$ 69	$ 73

Other Intangible Assets - Narra

Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
VOBA amortization	$ 160	$ 169	$ 180
VOBA amortization including adjustment	175
DAC amortization	(280)	(186)	(99)
DIS Amortization	(40)	(22)	(14)
Amortization of intangible assets	187	152	134
Expected amortization, 2025	172
Expected amortization, 2026	140
Expected amortization, 2027	112
Expected amortization, 2028	85
Expected amortization, 2029	72
Finite-Lived Intangible Assets [Line Items]
Definite lived	966	620
Depreciation and amortization	739	593	491
Trademarks, Tradenames and Other/Market Risk Benefit Offset
Finite-Lived Intangible Assets [Line Items]
Definite lived	94	22
Depreciation and amortization	$ 5	$ 1	$ 1

Other Intangible Assets - DAC (

Other Intangible Assets - DAC (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
DAC
DAC at beginning of period	$ 2,211	$ 1,402
Capitalization	1,100	916
Amortization	(280)	(186)	$ (99)
Reinsurance related adjustments		79
DAC at end of period	3,031	2,211	1,402
Indexed Annuities
DAC
DAC at beginning of period	1,378	971
Capitalization	652	510
Amortization	(156)	(103)
Reinsurance related adjustments		0
DAC at end of period	1,874	1,378	971
Fixed rate annuities
DAC
DAC at beginning of period	288	83
Capitalization	174	177
Amortization	(86)	(51)
Reinsurance related adjustments		79
DAC at end of period	376	288	83
Universal Life
DAC
DAC at beginning of period	545	348
Capitalization	274	229
Amortization	(38)	(32)
Reinsurance related adjustments		0
DAC at end of period	$ 781	$ 545	$ 348

Other Intangible Assets - Rec_2

Other Intangible Assets - Reconciliation of DAC to the Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
DAC	$ 3,036	$ 2,215
Indexed Annuities
Finite-Lived Intangible Assets [Line Items]
DAC	1,874	1,378
Fixed rate annuities
Finite-Lived Intangible Assets [Line Items]
DAC	376	288
Universal Life
Finite-Lived Intangible Assets [Line Items]
DAC	781	545
Funding Agreements
Finite-Lived Intangible Assets [Line Items]
DAC	4	4
PRT
Finite-Lived Intangible Assets [Line Items]
DAC	$ 1	$ 0

Other Intangible Assets - DSI (

Other Intangible Assets - DSI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Movement in Deferred Sales Inducements [Roll Forward]
DSI at beginning of period	$ 346	$ 200
Capitalization	319	168
Amortization	(40)	(22)	$ (14)
DSI at end of period	$ 625	$ 346	$ 200

Other Intangible Assets - Estim

Other Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 145
2026	132
2027	121
2028	110
2029	100
Thereafter	741
Total	$ 1,349	$ 1,446	$ 1,615

Other Intangible Assets - Defin

Other Intangible Assets - Definite and Indefinite Lived Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Net carrying amount	$ 966	$ 620
Customer relationships and contracts
Finite-Lived Intangible Assets [Line Items]
Cost	795	948
Accumulated amortization	(360)	(774)
Net carrying amount	$ 435	$ 174
Customer relationships and contracts | Minimum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	10 years	10 years
Customer relationships and contracts | Maximum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	20 years	20 years
Computer software
Finite-Lived Intangible Assets [Line Items]
Cost	$ 723	$ 651
Accumulated amortization	(446)	(385)
Net carrying amount	$ 277	$ 266
Computer software | Minimum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	2 years	2 years
Computer software | Maximum
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (years)	10 years	10 years
Value of distribution asset
Finite-Lived Intangible Assets [Line Items]
Cost	$ 140	$ 140
Accumulated amortization	(66)	(54)
Net carrying amount	$ 74	$ 86
Weighted average useful life (years)	15 years	15 years
Trademarks, tradenames, and other
Finite-Lived Intangible Assets [Line Items]
Cost	$ 234	$ 146
Accumulated amortization	(54)	(52)
Net carrying amount	$ 180	$ 94

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 4,830	$ 4,635
Goodwill associated with acquisitions	441	195
Goodwill, ending balance	5,271	4,830
Title | Operating Segments
Goodwill [Roll Forward]
Goodwill, beginning balance	2,788	2,620
Goodwill associated with acquisitions	11	168
Goodwill, ending balance	2,799	2,788
F&G | Operating Segments
Goodwill [Roll Forward]
Goodwill, beginning balance	1,749	1,749
Goodwill associated with acquisitions	430	0
Goodwill, ending balance	2,179	1,749
Corporate and Other
Goodwill [Roll Forward]
Goodwill, beginning balance	293	266
Goodwill associated with acquisitions	0	27
Goodwill, ending balance	$ 293	$ 293

F&G Reinsurance - Narrative (De

F&G Reinsurance - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) policy	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Effects of Reinsurance [Line Items]
Number of policies reinsured by foreign company not engaged in insurance | policy	0
Deposit assets	$ 11,039	$ 7,481
Reinsurance risk charge fee	42	$ 39	$ 36
Raven Re (VT) | Intercompany Reinsurance Agreements | Affiliate
Effects of Reinsurance [Line Items]
Remaining borrowing capacity	175
F&G Cayman Re Ltd | Intercompany Reinsurance Agreements | Affiliate
Effects of Reinsurance [Line Items]
Remaining borrowing capacity	400
Corbeau Re (VT) | Affiliate
Effects of Reinsurance [Line Items]
Excess of loss agreement, maximum loss coverage	$ 1,500

F&G Reinsurance - Effect of Rei

F&G Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Premiums Earned, Net [Abstract]
Direct	$ 3,001	$ 2,567	$ 1,882
Ceded	(141)	(154)	(178)
Net	2,860	2,413	1,704
Policyholder Benefits and Claims Incurred [Abstract]
Net	232	207	308
Traditional Life Insurance Premiums
Premiums Earned, Net [Abstract]
Direct	2,346	2,112	1,522
Ceded	(94)	(105)	(128)
Net	2,252	2,007	1,394
Policyholder Benefits and Claims Incurred [Abstract]
Direct	3,987	3,728	3,640
Ceded	(196)	(175)	(2,514)
Net	$ 3,791	$ 3,553	$ 1,126

F&G Reinsurance - Summary of Re

F&G Reinsurance - Summary of Reinsurance Recoverable (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Effects of Reinsurance [Line Items]
Allowance for expected credit loss	$ (20)	$ (21)	$ (10)
Reinsurance recoverable, net of allowance for credit losses	$ 13,380	8,977
Reinsurance, retrocession, quota share basis, percentage	90%
F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	$ 13,389	8,981
Allowance for expected credit loss	(20)	(21)
Reinsurance recoverable, net of allowance for credit losses	$ 13,369	8,960
Minimum
Effects of Reinsurance [Line Items]
Reinsurance, retrocession, quota share basis, percentage	30%
Maximum
Effects of Reinsurance [Line Items]
Reinsurance, retrocession, quota share basis, percentage	90%
Aspida Life Re Ltd | Certain MYGA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	$ 7,844	6,128
Somerset | Certain MYGA and DA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	2,822	716
Everlake | Certain MYGA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	1,168	509
Wilton Reassurance Company | Block of traditional, IUL, and UL | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	1,066	1,092
Other | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	$ 489	$ 536

F&G Reinsurance - Credit Loss (

F&G Reinsurance - Credit Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward]
Balance at Beginning of Period	$ (21)	$ (10)
Changes in the expected credit loss reserve	1	(11)
Balance at Ending of Period	$ (20)	$ (21)

Regulation and Equity - Narrati

Regulation and Equity - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2025
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	$ 33	$ 34
Combined statutory unearned premium reserve required	1,608
Net assets restricted from dividend payments without prior approval	1,141
Statutory capital and surplus	1,223	1,225
Statutory net income	587	503	$ 778
Minimum net worth required for compliance	1
Corbeau Re (VT)
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	1,230	765
Non-permitted statutory accounting practices deficit	(1,052)	(594)
F&G Cayman Re Ltd
Statutory Accounting Practices [Line Items]
Permitted practice, statutory surplus	(64)	102
Iowa
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	454	194
Iowa | F&G
Statutory Accounting Practices [Line Items]
Statutory Capital and Surplus:	1,654	2,009
New York | F&G
Statutory Accounting Practices [Line Items]
Statutory Capital and Surplus:	97	86
Vermont | Corbeau Re (VT) | F&G
Statutory Accounting Practices [Line Items]
Statutory Capital and Surplus:	178	171
Vermont | Raven Re (VT) | F&G
Statutory Accounting Practices [Line Items]
Statutory Capital and Surplus:	168	140
Vermont | Raven Re (VT)
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus	175	200
Statutory capital and surplus	168	140
Non-permitted statutory accounting practices deficit	$ (13)	$ (89)
Forecast
Statutory Accounting Practices [Line Items]
Statutory amount available for distributions without prior approval				$ 498
Forecast | Iowa
Statutory Accounting Practices [Line Items]
Statutory account practices, amount available for dividend (maximum)				0
Forecast | New York
Statutory Accounting Practices [Line Items]
Statutory account practices, amount available for dividend (maximum)				$ 10

Regulation and Equity - Statuto

Regulation and Equity - Statutory Income and Net Capital (Details) - F&G - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Iowa
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	$ 150	$ (462)	$ (243)
Statutory Capital and Surplus:	1,654	2,009
New York
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	8	5	(15)
Statutory Capital and Surplus:	97	86
Vermont | Raven Re (VT)
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	54	60	(111)
Statutory Capital and Surplus:	168	140
Vermont | Corbeau Re (VT)
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	(458)	(644)	0
Statutory Capital and Surplus:	178	171
Cayman Islands
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	(11)	133	71
Statutory Capital and Surplus:	734	543
Bermuda
Statutory Accounting Practices [Line Items]
Statutory Net income (loss):	139	151	$ (339)
Statutory Capital and Surplus:	$ 123	$ 11

Regulation and Equity - Equity

Regulation and Equity - Equity (Details) - USD ($) $ / shares in Units, $ in Millions		2 Months Ended	12 Months Ended
	Jul. 31, 2024	Feb. 21, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Aug. 03, 2021
Class of Stock [Line Items]
Treasury stock repurchased				$ 4	$ 549
2021 Repurchase Program
Class of Stock [Line Items]
Stock repurchase program number of shares authorized (in shares)						25,000,000
2024 Repurchase Program
Class of Stock [Line Items]
Stock repurchase program number of shares authorized (in shares)	25,000,000
Stock repurchase program, period	3 years
FNF Common Stock | 2021 Repurchase Program
Class of Stock [Line Items]
Treasury stock repurchased (in shares)			0	100,000
Treasury stock repurchased			$ 4
Treasury stock acquired (in usd per share)			$ 38.45
FNF Common Stock | 2024 Repurchase Program
Class of Stock [Line Items]
Treasury stock repurchased (in shares)			0
FNF Common Stock | 2024 Repurchase Program | Subsequent Event
Class of Stock [Line Items]
Treasury stock repurchased (in shares)		0

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) optionsToRenew	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Operating leases weighted average remaining lease term	4 years 3 months 18 days
Options to renew | optionsToRenew	1
Weighted average discount rate, percent	4.70%
Operating lease costs | $	$ 134	$ 137	$ 142
Line of Credit | Revolving Credit Facility | Revolving Credit Facility, due April 2022
Debt Instrument [Line Items]
Basis spread on variable rate (as percent)	1.40%
Minimum
Debt Instrument [Line Items]
Operating lease, term	1 year
Maximum
Debt Instrument [Line Items]
Operating lease, term	10 years

Leases - Future Payments Under

Leases - Future Payments Under Operating Lease Arrangements (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Leases [Abstract]
2025	$ 133
2026	108
2027	77
2028	52
2029	32
Thereafter	24
Total operating lease payments, undiscounted	426
Less: present value discount	41
Lease liability, at present value	$ 385	$ 394

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 557	$ 544
Accumulated depreciation and amortization	(384)	(376)
Property and equipment, net	173	168
Depreciation	53	55	$ 59
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	161	163
Data processing equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	155	145
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	126	121
Buildings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	93	95
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	14	14
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 8	$ 6

Accounts Payable and Other Ac_3

Accounts Payable and Other Accrued Liabilities - Schedule of Accounts Payable and Other Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Accounts Payable [Line Items]
Salaries and incentives	$ 433	$ 373
Accrued benefits	454	437
Contingent consideration - acquisitions	110	49
Trade accounts payable	191	339
Accrued recording fees and transfer taxes	7	15
Accrued premium taxes	30	3
Liability for policy and contract claims	102	92
Retained asset account	60	81
Remittances and items not allocated	224	284
Option collateral liabilities	680	588
Other accrued liabilities	465	387
Accounts payable and accrued liabilities	3,249	3,009
URL
Accounts Payable [Line Items]
URL/Deferred revenue	401	270
Deferred revenue
Accounts Payable [Line Items]
URL/Deferred revenue	$ 92	$ 91

Accounts Payable and Other Ac_4

Accounts Payable and Other Accrued Liabilities - Rollforward of Unearned Revenue Liabilities (URL) (Details) - Universal Life - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Contract With Customer Liability [Roll Forward]
Balance, beginning	$ 270	$ 166
Capitalization	151	119
Amortization	(20)	(15)
Balance, ending	$ 401	$ 270

Income Taxes - Tax Expense (Ben

Income Taxes - Tax Expense (Benefit) on Continuing Operations (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Current	$ 360	$ 241	$ 331
Deferred	7	(49)	108
Income tax expense on continuing operations	$ 367	$ 192	$ 439

Income Taxes - Tax Expense Allo

Income Taxes - Tax Expense Allocation (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023		Dec. 31, 2022
Income Tax Disclosure [Abstract]
Net earnings from continuing operations		$ 367	$ 192		$ 439
Other comprehensive earnings (loss):
Unrealized (loss) gain on investments and other financial instruments		(35)	275		(1,198)
Unrealized (loss) gain on foreign currency translation and cash flow hedging		(6)	2	[1]	(4)
Changes in current discount rate - future policy benefits	[2]	59	(50)		203
Changes in instrument - specific credit risk - market risk benefits	[3]	1	(9)		18
F&G 15% Distribution		(3)	(35)		9
Minimum pension liability adjustment		0	0		2
Total income tax expense (benefit) allocated to other comprehensive earnings		16	183		(970)
Total income tax expense (benefit)		$ 383	$ 375		$ (531)
Dividend to shareholders, pro rata percentage of common stock			15%		15%
[1] Net of income tax (benefit) expense of $(6) million and $2 million, and $(4) million for the years ended December 31, 2024 and 2023, and 2022, respectively. Net of income tax expense (benefit) of $1 million, $(9) million and $18 million for the years ended December 31, 2024, 2023 and 2022, respectively.

Income Taxes - Effective Tax Ra

Income Taxes - Effective Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Federal statutory rate	21%	21%	21%
State income taxes, net of federal benefit	1.80%	2.40%	2%
Stock compensation	(0.50%)	(0.20%)	(0.10%)
Tax credits	(0.70%)	(1.80%)	(0.70%)
Valuation allowance for deferred tax assets	(1.00%)	5%	5.40%
Benefit on Capital Loss Carryback	0%	0%	(1.30%)
Officers Compensation	0.80%	1.20%	0.40%
Non-deductible expenses and other, net	(0.30%)	0.10%	(1.30%)
Effective tax rate	21.10%	27.70%	25.40%

Income Taxes - Components Defer

Income Taxes - Components Deferred Tax Asset and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Deferred Tax Assets:
Employee benefit accruals	$ 129	$ 116
Net operating loss carryforwards	115	84
Tax credits	204	119
Investment securities	775	686
Capital loss carryover	19	38
Life insurance and claim related adjustments	451	547
Funds held under reinsurance agreements	822	500
Market Risk Benefits	56	61
Bermuda corporate income tax net operating loss carryforward	10	24
Other	42	26
Total gross deferred tax asset	2,623	2,201
Less: valuation allowance	164	197
Total deferred tax asset	2,459	2,004
Deferred Tax Liabilities:
Title plant	(53)	(53)
Amortization of goodwill and intangible assets	(71)	(98)
Other	(11)	(25)
Depreciation	(24)	(29)
Partnerships	(198)	(152)
Value of business acquired	(283)	(304)
Deferred acquisition costs	(543)	(361)
Funds held under reinsurance agreements	(945)	(621)
Title Insurance reserve discounting	(16)	(18)
Total deferred tax liability	(2,144)	(1,661)
Net deferred tax asset	$ 315	$ 343

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Valuation Allowance [Line Items]
Deferred tax assets, net	$ 315,000,000	$ 343,000,000
Decrease in deferred tax liability due to investments unrealized losses	89,000,000
Decrease in deferred tax asset, reinsurance receivable	322,000,000
Decrease in deferred tax asset related to life insurance receivables	96,000,000
Operating loss carryforwards	25,000,000
Tax credits	204,000,000	119,000,000
Valuation allowance	164,000,000	197,000,000
Bermuda corporate income tax net operating loss carryforward	10,000,000	24,000,000
Unrecognized tax benefits	0	0
Income taxes receivable	20,000,000	26,000,000
F& G Subsidiaries
Valuation Allowance [Line Items]
Deferred tax assets, net	295,000,000	372,000,000
Income taxes receivable	6,000,000	$ 28,000,000
General Business Credit Carryforward
Valuation Allowance [Line Items]
Valuation allowance	30,000,000
Bermuda Corporate Income Tax Net Operating Loss Carryforward
Valuation Allowance [Line Items]
Valuation allowance, decrease	14,000,000
Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	119,000,000
Valuation allowance, decrease	20,000,000
Begin to expire in 2023
Valuation Allowance [Line Items]
Operating loss carryforwards	547,000,000
Title
Valuation Allowance [Line Items]
Decrease in deferred tax liability due to investments unrealized losses	26,000,000
Operating loss carryforwards	44,000,000
Operating loss carryforwards, valuation allowance	25,000,000
Title | Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	71,000,000
Title | General Business Credit Carryforward
Valuation Allowance [Line Items]
Tax credits	30,000,000
F&G
Valuation Allowance [Line Items]
Decrease in deferred tax liability due to investments unrealized losses	63,000,000
Increase in deferred tax liability, deferred acquisition costs	182,000,000
Increase deferred tax liability, reinsurance receivable	324,000,000
Deferred tax assets, tax credit carryforwards increase	85,000,000
Operating loss carryforwards	503,000,000
F&G | Deferred Tax Asset, Capital Loss
Valuation Allowance [Line Items]
Valuation allowance	48,000,000
F&G | General Business Credit Carryforward
Valuation Allowance [Line Items]
Tax credits	$ 164,000,000

Employee Benefit Plans - Stock

Employee Benefit Plans - Stock Purchase Plan (Details) - Employee Stock - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense	$ 34	$ 30	$ 36
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, annual contributions per employee, percent	3%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
ESPP, annual contributions per employee, percent	15%

Employee Benefit Plans - 401(k)

Employee Benefit Plans - 401(k) Profit Sharing Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Retirement Benefits [Abstract]
Maximum annual contributions per employee, percent	40%	40%	40%
Employer matching contribution, percent of match, amount per dollar	0.50	0.50	0.50
Employer matching contribution, percent of employees' gross pay	6%	6%	6%
Defined contribution plan, cost recognized	$ 46	$ 45	$ 50

Employee Benefit Plans - Omnibu

Employee Benefit Plans - Omnibus Incentive Plan (Details) - shares	Jun. 15, 2016	May 22, 2013	May 25, 2011	May 29, 2008	Oct. 23, 2006	Dec. 31, 2024	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2006
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)						2,357,220
The Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)									8,000,000
Number of additional shares authorized (in shares)	10,000,000	6,000,000	6,000,000	11,000,000	16,000,000
Options outstanding (in shares)						0	0	996,113

Employee Benefit Plans - F&G Om

Employee Benefit Plans - F&G Omnibus Incentive Plan (Details) - shares	Jun. 01, 2020	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		2,357,220
F&G Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	2,096,429
Options outstanding (in shares)		100,000	643,623	1,172,607	1,527,936
F&G Omnibus Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)	2,411,585
Award vesting period	3 years
Expiration period	7 years
F&G Omnibus Plan | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock outstanding (in shares)		0

Employee Benefit Plans - Stoc_2

Employee Benefit Plans - Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
The Omnibus Plan
Options (in shares):
Stock options outstanding at beginning of period (in shares)		0	996,113
Exercised (in shares)			(996,113)
Stock options outstanding at end (in shares)	0		0
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)		$ 0	$ 25.53
Exercised (USD per share)			25.53
Stock options outstanding at end of period (USD per share)			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options exercisable (in shares)			0	996,113
F&G Omnibus Plan
Options (in shares):
Stock options outstanding at beginning of period (in shares)	643,623	1,172,607	1,527,936
Exercised (in shares)	(543,623)	(502,414)	(352,614)
Canceled (in shares)		(26,570)	(2,715)
Stock options outstanding at end (in shares)	100,000	643,623	1,172,607
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)	$ 38.80	$ 35.15	$ 35.97
Exercised (USD per share)	38.74	30.31	38.79
Cancelled (USD per share)		38.07	28
Stock options outstanding at end of period (USD per share)	$ 39.10	$ 38.80	$ 35.15
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options exercisable (in shares)	100,000	643,623	1,172,607	1,072,584

Employee Benefit Plans - Restri

Employee Benefit Plans - Restricted Stock Activity (Details) - Restricted Stock - FNF Common Stock - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
The Omnibus Plan
Shares:
Restricted shares outstanding at beginning of period (in shares)	1,875,395	1,841,544	1,639,226
Granted (in shares)	1,604,119	966,093	994,548
Canceled (in shares)	(16,603)	(23,975)
Vested (in shares)	(1,105,691)	(908,267)	(792,230)
Restricted shares outstanding at end of period (in shares)	2,357,220	1,875,395	1,841,544
Weighted Average Grant Date Fair Value (in dollars per share):
Weighted average grant date fair value outstanding at beginning of period (USD per share)	$ 43.69	$ 41.59	$ 41.97
Granted (USD per share)	60.23	44.44	40.83
Canceled (USD per share)	45.92	41.42
Vested (USD per share)	47.21	40.26	41.44
Weighted average grant date fair value outstanding at end of period (USD per share)	$ 53.28	$ 43.69	$ 41.59
F&G Omnibus Plan
Shares:
Restricted shares outstanding at beginning of period (in shares)	181,479	501,548	718,641
Granted (in shares)	0	0	0
Canceled (in shares)	(13,082)	(15,965)	(78,551)
Vested (in shares)	(168,397)	(304,104)	(138,542)
Restricted shares outstanding at end of period (in shares)	0	181,479	501,548
Weighted Average Grant Date Fair Value (in dollars per share):
Weighted average grant date fair value outstanding at beginning of period (USD per share)	$ 41.08	$ 42.31	$ 40.24
Granted (USD per share)	0	0	0
Canceled (USD per share)	48.28	45.63	37.79
Vested (USD per share)	40.53	42.87	34.11
Weighted average grant date fair value outstanding at end of period (USD per share)	$ 0	$ 41.08	$ 42.31

Employee Benefit Plans - Option

Employee Benefit Plans - Options Outstanding and Exercisable by Exercise Price (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
$0.00 - $39.10
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise price range, lower range limit (in dollars per share) | $ / shares	$ 0
Exercise price range, upper range limit (in dollars per share) | $ / shares	$ 39.10
The Omnibus Plan
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of outstanding options (in shares) | shares	100,000
Outstanding options, intrinsic value | $	$ 2
Number of exercisable options (in shares) | shares	100,000
Exercisable options, intrinsic value | $	$ 2
The Omnibus Plan | $0.00 - $39.10
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Number of outstanding options (in shares) | shares	100,000
Outstanding options, weighted average remaining contractual term (in years)	11 months 19 days
Outstanding options, weighted average exercise price (in dollars per share) | $ / shares	$ 39.10
Outstanding options, intrinsic value | $	$ 2
Number of exercisable options (in shares) | shares	100,000
Exercisable options, weighted average remaining contractual term (in years)	11 months 19 days
Exercisable options, weighted average exercise price (in dollars per share) | $ / shares	$ 39.10
Exercisable options, intrinsic value | $	$ 2

Employee Benefit Plans - Narrat

Employee Benefit Plans - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Intrinsic value of options exercised	$ 9	$ 8	$ 16
Stock-based compensation cost	$ 82	60	49
Weighted average	1 year 9 months 29 days
Restricted Stock | Board of Directors Chairman
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock awards granted	$ 50
Award vesting period	3 years
Restricted Stock | Board of Directors Chairman | Vesting Period Immediate
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock | Board of Directors Chairman | Vesting Period One of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock | Board of Directors Chairman | Vesting Period Two of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25%
Fair value of restricted stock awards vested	$ 12.5
Restricted Stock | Board of Directors Chairman | Vesting Period Three of Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	25%
Fair value of restricted stock awards vested	$ 12.5
The Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	98
The Omnibus Plan | Restricted Stock | FNF Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of restricted stock awards granted	97	43	41
Fair value of restricted stock awards vested	$ 76	$ 51	$ 38

Employee Benefit Plans - Pensio

Employee Benefit Plans - Pension Plans (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2001	Dec. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Consecutive months with highest compensation in which benefits are based	60 months
Months ending at retirement or termination in which benefits are based	120 months
Discount rate		4.67%
Benefit obligation		$ 64
Fair value of plan assets		$ 54

Financial Instruments with Of_3

Financial Instruments with Off-Balance Sheet Risk and Concentration of Risk (Details) - Geographic Concentration Risk - Title Insurance Premiums	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Texas
Concentration Risk [Line Items]
Concentration risk percentage	13.80%	14.30%	15%
California
Concentration Risk [Line Items]
Concentration risk percentage	12.90%	13%	12%
Florida
Concentration Risk [Line Items]
Concentration risk percentage	10.20%	10.70%	10.60%
Illinois
Concentration Risk [Line Items]
Concentration risk percentage	5.80%	6%	5.30%
Pennsylvania
Concentration Risk [Line Items]
Concentration risk percentage	5.20%	4.90%	5.20%

Market Risk Benefits - Schedule

Market Risk Benefits - Schedule of Balances and Changes in Market Risk Benefit (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Indexed Annuities
Market Risk Benefit [Line Items]
Balance beginning of period	$ 314	$ 164
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	209	102
Issuances and benefit payments	109	(10)
Attributed fees collected and interest accrual	147	131
Actual policyholder behavior different from expected	(5)	27
Changes in assumptions and other	24	29
Effects of market related movements	(162)	(70)
Balance, end of period, before effect of changes in the instrument-specific credit risk	322	209
Issuances and benefit payments	109	(10)
Attributed fees collected and interest accrual	147	131
Actual policyholder behavior different from expected	(5)	27
Changes in assumptions and other	24	29
Effects of market related movements	(162)	(70)
Effect of changes in the instrument-specific credit risk	98	105
Balance, end of period	420	314
Less: reinsured market risk benefits	61	0
Balance, end of period, net of reinsurance	$ 359	$ 314
Weighted-average attained age of policyholders weighted by total AV (years)	67 years 11 months 23 days	68 years 3 months 10 days
Net amount at risk	$ 1,327	$ 1,059
Fixed rate annuities
Market Risk Benefit [Line Items]
Balance beginning of period	1	1
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Balance, end of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Effect of changes in the instrument-specific credit risk	0	0
Balance, end of period	1	1
Less: reinsured market risk benefits	0	0
Balance, end of period, net of reinsurance	$ 1	$ 1
Weighted-average attained age of policyholders weighted by total AV (years)	72 years 6 months 29 days	72 years 7 months 2 days
Net amount at risk	$ 2	$ 2

Market Risk Benefits - Reconcil

Market Risk Benefits - Reconciliation of Asset and Liability (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Market Risk Benefit [Line Items]
Market risk benefits assets	$ 189	$ 88
Market risk benefits liability	549	403
Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	128	88
Market risk benefits liability	549	403
Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	61	0
Market risk benefits liability	0	0
Indexed Annuities
Market Risk Benefit [Line Items]
Market risk benefits assets	189	88
Market risk benefits liability	548	402
Indexed Annuities | Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	128	88
Market risk benefits liability	548	402
Indexed Annuities | Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	61	0
Market risk benefits liability	0	0
Fixed rate annuities
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	1	1
Fixed rate annuities | Direct
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	1	1
Fixed rate annuities | Reinsured
Market Risk Benefit [Line Items]
Market risk benefits assets	0	0
Market risk benefits liability	$ 0	$ 0

Contractholder Funds - Summary

Contractholder Funds - Summary of Balances and Changes in Contractholder Funds (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	$ 48,798
Balance, end of year	56,404	$ 48,798
Embedded derivative adjustment	12	11	$ (10)
Gross liability, end of period	56,404	48,798
Less: Reinsurance recoverable	13,380	8,977
Net amount at risk	74,279	60,389
Indexed Annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	27,164	24,766
Issuances	6,649	4,722
Premiums received	120	103
Policy charge	(195)	(182)
Surrenders and withdrawals	(3,832)	(2,005)
Benefit payments	(495)	(526)
Interest credited	821	270
Other	3	16
Balance, end of year	30,235	27,164	24,766
Issuances	6,649	4,722
Premiums received	120	103
Policy charge	(195)	(182)
Surrenders and withdrawals	(3,832)	(2,005)
Benefit payments	(495)	(526)
Interest credited	821	270
Other	3	16
Embedded derivative adjustment	219	243
Gross liability, end of period	30,454	27,407
Less: Reinsurance recoverable	861	17
Net liability, after reinsurance recoverable	$ 29,593	$ 27,390
Weighted-average crediting rate	2.90%	1.40%
Cash surrender value	$ 27,865	$ 25,099
Fixed rate annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	13,443	9,358
Issuances	5,125	5,061
Premiums received	1	1
Policy charge	0	0
Surrenders and withdrawals	(1,479)	(1,142)
Benefit payments	(315)	(240)
Interest credited	667	405
Other	0	0
Balance, end of year	17,442	13,443	9,358
Issuances	5,125	5,061
Premiums received	1	1
Policy charge	0	0
Surrenders and withdrawals	(1,479)	(1,142)
Benefit payments	(315)	(240)
Interest credited	667	405
Other	0	0
Embedded derivative adjustment	0	0
Gross liability, end of period	17,442	13,443
Less: Reinsurance recoverable	11,009	7,520
Net liability, after reinsurance recoverable	$ 6,433	$ 5,923
Weighted-average crediting rate	4.42%	4.85%
Cash surrender value	$ 16,266	$ 12,505
Universal Life
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,391	2,112
Issuances	208	199
Premiums received	495	382
Policy charge	(315)	(261)
Surrenders and withdrawals	(101)	(90)
Benefit payments	(18)	(27)
Interest credited	157	76
Other	0	0
Balance, end of year	2,817	2,391	2,112
Issuances	208	199
Premiums received	495	382
Policy charge	(315)	(261)
Surrenders and withdrawals	(101)	(90)
Benefit payments	(18)	(27)
Interest credited	157	76
Other	0	0
Embedded derivative adjustment	79	84
Gross liability, end of period	2,896	2,475
Less: Reinsurance recoverable	877	894
Net liability, after reinsurance recoverable	$ 2,019	$ 1,581
Weighted-average crediting rate	6.20%	3.44%
Cash surrender value	$ 2,177	$ 1,872
FABN
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,613	2,613
Issuances	600	0
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(820)	(53)
Interest credited	71	54
Other	(1)	(1)
Balance, end of year	2,463	2,613	2,613
Issuances	600	0
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(820)	(53)
Interest credited	71	54
Other	(1)	(1)
Embedded derivative adjustment	0	0
Gross liability, end of period	2,463	2,613
Less: Reinsurance recoverable	0	0
Net liability, after reinsurance recoverable	2,463	2,613
FHLB
Policyholder Account Balance [Roll Forward]
Balance, beginning of year	2,539	1,982
Issuances	1,804	1,256
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(1,606)	(763)
Interest credited	117	64
Other	(2)	0
Balance, end of year	2,852	2,539	$ 1,982
Issuances	1,804	1,256
Premiums received	0	0
Policy charge	0	0
Surrenders and withdrawals	0	0
Benefit payments	(1,606)	(763)
Interest credited	117	64
Other	(2)	0
Embedded derivative adjustment	0	0
Gross liability, end of period	2,852	2,539
Less: Reinsurance recoverable	0	0
Net liability, after reinsurance recoverable	$ 2,852	$ 2,539

Contractholder Funds - Reconcil

Contractholder Funds - Reconciliation to Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Policyholder Account Balance [Line Items]
Contractholder funds	$ 56,404	$ 48,798
Indexed Annuities
Policyholder Account Balance [Line Items]
Contractholder funds	30,454	27,407
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	17,442	13,443
Immediate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	286	311
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	2,896	2,475
Traditional life
Policyholder Account Balance [Line Items]
Contractholder funds	5	5
Funding Agreement-FABN
Policyholder Account Balance [Line Items]
Contractholder funds	2,463	2,613
FHLB
Policyholder Account Balance [Line Items]
Contractholder funds	2,852	2,539
PRT
Policyholder Account Balance [Line Items]
Contractholder funds	$ 6	$ 5

Contractholder Funds - Narrativ

Contractholder Funds - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Insurance [Abstract]
Change in total benefits and other changes in policy reserves (decrease) increase	$ 99	$ 89	$ 73

Contractholder Funds - Account

Contractholder Funds - Account Values by Range of Guaranteed Minimum Credit Rating (Details) $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Policyholder Account Balance [Line Items]
Contractholder funds	$ 56,404	$ 48,798
Indexed Annuities
Policyholder Account Balance [Line Items]
Contractholder funds	30,235	27,164	$ 24,766
Indexed Annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	24,718	22,965
Indexed Annuities | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1,239	1,446
Indexed Annuities | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,176	550
Indexed Annuities | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	3,102	2,203
Indexed Annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	27,114	26,315
Indexed Annuities | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	23,540	22,392
Indexed Annuities | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1,236	1,444
Indexed Annuities | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	492	526
Indexed Annuities | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,846	1,953
Indexed Annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,802	471
Indexed Annuities | 1.51%-2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	875	196
Indexed Annuities | 1.51%-2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Indexed Annuities | 1.51%-2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	684	24
Indexed Annuities | 1.51%-2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,242	250
Indexed Annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	319	378
Indexed Annuities | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	303	377
Indexed Annuities | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	2	1
Indexed Annuities | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Indexed Annuities | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	14	0
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	17,442	13,443	9,358
Fixed rate annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	865	921
Fixed rate annuities | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	29	35
Fixed rate annuities | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	798	1,559
Fixed rate annuities | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	15,750	10,928
Fixed rate annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	15,257	11,851
Fixed rate annuities | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	57	23
Fixed rate annuities | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	20	25
Fixed rate annuities | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	773	1,532
Fixed rate annuities | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	14,407	10,271
Fixed rate annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	493	489
Fixed rate annuities | 1.51%-2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	4	5
Fixed rate annuities | 1.51%-2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	7	8
Fixed rate annuities | 1.51%-2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	20	23
Fixed rate annuities | 1.51%-2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	462	453
Fixed rate annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	1,692	1,103
Fixed rate annuities | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	804	893
Fixed rate annuities | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	2	2
Fixed rate annuities | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	5	4
Fixed rate annuities | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	881	204
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	2,817	2,391	$ 2,112
Universal Life | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	2,785	2,348
Universal Life | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	7	21
Universal Life | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	24	21
Universal Life | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,452	2,013
Universal Life | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	2,421	1,987
Universal Life | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	7	5
Universal Life | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	24	21
Universal Life | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 1.51%-2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 1.51%-2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 1.51%-2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 1.51%-2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	365	378
Universal Life | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	364	361
Universal Life | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	0	16
Universal Life | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	$ 0	$ 0
Minimum | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0001	0.0001
Minimum | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0051	0.0051
Minimum | Greater Than 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150
Maximum | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0050	0.0050
Maximum | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150

Future Policy Benefits - Summar

Future Policy Benefits - Summary Balances and Changes in the Present Value of Expected Net Premiums and Present Value (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 8,749	$ 7,050
Traditional life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Balance, beginning of year	722	797
Beginning balance of original discount rate	874	974
Effect of actual variances from expected experience		(4)	$ (1)
Balance adjusted for variances from expectation		870	973
Interest accrual	17	19
Net premiums collected	(107)	(118)
Ending Balance at original discount rate	780	874
Effect of actual variances from expected experience		(4)	(1)
Effect of changes in discount rate assumptions	149	152
Balance, end of year	631	722
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	2,071	2,151
Beginning balance of original discount rate	2,492	2,665
Effect of actual variances from expected experience		44	(24)
Balance adjusted for variances from expectation		2,536	2,641
Interest accrual	54	56
Benefits payments	(222)	(205)
Ending Balance at original discount rate	2,368	2,492
Effect of actual variances from expected experience		44	(24)
Balance adjusted for variances from expectation		2,536	2,641
Interest accrual	54	56
Benefits payments	(222)	(205)
Effect of changes in discount rate assumptions	(435)	(421)
Balance, end of year	1,933	2,071
Net liability for future policy benefits	1,302	1,349
Less: Reinsurance recoverable	513	413
Net liability for future policy benefits, after reinsurance recoverable	$ 789	$ 936
Weighted-average duration of liability for future policyholder benefits (years)	6 years 3 months 10 days	7 years 4 months 9 days
PRT
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	$ 4,189	$ 2,165
Beginning balance of original discount rate	4,351	2,475
Effect of changes in cash flow assumptions		(3)	(9)
Effect of actual variances from expected experience		(11)	(7)
Balance adjusted for variances from expectation		4,337	2,459
Issuances	2,324	2,041
Interest accrual	240	109
Benefits payments	(484)	(258)
Ending Balance at original discount rate	6,417	4,351
Effect of changes in cash flow assumptions		(3)	(9)
Effect of actual variances from expected experience		(11)	(7)
Balance adjusted for variances from expectation		4,337	2,459
Issuances	2,324	2,041
Interest accrual	240	109
Benefits payments	(484)	(258)
Effect of changes in discount rate assumptions	(363)	(162)
Balance, end of year	6,054	4,189
Net liability for future policy benefits	6,054	4,189
Net liability for future policy benefits, after reinsurance recoverable	$ 6,054	$ 4,189
Weighted-average duration of liability for future policyholder benefits (years)	7 years 9 months 10 days	8 years 2 months 23 days
Immediate annuities
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	$ 1,415	$ 1,429
Beginning balance of original discount rate	1,788	1,858
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		(27)	(15)
Balance adjusted for variances from expectation		1,761	1,843
Issuances	30	22
Interest accrual	59	51
Benefits payments	(118)	(128)
Ending Balance at original discount rate	1,732	1,788
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		(27)	(15)
Balance adjusted for variances from expectation		1,761	$ 1,843
Issuances	30	22
Interest accrual	59	51
Benefits payments	(118)	(128)
Effect of changes in discount rate assumptions	(435)	(373)
Balance, end of year	1,297	1,415
Net liability for future policy benefits	1,297	1,415
Less: Reinsurance recoverable	109	116
Net liability for future policy benefits, after reinsurance recoverable	$ 1,188	$ 1,299
Weighted-average duration of liability for future policyholder benefits (years)	12 years 7 months 17 days	12 years 5 months 19 days

Future Policy Benefits - Summ_2

Future Policy Benefits - Summary of Balances and Changes in the Deferred Profit Liability (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Balance, beginning of year	$ 87	$ 69
Effect of modeling changes		0	$ 4
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		8	16
Balance adjusted for variances from expectation		95	89
Issuances	3	3
Interest accrual	1	2
Amortization	(9)	(7)
Balance, end of year	90	87
Effect of modeling changes		0	4
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		8	16
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Balance, beginning of year	10	4
Effect of modeling changes		0	0
Effect of changes in cash flow assumptions		(8)	1
Effect of actual variances from expected experience		0	5
Balance adjusted for variances from expectation		2	10
Issuances	1	0
Interest accrual	4	1
Amortization	(1)	(1)
Balance, end of year	$ 6	10
Effect of modeling changes		0	0
Effect of changes in cash flow assumptions		(8)	1
Effect of actual variances from expected experience		$ 0	$ 5

Future Policy Benefits - Reconc

Future Policy Benefits - Reconciliation of Net FPB to the Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 8,749	$ 7,050
Traditional life
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	1,302	1,349
Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	1,297	1,415
Deferred profit liability	90	87	$ 69
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	6,054	4,189
Deferred profit liability	6	10	$ 4
Immediate annuities DPL
Liability for Future Policy Benefit, Activity [Line Items]
Deferred profit liability	90	87
PRT DPL
Liability for Future Policy Benefit, Activity [Line Items]
Deferred profit liability	$ 6	$ 10

Future Policy Benefits - Liabil

Future Policy Benefits - Liability For Future Policy Benefit Expected Future Policy Benefit Undiscounted (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Traditional life
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	$ 2,705	$ 2,935
Expected future gross premiums	914	1,082
Liability For Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	1,948	2,075
Expected future gross premiums	681	789
Immediate annuities
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	3,189	3,291
Expected future gross premiums	0	0
Liability For Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	1,297	1,413
Expected future gross premiums	0	0
PRT
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	10,038	6,709
Expected future gross premiums	0	0
Liability For Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	6,054	4,350
Expected future gross premiums	$ 0	$ 0

Future Policy Benefits - Gross

Future Policy Benefits - Gross Premium Income and Interest Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	$ 2,346	$ 2,111	$ 1,522
Interest expense	336	197	149
Traditional life
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	111	123	137
Interest expense	37	37	39
Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	18	24	23
Interest expense	59	51	60
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	2,217	1,964	1,362
Interest expense	$ 240	$ 109	$ 50

Future Policy Benefits - Weight

Future Policy Benefits - Weighted Average Rates (Details)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Traditional life
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	2.34%	2.33%	2.32%
Current discount rate	5.44%	5.03%	5.37%
Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.17%	3.14%	3.07%
Current discount rate	5.45%	4.98%	5.21%
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.72%	4.61%	3.20%
Current discount rate	5.54%	5.03%	5.40%

Future Policy Benefits - Actual

Future Policy Benefits - Actual Experience and Expected Experience for Mortality and Lapses (Details)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Actual experience | Traditional life
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.40%	1.70%	1.50%
Lapse rate	0.10%	0%	0%
Actual experience | Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	2.70%	3.20%	3%
Lapse rate	0%	0%	0%
Actual experience | PRT
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	2.70%	3.20%	1.90%
Lapse rate	0%	0%	0%
Expected experience | Traditional life
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.50%	1.40%	1.30%
Lapse rate	0.50%	0.30%	0.30%
Expected experience | Immediate annuities
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.90%	1.80%	1.90%
Lapse rate	0%	0%	0%
Expected experience | PRT
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	2.50%	2.30%	2.50%
Lapse rate	0%	0%	0%

Future Policy Benefits - Additi

Future Policy Benefits - Additional Information, Cohort NPR (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)
Insurance [Abstract]
NPR before capping	108%
Reserves before NPR capping	$ 1,147
Reserves after NPR capping	1,174
Loss Expense	$ 27

Schedule II - Condensed Finan_3

Schedule II - Condensed Financial Information - Balance Sheets (Parent Company) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
ASSETS
Cash	$ 3,479	$ 2,767
Investments in unconsolidated affiliates	3,731	3,334
Notes receivable	471	442
Property and equipment, net	173	168
Prepaid expenses and other assets	2,047	1,900
Total assets	95,372	80,614	$ 65,143
Liabilities:
Accounts payable and accrued liabilities	3,249	3,009
Income taxes payable	52	0
Deferred tax liability	0	29
Notes payable	4,321	3,887
Total liabilities	86,840	73,154
Equity [Abstract]
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2024 and 2023; outstanding of 275 and 273 as of December 31, 2024 and 2023, respectively, and issued of 331 and 329 as of December 31, 2024 and 2023, respectively	0	0
Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	0	0
Additional paid-in capital	5,976	5,913
Retained earnings	5,982	5,244
Accumulated other comprehensive earnings	(2,052)	(2,119)
Treasury stock	(2,152)	(2,130)
Total Fidelity National Financial, Inc. shareholders’ equity	7,754	6,908
Total liabilities and equity	$ 95,372	$ 80,614
Treasury stock (in shares)	56,000,000	56,000,000
Parent Company
ASSETS
Cash	$ 534	$ 397
Short-term investments	252	487
Investments in unconsolidated affiliates	3	3
Notes receivable	212	268
Investments in and amounts due from subsidiaries	8,882	7,949
Property and equipment, net	2	3
Prepaid expenses and other assets	433	318
Total assets	10,318	9,425
Liabilities:
Accounts payable and accrued liabilities	385	358
Income taxes payable	51	0
Deferred tax liability	0	29
Notes payable	2,128	2,126
Total liabilities	2,564	2,513
Equity [Abstract]
Preferred stock, $0.0001 par value; authorized 50,000,000 shares; issued and outstanding, none	0	0
Additional paid-in capital	5,976	5,913
Retained earnings	5,982	5,244
Accumulated other comprehensive earnings	(2,052)	(2,119)
Treasury stock	(2,152)	(2,126)
Total Fidelity National Financial, Inc. shareholders’ equity	7,754	6,912
Total liabilities and equity	$ 10,318	$ 9,425
Treasury stock (in shares)	56,000,000	56,000,000
Parent Company | FNF Common Stock
Equity [Abstract]
FNF common stock, $0.0001 par value; authorized 600 shares as of December 31, 2024 and 2023; outstanding of 275 and 273 as of December 31, 2024 and 2023, respectively, and issued of 331 and 329 as of December 31, 2024 and 2023, respectively	$ 0	$ 0

Schedule II - Condensed Finan_4

Schedule II - Condensed Financial Information - Balance Sheets (Parent Company) (Parenthetical) (Details) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Condensed Balance Sheet Statements, Captions [Line Items]
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	275,000,000	273,000,000
Common stock, shares issued (in shares)	331,000,000	329,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	56,000,000	56,000,000
Parent Company
Condensed Balance Sheet Statements, Captions [Line Items]
Common stock, par value per share (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares outstanding (in shares)	275,000,000	273,000,000
Common stock, shares issued (in shares)	331,000,000	329,000,000
Preferred stock, par or stated value per share (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	56,000,000	56,000,000

Schedule II - Condensed Finan_5

Schedule II - Condensed Financial Information - Statement of Earnings (Parent Company) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Other fees and revenue	$ 5,321	$ 4,717	$ 4,333
Recognized gains and losses, net	83	(164)	(1,493)
Total revenues	13,681	11,752	11,565
Expenses:
Personnel costs	3,148	2,908	3,192
Other operating expenses	1,558	1,521	1,721
Total expenses	11,939	11,059	9,835
Earnings before income taxes and equity in earnings of unconsolidated affiliates	1,742	693	1,730
Income tax expense	367	192	439
Net earnings attributable to FNF common shareholders	1,270	517	1,294
Beginning balance	7,460	6,569	10,004
Dividends declared	(532)	(498)	(490)
Ending balance	8,532	7,460	6,569
Retained Earnings
Expenses:
Beginning balance	5,244	5,225	4,818
Dividends declared	(532)	(498)	(490)
Ending balance	5,982	5,244	5,225
Parent Company
Revenues:
Other fees and revenue	38	33	(37)
Interest and investment income and realized gains	76	74	43
Recognized gains and losses, net	2	(31)	(42)
Total revenues	116	76	(36)
Expenses:
Personnel costs	94	70	(11)
Other operating expenses	28	47	15
Interest expense	76	77	92
Total expenses	198	194	96
Earnings before income taxes and equity in earnings of unconsolidated affiliates	(82)	(118)	(132)
Income tax expense	(20)	(29)	(33)
Losses before equity in earnings of subsidiaries	(62)	(89)	(99)
Equity in earnings of subsidiaries	1,332	606	1,393
Net earnings attributable to FNF common shareholders	1,270	517	1,294
Parent Company | Retained Earnings
Expenses:
Net earnings attributable to FNF common shareholders	1,270	517	1,294
Beginning balance	5,244	5,225	4,818
Dividends declared	(532)	(498)	(490)
Distribution of F&G to FNF common shareholders	0	0	(397)
Ending balance	$ 5,982	$ 5,244	$ 5,225

Schedule II - Condensed Finan_6

Schedule II - Condensed Financial Information - Statement of Cash Flow (Parent Company) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net earnings attributable to FNF common shareholders	$ 1,270	$ 517	$ 1,294
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	739	593	491
Stock-based compensation cost	82	60	49
Net change in income taxes	83	(50)	66
Net cash provided by (used in) operating activities	6,815	6,478	4,355
Cash Flows From Investing Activities:
Net proceeds from (purchases of) short-term investment activities	(1,076)	340	(2,571)
Net cash used in investing activities	(7,862)	(9,090)	(10,524)
Cash Flows From Financing Activities:
Debt service payments	(250)	0	(400)
Dividends paid	(532)	(500)	(489)
Purchases of treasury stock	0	(6)	(553)
Exercise of stock options	21	15	39
Payment for shares withheld for taxes and in treasury	(34)	(17)	(15)
Net cash provided by financing activities	1,759	3,093	4,095
Net change in cash and cash equivalents	712	481	(2,074)
Cash and cash equivalents at beginning of period	2,767	2,286	4,360
Cash and cash equivalents at end of period	3,479	2,767	2,286
Parent Company
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net earnings attributable to FNF common shareholders	1,270	517	1,294
Adjustments to reconcile net earnings to net cash provided by operating activities:
Equity in earnings of subsidiaries	(1,332)	(606)	(1,393)
Depreciation and amortization	1	1	1
Stock-based compensation cost	82	57	48
Net change in income taxes	5	(262)	748
Net (increase) decrease in prepaid expenses and other assets	(113)	(72)	41
Net increase (decrease) in accounts payable and other accrued liabilities	27	70	(51)
Net cash provided by (used in) operating activities	(60)	(295)	688
Cash Flows From Investing Activities:
Purchase of F&G preferred stock	(250)	0	0
Net proceeds from (purchases of) short-term investment activities	235	82	(509)
Additions to notes receivable	(1)	(12)	(87)
Collections of notes receivable	55	47	79
Net cash used in investing activities	39	117	(517)
Cash Flows From Financing Activities:
Debt service payments	0	0	(400)
Dividends paid	(532)	(500)	(489)
Purchases of treasury stock	0	(6)	(553)
Exercise of stock options	21	15	39
Payment for shares withheld for taxes and in treasury	(22)	(17)	(15)
Additional investments in non-controlling interests	(12)	(12)	(2)
Net dividends from subsidiaries	703	689	140
Net cash provided by financing activities	158	169	(1,280)
Net change in cash and cash equivalents	137	(9)	(1,109)
Cash and cash equivalents at beginning of period	397	406	1,515
Cash and cash equivalents at end of period	$ 534	$ 397	$ 406

Schedule II - Condensed Finan_7

Schedule II - Condensed Financial Information - Notes to Financial Statements (Parent Company) (Details)			12 Months Ended
	Jan. 12, 2024 USD ($) $ / shares shares	Jan. 11, 2024	Dec. 31, 2024 USD ($) $ / shares	Dec. 31, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($)	Feb. 16, 2024 USD ($)	Sep. 17, 2021	May 16, 2019	Aug. 13, 2018
Debt Instrument [Line Items]
Notes payable			$ 4,321,000,000	$ 3,887,000,000
Interest paid			200,000,000	157,000,000	$ 125,000,000
Income taxes			$ 237,000,000	$ 216,000,000	387,000,000
Preferred stock, par or stated value per share (in dollars per share) | $ / shares			$ 0.0001	$ 0.0001
6.875% Series A Mandatory Convertible Preferred Stock
Debt Instrument [Line Items]
Preferred stock, dividend rate, percentage		6.875%
6.875% Series A Mandatory Convertible Preferred Stock | F&G
Debt Instrument [Line Items]
Payments To Purchase Preferred Stock Of Subsidiary	$ 250,000,000
Preferred stock investment, shares issued in transaction (in shares) | shares	5,000,000
Preferred stock, dividend rate, percentage	6.875%
Preferred stock, par or stated value per share (in dollars per share) | $ / shares	$ 0.001
Preferred stock, liquidation preference (in usd per share) | $ / shares	$ 50
6.875% Series A Mandatory Convertible Preferred Stock | F&G | Maximum
Debt Instrument [Line Items]
Preferred stock, convertible, conversion ratio	1.1111
6.875% Series A Mandatory Convertible Preferred Stock | F&G | Minimum
Debt Instrument [Line Items]
Preferred stock, convertible, conversion ratio	0.9456
4.50% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage								4.50%	4.50%
3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage							3.20%
Revolving Credit Facility | Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Notes payable			$ 4,000,000	$ 2,000,000
Line of credit facility						$ 800,000,000
Parent Company
Debt Instrument [Line Items]
Notes payable			2,128,000,000	2,126,000,000
Interest paid			73,000,000	73,000,000	95,000,000
Income taxes			229,000,000	213,000,000	459,000,000
Cash dividends from subsidiaries and affiliates			600,000,000	400,000,000	800,000,000
Payments To Purchase Preferred Stock Of Subsidiary			$ 250,000,000	$ 0	$ 0
Preferred stock, par or stated value per share (in dollars per share) | $ / shares			$ 0.0001	$ 0.0001
Parent Company | 4.50% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage			4.50%
Notes payable			$ 447,000,000	$ 446,000,000
Parent Company | 3.40% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage			3.40%
Notes payable			$ 646,000,000	644,000,000
Parent Company | 2.45% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage			2.45%
Notes payable			$ 595,000,000	594,000,000
Parent Company | 3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage			3.20%
Notes payable			$ 444,000,000	444,000,000
Parent Company | Revolving Credit Facility | Revolving Credit Facility
Debt Instrument [Line Items]
Notes payable			$ (4,000,000)	$ (2,000,000)

Schedule III - F&G Supplement_2

Schedule III - F&G Supplementary Insurance Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Deferred acquisition costs	$ 3,036	$ 2,215	$ 1,411
Future policy benefits, losses, claims and loss expenses	8,749	7,050	5,021
Other policy claims and benefits payable	102	92	109
Life insurance premiums and other fees	2,860	2,413	1,704
Interest and investment income	2,719	2,211	1,655
Benefits, claims, losses and settlement expenses	(3,791)	(3,553)	(1,126)
Amortization of deferred policy acquisition costs	(280)	(191)	(99)
Other operating expenses, net of deferrals	$ (203)	$ (146)	$ (102)

Schedule IV - F&G Reinsurance (

Schedule IV - F&G Reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Life insurance in force
Gross Amount	$ 10,906	$ 8,448	$ 6,296
Ceded to other companies	(1,370)	(1,436)	(1,524)
Assumed from other companies	0	0	0
Net Amount	$ 9,536	$ 7,012	$ 4,772
Percentage of amount assumed to net	0%	0%	0%
Premiums Earned, Net [Abstract]
Gross Amount	$ 3,001	$ 2,567	$ 1,882
Ceded to other companies	(141)	(154)	(178)
Assumed from other companies	0	0	0
Net Amount	$ 2,860	$ 2,413	$ 1,704
Percentage of amount assumed to net	0%	0%	0%
Traditional life insurance premiums
Premiums Earned, Net [Abstract]
Gross Amount	$ 129	$ 148	$ 160
Ceded to other companies	(94)	(105)	(128)
Assumed from other companies	0	0	0
Net Amount	$ 35	$ 43	$ 32
Percentage of amount assumed to net	0%	0%	0%
Life-contingent PRT premiums
Premiums Earned, Net [Abstract]
Gross Amount	$ 2,217	$ 1,964	$ 1,362
Ceded to other companies	0	0	0
Assumed from other companies	0	0	0
Net Amount	$ 2,217	$ 1,964	$ 1,362
Percentage of amount assumed to net	0%	0%	0%
Annuity product charges and other fees
Premiums Earned, Net [Abstract]
Gross Amount	$ 655	$ 455	$ 360
Ceded to other companies	(47)	(49)	(50)
Assumed from other companies	0	0
Net Amount	$ 608	$ 406	$ 310
Percentage of amount assumed to net	0%	0%	0%